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Abstract 
The neural tube is the developmental precursor of the central nervous system (CNS). Neural 
tube defects (NTDs) are among the commonest birth defects, affecting approximately 1 in 
1000 pregnancies. They occur when the neural tube fails to close completely during 
neurulation, and result in an open region of the CNS. Spina bifida is an NTD affecting the spinal 
region, and it can lead to lifelong disability, including incontinence, motor difficulties, and 
paralysis below the level of the lesion. Exencephaly is an NTD affecting the cranial region, and 
is not compatible with life. 
Splotch mice carry a mutation in the Pax3 gene which leads to a functionally null Pax3 protein. 
Pax3 is important in the development of a number of tissues, and mutant embryos have 
defects in muscle development, and neural crest-derived tissues, such as the heart, peripheral 
nervous system and melanocytes. Additionally, embryos develop NTDs; they demonstrate 
spina bifida with complete penetrance and exencephaly with partial penetrance. 
The cellular mechanism behind the development of NTDs in Splotch embryos is not well 
understood. However excess apoptosis, premature neuronal differentiation, and reduced 
proliferation in the neural tube have all been proposed as potential causes. Furthermore, 
research has suggested a potential link between Pax3 and canonical Wnt signalling. The aim of 
this research was to study cellular defects in Splotch mice which are potentially causative of 
NTDs, and also to study the interaction between Pax3 and canonical Wnt signalling. 
It was found that excess apoptosis and premature neuronal differentiation are not causative of 
spina bifida in Splotch mice. However, reduced proliferation is present in the neural tube, and 
may be causative. Additionally, β-catenin loss- and gain-of-function mutations were used to 
study interaction between Pax3 and canonical Wnt signalling. β-catenin loss-of-function 
reduces Pax3 expression, and β-catenin gain-of-function worsens NTDs in Pax3 mutant 
embryos, whereas loss-of-function partially rescues exencephaly, but not spina bifida, in these 
embryos. β-catenin gain- and loss-of-function both also worsen neural crest defects in Pax3 
mutant embryos. Therefore, Canonical Wnt signalling interacts with Pax3 during development, 
and affects the cranial and spinal regions of the neural tube differently. 
In summary, Pax3 mutation results in a number of defects in developing embryos, including 
NTDs and neural crest defects. Cellular processes have been studied in this research to identify 
abnormalities which could be causative of these defects, and a potential molecular link 
between Pax3 and the canonical Wnt signalling pathway has been identified, which could 
contribute to the observed phenotype. 
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1    General Introduction 
1.1    Neurulation 
The neural tube (NT) is the precursor of the central nervous system (CNS) in the developing 
embryo. Neural tube closure (neurulation) occurs in mice during the period from embryonic 
day (E) 8.5 to E10.5, and in humans between 22-28 days following conception (Copp et al., 
2003; Mastroiacovo and Leoncini, 2011). 
The mechanisms of neurulation differ greatly between organisms. For instance in mammals, 
amphibians and birds the NT forms from a plate which bends and fuses to form a tube. 
However, in teleosts such as zebrafish, the NT forms as the result of cavitation of a solid rod. 
For the purpose of this thesis the focus will be on mammalian neurulation unless stated 
otherwise. 
Neurulation begins with the specification of the neural plate on the dorsal surface of the 
embryo. This flat region of tissue undergoes convergent extension along the rostro-caudal axis, 
and bends ventrally along the midline. Further hinge points form along the same axis, in the 
lateral regions of the neural tube. This brings the edges of the neural folds into close 
apposition, and they fuse along the midline, forming a tube (Figure 1A). 
The neural tube extends the full length of the embryo. In the cranial region it forms the brain 
later in development, and in the spinal region it forms the spinal cord. 
1.1.1    Specification of the neural plate and the neural plate border 
Neurulation begins with the specification of the neural plate – a flat region of thickened 
ectodermal tissue on the dorsal surface of the embryo. Signals specifying the neural plate 
emanate from an organiser. This is the Spemann’s organiser in amphibians, the dorsal shield in 
teleosts, and the node in amniotes (LaBonne and Bronner-Fraser, 1999). Although little 
research has been carried out regarding neural plate and neural plate border specification in 
mice, evidence suggests that the mechanisms are conserved between amniotes, such as the 
mouse and chick (Wilson and Edlund, 2001). 
A gradient of bone morphogenetic protein (BMP) signalling is important in early specification 
of both the neural plate and the neural plate border. BMP-4 has been shown in Xenopus to 
have a ventralising effect on mesodermal tissue (Dale et al., 1992). Until gastrulation in 
Xenopus BMP signalling is active throughout the ectoderm, although the dorsal mesoderm 
expresses BMP inhibitors, such as noggin, chordin and follistatin. Additional signalling 
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Figure 1.1: The neural tube during neurulation. The neural plate begins as a thickened region 
of dorsal surface ectoderm (SE), the neurectoderm (NE, A i). In the region directly dorsal to the 
notochord, a hinge point develops – the medial hinge point (MHP) – which causes invagination of 
the NT (NTC, A ii). Dorsolateral hinge points (DLHPs) form in the region of the NT where the 
neurectoderm is in contact with the surface ectoderm, and this brings the neural folds into 
apposition (A iii). Finally, fusion and remodelling of the NT occurs along the midline to form a closed 
tube (A iv). 
NT closure begins at three different closure points (B). Closure 1 initiates at the hindbrain-cervical 
boundary, closure 2 initiates at the midbrain-forebrain boundary, and closure 3 initiates at the 
rostral limit of the forebrain. These closures spread rostrally and caudally along the midline. 
Neuropores are open regions of the NT between closure points. 
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pathways also contribute to the clearing of BMP in the dorsal ectoderm of the NT: Wnt 
signalling in the dorsal region inhibits BMP-4 expression in this region (Baker et al., 1999), and 
it has been shown in chick that Fibroblast Growth Factor (FGF) signalling is also required to 
repress BMP signalling (Wilson et al., 2000). Therefore, a dorso-ventral gradient of BMP-4 is 
set up in the embryo. It appears that low levels of BMP-4 induce neural plate, intermediate 
levels induce neural crest (NC) fate, and high levels suppress neural fate while promoting 
epidermis development (Delaune et al., 2005; Neave et al., 1997; Wilson and Hemmati-
Brivanlou, 1995). This was discovered by injecting varying amounts of RNA encoding Bmp-4 
(20-220 pg) into 1-4 cell stage zebrafish embryos, and observing the resulting patterning of the 
embryos, and the tissues which developed (Neave et al., 1997). 
Experiments in the mouse support the theory that BMP signalling plays an important role in 
neurulation; embryos which are genetically null for Noggin develop spina bifida, and may also 
develop exencephaly (McMahon et al., 1998; Stottmann et al., 2006). This suggests that BMP 
inhibition is vital for the correct progression of neurulation in mice. In support of this, ventral 
expansion of the BMP NT expression domain through use of a BMP-4 mutant allele in mice has 
been shown to cause exencephaly (Hu et al., 2004). However, the repression of BMP inhibitor 
expression, such as that of Noggin or Chordin, does not prevent formation of the neural plate 
in the mouse. Therefore, it appears that BMP inhibition can promote neural fate, but is not 
sufficient to induce it (Wilson and Edlund, 2001). 
However, BMP-4 expression is highly dynamic. For example, at late gastrula stages in the 
Xenopus it has been shown that expression levels of BMP-4 and the downstream gene MSX1 
are highest in the neural plate border (Suzuki et al., 1997). In order for the neural plate border 
to develop, it first requires a period of intermediate BMP-4 expression, followed by a period of 
increased expression. Although low BMP expression is necessary for neural induction, it is not 
sufficient – BMP inhibition alone is not able to induce neural marker genes in ectodermal 
tissue in vivo, although it suppresses epidermal fate (Delaune et al., 2005; Mayor et al., 1995; 
Streit et al., 1998). 
High levels of FGF signalling and low levels of Wnt signalling are also required to induce border 
or neural fate in the ectoderm. FGF signalling is seen in the neural plate border region during 
neural specification in the chick embryo (Eblaghie et al., 2003). Injection of eFGF (the Xenopus 
homologue of FGF4) RNA into Xenopus embryos during the late gastrula phase induces 
expression of neural marker genes and reduces expression of epidermal marker genes. 
Additionally, Xenopus embryos treated with SU5402 to block FGFR activity fail to develop the 
neural plate or neural plate border, and develop only ectoderm (Delaune et al., 2005), and a 
4 
 
truncated FGF receptor prevents neural induction in Xenopus embryos (Launay et al., 1996). 
Likewise, in chick, it was found that beads soaked in FGF4 and FGF8 are able to induce 
expression of early neural markers in ectoderm, but are not able to fully initiate neural 
induction (Streit and Stern, 1999). FGFs appear to function in the role of neural inducer by 
blocking BMP signalling on several levels. For instance, FGF signalling has been shown to inhibit 
expression of Bmp4 and Bmp7 (Wilson et al., 2000) as well as inducing expression of the BMP 
inhibitor chordin in zebrafish (Londin et al., 2005). BMP-mediated repression of FGF signalling 
in the chick is also observed (Wilson et al., 2001). 
In chick, genes involved in canonical Wnt signalling, including Wnt3a, Wnt8c and Frizzled8 are 
expressed in the lateral regions of the ectoderm, which will later form non-neural tissue. Chick 
epiblast explants treated with Wnts developed only ectoderm. Canonical Wnt signalling 
represses neural fate by preventing FGFs from repressing BMP activity (Wilson et al., 2001). 
Positioning of the neural plate border is also dependent on the balance of BMP, FGF and Wnt 
signalling. Transplantation of cell pellets transfected with the BMP antagonist chordin at the 
neural plate border widens the neural plate at the expense of non-neural ectoderm in the 
chick embryo (Streit et al., 1998; Streit and Stern, 1999). Additionally, transplantation of BMP-
4-secreting cells to the same region will narrow the neural plate (Streit and Stern, 1999). This 
suggests that positioning of the neural plate border is reliant on the balance between BMP 
expression and the expression of its antagonists. FGFs, including FGF8, are known to be 
expressed in the paraxial mesoderm, and are able to induce expression of msx-1 in the 
overlying neural plate border. In chick, BMP-4 and Msx-1 act in a positive feedback loop to 
increase expression of BMP-4 at the neural plate border (Streit and Stern, 1999). It has been 
shown that noggin in combination with FGF – but not alone – is able to induce NC markers in 
Xenopus animal caps (Mayor et al., 1995). In addition, inhibition of FGF signalling in Xenopus 
reduces expression of NC markers at the neural plate border (Mayor et al., 1997). This suggests 
that an intact FGF signalling pathway is required for NC specification, and that FGFs interact 
with the BMP signalling pathway. 
Wnt molecules such as Wnt1 and Wnt3a are expressed in the dorsal region of the Xenopus NT, 
and enable competent cells to be specified to a NC fate (Saint-Jeannet et al., 1997) . See 
section 1.3.1 for more information about the specification of the NC, and the role of Wnt 
signalling in this process. 
1.1.2    Convergent extension in the neural plate 
Convergent extension is a cellular process that enables tissues to elongate in one axis while 
narrowing in another. It is important in shaping and patterning the developing NT in vertebrate  
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embryos (Elul et al., 1997). Research into convergent extension has largely been carried out in 
teleosts and amphibians. 
Convergent extension consists of two interlinked processes; convergence and extension. 
Extension refers to the elongation of the tissue along the antero-posterior axis, and 
convergence refers to the medio-lateral narrowing of the tissue. 
Convergent extension involves multiple cellular processes, including cell shape changes within 
the tissue. Cells become columnar in shape, which acts to narrow the tissue (Jacobson and 
Gordon, 1976), and also elongate along the axis of extension. These alterations are caused by 
changes in the cytoskeletons of the cells in the tissue (Schoenwolf and Powers, 1987). 
Convergent extension also involves the movement of cells relative to one another in order to 
form a longer, narrower tissue (Figure 1.2). Cytoskeletal changes within cells create directional 
protrusive activity, which allows cells to interact with and create traction between adjacent 
cells. Therefore, when it takes place in a stiff tissue, convergent extension can create force to 
alter the morphology of the developing embryo (Elul et al., 1997; Keller et al., 2000; Keller et 
al., 1985). This remodelling of the tissue may also involve collective migration of cells as a 
sheet (Tada and Heisenberg, 2012). 
Figure 1.2: An example of cell intercalation. Four cells are shown in common formation. The 
directions of the change in tissue shape are shown by arrows (A). The tissue narrows in one axis 
(blue arrows) and elongates in another (red arrows). Actin-dependent changes in cell shape (B) draw 
the cell surfaces into a single point, in a rosette formation (C). The cells again change shape to form 
new cell-cell contacts, moving relative to the other cells in the formation (D). These alterations in 
cell-cell contacts change the shape of the tissue. 
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The neural plate is specified as an elliptical tissue, and it elongates into an extended keyhole 
shape along the antero-posterior axis through convergent extension movements. The neural 
plate thickens dorso-ventrally, narrows medio-laterally, and extends rostro-caudally, with 
some medio-lateral widening in the cranial region. These shape changes rely largely on forces 
generated within the neural tube (Schoenwolf and Alvarez, 1989). Elongation of the cells aids 
in both the thickening and narrowing of the neural tube (Copp et al., 2003; Schoenwolf, 1985; 
Schoenwolf and Alvarez, 1989). The movements push the cranial and caudal regions apart, 
thus contributing to lengthening of the embryo (Keller et al., 2000). Although cell number in 
the NT stays constant during amphibian neurulation, it is likely that the high level of 
proliferation seen in the NT during neurulation in birds and mammals contribute to the 
morphological changes (Schoenwolf and Alvarez, 1989). Convergent extension is thought to be 
one of the main processes driving gastrulation in Xenopus (Keller et al., 1985). 
In the mouse convergent extension is dependent on the planar cell polarity (PCP) pathway, 
which is a non-canonical Wnt signalling pathway. Failure of PCP signalling results in failure of 
convergent extension in the neural tube (Roszko et al., 2009; Wang et al., 2006). Mice with 
mutations in the PCP pathway develop severe neural tube defects (NTDs), including 
craniorachischisis, which occurs when closure 1 fails (Chen et al., 2013; Curtin et al., 2003). This 
data demonstrates that closure 1 in the mouse is dependent upon convergent extension. 
Evidence shows that this may also be true in humans, as mutations in genes encoding 
components of the PCP pathway, such as VANGL1, VANGL2, SCRIB and CELSR1, have been 
found in cases of human NTDs (Cai and Shi, 2014; Lei et al., 2013). 
Multiple cell adhesion molecules have been associated with convergent extension. For 
example, cadherins mediate calcium-dependent cell-cell adhesion. Several cadherins are found 
in the early Xenopus embryo, and both C-cadherin and cadherin-11 are found to be reduced 
during convergent extension movements. This reduces cell-cell adhesion, which allows for 
greater freedom in morphological cellular movements (Brieher and Gumbiner, 1994; Hadeball 
et al., 1998; Lee and Gumbiner, 1995; Zhong et al., 1999). Correct expression of N-cadherin in 
the early Xenopus neural plate also appears to be essential for normal development of the 
neural tube, and this could be due to effects on cell mixing and convergent extension (Detrick 
et al., 1990; Keller et al., 2000). 
1.1.3    Development of the hinge points 
Once the neural plate has been specified, hinge points form along the rostro-causal axis. They 
form an invagination in the NT, and bend the neural folds into apposition. Fusion of the folds 
forms a closed tube with a central lumen.  
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The NT forms two different types of hinge point, and different mechanisms are involved in the 
formation of each. The medial hinge point (MHP) forms along the midline of the NT, directly 
above the notochord. The neural folds are elevated either side of the MHP. Two DLHPs form, 
one on each neural fold, at the point of attachment of the surface ectoderm to the neural 
folds. They bring the neural folds into apposition in preparation for fusion (Figure 1.1A). 
Three modes of NT morphogenesis have been described (Shum and Copp, 1996). They differ 
with developmental stage and position along the rostro-caudal axis. In mode 1 the NT only 
forms the MHP. In mode 2 the NT exhibits defined DLHPs as well as the MHP, and the closed 
NT has a diamond-shaped lumen. In mode 3 the hinge points are less clearly defined; bending 
is observed across the whole of the neural folds, and the closed NT forms a circular lumen 
(Figure 1.3). During early NT closure the posterior neuropore (PNP) closes using mode 1. Later 
in NT closure the PNP closes using first mode 2, and then mode 3. Modes also differ according 
to rostro-caudal position along the NT; mode 1 is evident in the rostral spinal NT, mode 2 at 
mid-spinal levels, and mode 3 in the caudal-most regions of the NT (Shum and Copp, 1996). 
Convergent extension requires directional extension, and hinge point formation requires the 
definition of an apico-basal axis. Therefore coordinated cell polarity within the NT is essential. 
Polarity is established through mutual exclusion of apical and basolateral polarity complexes, 
which results in functionally distinct regions containing different populations of proteins (Eom 
et al., 2013; Margolis and Borg, 2005). The formation of the apico-basal axis allows the cells to 
act in union as a polarised tissue, which is particularly important for the morphological changes 
required in hinge point formation. 
Cell shape changes within the NT are important for hinge point formation (Karfunkel, 1972; 
Kinoshita et al., 2008). Cells of the MHP and DLHPs shorten apico-basally, and often form a 
wedge shape, which aids bending of the tissue. Wedge-shaped cells have undergone apical 
constriction and basal nuclear positioning in order to narrow the apical region and widen the 
basal region. The hinge points contain a high proportion of wedge-shaped cells compared to 
straight regions of the NT (Karfunkel, 1974; Smith and Schoenwolf, 1988). 
Apical constriction may play a role in the formation of the hinge points. The polarised cells of 
the NT have an apical ring of actin and myosin II at the luminal region. This constricts in the 
cells of the hinge points during neurulation, reducing the apical surface area of the cells 
(Quintin et al., 2008; Schroeder, 1970). In the presence of the either the actin 
depolymerisation agent cytochalasin or the myosin-II inhibitor blebbistatin apical constriction 
fails to occur in the chick (Karfunkel, 1972; Kinoshita et al., 2008). However, it is unclear 
whether apical constriction and the actin cytoskeleton play important roles in mouse  
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neurulation, as treatment of mouse embryos with cytochalasin prevented cranial NT closure, 
but not spinal NT closure. Additionally, cytochalasin-treated embryos still formed hinge points 
(Ybot-Gonzalez and Copp, 1999). Therefore, the requirement and role of the actin cytoskeleton 
during neurulation may vary with spinal level. 
In addition to the activity of the actin cytoskeleton, microtubules polymerise parallel to the 
apico-basal axis in the cells of the NT (Messier, 1969). They elongate the cell along this axis, 
producing the columnar shape typical to cells of the neurepithelium. Disruption of the 
microtubules in cells of neurulating Xenopus embryos through treatment with vinblastine 
results in the cells losing their columnar shapes and ‘rounding up,’ and the collapse of the 
hinge points and neural folds (Karfunkel, 1971). 
Control of the cell cycle is also likely to have a role in morphogenetic changes of the NT. The 
wedge-shaped cells seen in the MHP have basally localised nuclei, which is likely to contribute 
to the narrow apical region and wider basal region (Smith and Schoenwolf, 1987). During the 
mitosis phase of the cell cycle the nucleus is apically located. Cells in the hinge points spend a 
shorter time in the mitotic part of the cell cycle compared to cells in non-bending regions, but 
each cell cycle is longer. This results in a higher proportion of hinge point cells having a basally 
Figure 1.3: Modes of neural tube closure. The shape of the neurepithelium during NT closure is 
dependent upon developmental stage and position along the rostro-caudal axis. In mode 1 the 
neurepithelium has a MHP. In mode 2 the neurepithelium exhibits both a MHP and DLHPs. In mode 
3 the neurepithelium exhibits bending across the whole medio-lateral axis, and has no clear hinge 
points. 
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localised nucleus at any given time, which contributes to the basal widening of the cell in the 
hinge point, and the bending of the tissue (Smith and Schoenwolf, 1988). 
The notochord releases the morphogen Sonic Hedgehog (Shh), which plays an important role 
in the development of the MHP. In chicks, removal of the notochord prevents floor plate 
formation, whereas implantation of a second notochord induces formation of a second floor 
plate (van Straaten et al., 1985; Wilson and Maden, 2005). Additionally, blocking Shh activity in 
neural explants using antibodies targeted against the N-terminal region prevents the 
formation of floor plate cells in vitro (Ericson et al., 1996). Likewise, ectopic expression of a 
Shh-expressing transgene in the dorsal NT of the mouse causes ectopic expression of the floor 
plate gene Hnf3β (Echelard et al., 1993).  
Formation of the DLHPs is not well understood, although BMP expression appears to play an 
important role. In the mouse, low BMP expression is necessary for formation of the DLHPs, but 
they also appear to require low Shh expression. Therefore the DLHPs form in the lateral 
regions of the NT, where both BMP and Shh expression are low, and Noggin expression is high 
(Ybot-Gonzalez et al., 2007) (Figure 1.4). Increased BMP expression in the mouse NT caused by 
a null mutation in Noggin inhibits formation of the DLHPs (Stottmann et al., 2006). 
Additionally, genetic knockout of the Zic2 gene results in a high frequency of spina bifida due 
to loss of the DLHPs (Nagai et al., 2000). Zic2 mutants fail to express dorsal BMP antagonists, 
which results in the loss of the DLHPs (Ybot-Gonzalez et al., 2007). 
In the chick, formation of the MHP occurs in the region of the NT directly dorsal to the 
notochord, and requires low BMP signalling (Eom et al., 2011). Blocking BMP signalling is able 
to induce formation of an ectopic MHP, whereas an increase in BMP signalling prevents the 
formation of the MHP, and thus the floor plate later in development (Eom et al., 2011; Eom et 
al., 2012). BMP is expressed dorsally in the NT, but is repressed by the BMP antagonist Noggin. 
Shh from the floor plate and notochord suppress Noggin. Therefore the MHP forms in the 
region where BMP signalling is low and Shh expression is high (Figure 1.4). 
1.1.4    Fusion of the neural folds 
Fusion between the tips of the neural folds to form a closed tube begins at around E8.5 in the 
mouse (the 5-7 somite stage). It begins at three defined positions along the rostro-caudal axis, 
and spreads rostrally and caudally from these points. Closure 1 begins at the hindbrain-cervical 
boundary, closure 2 at the forebrain-midbrain boundary, and closure 3 at the rostral limit of 
the forebrain (Greene et al., 2009). The open regions between closure points are known as 
neuropores, and NT closure should be fully completed by around E10.5 (the 27-30 somite  
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stage) in the mouse (Figure 1.1B). See Figure 1.5 for a timeline of neuropore closure and NC 
development. 
The behaviour of the tissues involved in fold fusion vary according to their positions on the 
rostro-caudal axis. For instance, in the rhombencephalon and mesencephalon the non-neural 
epithelium makes first contact, whereas in the anterior neuropore, the neural epithelium is the 
first to make contact. However, regardless of the tissue the cells demonstrate the same 
behaviour at the point of fusion; finger-like projections extend from the cells at the tips of both 
neural folds, and intercalation of these projections brings the folds into contact (Ray and 
Niswander, 2012). In the fully closed NT both the neural folds and the surface ectoderm have 
fused. 
Several genes have been implicated in both the initial fusion event and in the maintenance of 
the fused tissue. Loss- or gain-of-function of the Grainyhead-like gene Grhl2 in mice results in 
the development of NTDs due to failure of fusion of the neural folds (Brouns et al., 2011;  
Figure 1.4: Hinge point formation. The MHP (red) forms directly dorsal to the notochord (pale 
blue), where levels of Shh are high, and BMP is low. The DLHPs (dark blue) form where the NT is in 
contact with the surface ectoderm, where both Shh and BMP are low. The gold shape indicates the 
concentration gradient of Shh along the dorso-ventral axis of the NT. The purple shape indicates the 
concentration gradient of the BMP inhibitor Noggin. The green shape indicates the concentration 
gradient of BMP. The brackets indicate the positions on the NT and concentration gradients which 
are optimum for the formation of the MHP and DLHPs. 
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Pyrgaki et al., 2011; Werth et al., 2010). The Grhl2 transcription factor appears to play a 
general role in tissue fusion, including that of the facial tissues and body wall. It is known to 
regulate the expression of several genes encoding adhesion molecules, such as E-cadherin, 
cadherin-3, Desmocolin-2 and Desmoglein-2, as well as several members of the Claudin gene 
family, which are involved in tight junction formation (Pyrgaki et al., 2011; Werth et al., 2010). 
The Ephrin signalling network is necessary for neural fold fusion in the mouse, in particular 
signalling between ephrin-A and the receptor EphA in the both the cranial and spinal regions 
(Abdul-Aziz et al., 2009; Holmberg et al., 2000). These molecules may be responsible for the 
initial adhesion between the neural folds. Signalling with G-protein-coupled receptors also 
functions in neural fold fusion – mutations in the protein Gpr161 lead to defects in both fusion 
of the neural folds and the lens of the eye (Matteson et al., 2008). 
Further NT fusion defects are found in embryos carrying a mutation in the gene Nf2. This 
mutation causes NTDs due to reopening of the initially fused tissue. This could be due to 
failure of development of epithelial junctions between cells following the initial fusion event 
(McLaughlin et al., 2007). 
Fusion is followed by remodelling of the neurectoderm and overlying surface ectoderm to 
form continuous and stable tissues. The processes involved in the remodelling are not well 
understood, although it appears to be linked to apoptosis of a number of the cells at the fusion 
site. However the relationship between apoptosis and remodelling during NT closure is 
uncharacterised (Pai et al., 2012). 
1.1.5    Cranial closure versus caudal closure 
It would be logical to assume that the same mechanisms are employed in the closure of the 
neural tube in the cranial and caudal regions. However, research has shown a number of key 
differences in the mechanisms of NT closure between the cranial and spinal regions, as 
described below. 
In the cranial region, the first stage of NT closure is assisted by an expansion in the surrounding 
mesenchyme. Proliferation and an expansion of extracellular space in the paraxial mesoderm 
push the neural folds into a biconvex ‘V’ shape (Morriss and Solursh, 1978). This mechanism is 
necessary for closure, as prevention of the proliferation and expansion of the paraxial 
mesoderm in the cranial region through mutation of the gene twist in mouse embryos resulted 
in open neural folds (Chen and Behringer, 1995). This is not true for the spinal region; the 
expansion and proliferation of the mesenchyme does not occur in wild type embryos, and 
removal of the tissue does not affect NT closure (van Straaten et al., 1993). 
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In the second stage of cranial NT closure the neural folds become convex, and the tips become 
apposed. This mechanism is dependent on the actin cytoskeleton, and mutation in a number 
of the proteins involved in the formation and maintenance of a functional actin cytoskeleton 
cause exencephaly (Brouns et al., 2000; Hildebrand and Soriano, 1999; Stumpo et al., 1995; Xu 
et al., 1998). However, all these mutant mouse embryos show normal spinal NT closure. In 
support of this, treatment in culture of mouse embryos with the actin polymerisation inhibitor 
cytochalasin D prevents closure of the cranial NT, but not the spinal NT (Ybot-Gonzalez and 
Copp, 1999). 
It has been suggested that the direction of cell division may be different between the cranial 
and spinal regions of the neural plate, with more transverse divisions observed in the cranial 
region, and more longitudinal divisions observed in the spinal regions of chick embryos 
(Schoenwolf and Alvarez, 1989). 
The cranial region of the NT appears to be more susceptible to morphological abnormalities, 
whether these abnormalities are genetic or environmental in origin (Copp et al., 2003). Indeed, 
there are four times as many mouse mutants which develop only exencephaly compared to 
mutants which develop either spina bifida or both spina bifida and exencephaly (Harris and 
Juriloff, 2010). This suggests that the mechanisms controlling closure of cranial region are 
more susceptible to disruption, and/or the closure is less robust when compared to the spinal 
region. It is possible that the spinal region has more redundant pathways and mechanisms 
active during closure, which may compensate for mutations and abnormalities. Alternatively, 
different mechanisms may be responsible for NT closure in the cranial and spinal regions, 
which have different susceptibilities to teratogens and mutations. 
Genetic risk factors for NTDs may be inherited, and a number of studies have been carried out 
observing NTD occurrence within families (Chatkupt et al., 1993; Hol et al., 2000; Partington 
and McLone, 1995; Sergi et al., 2013). It is often the case that a single form of NTD is seen 
within a family. For instance, a family may have a significantly higher rate of spina bifida, but a 
normal rate of anencephaly, or vice-versa. Risk factors are often specific for a particular type of 
NTD, which suggests different mechanisms are involved in the closure of the cranial and spinal 
regions. 
 
1.2    Neural tube defects 
Neural tube defects (NTDs) are among the most common birth defects observed today. On 
average they are seen in around 1 in 1000 pregnancies (Mitchell, 2005), but rates can vary 
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hugely from around 0.5 in 1000 births in America (Wallingford et al., 2013) to 13.9 in 1000 
births in certain areas of China (Li et al., 2006). 
NTDs occur when NT closure fails in an embryo, leaving an open region. They vary in type and 
severity depending on the reason for failure and the position of the open region, and thus may 
or may not be compatible with life. 
1.2.1    Commonly observed defects 
The type of NTD which develops depends on the affected region and the severity of the defect. 
The two most commonly observed NTDs are spina bifida and anencephaly. 
1.2.1.1    Spina bifida 
Spina bifida occurs when the open lesion is positioned in the spinal region of the NT. With 
appropriate treatment and medical care, this is often compatible with life, but may cause 
severe, lifelong disabilities in those affected, including movement difficulties or paralysis below 
the lesion, hydrocephalus, skeletal abnormalities, and incontinence (Copp et al., 2013). 
Spina bifida is usually caused by failure of completion of closure 1, leaving the posterior 
neuropore open. The size of the open region may govern the severity of the defect. By birth, 
the lesion may be covered by the meninges (myelomeningocele), or open to the intrauterine 
environment (myelocele) (Greene and Copp, 2009). 
1.2.1.2    Anencephaly 
Anencephaly occurs when the cranial region is affected by the NTD, and is not compatible with 
life. The skull vault fails to close over the open region of the NT, leaving the developing brain 
open to the intrauterine environment (Copp et al., 2013). Affected embryos usually die during 
gestation, although some may survive until birth. 
Failure of completion of closure 2 (or closure 3 in the murine embryo) results in the 
development of exencephaly. This develops into anencephaly later in gestation, as the brain 
tissue is destroyed and the cranial vault remains open. 
Exencephaly is more common in females than in males (Janerich, 1975; Tennant et al., 2011), 
although the reasons for this are unknown. This was initially thought to be due to a slight 
decrease in the rate of development in female embryos, which would mean that females spent 
longer in the vulnerable period of neurulation (Toriello and Higgins, 1985). However, it has 
been found that although females are slightly behind males in developmental stage at 
neurulation, the rate of development is the same (Brook et al., 1994). 
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Female embryos undergo X-inactivation through methylation of the second X-chromosome. 
Recently it has been suggested that the inactive X-chromosome may act as a sink of methyl 
groups, which could cause a deficit of methyl groups in other systems (Juriloff and Harris, 
2012). In support of this, research into the Trp-53 mutant mouse has shown that the observed 
disproportion in the occurrence of exencephaly in males and females is reliant on the presence 
of two X-chromosomes, not on the absence of a Y-chromosome (Juriloff and Harris, 2012). 
Additionally, folic acid is able to rescue NTDs in some mutant embryos, and the folate cycle is 
known to affect the availability of methyl groups within the cell (see section 1.2.4 for more 
information). Therefore, it is possible that increased frequency of exencephaly in female 
embryos is the result of insufficient methyl group availability. This could affect methylation of 
both proteins and DNA. 
1.2.2    Risk factors 
NTDs are an extremely heterogeneous defect, and can develop for a huge variety of cellular or 
physiological reasons. They are caused by either genetic or environmental factors, or most 
commonly a combination of the two.  
1.2.2.1    Genetic 
NTDs in humans are known to have a partially genetic aspect in their occurrence. Women who 
have been affected by an NTD pregnancy have a 2-5% chance of being similarly affected in a 
future pregnancy, representing around a 50 times higher risk than the general population 
(Carter and Evans, 1973; Detrait et al., 2005; Nevin and Johnston, 1980). Additionally, NTDs are 
often associated with known genetic syndromes and chromosome rearrangements, such as 
Meckel Syndrome and trisomy 13 (Hume, Jr. et al., 1996; Seller, 1975). However, many of the 
human risk genes have proved difficult to identify. A number of candidate genes have been 
used for screening, but few have been associated with NTD development (Boyles et al., 2005). 
It is likely that many cases show oligogenic inheritance, as cases of NTDs within a family tend 
to involve individuals related at the second or third degree (Detrait et al., 2005). This makes 
identification of risk genes even more difficult. 
More than two hundred genes have been identified as risk genes for NTDs in mice. However, 
there is rarely complete penetrance of NTDs for any of the mutations observed. A wide variety 
of cellular processes can be affected by these genes, later leading to the development of an 
NTD. Some examples of these processes, and the relevant mouse mutant models, are 
described in Table 1.1. 
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Mouse 
Mutant 
Model 
Affected Cellular Process Reference 
Curly tail 
Proliferation and gut development: Reduced 
proliferation in the gut and notochord prior to the 
27 somite stage results in excess curvature of the 
spine, and cause spina bifida.  
(Copp et al., 
1988a) 
Folbp1-/- 
Folate one-carbon metabolism: Disruption of folate 
homeostasis. Embryos develop NTDs at E9.5. 
(Piedrahita et al., 
1999) 
Grhl2 
Neural fold fusion: Embryos have downregulation of 
genes involved in cell adhesion at E9.5, and develop 
exencephaly and cleft face at this stge. 
(Pyrgaki et al., 
2011) 
Loop tail 
Planar cell polarity: Embryos have reduced 
convergent extension of the NT from E8.5 and 
develop craniorachischisis. 
(Gravel et al., 
2010) 
Zic2Ku/Ku 
Hinge point development: Failure to express BMP 
inhibitors in the dorsal NT, thus DLHPs don’t develop 
from the 9 somite stage. Embryos have spina bifida. 
(Ybot-Gonzalez et 
al., 2007) 
Apaf1-/- 
Apoptosis: decreased apoptosis in the cranial region 
and increased proliferation. Embryos develop 
exencephaly at E9.5. 
(Yoshida et al., 
1998) 
Dnmt3b-/- 
DNA methylation: Disrupted de novo methylation. 
Embryos develop exencephaly at E9.5. 
(Okano et al., 
1999) 
Palld-/- 
Cytoskeletal function: Disruption of the actin 
cytoskeleton. Embryos develop exencephaly at E9.5. 
(Luo et al., 2005) 
Cecr2Gt45Bic/Gt45Bic 
Chromatin remodelling: Disruption of ATP-
dependent chromatin remodelling. Embryos develop 
exencephaly from E8.5. 
(Banting et al., 
2005) 
 
 
 
 
Table 1.1: Abnormal cellular processes found in neural tube defect mouse models. 
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These risk genes can increase the likelihood that an embryo will develop an NTD, especially in 
combination with other high risk genes, or with environmental factors which also increase the 
NTD risk. This may even occur in embryos heterozygous for a risk gene: compound 
heterozygote embryos, or heterozygous embryos exposed to adverse conditions may develop 
NTDs. For instance, the Pax3 gene rarely causes NTDs in heterozygous mutant form, but when 
combined with heterozygous Grhl3 or Nf1 mutations, the interaction results in the 
development of NTDs (Estibeiro et al., 1993; Lakkis et al., 1999). Additionally, Pax3 
heterozygous embryos develop exencephaly when exposed to arsenite (Martin et al., 2003).  
Modifier genes may affect the rate of NTD development caused by a mutation, without 
causing NTDs themselves. This may cause differences in NTD development between mouse 
genetic backgrounds which carry the exact same mutation. For example, the Cecr2 mutation 
causes exencephaly in 74% mutant embryos on a BALB/c genetic background. However, on the 
FVB/N background, the mutation results in 0% exencephaly. This NTD resistance was found to 
be linked to a modifier locus on chromosome 19 (Davidson et al., 2007). Additionally, 
polymorphisms in the position of closure 2 have been found between mouse embryos with 
different genetic backgrounds, and this has been shown to affect susceptibility to exencephaly 
(Fleming and Copp, 2000). Most strains develop closure 2 at the midbrain-forebrain boundary, 
but in embryos with a SWV/Bc background closure 2 is positioned more rostrally. This results 
in a larger hindbrain neuropore, and thus the strain is more susceptible to exencephaly when 
exposed to teratogens such as valproic acid or hyperthermia (Finnell et al., 1986; Finnell et al., 
1988). On the other hand, the DBA/2 background confers resistance to the teratogenic 
induction of exencephaly, as the strain initiates closure 2 at a position caudal to the midbrain-
hindbrain boundary, resulting in a smaller hindbrain neuropore (Finnell et al., 1986; Finnell et 
al., 1988; Fleming and Copp, 2000). 
1.2.2.2    Environmental 
A number of environmental factors and teratogens have been linked to the development of 
NTDs. Some examples are given in Table 1.2. 
Environmental factors may have an effect on a variety of cellular processes and pathways. For 
example, an intact folate cycle is essential in NT development. The drug Carbamazepine is 
thought to affect the folate status of the mother, thus inducing NTDs in the embryo 
(Hernandez-Diaz et al., 2001) (see section 1.2.4 for more information about folate and NTDs). 
Additionally, the acetylation status of the DNA needs to be tightly regulated, as this 
contributes to the control of gene expression. The action of histone deacetylases (HDACs) is 
vital in the control of cellular processes such as proliferation and differentiation through  
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Environmental Factor/Teratogen Reference 
Maternal diabetes (Correa et al., 2008) 
Vitamin B12 insufficiency (Ray and Blom, 2003) 
Maternal hyperthermia (Lynberg et al., 1994; Suarez et al., 2004) 
Maternal obesity (Watkins et al., 1996; Watkins et al., 2003) 
Carbamazepine (used to treat epilepsy) (Hernandez-Diaz et al., 2001) 
Trimethoprim (antibiotic) (Hernandez-Diaz et al., 2001) 
Valproic acid (used to treat epilepsy) (Lammer et al., 1987; Menegola et al., 2005) 
 
 
 
 
 
chromatin condensation and transcriptional repression (Johnstone, 2002). Inhibition of HDACs 
with Trichostatin A has been shown to cause NTDs in the chick (Murko et al., 2013). Valproic 
acid appears to act as a histone deacetylase inhibitor (HDACi), and been found to cause NTDs 
(Lammer et al., 1987; Menegola et al., 2005). 
1.2.3    Mechanism of tissue damage 
The mechanism by which exposed neural tissue is damaged in NTD cases is currently under 
debate. The central nervous system of embryos with spina bifida appears to initially develop 
normally, and then degenerate later in gestation (Keller-Peck and Mullen, 1996; Stiefel et al., 
2007). Research has reported the presence of apparently healthy neural tissue in the open 
neural tube of an E12 mouse embryo with spina bifida, showing mitotic figures, an intact 
ependymal surface, and appropriate cell density, although possibly with slightly more 
intercellular space than seen in wild type embryos. It also appears that neuronal 
differentiation occurs normally in the open region of spina bifida lesions (Keller-Peck and 
Mullen, 1996; Stiefel and Meuli, 2007). Nerve fibres develop normally in embryos with spina 
bifida, and neuronal connections are made between the spinal cord and peripheral tissues 
(Stiefel et al., 2007). 
Table 1.2: Environmental factors which have been linked to neural tube defect 
development. 
19 
 
However, by E16.5 the neural tissue begins to show signs of degeneration, including abrasions 
and haemorrhage. By approximately E17.5 connections are lost between the spinal cord and 
the peripheral tissue, and the nerves degenerate. Hind limb pain reactions were observed 
among only 45% of murine embryos with spina bifida at E18.5, and tail pain reactions in 20%, 
compared to 100% in wild type embryos of the same gestational age (Stiefel et al., 2007). By 
E19 the tissue was showing severe damage, including apoptosis and necrosis, and loss of the 
ependymal surface. Eventually the exposed neural tissue is completely lost (McLone et al., 
1997; Stiefel et al., 2007; Stiefel and Meuli, 2007). 
It has been suggested that the amniotic fluid itself could be at least partially responsible for 
the tissue damage seen in the exposed neural tube. The presence of urine in the fluid, or a 
difference of osmolarity could mediate the toxic effect. However, this is difficult to study using 
a murine model, as the gestation, and thus the amount of time exposed to the amniotic fluid, 
is far shorter than that of humans (McLone et al., 1997). Some neuronal loss could be linked to 
reduced afferent stimulation of neurons in the open neural tube, which could be due to 
abnormal NC development rather than tissue damage (Moase and Trasler, 1989). Additionally, 
contact with the uterus wall could cause traumatic injury to the exposed neurons (McLone et 
al., 1997). 
Treatment of spina bifida in which intrauterine fetal surgery is used to cover the lesion is 
currently practised in several centres (Stiefel et al., 2007). Results have been diverse, with 
some studies showing improvements in the frequency and severity of hydrocephalus and 
hindbrain herniation in infants with spina bifida (Bruner et al., 1999; Farmer et al., 2003; 
Sutton et al., 1999), and a reduction in neuronal damage (Johnson et al., 2003; Verbeek et al., 
2012). However, some studies have shown no difference between infants with spina bifida, 
and those affected by spina bifida who were given the fetal surgery (Holmes et al., 2001; Tubbs 
et al., 2003). Additionally, many studies have reported a higher rate of premature birth, and 
complications and mortality during gestation and neonatal life in the infants who have 
undergone fetal surgery (Bruner et al., 1999; Johnson et al., 2003; Sutton et al., 1999; Verbeek 
et al., 2012). 
A major study in the outcomes of prenatal surgery was the Management of Myelomeningocele 
Study (MOMS). This was a randomised trial comparing the outcome of prenatal surgery against 
postnatal surgery for myelomeningocele (Adzick et al., 2011). The trial involved randomly 
assigned prenatal (prior to 26 weeks of gestation) or postnatal surgery for 158 women. The 
children were followed for 30 months postnatally, and were assessed for a number of 
outcomes, including pregnancy complications, premature birth, mental development, motor 
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development, and the need for the placement of a cerebrospinal shunt. Children in the 
prenatal surgery group showed an improvement in a number of postnatal outcomes; for 
example, only 40% required shunt placement compared to 82% in the postnatal surgery group, 
and they also scored better in a mental development test. Additionally, a higher number of 
children from the prenatal surgery group performed better than expected for the level of their 
lesions in motor function tests compared to the postnatal surgery group. However, the 
prenatal surgery group were more at risk of pregnancy complications; the children had a 
higher risk of preterm birth, and therefore respiratory distress. There was also a higher risk of 
chorioamniotic separation, which can result in premature membrane rupture. 
Many studies appear to support the conclusion that prenatal surgery to repair spina bifida can 
improve postnatal outcome in CNS function and complications such as shunt requirement. 
However, this should be weighed against evidence that prenatal surgery carries a higher risk 
than postnatal surgery for complications in pregnancy, including a higher risk premature 
delivery, spontaneous membrane rupture, and fetal mortality. Long term studies will also be 
required to observe the stability and persistence of the improved outcomes. 
1.2.4    Folate and neural tube defects 
Folate enters one-carbon metabolism, which plays two main roles in the cell; the synthesis of 
pyrimidines and purines, and donation of methyl groups to macromolecules (Copp et al., 2013; 
Kim et al., 2009; Waterland and Jirtle, 2003). 
Folic acid is a synthetic and environmentally stable form of folate, which is recommended as a 
supplement for women during the very early stages of pregnancy. It has been shown to 
prevent up to 72% NTD recurrence in women who have previously had an NTD pregnancy 
(MRC, 1991). In America in 1998 it was advised that wheat flour be fortified with folic acid 
(Food and Drug Administration, 1996), and this has reduced the number of NTD pregnancies 
by around 19-32% (Boulet et al., 2008; Crider et al., 2011; Williams et al., 2002). However, 
supplementation is not able to prevent all cases of NTD, which suggests that some forms are 
folic acid resistant (Heseker et al., 2009). 
On average, mothers carrying NTD-affected fetuses have been shown to have a reduction in 
the plasma levels of folate. Thus, sub-optimal levels are a risk factor, but the levels were 
consistently above the level of deficiency (Kirke et al., 1993; Mills et al., 1995). This suggests 
that the defect may be metabolic, rather than caused by a simple deficiency. Several folate-
related genes have been identified as potential risk genes for NTDs. 
Methylenetetrahydrofolate reductase (MTHFR) is a cytoplasmic enzyme involved in folate 
metabolism, and mitochondrial 10-formyl-tetrahydrofolate synthetase (MTHFD1L) is involved 
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in mitochondrial one-carbon metabolism. Both of these genes have allelic forms which 
increase the risk of NTDs (Parle-McDermott et al., 2009; van der Put et al., 1995). 
Folate is thought to play a role in cellular proliferation, in part due to its link to pyrimidine and 
purine synthesis (Beaudin and Stover, 2007). Abnormalities in proliferation can be found in 
cases of NTD, both in the NT (Smith and Schoenwolf, 1987) and in the surrounding tissues 
(Copp et al., 1988a). A reduction in proliferation has also been found to induce NTDs after the 
use of anti-mitotic agents. For example, mouse embryos treated with hydroxyurea, which 
inhibits DNA synthesis, have a 30% incidence of exencephaly (Copp et al., 1990). Additionally, 
the anti-mitotic Mytomycin C has been found to increase the rate of exencephaly development 
in the curly tail (ct) mouse (Seller and Perkins, 1986). A reduction in proliferation within the NT 
is thought to affect the mechanical properties of the NT, for example through the shapes of 
the cells or the tissue, and thus affect NT closure.  
As mentioned previously, folate is essential for the transfer of methyl groups from the one-
carbon metabolism to macromolecules for methylation (Copp et al., 2013; Kim et al., 2009; 
Waterland and Jirtle, 2003). Methylation of macromolecules, including DNA, has been shown 
to play an important role in NT closure. It has been demonstrated that a reduction in DNA 
methylation, either genetically (in the mouse) (Okano et al., 1999) or through the use of 
inhibitors (in the chick) (Afman et al., 2005) can cause NTDs. Abnormal DNA methylation has 
also been found in some cases of NTD in humans (Zhao et al., 2006). These defects could be 
related to epigenetic differences which result from abnormal methylation. For example, 
abnormal DNA methylation could affect the structure of the chromatin and the binding of DNA 
to certain proteins, which may affect the expression levels of certain genes (Greene et al., 
2011). The change in gene expression could contribute to the development of NTDs. 
 
1.3    The Neural Crest 
NC cells are a transient, highly migratory subset of cells found in vertebrates during 
development. They are multipotent cells which are specified at the border of the neural plate 
and the surrounding ectoderm. During neurulation NC cells undergo EMT (epithelial to 
mesenchymal transition), and migrate along defined paths to populate target tissues. They 
contribute to a variety of tissues and organs within the developing embryo, including 
craniofacial structures, pigmentation cells, and the neurons and glia of the peripheral nervous 
system, (Basch et al., 2004). 
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The NC undergo several stages of development. They are first specified at the neural plate 
border. This involves multiple pathways, including BMP, Wnt and FGF signalling. Specification 
induces the expression of genes involved in maintenance and expansion of the NC, such as 
Pax3, FoxD3, Sox and Snail. The NC cells then delaminate and migrate to target tissues, which 
requires the expression of genes involved in EMT, cell polarity and cell guidance, such as 
Cadherin genes, FoxD3, ErbB3, Sox9 and Twist. Finally, once cells reach the target tissue they 
differentiate according to migration path, and premigratory and postmigratory positional 
information. 
1.3.1    Specification 
The NC are first specified at the border of the neural plate, where it meets the surrounding 
non-neural ectoderm. Extracellular signalling plays an important role in this specification, and 
signalling molecules are released from the neural plate, the epidermis, and the underlying 
mesoderm (Mayor et al., 1995; Moury and Jacobson, 1990; Selleck and Bronner-Fraser, 1995). 
Indeed, it has been found that in Xenopus removal of the paraxial mesoderm underlying the 
non-neural ectoderm can prevent formation of the NC (Bonstein et al., 1998). 
Both the neural ectodermal and presumptive epidermal lineages are able to contribute to the 
NC population. This has been shown to happen in multiple species in vitro, and in vivo studies 
also indicate dual lineage of the NC within the embryo (LaBonne and Bronner-Fraser, 1999; 
Moury and Jacobson, 1990; Selleck and Bronner-Fraser, 1995). 
NC specification involves two stages of signalling – an induction step and a maintenance and 
expansion step. The signalling pathways BMP, Wnt, and FGF are vital in induction, and 
molecules such as Pax3, Msx and Zic2 enable specification of the NC cells to specific fates. 
Additionally, molecules such as Slug, Snail and Sox10 are important in cell survival and 
maintenance of the newly acquired NC fate (Steventon et al., 2005). These processes are 
controlled by a complex gene regulatory network. 
1.3.1.1    Induction and Specification 
The induction of the neural plate border region is described in section 1.1.1, as initial 
specification of the neural plate and the neural plate border are very closely linked. However, 
once the regions have been induced, gene expression and specification of the cells in the 
neural plate border begin to deviate from those in the neural plate. 
Canonical Wnt signalling appears to have a key function in the specification of the NC. 
However, its exact role is not fully understood. Wnt1, Wnt3a and Wnt3 RNA have all been 
detected in the dorsal midline of the NT of both mouse and Xenopus embryos (Parr et al., 
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1993; Roelink and Nusse, 1991; Wolda et al., 1993). This is the region of the NT in which the NC 
are induced. 
In the Xenopus embryo overexpression of Xwnt1 (Xenopus Wnt1) and Xwnt3a proteins due to 
injection of RNA increases the expression domain of NC markers in ectoderm tissue neuralised 
by noggin or chordin, which inhibit BMP-Smad signalling from the ectoderm (Hegarty et al., 
2013; Saint-Jeannet et al., 1997). This suggests that in tissue that has been made competent to 
respond by BMP antagonists, cells may be specified to form NC by Wnt signalling. In support of 
this, it was observed that Xenopus ectodermal animal caps exposed to both chordin and Xwnt8 
expressed NC markers, whereas those exposed only to chordin did not (LaBonne and Bronner-
Fraser, 1998). Additionally, injection of cells expressing a non-autonomous dominant-negative 
Wnt1 into the NTs of chick embryos reduced the expression of NC markers (Garcia-Castro et 
al., 2002). 
FGF signalling appears to play a similar role to Wnt signalling in inducing NC specification – 
Xenopus animal caps injected with mRNA for both chordin and eFGF also expressed NC 
markers (LaBonne and Bronner-Fraser, 1998). However, this response was not as strong as 
animal caps expressing chordin and Xwnt8. A dominant negative Xwnt8 mutation prevented 
the NC induction by eFGF. This suggests that eFGF induces the expression of Xwnt8, which in 
turn induces the expression of the NC markers (LaBonne and Bronner-Fraser, 1998). 
Evidence suggests that the signalling described may be controlled by the transcription factors 
Snail and Slug (Snail2) in Xenopus; snail2 Xenopus morphants show reduced levels of Xwnt8, 
bmp4, and frzb1, whereas chordin was increased (Shi et al., 2011). This could be due to the 
role of snail2 in the formation of the mesoderm (Bonstein et al., 1998). On the other hand, it 
has also been suggested that Wnt signalling may directly induce expression of slug in Xenopus 
(Vallin et al., 2001). Therefore, there could be feedback mechanisms tightly connecting and 
controlling the expressions of these pathways. The exact roles of these proteins in the early 
development of mammalian NC are unknown. 
1.3.1.2    Maintenance and Expansion 
Expression of maintenance and expansion genes represents the second stage of NC 
specification; the cells become firmly specified as NC, and undergo a population expansion 
prior to migration. The population expansion is vital for the correct development of the NC and 
NC-derived tissues. This is demonstrated by the NC defects seen in embryos carrying 
mutations which affect the proliferation of the NC prior to migration (Conway et al., 2000; 
Ikeya et al., 1997). 
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The genes involved in maintenance and expansion are expressed solely in the prospective NC 
cells, and function to maintain and increase the precursor population, while inducing 
expression of proteins involved in migration. These genes include the transcription factors 
FoxD3, Hairy2, Twist and Id3, and also genes in the families Msx, Sox and Snail. Several of these 
genes and their functions in NC development are discussed here. 
Snail and Slug are closely related zinc-finger transcriptional repressors with some functional 
redundancy (Carl et al., 1999; Gray et al., 1994; Hemavathy et al., 2000). They are expressed in 
the border region, in NC cells, but the exact timing and function of the proteins appears to 
differ between vertebrate species. In the mouse Snail is expressed in premigratory NC cells, 
whereas in the chick Snail is not expressed in the NC prior to migration. Conversely, Slug in the 
mouse is not expressed in premigratory NC, but is found in premigratory NC in the chick 
(Sefton et al., 1998). In Xenopus, both Xsnail and Xslug are expressed in the NC long before 
migration begins (Mayor et al., 1995). Snail has also been found to inhibit neurectodermal fate 
in Drosophila (Leptin, 1991), and it may play a similar role in the border region of vertebrates. 
The functional roles of Slug and Snail also differ between species. In Xenopus Xslug and Xsnail 
are necessary for both NC formation and migration (Aybar et al., 2003; LaBonne and Bronner-
Fraser, 2000). However, in the mouse embryo neither Slug nor Snail expression are necessary 
for NC formation or migration – E9.5 double mutant mouse embryos which are null for both 
Snail1 (Snail) and Snail2 (Slug) appear to develop NC cells, which migrate normally (Murray and 
Gridley, 2006). 
Additionally, Slug and Snail have roles in cell survival. Expression of SNAIL2 acting as an anti-
apoptotic agent in humans has been found in cases of leukaemia (Inukai et al., 1999). 
Furthermore, aberrant expression of either SNAIL or SLUG infers resistance to apoptosis due to 
DNA damage in human cancer cell culture (Kajita et al., 2004). 
On the other hand, Snail inhibits cell cycle progression in the mouse NC population by 
repressing CyclinD2 transcription, thus inhibiting the progression of the cells to late G1 phase 
(Vega et al., 2004a). This is also true for Slug in the chick embryo (Vega et al., 2004a). The 
genes favour cell shape changes over proliferation, and therefore favour preparation for the 
impending cell migration over population expansion. However, population expansion still 
occurs in the NC cells, as the expression of these genes is in balance with the expression of 
genes which promote proliferation in the NC. 
Mouse embryos mutant for both Wnt1 and Wnt3a show a reduction in the number of NC 
derived cells, which suggests that they may play a role in expansion of the NC population prior 
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to migration (Ikeya et al., 1997). In support of this, ectopic expression of Wnt1 in the murine 
NT resulted in higher than normal proliferation in the affected area (Dickinson et al., 1994). 
Therefore Wnts may act on proliferation in the NC population. Studies in Xenopus show that 
the effects of Xwnt1 on the developing NC are mediated by the Wnt receptor Xfz3 (Deardorff 
et al., 2001). 
c-Myc is a basic helix-loop-helix zipper (bHLHZ) transcription factor which is downstream of 
Wnt signalling (He et al., 1998). It is involved in a wide variety of cellular processes, including 
proliferation, differentiation and cell survival (Bellmeyer et al., 2003). c-Myc is expressed early 
during the formation of the neural plate border, and reduction of expression in Xenopus 
prevents the formation of the NC precursor cells (Bellmeyer et al., 2003). Evidence suggests 
that c-Myc has no effect on cell proliferation or apoptosis in the neural plate border. However, 
c-Myc suppression by Morpholinos in the neural plate border of Xenopus induced this tissue to 
form CNS instead of NC precursors, suggesting that c-Myc plays a role in cell fate decisions 
(Bellmeyer et al., 2003). 
The role of Notch in NC induction and maintenance appears to differ between species. In 
Xenopus, it has been shown that HLH transcription factor Hairy2 – a component of the Notch 
pathway – is expressed downstream of BMP, Wnt and FGF signalling, and is necessary to 
maintain proliferation and prevent differentiation of the NC, and as a survival factor for these 
cells. Hairy2 is able to induce Notch signalling, which in turn controls expression of NC genes 
such as id3, sox9 and snail2 (Nichane et al., 2008a; Nichane et al., 2008b). In the chick, it 
appears that the primary role of Notch signalling is to regulate the level of BMP4 expression 
during the development of the NC, and restrict NC differentiation to the neural plate border 
(Endo et al., 2002). In the mouse, it represses neuronal differentiation, and may also promote 
proliferation of the NC population (De Bellard et al., 2002; Yun et al., 2002). 
Id3 (Inhibitor of DNA binding) is a helix-loop-helix (HLH) transcription factor. Its expression is 
induced by Myc activity (Light et al., 2005), and it appears to be necessary for the specification 
of the NC – Id3 depleted Xenopus embryos do not express the NC markers slug, sox10, twist, 
and foxD3 (Kee and Bronner-Fraser, 2005; Light et al., 2005). Additionally, NC lacking Id3 fail to 
proliferate, and instead undergo apoptosis (Kee and Bronner-Fraser, 2005). Therefore, Id3 
maintains NC cells as multipotent precursors, preventing differentiation, while also facilitating 
NC cell survival and population expansion through cell cycle progression. 
Several of the Sox transcription factors are expressed in the neural plate border, including 
Sox8, Sox9 and Sox10. This is true for a variety of organisms, such as Xenopus, zebrafish, chick, 
human, and mouse, but the exact function, timing and expression patterns of the genes differs 
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between species (Hong and Saint-Jeannet, 2005). For example, in chick and mouse Sox10 is the 
earliest Sox gene to be expressed in the developing NC. However, in Xenopus and zebrafish 
sox10 is one of the final Sox genes involved in NC induction (Hong and Saint-Jeannet, 2005). In 
many organisms Sox10 is detected mostly in the peripheral nervous system (PNS) (Cheng et al., 
2000; Dutton et al., 2001; Southard-Smith et al., 1998). In Xenopus and chick embryos sox10 is 
transiently expressed in the migrating cranial NC and the pharyngeal arches (Aoki et al., 2003; 
Cheng et al., 2000). However in zebrafish and mouse embryos expression is not seen in the 
pharyngeal arches (Dutton et al., 2001; Southard-Smith et al., 1998). 
Several of the Sox mutant embryos generated so far exhibit abnormalities in the NC. For 
example, conditional deletion of Sox9 in the NC of mice resulted in craniofacial malformations 
involving the bone and cartilage tissue derived from the cranial NC (Mori-Akiyama et al., 2003). 
Similarly, in Xenopus injection of Morpholino against sox9 resulted in the loss of NC 
derivatives, and craniofacial defects involving the skeleton (Spokony et al., 2002). 
Furthermore, loss of Sox10 in several model organisms appears to cause defects in the trunk 
and vagal NC. The enteric nervous system (ENS) of Sox10 mutant mice develops abnormally, 
resulting in aganglionosis of much of the gut (Herbarth et al., 1998). Zebrafish mutants carrying 
a sox10 mutation show a similar gut defect, in addition to a pigmentation defect (Kelsh and 
Eisen, 2000). Many of the Sox mutants studied show relatively normal NC specification and 
migration, but the NC fail to terminally differentiate once they have reached the appropriate 
position in the embryo. Some of the Sox genes may also be implicated in cell survival; Sox9 
mutant mouse embryos demonstrate very high levels of apoptosis among the populations of 
premigratory and early migratory NC cells (Cheung et al., 2005). 
FoxD3 is a Forkhead/Winged helix transcription factor, and is expressed in both premigratory 
and migratory NC, where it acts as a transcriptional repressor (Hochgreb-Hagele and Bronner, 
2013; Teng et al., 2008). FoxD3 is important in the maintenance and migration of the NC 
population, and conditional deletion of the gene in mouse embryos results in abnormalities of 
a number of NC derived tissues (including craniofacial structures, PNS and ENS) due to 
migration failure and apoptosis of the NC (Teng et al., 2008). Similar results were found in 
zebrafish mutants (Hochgreb-Hagele and Bronner, 2013; Lister et al., 2006; Stewart et al., 
2006). Additionally, ectopic expression of FoxD3 in Xenopus and chick NT resulted in the 
expression of NC markers in the affected cells (Dottori et al., 2001; Sasai et al., 2001). Research 
has also shown that FoxD3 suppresses both melanocyte and neural differentiation in chick, 
suggesting that it acts to maintain the NC as precursors by preventing differentiation (Dottori 
et al., 2001; Kos et al., 2001; Nitzan et al., 2013). Zebrafish embryos mutant for foxd3 have 
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been found to have reduced expression of snailb and sox10, which suggests that foxd3 may 
have a role in controlling the expression of these other NC genes (Stewart et al., 2006). 
Pax3 mutant mouse embryos develop a number of NC defects, including pigmentation defects 
and conotruncal heart defects (Auerbach, 1954; Franz, 1989). For more information on the role 
of Pax3 in NC development see section 1.4.4.2. 
Apoptosis in the NC is important during development, and is a highly controlled process. For 
example, cranial NC cells which are specified in rhombomeres 3 and 5 undergo apoptosis. This 
is mediated by Msx2, which is induced by BMP4, and is inhibited by Snail2 and the Wnt 
antagonist Sfrp2, which act as survival factors. The survival or apoptosis of these hindbrain NC 
depend on the balance of pro-apoptotic and anti-apoptotic signals (Ellies et al., 2000; Graham 
et al., 1993; Graham et al., 1994; Morales et al., 2005; Vega et al., 2004b). 
1.3.2    Migration 
NC migration is closely tied in with the maintenance and expansion stage of NC development. 
This step prepares the cells for migration, and many genes are common to both stages. 
The migration of the NC follows a pre-defined pattern, specified by a ‘track’ of adhesion 
molecules in the extracellular matrix (ECM), including fibronectin, laminin-1 and collagen. A 
variety of different adhesion molecules including integrins and cadherins on the surface of the 
NC cells allow them to follow this pathway from their region of origin to their target tissue 
(Maschhoff and Baldwin, 2000; Theveneau and Mayor, 2012). Additionally, repulsive signals, 
such as those generated by Eph-ephrin signalling or Twist, are expressed in tissues surrounding 
the migration route. This ensures that cells migrate only along the defined path (Smith et al., 
1997; Soo et al., 2002). 
Migration of the NC is a multi-step process. First EMT of the specified NC allows them to 
delaminate from the surrounding neural ectoderm, losing epithelial structure and becoming 
mesenchymal. This process requires a number of cellular alterations, such as loss of polarity, 
cytoskeletal changes and changes in cell-cell and cell-ECM adhesion. Next, the cells must move 
through the embryonic tissues, following the specified track laid down for them, to their end 
position. Once the cells have reached this position, they are able to terminally differentiate 
(see section 1.3.3). 
In order for delamination and migration to occur, significant changes in cell-cell and cell-matrix 
adhesion need to occur. Adhesion molecules of both the NC and the ECM through which they 
move are vital in permitting and promoting migration, and in ensuring the cells reach their 
target tissue (Lofberg et al., 1985).  The NC cells and the surrounding tissues express different 
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combinations of adhesion molecules. For example, the mammalian NT expresses high levels of 
N-cadherin, whereas the NC cells have very low expression of N-cadherin (Nakagawa and 
Takeichi, 1995). 
Additionally, different subpopulations of NC cells express different combinations of adhesion 
molecules, such as integrins and type II cadherins, and migratory paths to different regions of 
the embryo use different adhesion molecules, including fibronectin, hyaluronic acid, and 
collagen (Bronner-Fraser, 1985; Nakagawa and Takeichi, 1995; Thiery et al., 1982). This aids 
the colonisation of separate regions with the appropriate subpopulations of NC (Nakagawa 
and Takeichi, 1995). 
Some NC cells may proliferate as they migrate. Studies of cranial NC in the chick have shown 
that migrating cells undergo mitotic events at a low frequency, and that the rate of 
proliferation in the population increases once cells enter the branchial arches. The data also 
shows that cranial NC cells are able to increase the rate of proliferation during migration to 
compensate for low numbers of migrating cells (Ridenour et al., 2014). The NC which migrate 
to the gut and form the ENS have also been examined in the chick, and have been found to 
proliferate during migration. The migrating cells of the leading edge are reported to proliferate 
at a higher rate than the trailing cells (Landman et al., 2011). 
1.3.2.1    Signalling in neural crest delamination and migration 
Levels of Wnt, FGF and BMP signalling appear to be important to allow delamination and 
migration of the NC. For example, Bmp2 expression is necessary for migration of the cranial NC 
in mice (Kanzler et al., 2000), and a Bmp4-Noggin balance is necessary for delamination 
through the control of rhoB and cadherin-6b expression in chick embryos (Sela-Donenfeld and 
Kalcheim, 1999). Additionally, Xwnt11 is normally expressed immediately adjacent to the NC 
population in Xenopus; inhibition of Xwnt11 activity represses NC migration, whereas ectopic 
expression induces migration of the NC towards the Xwnt11 activity (De et al., 2005). In chick 
FGF8 has been found to be chemotactic for migrating cardiac NC -  FGF8 is expressed in the 
pharyngeal ectoderm and endoderm, and NC from NT explants migrate towards sources of 
FGF8 (Sato et al., 2011). 
FoxD3 is described previously, as it has a role in maintenance of the newly specified NC. FoxD3 
is also important in NC migration. Some research has shown that transfection of FoxD3 into 
chick NT explants is able to induce ectopic expression of NC markers, but is not sufficient to 
enable delamination and migration of these NC cells (Cheung et al., 2005). On the other hand, 
in vivo studies of electroporated chick NTs have demonstrated disassembly of the basement 
membrane and migration of the affected cells (Dottori et al., 2001). Therefore, the exact role 
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of FoxD3 during migration is not known. However, FoxD3 is able to induce changes in the cell-
cell and cell-ECM adhesion molecules which favour migration. For example, FoxD3 
downregulates N-cadherin, and upregulates Integrin-β1 and Laminin expression in mouse 
embryos (Cheung et al., 2005). Additionally, research has shown FoxD3 to be a promoter of 
EMT in the NC through the activity of Tetraspanin18 (Tspan18). Tspan18 is a scaffolding 
protein which maintains cadherin-6b. This protein is unfavourable to EMT. The NTs of chick 
embryos which have been electroporated with an anti-FoxD3 Morpholino fail to downregulate 
Tspan18 at the appropriate time. Thus it appears that FoxD3 downregulates Tspan18 
expression, which in turn downregulates cadherin-6b, enabling EMT to occur (Fairchild et al., 
2014; Fairchild and Gammill, 2013). 
The Sox genes are discussed previously, as they have a role in maintenance and expansion of 
the NC. In addition to this role, Sox9 is expressed in premigratory NC, and is important in 
initiation of migration in these cells (Cheung and Briscoe, 2003). Expression of Sox9 in chick 
neural explants induced the expression of NC marker genes. The tissue explants demonstrated 
basement membrane disassembly in the regions expressing Sox9, and a small proportion of 
the cells displayed migratory behaviour (Cheung and Briscoe, 2003). Sox9 mutant mouse 
embryos have lower expression levels of Snail in premigratory NC, which suggests that Sox9 
may control expression of Snail in these cells (Cheung et al., 2005). Sox9 is not able to 
efficiently induce delamination and migration of NC when transfected alone. However, when 
combined with certain other signalling molecules Sox9 is able to induce this more efficiently 
than either molecule alone (Cheung et al., 2005). 
RhoB is a member of the rho family of GTP binding proteins, and is expressed in the 
premigratory NC, and transiently in the migratory NC. Its expression in the NC is induced by 
BMP, and inhibition of RhoB activity in chick NT explants by use of the Rho inhibitor 
Clostridium botulinum exotoxin C3 prevents delamination of the NC cells (Liu and Jessell, 
1998). Research has also shown that RhoB can induce NC migration at low efficiency, and may 
promote apoptosis in transfected cells (Cheung et al., 2005). However, when expression 
constructs were transfected together, RhoB and Sox9 produce dramatic changes in NT cells of 
chick explants; cells expressed NC markers, lost polarity, became rounded in shape, and 
migrated out of the explant at much higher efficiency than when expressing either RhoB or 
Sox9 alone. Apoptosis was also reduced compared to RhoB-transfected explants (Cheung et al., 
2005). 
The role of Notch signalling in NC maintenance and expansion is described previously. The 
function of Notch signalling during NC migration is not well understood, and appears to differ a 
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great deal between species. However, it has been shown in mice that loss of Delta-1 results in 
abnormalities in the development of the dorsal root ganglia (DRG) and sympathetic ganglia, 
suggesting that Notch signalling plays a role in the migration of these cells (De Bellard et al., 
2002). 
The genes Snail and Slug are discussed previously relating to their roles in premigratory NC. 
They are also involved in NC migration, and again, the exact role is dependent upon species. In 
the chick the NC marker Slug – but not the closely related Snail – is expressed in the migratory 
NC, and the repression of Slug prevents EMT in these cells (Nieto et al., 1994; Sefton et al., 
1998). Studies have shown that electroporation of Slug into the chick hindbrain NT increased 
the population of migratory NC, but no difference is seen in the spinal region (Cheung et al., 
2005; del Barrio and Nieto, 2002). 
Conversely, the mouse expresses both Slug and Snail in migrating NC, although deletion of 
neither Slug nor Snail in the mouse inhibits the delamination or migration of the NC (Murray 
and Gridley, 2006; Sefton et al., 1998). However, mouse Snail has been shown to induce EMT 
in carcinomas through the downregulation of E-cadherin, and ectopic expression of Snail or 
Slug has been found to initiate EMT in vitro (Bolos et al., 2003; Cano et al., 2000). 
Downregulation of Cadherin-6b and upregulation of Cadherin-7 are important steps in EMT. 
Slug expression in chick is important for the downregulation of Cadherin-6b (Taneyhill et al., 
2007). Similarly, Snail is able to downregulate several members of the matrix 
metalloproteinase (MMP) family in vitro (Miyoshi et al., 2004). The MMPs are important for 
the breakdown of the ECM, thus allowing the NC to migrate. The role of the Snail family of 
transcription factors is still not completely understood. 
Cotransfection of Sox9 and Slug into chick NT explants induced strong expression of NC marker 
genes. Additionally, higher numbers of rounded and migratory cells were seen when compared 
to explants transfected with Sox9 or Slug alone. Cotransfection of Sox9 and Snail gave similar 
results (Cheung et al., 2005). 
Twist is a basic helix-loop-helix (bHLH) transcription factor, and is expressed early in the 
development of the NC (Hopwood et al., 1989; O'Rourke and Tam, 2002). Twist is thought to 
play an important role in EMT both in the NC and in cancers; expression has been found in 
metastatic cancer cell lines, and repression of Twist inhibits metastasis when these cells are 
transplanted into mice. Additionally, Twist is known to downregulate E-cadherin, much like 
Slug and Snail, which also induce EMT (Yang et al., 2004). 
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ErbB2 and ErbB3 are members of the epidermal growth factor (EGF) family of proteins. They 
dimerise to form a heterodimer in order to bind the EGF-like proteins Neuregulin (Nrg) 1 or 
Nrg2 (Carraway, III and Cantley, 1994). erbB2 or erbB3 mutant zebrafish lack DRG and 
sympathetic neurons (Honjo et al., 2008). In wild type zebrafish embryos the migrating NC 
usually pause in the location of presently differentiating DRG, but this pause was not seen in 
embryos mutant for erbB3. This suggests that in zebrafish ErbB3 is necessary for recognition of 
the positional signal which retains migrating NC in the correct region for DRG differentiation 
(Budi et al., 2008; Honjo et al., 2008). Murine embryos mutant for ErbB2 or ErbB3 also exhibit 
reduced DRG and sympathetic neurons. However, this appears to be due to failure of the NC to 
migrate to this region; NC cells leave the NT, but migrate only a short distance (Britsch et al., 
1998). Therefore, ErbB3 is important in migration of the NC population, but its exact role 
appears to differ between species. 
1.3.2.2    Neural crest cell guidance during migration 
The guidance of NC migration is necessary to ensure that NC cells which have been made 
competent for a particular fate migrate towards the tissue in which that fate will be possible 
and appropriate. Multiple mechanisms are in place to ensure that the NC migrate in streams 
towards the correct tissues. 
Specific adhesion molecules are often expressed only in certain tissues, or in certain 
subpopulations of NC. This specificity aids the guidance of the subpopulations to their target 
tissue. For example, in Xenopus the adhesion molecule Cadherin-11 is expressed only in the 
cranial NC (Vallin et al., 1998), and its suppression results in failure of the migrating cranial NC 
to reach their target tissue, the pharyngeal pouches (Kashef et al., 2009). Also, α7-integrin is 
observed on a subpopulation of migrating trunk NC in the chick (Kil and Bronner-Fraser, 1996). 
The NC cells migrate in a highly directional manner, and show polarisation of the cytoskeleton 
parallel to the direction of travel. In Xenopus and zebrafish, this polarisation is dependent on 
the PCP pathway, and suppression or deletion of components of this pathway, such as Wnt11, 
inhibits NC migration (De et al., 2005; Matthews et al., 2008). However, mouse embryos which 
lack PCP signalling have normally migrating NC cells. Therefore, PCP signalling is non-essential 
in mammalian NC migration (Pryor et al. Submitted manuscript). PCP signalling usually acts to 
polarise tissues through its effects on the cytoskeleton, and it has been suggested that in 
Xenopus and zebrafish NC cells may interact in some way which allows them to act as a ‘tissue’ 
regarding PCP signalling (Kuriyama and Mayor, 2008).  
Indeed, evidence suggests that the NC may interact through tissue-specific attractive-repulsive 
forces, which enable them to move in a stream. NC cells demonstrate the repulsive force CIL 
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(contact inhibition of locomotion) which induces a change in the direction of migration if cell-
cell contact is made between the NC (Carmona-Fontaine et al., 2008). In addition to CIL, NC 
cells also exhibit coattraction. This is an attractive force between NC cells, mediated by the 
complement protein C3 – which acts as a chemoattractant for the NC – and its receptor C3aR, 
both of which are expressed by migrating NC cells (Carmona-Fontaine et al., 2011). In 
combination, CIL and coattraction are able to explain the collective migration of NC cells seen 
in vivo. 
Chemotaxis is also used to attract NC to their destination. For instance, as mentioned 
previously, FGF8 is expressed in the pharyngeal ectoderm and endoderm, and attracts chick 
cardiac NC cells to their destination (Sato et al., 2011). Additionally, Glial-derived neurotrophic 
factor (GDNF) and netrins act as chemoattractants for migrating ENS-fated NC cells in the gut 
of mouse embryos (Jiang et al., 2003; Young et al., 2001). 
Repulsive molecules in surrounding tissues and the ECM prevent NC cells from migrating away 
from their path. Eph receptors and the ephrin ligands are cell surface molecules which provide 
repulsive cues. For example, in Xenopus the cells of the third branchial arch and a subset of 
cranial NC express EphA4 and EphB1. The adjacent second arch expresses the ligand for these 
receptors, Ephrin-B2. Therefore, this tissue repels the subpopulation of NC cells, and prevents 
mixing of the second and third arch NC populations (Smith et al., 1997). The Semaphorin family 
of proteins plays a similar role; Collapsin-1 in chick is a Semaphorin which is expressed in 
regions surrounding NC migration routes for both hindbrain and trunk NC cells. A Collapsin-1 
receptor, Neuropilin-1, is expressed in the NC cells which migrate along these pathways 
(Eickholt et al., 1999). 
Twist expression is found in both the NC cells and the paraxial mesoderm surrounding the NC 
migration path, and it appears to act on both tissues individually to enable correct migration in 
mouse embryos. Twist mutant mouse embryos show a merging of NC streams into the first 
and second branchial arches, which form two distinct streams in the wild type embryo. 
However, wild type NC cell transplants into the Twist mutant embryos showed that the wild 
type NC cells were more likely to follow the correct path, but also merged streams. This 
suggests that Twist expression is required in the NC cells to enable them to follow the correct 
migration path, but also in the surrounding paraxial mesenchyme to produce a repulsive signal 
which maintains the tight migration path (Soo et al., 2002). 
In the spinal region, NC cells are able to migrate through or around different regions of the 
somite. The migration path is representative of their fate. For instance, NC cells which travel 
through the medial region of the somite develop sensory and sympathetic ganglia, and 
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Schwann cells, whereas cells which travel between the somite and the surface ectoderm form 
melanocytes (Kuriyama and Mayor, 2008; Le Douarin and Teillet, 1974). Control of which 
pathway the NC cells follow is largely dependent upon Eph-ephrin signalling between the NC 
cells and the surrounding tissue (Santiago and Erickson, 2002). However, Slit/Robo signalling is 
also implicated; this is a repulsive signalling pathway which is active during early NC cell 
migration in the trunk. In chicks the Slit ligands are expressed in the dermomyotome, whilst 
the early migrating NC express the Slit receptors Robo1 and Robo2. Slit2 is essential for 
preventing migration through the dorsal pathway, between the surface ectoderm and the 
dermomyotome (Jia et al., 2005). 
1.3.3    Differentiation 
The NC contribute to almost every tissue in the embryo, and are able to form an enormous 
variety of cell types. NC cells are multipotent in vitro, but in vivo the differentiation is highly 
controlled and context dependent (Anderson, 1994). 
Upon initial specification the NC appear to be multipotent. However they become more 
specified with development. Prior to migration, the cells begin to demonstrate some lineage 
restriction (Schilling and Kimmel, 1994), and upon migration to a particular target tissue 
become increasingly constrained to a particular fate through a series of environmental and 
epigenetic factors (Koblar et al., 1999). 
Upon completion of migration NC cells may undergo another round of proliferation prior to 
terminal differentiation. For example, it was shown that NC-derived neural precursors in the 
developing DRG are Sox10-positive until terminal differentiation, upon which they lose Sox10 
expression and become Tuj1-positive. Sox10-positive cells were found to be proliferative, and 
become Tuj1-positive upon the final cell division (Britsch et al., 2001; Gonsalvez et al., 2014; 
Memberg and Hall, 1995). 
Once cells have reached the target tissues they terminally differentiate into the fated cell type. 
Many of the mechanisms and signalling pathways which regulate this progressive acquisition 
of cell fate and final differentiation are not well understood, but a selection are discussed 
below. 
The spatial position of NC on the rostrocaudal axis as they become specified is central to the 
fate of the cells. Additionally, as discussed previously, NC cells of different fates migrate past 
the somites via different pathways – either between the surface ectoderm and the 
dermomyotome, or through the sclerotome (Kuriyama and Mayor, 2008; Le Douarin and 
Teillet, 1974). 
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The Hox genes play an important role in the rostrocaudal patterning of the NC, as they control 
the rostrocaudal patterning of much of the embryo. For example, in the cranial region of the 
mouse embryo each branchial arch expresses a different combination of Hox genes. The NC of 
branchial arches 2 and 3, but not branchial arch 1 show similar expression patterns and 
express Hox2.8, Hox2.7 and Hox2.9, whereas Hox2.6 is only expressed caudally of the branchial 
arches (Hunt et al., 1991). Additionally, electroporation of Hoxb1 into the NT of chick embryos 
was able to upregulate Slug expression, which indicates NC specification (Gouti et al., 2011). 
The cardiac NC arise from the NT adjacent to somites 1-3, and migrate into branchial arches 3, 
4 and 6 (McKeown et al., 2013). In the mouse cardiac NC subpopulation Twist1 is able to 
directly interact with Sox10, which binds the promoter of the neurogenic Phox2b gene. In 
doing so it represses Phox2b transcription, and inhibits neuronal differentiation in the cardiac 
NC (Vincentz et al., 2013). The cardiac NC cells provide signalling to aid in embryonic 
cardiogenesis, and also contribute to the heart valves and form parasympathetic nerves (Brade 
et al., 2013). 
Timing of migration may also be crucial for differentiation in some NC subpopulations. In the 
zebrafish, early migrating cranial NC cells differentiate to form the facial skeleton and 
connective tissue, whereas later migrating cranial NC form the PNS of the cranial region (Bhatt 
et al., 2013). 
Sensory neurons are derived from the trunk NC and differentiate in the DRG. Differentiation of 
these NC cells occurs in three waves, each of which is controlled by different neurogenic 
signalling molecules. The first wave of differentiation generates large-diameter touch and 
movement neurons. The second wave generates more large-diameter touch and movement 
neurons, but also small-diameter pain neurons. The third wave generates mostly nociceptive 
neurons (Bhatt et al., 2013). The first two waves of differentiation are controlled by the bHLH 
transcription factors Neurogenin2 (Ngn2) and Neurogenin1 (Ngn1) respectively (Fode et al., 
1998; Ma et al., 1996). Mutation of Ngn2 disrupted differentiation of the sensory neurons in 
mice (Fode et al., 1998). Additionally, overexpression of ngn1 in Xenopus resulted in ectopic 
neurogenesis (Ma et al., 1996). 
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1.4    Pax3 
1.4.1    The Pax family of transcription factors 
The Paired-box (Pax) genes encode a family of transcription factors which have important roles 
in a wide variety of processes during embryonic development. They share sequence homology, 
and have conserved structural domains (Balczarek et al., 1997). Pax proteins have an N-
terminal paired domain and a C-terminal transactivation domain (Thompson and Ziman, 2011).  
Different isoforms of the Pax proteins can be produced through alternate splicing of the RNA 
as a response to certain environmental cues. These isoforms can have slightly different DNA 
binding properties and responses (Thompson and Ziman, 2011). 
1.4.1.1    The paired domain 
The paired domain (PD) is a conserved DNA-binding domain found in Pax proteins. The N-
terminal and C-terminal regions of the PD act as two independent globular domains.  The N-
terminal domain is the larger of the two, and consists of a short region of parallel β-sheet, a β 
turn, three α-helices, and an extended C-terminal tail. The C-terminal domain has three α-
helices. The helical units of both regions show similarity to the homeodomain (Xu et al., 1995). 
The N-terminal domain is concerned with sequence-specific DNA binding. The β-sheet region 
contacts the sugar phosphate backbone of the DNA, and the β turn and extended C-terminal 
tail of the region contact the minor groove. The first helix contains a helix-turn-helix (HTH) 
domain, the second helix contacts the phosphate molecules, and the third helix binds the 
major groove (Xu et al., 1995). 
Like the N-terminal region, the C-terminal domain also contains three α-helices, and shows 
similarities to the structure of the homeodomain. However, the region does not necessarily 
bind to DNA, and shows a higher degree of physical flexibility. There are also longer loops of 
amino acids between the helices compared to the standard homeodomain. This site shows 
DNA binding in some PD-containing proteins, and is thought to contribute to the binding site-
specificity of the PD as a whole (Xu et al., 1995). 
1.4.1.2    Roles of Pax genes in cell function 
The Pax genes are involved in multiple developmental processes. Their expression is confined 
to tightly controlled regions, which suggests a potential role in the patterning of the embryo. 
Antero-posterior, as well as dorso-ventral restrictions in expression of the Pax genes suggests 
roles in patterning along multiple axes. Pax genes are frequently found to hold cells in a non-
apoptotic progenitor state until environmental signals are able to induce either proliferation or 
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full differentiation and maturation of the population (Blake and Ziman, 2014). Thus, they are 
important for maintaining the correct balance of proliferation and differentiation in developing 
tissues.  Additionally, repressive interactions between Pax genes helps to establish and 
stabilise boundaries between regions, whereas coordinated expression can reinforce 
patterning (Thompson and Ziman, 2011). Organisms which are heterozygous for mutations in 
Pax3 genes often show a phenotype, which suggests that, not just the presence, but the 
dosage of the genes is also important (Bernasconi et al., 1996). 
A number of Pax genes are known to play roles in cell survival and apoptosis. This is seen in 
embryonic development, but also in the development of carcinomas. For instance, research on 
rhabdomyosarcoma (RMS) cells has found that Pax3 or Pax7 may be upregulated in these 
cancerous cells, and that downregulation can increase the rate of cell death, suggesting that 
the Pax genes are necessary for their survival (Bernasconi et al., 1996). 
Pax genes are known to act as survival factors in some tissues. For example, Pax7 is necessary 
for the maintenance of satellite cells in adult muscle. These cells are quiescent stem cells, and 
are able to proliferate and differentiate in the event of muscle damage in the adult. However, 
in Pax7 mutant mice the satellite cells rapidly apoptose after birth, suggesting that Pax7 is a 
necessary anti-apoptotic factor for these cells (Relaix et al., 2006). 
Pax gene misexpression may also occur in cystic or proliferative disorders. Pax2 would usually 
be downregulated in the kidney following differentiation, but it is known to be expressed in 
the epithelial cells of cystic kidneys. It also upregulates expression of BCL2, which protects cells 
against apoptosis in the hyperproliferative epithelia of cystic kidneys (Winyard et al., 1996). 
1.4.1.3    Roles of Pax genes in tissue development and differentiation 
The Pax transcription factors have roles in a huge variety of development processes and 
systems. They act on aspects such as cell survival – as described above – and the proliferation 
differentiation balance, but also induce expression of certain differentiation genes to control 
cell fate. 
Most Pax genes (with the exception of Pax1) have roles in the development of the CNS, 
including the NC. They are able to affect migration, specification and proliferation, as well as 
differentiation of specific cell types, and they play key roles in patterning of the developing 
brain and spinal cord. 
Research has suggested that both Pax6 and Pax7 are involved in the specification of large 
regions of the CNS during early development, and at later stages in the differentiation of 
specific cell types (Kawakami et al., 1997). Pax3 and Pax7 are expressed in the dorsal region of 
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the neural tube, whereas Pax6 is expressed in the mid-ventral region (Goulding et al., 1991; 
Jostes et al., 1990; Walther and Gruss, 1991). In chick embryos Pax7 is required for the 
specification of NC cells prior to gastrulation (Basch et al., 2006), and in mouse embryos Pax6 
is expressed in the early developing forebrain and hindbrain, in closed regions of the neural 
tube, and in the developing eye (Walther and Gruss, 1991). As development progresses, 
expression of the genes can be associated with specific cellular populations; for instance, in 
the mouse Pax7 is expressed in the mesencephalon, and Pax6 is expressed in the olfactory 
bulbs, the telencephalon and the diencephalon in the developing brain (Jostes et al., 1990; 
Walther and Gruss, 1991). 
Pax2, Pax5 and Pax8 are expressed later in neurulation, at approximately E10. The difference 
in the timing of expression between the Pax genes occurs because Pax3, Pax6 and Pax7 are 
expressed in the precursor cells of the CNS, whereas Pax2, Pax5 and Pax8 are expressed in 
post-mitotic neuroblasts (Goulding, 1992). 
Some Pax genes are involved in the development of the NC and their derivatives. All NC cells 
require Pax3 for correct migration and expansion of the progenitor population (Conway et al., 
2000). A subset of the NC migrating to the craniofacial region from the cephalic region of the 
neural tube additionally require Pax7, and it has been found that mouse embryos lacking a 
functional copy of this gene develop craniofacial abnormalities, including skull and cartilage 
abnormalities (Mansouri et al., 1996). 
Many Pax proteins are also involved in the differentiation of non-neuronal cell types. Pax5 is 
expressed in much of the developing CNS, the fetal liver, B-lymphocytes and adult testis 
(Adams et al., 1992). Pax5 mutant mice lack B-lymphocytes, as the development of these cells 
is arrested at an early precursor stage (Urbanek et al., 1994). Therefore, B-lymphocytes require 
Pax5 in order to differentiate. It has been shown that Pax5 is necessary both for the induction 
of expression of B-lymphocyte-specific differentiation genes, and the inhibition of gene 
expression linked to other cell fates (Nutt et al., 1999). 
Pax2 is expressed in the CNS and the urogenital system in the developing embryo (Dressler et 
al., 1990). Pax2 mutant embryos have been found to lack the ureter, genital tract, and kidneys 
(Torres et al., 1995). Evidence suggests that Pax2 acts through epigenetic means during 
urogenital development; association of Pax2 with its binding elements results in H3K4 histone 
methylation, which will alter expression of genes relating to urogenital development (Patel et 
al., 2007). 
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The Pax6 gene is important in the development of the CNS, the eyes, and the pancreas. 
Heterozygosity in humans leads to Aniridia – a disorder which comprises a number of eye 
defects. Homozygous mutation in mice causes much more severe eye defects, and in 
Drosophila prevents eye development altogether (Shaham et al., 2012). Pax6 is required in 
multiple processes during eye development. For example, research has shown Pax6 to be 
necessary for the maintenance and differentiation of both the iris and ciliary body cells (Davis 
et al., 2009). 
1.4.2    Pax3 gene and protein structure 
This project focusses on one of the Pax genes, Pax3. The Pax3 gene is located on chromosome 
1 in the mouse, and chromosome 2 in the human (Walther et al., 1991; Wilcox et al., 1992). 
The Pax3 protein contains another active site, the paired-type homeodomain, in addition to 
the PD (Figure 1.6). The protein is important in the development of a number of tissues, 
including the CNS, the NC, and some muscles, such as those of the limbs. 
Seven different isoforms of Pax3 exist in man – PAX3 a-h. PAX3e is full length, containing 10 
exons. The remaining isoforms are alternatively truncated and spliced (Wang et al., 2007). The 
isoforms may be expressed in different tissues in the body. For example, a report describes 
how the human PAX3b protein was found in most tissues studied, but PAX3a was found only in 
the cerebellum, oesophagus and skeletal muscle (Tsukamoto et al., 1994). Additionally, the 
isoforms may play different roles during development; it has been found that the isoforms 
PAX3c, PAX3e and PAX3g have different effects on the expression of downstream genes (Wang 
et al., 2007), and isoforms PAX3a-h appear to differentially affect cellular mechanisms in 
cultured melanocytes, including proliferation, migration and apoptosis (Wang et al., 2006). The 
cues which initiate alternative splicing in Pax3 are unknown. 
1.4.2.1    The paired type homeodomain 
Although the Pax proteins are characterised by the presence of the PD, Pax3, Pax4, Pax6, and 
Pax7 contain an additional domain known as the paired-type homeodomain (HD) (Figure 1.6). 
It contains three α-helices, called α1, α2 and α3, which are connected by short loops. There is 
also an N-terminal arm, which inserts into the minor groove and interacts with DNA in a 
sequence-specific manner. Upon interaction of the N-terminal arm, helix α3 inserts into the 
major groove, and interacts with the bases and the sugar-phosphate backbone of the DNA 
(Birrane et al., 2009; Kissinger et al., 1990). 
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1.4.2.2    Interactions between the binding sites of Pax3 protein 
The PD and HD of Pax3 are structurally independent, and have separate roles in the 
functioning of the protein, but they are also able to influence the function of the other. This 
has been demonstrated in the Splotch-delayed mouse, which has an amino acid substitution at 
position 9 of the PD; the glycine to arginine substitution dramatically reduces DNA binding of 
both active sites (Underhill et al., 1995). This mutation was found to be contained within a β-
turn, which contributes to a β-hairpin motif (Xu et al., 1995). It was discovered that the PD 
contributes to the sequence-specificity of homeodomain DNA binding in the Pax3 protein 
(Underhill and Gros, 1997). The substitution within the β-turn disrupts the folding of the β-
hairpin motif, which reduces the DNA binding of both the PD and the HD. It has also been 
found that in wild type Pax3 protein helix 2 of the PD is closely apposed to the amino terminus 
of the homeodomain (Apuzzo and Gros, 2007). This suggests the possibility of interaction. 
Additionally, small structural alterations in the PD impairs the ability of the HD to bind DNA, 
which suggests some functional interdependence (Apuzzo and Gros, 2002). 
1.4.3    The Splotch mouse 
The Splotch mouse was first identified in 1947 (Russell, 1947), and then described in detail a 
few years later (Auerbach, 1954). The mutant embryos were identified through the 
development of spina bifida, lack of pigmentation in tissue transplants, and lethality at E14.0 in 
gestation (Auerbach, 1954). The embryos carry a mutation in the Pax3 gene, and show defects 
in Pax3 positive tissues. 
Figure 1.6: The structure of the Pax3 gene. The Pax3 gene consists of 9 exons, which encode 
two DNA binding domains – the paired domain, and the paired-type homeodomain. 
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1.4.3.1    The Splotch phenotype 
Pax3 mutant mice are known as Splotch mice due to a white belly patch seen on the adult 
heterozygotes (Russell, 1947). This is caused by a mild pigmentation defect, but the 
heterozygous mice are otherwise healthy and breed normally. 
Splotch mutant embryos die at around E13.5-14.0 in gestation, and demonstrate fully 
penetrant spina bifida and partially penetrant exencephaly (Auerbach, 1954). Lethality is due 
to the presence of heart defects, such as persistent truncus arteriosus and outflow tract 
malformations (Conway et al., 1997b; Franz, 1989). 
The heart defects seen in the mutant embryos are the result of NC abnormalities. Other NC 
defects include lack of pigmentation and abnormalities of the PNS and ENS (Auerbach, 1954; 
Lang et al., 2000; Moase and Trasler, 1989). Mutant embryos also have defects of the 
musculature, in particular affecting the limbs (Franz et al., 1993). 
1.4.3.2    Pax3 mutations in mice 
In 1991, a Pax3 mutation was found in the Splotch mouse (Epstein et al., 1991). It was later 
demonstrated that no recombination took place between the Splotch locus and Pax3, 
indicating very close linkage, and Pax3 gene mutations were also found in multiple alleles of 
Splotch (Goulding et al., 1993). This evidence identified Pax3 as the key mutated gene in the 
Splotch mouse. 
Since the discovery of Pax3 as the mutant gene in the Splotch mouse, multiple Pax3 mutant 
alleles have been discovered or developed. They differ slightly in phenotype and severity. The 
alleles are described in Table 1.3.  
1.4.4    Processes downstream of Pax3 
Pax3 influences a number of signalling pathways and cellular processes, including general 
mechanisms such as apoptosis and proliferation, and more tissue-specific mechanisms, such as 
differentiation of certain cell types, and cellular migration. Understanding the phenotype of 
the Splotch mouse requires an understanding of processes downstream of Pax3 during 
embryonic development. 
1.4.4.1    Apoptosis 
There is a great deal of debate about the role of Pax3 in cell survival, and the implications of 
this in the development of NTDs in Pax3 mutant mouse embryos. Several studies have shown 
links between Pax3 expression and apoptosis, suggesting that – like many Pax genes – Pax3 is 
important in cell survival in multiple tissues  
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(Borycki et al., 1999; Scholl et al., 2001; Underwood et al., 2007). However, whether this has 
any significance in NT closure remains unclear. 
It is known that mothers with pre-gestational diabetes mellitus (PGDM) have a higher 
incidence of birth defects and NTDs in their offspring compared to the general population 
(Correa et al., 2008). This is a complication known as diabetic embryopathy. Mothers with 
PGDM are defined as having been diagnosed by a physician with either type 1 or type 2 
diabetes mellitus prior to pregnancy. It has been shown that embryos from diabetic mice had 
not only an increased incidence of NTDs, but also reduced Pax3 expression and increased NT 
apoptosis (Phelan et al., 1997). Oxidative stress was found to reduce Pax3 expression, which 
demonstrates that these effects are caused by hypoxia in the embryo as a result of high levels 
of glucose just prior to NT closure (Chang et al., 2003; Chappell, Jr. et al., 2009; Fine et al., 
1999; Li et al., 2005). Hyperglycemia-induced oxidative stress increases the activity of the 
methyltransferase Dnmt3b. This protein was found to be required for methylation of Pax3 
regulatory elements, and thus silencing of Pax3, which allows differentiation of the 
neurepithelial tissue to occur. Therefore, in the hyperglycemic condition of diabetic pregnancy, 
Pax3 regulatory elements are hypermethylated, and Pax3 expression is reduced (Wei and 
Loeken, 2014). Oxidative stress has been previously linked to the development of NTDs. For 
example, exposure of embryos to either valproic acid or arsenic causes oxidative stress, which 
leads to NTD development (Han et al., 2011; Tung and Winn, 2011). It is possible that these 
teratogens also mediate their NTD-inducing effects through a reduction in Pax3 expression. 
Research has shown that apoptosis is increased in Pax3-deficient pre-somitic mesoderm (PSM) 
both in vitro and in vivo, suggesting that Pax3 plays a role in cell survival in this tissue (Borycki 
et al., 1999). Increased levels of apoptosis were also observed in the NC-derived DRG of Pax3-
deficient E11.5 embryos. However, the same research found no difference in the level of 
apoptosis in the NT of Pax3-deficient embryos, both in vitro and in vivo (Borycki et al., 1999). 
Pax3 expression has been found to affect the levels of p53 protein. Pax3 overexpression 
suppresses p53-dependent transcription and reduces p53 protein levels in vitro (Underwood et 
al., 2007). Additionally, suppression of Pax3 activity by mutation increases p53 protein levels in 
vivo (Pani et al., 2002). This demonstrates a method by which Pax3 may exert control on the 
levels of apoptosis in a developing embryo. Thus, loss of Pax3 is hypothesised to lead to an 
increase in p53-dependent apoptosis. p53 mutation has been shown to rescue both NTDs (Pani 
et al., 2002) and cranial NC cell migration (Morgan et al., 2008) in Pax3 mutant mice. 
Aberrant Pax3 expression has been reported in a range of cancers, such as rhabdomyosarcoma 
and melanoma. For instance, upregulation of Pax3 has been reported in melanoma tissue, but 
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not in surrounding healthy tissue, and was found to contribute to the survival of the malignant 
cells (Scholl et al., 2001). Additionally, fusions of Pax3 and a member of the Forkhead gene 
family have been observed in alveolar rhabdomyosarcoma, leading to abnormal Pax3 
transcription factor activity (Galili et al., 1993; Shapiro et al., 1993). The presence of Pax3 is 
usually associated with survival of cancerous tissue. 
1.4.4.2    The neural crest 
Pax3 mutation causes defects in a range of NC-derived tissues, including the PNS, heart, 
pigmentation cells, and the ENS (Auerbach, 1954; Conway et al., 1997b; Koblar et al., 1999; 
Lang et al., 2000; Lang et al., 2005). This suggests it plays an important role early in the 
development of the NC. Some examples of the functions of Pax3 in NC differentiation are given 
here. 
Overexpression of pax3 in Xenopus has been found to upregulate expression of the NC 
specification genes slug, snail, and foxd3 adjacent to the neural plate border. Additionally, 
knockdown of pax3 expression in Xenopus through the use of Morpholinos resulted in a 
reduction in the expression of slug and foxd3, but not msx1. Further research suggests that 
Msx1 induces the expression of both pax3 and zic1 in Xenopus, and that these proteins act 
together to induce NC fate. This activity requires Wnt signalling (Dottori et al., 2001; Monsoro-
Burq et al., 2005; Sato et al., 2005). 
Schwann cells develop from a subset of NC cells, and act as an insulating sheath for neuronal 
fibres in the CNS and the PNS. First, Schwann cell precursors differentiate from the NC 
population, and these then develop into immature Schwann cells. Finally the immature cells 
mature postnatally into myelinating or nonmyelinating Schwann cells (Jessen and Mirsky, 
1998). Pax3 expression is necessary for the development of the nonmyelinating Schwann cells, 
which sheathe small diameter axons. Reduction in Pax3 expression results in the loss of 
embryonic Schwann cells (Kioussi et al., 1995). 
Pax3 mutant mouse embryos develop heart defects due to NC abnormalities (Conway et al., 
1997a; Conway et al., 1997b). These abnormalities include septation defects and outflow tract 
defects (Conway et al., 1997b; Conway et al., 2000). The mutant embryos were found to have 
reduced migration of the NC into the developing heart (Conway et al., 1997a). This is thought 
to be due to a reduction in the proliferation of the NC prior to migration (Conway et al., 2000). 
This defect could also be due to abnormalities in the environment through which the NC 
migrate (see below) (Henderson et al., 1997; Mansouri et al., 2001). As discussed previously, 
research has found that Pax3 mutant embryos have excessive p53-mediated apoptosis in the 
migrating NC. Additionally, reduction in p53 expression rescued the migration defect seen in 
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Pax3 mutant embryos, suggesting that Pax3 acts to suppress apoptosis in these cells (Morgan 
et al., 2008). 
The microphthalmia-associated transcription factor (MITF) is a ‘master regulator’ of 
melanocyte fate. Pax3 promotes the development of melanocytes by binding to the promoter 
of the MITF gene in combination with Sox10, and initiating the expression of MITF (Bondurand 
et al., 2000). However, Pax3 is also able to repress melanocyte fate by forming a repressor 
complex which prevents transcription of MITF target genes (Lang et al., 2005). Therefore Pax3 
initiates the development of melanogenic precursors, but prevents terminal differentiation. 
There are several possible explanations for the NC defects seen in Pax3 mutant mice. 
Undoubtedly there are abnormalities in specification and differentiation, but research has also 
suggested defects in NC migration (Moase and Trasler, 1990). Evidence suggests that Pax3 
mutant NC are capable of migration through both the dorso-ventral and dorso-lateral 
migration pathways (Chan et al., 2004). However, abnormalities are present in the ECM, and 
also in the migration abilities and adhesive properties of the NC. For example, the ECM protein 
Versican is overexpressed in Pax3 mutant embryos, which reduces NC migration (see below) 
(Henderson et al., 1997). Additionally, Pax3 has been shown to control cell surface properties 
of the NC, which affect interactions between the NC and the ECM (Mansouri et al., 2001). 
Pax3 has been associated with cell aggregation and mesenchymal-to-epithelial transition 
(MET). It has been reported that Pax3 mutant embryos lose the epithelial structure of the 
dermomyotome in the somites (Daston et al., 1996; Mansouri et al., 2001). Moreover, ectopic 
Pax3 expression in vitro has been shown to induce cells to form an epithelial-like aggregate 
through activation of a PCP Wnt signalling cascade (Wiggan et al., 2002; Wiggan and Hamel, 
2002). This suggests changes in cell-cell interactions induced by Pax3 signalling. Indeed, these 
cells were found to show reduced cadherin-11 expression at sites of cell-cell contact, which is 
consistent with epithelial identity (Wiggan et al., 2002). Additionally, fractionation of the 
cellular components revealed that ectopic Pax3 signalling induced the change of cadherin and 
catenin positioning from the detergent-soluble cytoplasmic fraction to the detergent-insoluble 
cytoskeletal fraction (Wiggan et al., 2002). This change is associated with an increase in cell 
adhesion. 
The neural cell adhesion molecule (NCAM) is a direct transcriptional target of Pax3 (Bennett et 
al., 1998). Expression of NCAM is finely controlled, and the level of expression is particularly 
important during NC migration. EMT requires low expression of NCAM, and so it is 
downregulated just prior to migration of the NC, and in the migrating cells (Edelman, 1986). It 
is later upregulated on the cell surfaces of multiple differentiated NC-derived cell types, 
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including Schwann cells and neurons (Edelman, 1986). Pax3 mutant embryos still express 
NCAM, but of an altered size (Moase and Trasler, 1991). Research suggests that Pax3 is 
involved in post-translational modification of NCAM, specifically in sialylation (Glogarova and 
Buckiova, 2004; Moase and Trasler, 1991); Pax3 mutant mouse embryos show lower levels of 
polysialylated NCAM compared to wild type (Glogarova and Buckiova, 2004). This is likely to 
affect the adhesive properties of the NC population. 
The protein Versican is a chondroitin-sulphate proteoglycan (CSPG) expressed in the ECM 
(Zimmermann and Ruoslahti, 1989). It is expressed in regions outside the normal migratory 
paths of the NC, and acts as a repulsive molecule to maintain the pathway (Henderson et al., 
1997). Versican is overexpressed in Splotch mutant mouse embryos; Versican and Pax3 are 
expressed reciprocally in wild type embryos, but Pax3 mutation results in the expansion of the 
regions expressing Versican (Henderson et al., 1997). This disrupts the migration of the NC 
population. 
1.4.4.3    Myogenesis 
Vertebrates have three stages of limb muscle differentiation, all of which appear to involve 
Pax3 in some role. During primary myogenesis cells are specified as muscle precursors in the 
somite, and then they migrate to the limb buds, where they express muscle markers and 
differentiate. Secondary myogenesis involves growth of the fetal muscle from a subset of 
undifferentiated myogenic precursor cells within the developing muscle tissue. Adult 
myogenesis occurs following muscle damage, and also involves undifferentiated muscle 
precursor cells, known as satellite cells (Yokoyama and Asahara, 2011). 
Muscles in the vertebrate trunk and limbs are derived from the myotome of the somite. The 
myotome itself consists of two populations of myogenic precursor cells. The medial region of 
the myotome contains cells fated to form the muscles of the back, whereas the lateral region 
contains cells which migrate into the limb buds to form the limb musculature (Ordahl and Le 
Douarin, 1992). 
Pax3 is expressed in the pre-somitic mesoderm, and then following somitogenesis is expressed 
throughout the newly-formed somite. However, as development continues the expression 
becomes restricted to the dermomyotome in the dorsal region of the somite (Buckingham and 
Relaix, 2007), and then to the lateral region of the dermomyotome (Bober et al., 1994). The 
cells of this region later form the limb musculature. Shh signals from the notochord and 
Wnt1/Wnt3 signals from the NT are sufficient for initiating the expression of Pax3 and Pax7 in 
the somites (Goulding et al., 1994; Maroto et al., 1997; Munsterberg et al., 1995). In mice 
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lacking Pax3 expression the population of myogenic precursors doesn’t develop. Therefore, 
the mice do not form limb muscles (Bober et al., 1994; Goulding et al., 1994). 
Pax3 appears to be necessary for the migration of muscle progenitor cells from the somites 
into the limb buds (Bober et al., 1994; Tajbakhsh et al., 1997). The migrating cells express Pax3, 
but no muscle markers or differentiation genes until they have reached their positions in the 
limb buds (Bober et al., 1994). Pax3 is required for the migration of the specified myogenic 
precursors, but experiments have shown that the cells from the appropriate region are 
competent to form myoblasts when they are transplanted into the limb bud (Daston et al., 
1996). Therefore Pax3 is not necessary for the final differentiation of the cells. The gene c-met 
appears to act downstream of Pax3, and is necessary for migration of the myogenic precursors 
into the limb bud (Bladt et al., 1995). 
Pax3 and the closely related Pax7 have been found to regulate the onset of myogenesis 
through induction of the expression of the myogenic determination genes MyoD and Myf5 
(Myogenic factor 5) (Bajard et al., 2006; Maroto et al., 1997). This has been demonstrated in 
both embryonic myogenic precursor cells, and in adult muscle progenitor cells – satellite cells – 
which aid in muscle healing and growth (Maroto et al., 1997; Tajbakhsh et al., 1997). Both Pax3 
and Myf5 are thought to act upstream, and therefore be necessary for the induction of MyoD 
expression in muscle precursor cells (Tajbakhsh et al., 1997). The loss of both Myf5 and MyoD 
results in loss of the myoblasts during development (Daston et al., 1996). 
Myogenic precursors and satellite cells express both Pax3 and Pax7, and in the absence of this 
gene expression only the very earliest embryonic muscle forms (Relaix et al., 2005). This Pax3+, 
Pax7+ cell population is derived from the dermomyotome of the somite, and constitutes the 
majority of proliferating cells in the embryonic or adult muscle tissue, allowing both secondary 
myogenesis and adult muscle healing to occur (Ben-Yair and Kalcheim, 2005). Cells which fail 
to express these genes either apoptose or adopt non-myogenic fates (Relaix et al., 2005). 
On the other hand, muscle development in the cranial region appears to be Pax3-independent. 
The gene is not expressed in cranial muscles (Tajbakhsh et al., 1997). Additionally, Pax3 mutant 
mice fail to develop trunk muscles, but the muscles in the head develop normally (Tajbakhsh et 
al., 1997). 
1.4.5    Possible mechanisms underlying the development of neural tube defects in 
Splotch mutant embryos 
Given the roles of Pax3 during embryonic development, there are a number of cellular defects 
which could potentially cause NTDs in Splotch mutant (Sp2H/Sp2H) embryos. 
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1.4.5.1    Excess apoptosis 
The link between apoptosis and NTDs is unclear. Some research has shown an increase in NTDs 
in embryos with reduced apoptosis. For example, it was observed that embryos homozygous 
for a mutation in the pro-apoptotic gene p53 developed exencephaly with a penetrance of 
between 8 and 16%. This NTD was found to only affect the female embryos (Sah et al., 1995). 
On the other hand, rat embryos with retinoic acid-induced NTDs had increased apoptosis in 
the neural folds (Wei et al., 2012). Therefore, excess apoptosis may also be associated with 
NTDs. 
However, a number of publications argue against a causative link between insufficient 
apoptosis and NTDs. Apoptosis is unnecessary to complete the closure of either the cranial or 
caudal regions of the NT (Massa et al., 2009). Additionally, some studies have found p53 null 
mice to be phenotypically normal, although they have an increased risk of cancerous tumour 
development (Donehower et al., 1992). 
Previous research has shown that diabetes reduces Pax3 expression, and that this, in turn, 
increases apoptosis in the NT (Phelan et al., 1997). Further research suggested that excess p53-
mediated apoptosis in the neural tubes of Pax3 mutant embryos could cause the NTDs seen in 
these mice (Pani et al., 2002). This theory is supported by evidence discussed in section 
1.4.4.1, which suggests that Pax3 plays an important role in cell survival. 
Pax3 has been found to reduce p53-mediated gene expression, and reduce levels of p53 
protein (Underwood et al., 2007). It was also reported that the Pax3 mutation resulted in 
raised levels of the p53 protein, and increased apoptosis in the neural folds (Pani et al., 2002; 
Phelan et al., 1997). Pax3Sp/+ p53+/- mice were intercrossed to generate double mutant 
embryos lacking both Pax3 and p53 function. NTDs occurred with lower frequency in Pax3Sp/Sp 
p53-/- embryos, (Pani et al., 2002). These results suggest that the reduction in apoptosis caused 
by the p53 mutation could rescue the NTDs in the Splotch mutant mice, and the conclusion 
was that Pax3 acts to inhibit apoptosis during neural tube closure. Further research from this 
lab suggests that Pax3 protein is responsible for the ubiquitination and degradation of the p53 
protein, thus reducing the rate of apoptosis in the neural tube (Wang et al., 2011). 
On the other hand, unpublished data from our laboratory suggests that p53-mediated 
apoptosis is not involved in NTD development in Splotch mice. TUNEL staining has shown no 
increase in apoptosis in the neural folds of Sp2H/Sp2H embryos, and inhibition of apoptosis with 
the pan-caspase inhibitor Z-VAD-FMK (Zhu et al., 1995) did not rescue NTDs in these mice. 
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1.4.5.2    Premature neuronal differentiation 
The timing of neuronal differentiation is known to be important in controlling the 
development of the NT, and premature neuronal differentiation has been associated with 
several models of NTDs. Multiple genes have been found to inhibit neuronal differentiation in 
the developing NT, and mutation in these genes may result in premature neuronal 
differentiation and NTD development. For example, mutations in several of the Zic genes have 
been associated with NTDs, including Zic2, Zic3 and Zic5, and these genes are known to 
maintain neurepithelial cells in a proliferative, undifferentiated state during NT development 
(Aruga et al., 2002a; Aruga et al., 2002b; Aruga, 2004; Nagai et al., 2000). Additionally, 
teratogens may alter the expression of genes which control the timing of neuronal 
differentiation. For example, excess glucose induces NTDs in developing embryos, and has 
been found to induce premature neuronal differentiation in the NT. Exposure to high glucose 
concentration causes changes in the expression levels of genes such as Shh, Bmp4, Neurog1/2, 
Hes1/5 and Olig1, which control differentiation and proliferation in the NT (Fu et al., 2006). 
On the other hand, the protein Geminin is thought to promote neuronal differentiation in the 
NT, but its mutation causes spina bifida in mouse embryos (Patterson et al., 2014). This 
suggests that developmental timing of neuronal differentiation is important in the formation 
and closure of the NT. 
Pax3 is known to play a role in the patterning and differentiation of the PNS, which is NC-
derived (discussed in section 1.4.4.2). Pax3 is normally associated with the maintenance of 
multipotency and the prevention of differentiation. Therefore, loss of Pax3 expression is often 
accompanied by differentiation; in vitro studies have shown that loss of Pax3 expression 
induces multipotent cells to differentiate into neurons (Reeves et al., 1999), and in vivo studies 
have demonstrated premature neuronal differentiation in Sp2H/Sp2H embryos (Nakazaki et al., 
2008). 
Loss of Pax3 expression prevents sensory neuronal differentiation in the ophthalmic trigeminal 
placode. Ectopic expression of Pax3 in other placodes induces expression of the markers of 
ophthalmic trigeminal placode development, but no neurons differentiate (Dude et al., 2009). 
In addition, Pax3-negative NC cell culture produces 5-fold fewer sensory neurons than Pax3-
positive NC cell culture (Koblar et al., 1999). These results suggest that Pax3 expression is 
necessary for the determination of certain neuronal fates, but that it holds the cells in a 
precursor state and prevents differentiation. 
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Pax3 is able to regulate the expression of genes involved in the terminal differentiation of PNS 
neurons. It binds to cis-regulatory elements of the proneural bHLH genes Hairy and enhancer 
of split homologue-1 (Hes1) and Neurogenin2 (Ngn2) (Nakazaki et al., 2008), which are 
involved in determination of neuronal cell fate. The expression levels of Hes1 and Ngn2 are 
reduced in Pax3 mutant mouse embryos, and these embryos exhibit premature neuronal 
differentiation (Nakazaki et al., 2008), suggesting that Pax3 is involved in regulating the 
acquisition of neuronal fate. 
Ngn2 is involved in the acquisition of sensory neuronal fate (Fode et al., 1998). It acts in part 
through induction of Delta1 expression, which leads to initiation of Notch signalling to induce 
neuronal differentiation (Ma et al., 1996). Expression of Delta induces Notch expression in 
adjacent cells, and Notch promotes the expression of the Hes genes, including Hes1, which 
inhibit Ngn2 expression, and maintain cells in a neural progenitor state. Thus the oscillation of 
these genes controls the patterning and timing of neuronal differentiation (Kageyama et al., 
2008; Shimojo et al., 2008). Pax3 induces expression of both Hes1 and Ngn2, and therefore 
regulates lateral inhibition and neural differentiation through the activity of the Notch 
pathway. 
Unpublished research in our laboratory has shown premature neuronal differentiation in the 
cranial region of the neural tube of Sp2H/Sp2H embryos. This neuronal differentiation occurs 
prior to cranial NT closure, and may be the cause of exencephaly in these embryos; neurons 
are not epithelial cells, and so premature neuronal differentiation may alter the morphology 
and behaviour of the neurepithelium prior to fusion, thus making fusion more likely to fail. This 
defect is particularly prominent in the prospective midbrain. However, neuronal differentiation 
in the spinal region of the NT in Sp2H/Sp2H embryos has not previously been studied. 
1.4.5.3    Reduced proliferation in the neural plate 
The rates of proliferation in tissues including the NT and tissues surrounding the NT are known 
to play a role in NT closure and in the development of NTDs. For instance, the drug valproic 
acid is known to cause NTDs in embryos, and evidence suggests that it reduces proliferation in 
the developing neurepithelium (Wlodarczyk et al., 1996). On the other hand, the humpty 
dumpty mouse mutant carries a mutation in the protein phosphatase Phactr4, and the 
embryos develop exencephaly. In this case, the NTD is caused by an increase in proliferation in 
the ventral NT caused by loss of Phactr4 activity (Kim et al., 2007). Therefore it appears that 
the rate of proliferation in the NT must be finely balanced for closure to occur successfully. 
Changes in the relative rates of proliferation between tissues can also cause NTDs. For 
example, a reduction in proliferation in the gut and notochord of the curly tail (ct) mouse leads 
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to spina bifida. This is due to the imbalance in proliferation in the gut and notochord compared 
to the NT, which causes curvature of the spinal region. Thus the NT is mechanically prevented 
from closing (Copp et al., 1988a). NTDs in ct embryos can be rescued through growth 
retardation caused by food deprivation in the mothers; the reduction in proliferation is greater 
in the more rapidly proliferating NT. Therefore, the proliferation imbalance is corrected, and 
spina bifida does not develop (Copp et al., 1988b). 
Changes in proliferation have been widely reported in Pax3-negative tissues. For example, a 
reduction in the proliferation rate of myogenic precursors has been demonstrated in cultured 
Pax3-deficient cells (Collins et al., 2009), and there is also a reduction in the expansion of the 
NCC population in Splotch mice prior to NCC migration (Conway et al., 2000). 
In the NT, Spd mutant embryos first show a reduced proliferation rate compared to controls, 
and then later in development, an increased rate compared to controls, resulting in 
overexpansion of the neural tissue (Keller-Peck and Mullen, 1997). These mice develop spina 
bifida. 
Alterations to proliferation have been reported in NTDs in multiple animal models (Murko et 
al., 2013; Wang et al., 2013; Wei et al., 2012). However, these proliferation defects are 
accompanied by other cellular defects, such as alterations in apoptosis or differentiation. 
Therefore, little is known about proliferation in the NT of the Splotch mouse, or about the 
effects of altered proliferation on the development of NTDs as separate from apoptosis or 
premature differentiation. 
Unpublished data from our laboratory has shown that premature neuronal differentiation 
observed in the cranial NT of Sp2H/Sp2H embryos is accompanied by reduced proliferation. This 
does not clarify which – if either – of these mechanisms is causative, but the data presents a 
possible causative mechanism for study in the spinal region of the NT in Sp2H/Sp2H embryos. 
1.4.6    Splotch and folate 
The Splotch mouse model is known to be sensitive to folate levels – supplementation has been 
found to rescue the NTDs usually seen in these mice. However, more unusually, folate 
deficiency has been found to increase the frequency of NTD development (Burren et al., 2008; 
Fleming and Copp, 1998). Additionally, Splotch embryos have an abnormal result on the dU 
(deoxyuridine) suppression test, which is a measure of thymidylate synthesis and can indicate 
abnormalities in the folate cycle. Exposure to folic acid results in a dU suppression test result 
closer to wild type, suggesting that folate supplementation is able to rescue some of the folate 
cycle defects which result in NTD development in the Splotch mouse (Fleming and Copp, 1998). 
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As mentioned previously (section 1.2.4) folate may be related to NTDs due to its influence on 
proliferation. As the proliferation-differentiation balance is disrupted in the Splotch mouse it 
may be this mechanism that is rescued by folate supplementation, or worsened by deficiency. 
In support of this, Pax3 mutant neurospheres generated from Splotch NTs show increased NC 
cell proliferation when exposed to folate (Ichi et al., 2012). Furthermore, folate 
supplementation reverses abnormal epigenetic alterations seen in Splotch embryos which 
affect the Pax3 downstream proneural effectors Hes1 and Ngn2 (Ichi et al., 2010). 
1.4.7    Canonical Wnt signalling in Splotch 
Evidence suggests that canonical Wnt signalling may interact with Pax3 signalling. Both 
pathways are important in regulation of the proliferation-differentiation balance in the NT, and 
indeed, both promote the maintenance of the proliferative state while repressing 
differentiation (Keller-Peck and Mullen, 1997; Megason and McMahon, 2002). See section 1.6 
for more detail regarding the canonical Wnt signalling pathway. 
Several studies have been published which demonstrate a link between Pax3 and the Wnt 
signalling pathway. For example, the region of Pax3 expression in the neural plate has been 
shown to expand upon ectopic expression of Wnt8 in Xenopus, and shrink when Wnt8 
expression is inhibited (Bang et al., 1999). In addition, Wnt signalling was shown to induce 
Pax3 expression in Xenopus NC, which are derived from the neural plate border (Monsoro-
Burq et al., 2005). It has also been suggested that Wnt signalling may influence Pax3 signalling 
through the activity of Msx1 in mouse limb muscle development, and Ap2a in the NC (de et al., 
2011; Miller et al., 2007). Cultured chick neural plate cells have been shown to upregulate 
Pax3 along with other NC markers in response to supplementation of either Wg or Wnt3a 
(Taneyhill and Bronner-Fraser, 2005) 
Ectopic Wnt1 expression in the ventral NT increased the rate of proliferation of the cells in this 
region by acting through β-catenin to shorten the cell cycle. Transfection of Wnt1 into one half 
of the NT caused lateral bulging of the transfected half due an increase in the number of cells 
in this region. Furthermore, the expression pattern of Pax3 is overlapping with that of Wnt1 
and Wnt3a in the neural folds, and Pax3 has been reported to directly induce Wnt1 expression 
(Fenby et al., 2008; Megason and McMahon, 2002). Therefore, it is possible that Pax3 and 
canonical Wnt signalling may have interlinking roles in the development of the NT. Since both 
premature neuronal differentiation and reduced proliferation have been suggested as 
potential mechanisms of NTD development, it is also possible that canonical Wnt signalling 
may be involved in the formation of NTDs. 
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Recent evidence suggests that β-catenin may function upstream of Pax3. Conditional knock-
out of β-catenin using a Pax3Cre allele resulted in the development of NTDs, and the 
knockdown of Pax3 and Cdx2 expression. Binding sites for TCF/LEF1 were found in the Pax3 
promoter, which suggests that Pax3 may be a direct target of β-catenin (Zhao et al., 2014). 
 
1.5    Waardenburg Syndrome 
Pax3 mutation in humans has been associated with certain types of the developmental 
disorder Waardenburg syndrome (WS). WS was first described in 1951 by the Dutch 
ophthalmologist and geneticist Petrus J. Waardenburg (WAARDENBURG, 1951). It is an 
autosomal dominant developmental disorder with a frequency in the general population of 
around 1 in 40 000, and accounts for approximately 2% cases of congenital deafness (Van et 
al., 1995). 
1.5.1    Symptoms 
WS has a number of characteristic symptoms. Additionally, a number of symptoms are seen 
with varying penetrance, and can be rare, or particular to a certain family. Even the most 
common symptoms have highly variable penetrance between families. 
Common characteristics of WS include total or partial heterochromia irides (abnormal iris 
pigmentation), synophrys (hyperplasia of the medial portion of the eyebrows), poliosis (a 
white forelock), patches of skin hypopigmentation, dystopia canthorum (broad nasal root), and 
unilateral or bilateral sensorineural deafness. However, many other symptoms have been 
associated with the disease, including premature greying, limb defects, gut defects, 
microphthalmia, facial clefts, and genito-urinary abnormalities (Asher, Jr. and Friedman, 1990; 
Delezoide and Vekemans, 1994). 
1.5.2    The four types of Waardenburg Syndrome 
WS is a heterogeneous disease which can be caused by mutations in many different genes. 
However, mutations in certain genes are associated with particular groups of symptoms. 
Therefore, the syndrome has been clustered into four types according to common symptoms 
(Read and Newton, 1997). 
Type I WS (WS1) usually exhibits the common symptoms listed above. It differs from WS2 only 
by the absence of dystopia canthorum in type II (Farrer et al., 1994; Tassabehji et al., 1993). 
WS3 is also known as Klein-Waardenburg syndrome, and shows limb abnormalities. WS4 is 
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also known as Shah-Waardenburg, or Waardenburg-Hirschprung disease, and is characterised 
by the presence of an aganglionic megacolon. 
Both WS1 and WS3 have been associated with mutations in the Pax3 gene (Farrer et al., 1994; 
Hoth et al., 1993; Tassabehji et al., 1992). Despite similarities to WS1, WS2 has been shown not 
to be linked to Pax3 mutation (Arias, 1993; Farrer et al., 1994). However, mutations in the 
MITF gene have been found in some, but not all WS2 patients (Tassabehji et al., 1994). It is 
likely that a diagnosis of WS2 is given to a large group of heterogeneous melanocyte defects. 
WS4 has been associated with mutations in several different genes, including Sox10, 
Endothelin-3, and the Endothelin-B receptor gene (Edery et al., 1996; Pingault et al., 1998; 
Puffenberger et al., 1994). 
1.5.3    Pax3 mutations and neural tube defects in Waardenburg Syndrome 
Pax3 mutations are known to cause WS1 and WS3 (Farrer et al., 1994; Hoth et al., 1993; 
Tassabehji et al., 1992).  The majority of cases of WS1 and WS3 which have been described 
have been heterozygous for Pax3 mutation.  The disease has a dominant inheritance pattern, 
and one affected allele will produce a phenotype. A large number of different Pax3 mutations 
have been reported in humans, and these are often family specific. WS is known to be an 
extremely heterogeneous disease, and it is probable that position and severity of the mutation 
within the protein is linked to the nature of the phenotype which develops. 
Pax3 mutation in the population is relatively rare. According to the ExAC database a large 
number of missense mutations have been identified, the majority of which have been found in 
a single individual. However, very few mutations have been identified which are predicted to 
be deleterious. The database lists 8 loss-of-function mutations, 5 of which were found in just 
one individual. The remaining loss-of-function mutations are predicted to have a frequency of 
around 1/10 000 or less. The most common of the loss-of-function alleles is also reported to 
have occurred in homozygous form in one individual. 
Pax3 mutations found in affected families tend to cluster around the sites of the paired-type 
homeodomain and the paired domain. There are three common types of mutation (Read and 
Newton, 1997). The first includes deletions, frameshift mutations, splice site mutations and 
nonsense mutations which result in a null allele. These mutations can be found anywhere 
between exons 2-6, but rarely affect the 3’ region of the gene. The second common type of 
mutation consists of an amino acid substitution in the N-terminal region of the paired domain 
(Xu et al., 1995). The third common type of mutation involves the third α-helix of the 
homeodomain, which is important in the recognition of the target DNA sequence (Kissinger et 
al., 1990). These mutations all result in loss of function to some degree, and all result in the 
54 
 
same group of symptoms. Variations in symptoms are likely to be due to the Pax3 dosage 
sensitivity of different tissues. For example, the frontal bone (the skull bone which 
encompasses the forehead and part of the eye sockets) must be highly sensitive to Pax3 
dosage, and is therefore almost always affected by mutation. Thus dystopia canthorum is 
virtually universal in cases of Pax3 mutation. However, other symptoms such as pigmentation 
defects and limb abnormalities are much more variable, which suggests that melanocytes and 
limb bud mesenchyme are less sensitive to Pax3 dosage (Read and Newton, 1997). 
Several cases of suspected homozygosity of Pax3 mutation have been reported, and a small 
number have been confirmed. A case was reported in 1995 of a fetus showing severe 
symptoms of WS3, and also anencephaly. The parents were siblings with WS1, and the 
pregnancy was terminated at 15 weeks. The fetal tissue was not genotyped, but it is likely that 
the fetus was homozygous for mutations in Pax3 (Ayme and Philip, 1995). Another case was 
described in 1995 in which a baby was born with suspected homozygous mutation of Pax3. 
The pregnancy was normal, but the child was born with severe symptoms of WS3. The parents 
were cousins who were both affected with WS1. Genotyping confirmed that the baby carried 
two copies of the Pax3 mutant allele found in other members of the family, including the 
parents (Zlotogora et al., 1995). 
Whether there is a link between NTDs and Pax3 mutation in humans is not well established. 
Individuals have been reported with both WS and spina bifida (Ayme and Philip, 1995; 
Carezani-Gavin et al., 1992; Hol et al., 1995; Moline and Sandlin, 1993). In some cases, the two 
defects have been inherited together within a family (Begleiter and Harris, 1992; Chatkupt et 
al., 1993). It is not known whether the NTD is part of the syndrome of WS, or whether it could 
be associated with a different susceptibility locus, possibly closely linked to the Pax3 locus. 
Linkage analysis has suggested no linkage between spina bifida and the Pax3 gene, which 
suggests that it is not a major susceptibility gene in the development of NTDs in humans 
(Chatkupt et al., 1995). However, it may still act as a risk gene; recent studies have shown that 
single nucleotide polymorphisms in Pax3 are more common in the genomes of patients with 
spina bifida than the general population (Agopian et al., 2013; Lu et al., 2007). NTDs in humans 
are known to be multigenic. Thus Pax3 mutations could be associated with the development of 
spina bifida in combination with other risk alleles and/or environmental factors. 
1.5.4    Splotch as a model for Waardenburg Syndrome 
Pax3 mutations are the cause of defects observed in both the Splotch mouse and in cases of 
WS1 and WS3. Several common phenotypic aspects occur in these disorders in both mice and 
humans. For instance, pigmentation abnormalities affecting the skin and hair/fur are seen in 
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both cases, and WS3 individuals also have limb abnormalities, which are seen in Splotch mice 
(Auerbach, 1954; Bober et al., 1994; Hoth et al., 1993; WAARDENBURG, 1951). Additionally, 
heart defects are very common in Splotch mutant embryos, and are occasionally seen in WS 
individuals (Banerjee, 1986; Mathieu et al., 1990). 
Although the Splotch mouse carries a mutation in the gene responsible for WS1 and WS3, 
several differences in phenotype are also apparent. These differences could in part be due to 
the position and nature of the mutations, or due to the fact that Splotch mice are often studied 
in homozygous form, whereas most affected WS individuals are heterozygous for the 
mutation. 
One of the major disabilities commonly found in WS in humans is sensorineural deafness 
(WAARDENBURG, 1951). Inner ear abnormalities have been reported in Splotch homozygous 
mutant embryos, and are usually seen in combination with exencephaly; the inner ear of 
Splotch embryos with closed NTs often develop normally  (Deol, 1966). The abnormalities are 
likely due to the effects of the Pax3 mutation on NC and probably also neurectodermal cells 
which contribute to inner ear development (Freyer et al., 2011). For instance, higher levels of 
apoptosis and lower levels of polysialylated NCAM in the developing inner ear have been 
reported in Splotch mutant embryos (Buckiova and Syka, 2004). However, the development of 
the inner ear is normal in heterozygotes, and their hearing is unaffected (Buckiova and Syka, 
2004; Steel and Smith, 1992). 
The Splotch mouse is frequently used as an experimental model for NTDs. However, the link 
between NTDs and WS appears to be weak, and Pax3 is not known as a susceptibility gene for 
NTDs in humans (Chatkupt et al., 1995). However, NTDs are rare in heterozygous Splotch mice, 
and most WS patients studied are also heterozygous. Additionally, sample sizes of human 
homozygous Pax3 mutant cases are very low. Studies have shown that certain gene variations 
of Pax3 in humans may increase the risk of spina bifida (Agopian et al., 2013; Lu et al., 2007). 
Therefore Pax3 may act as a risk gene in humans, and certain Pax3 alleles may increase the risk 
of developing an NTD in combination with other risk alleles. 
The study of Splotch mice enables cellular mechanisms to be identified which result in defects 
in WS patients. For example, neural crest defects present in Splotch embryos are equivalent to 
some of the defects identified in WS patients, including pigmentation abnormalities, and 
defects in limb development in Splotch embryos are likely to be equivalent to the limb defects 
seen in WS3 patients (Auerbach, 1954; Bober et al., 1994; Hoth et al., 1993; WAARDENBURG, 
1951). Study of these abnormalities in the Splotch mouse has shed light on the mechanisms 
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behind the defects seen in WS patients. Additionally, Splotch embryos provide a useful model 
for the study of developmental defects which result in NTDs. 
 
1.6    The canonical Wnt signalling pathway 
The Wnt signalling pathways are highly evolutionarily conserved, and are found in a huge 
range of organisms, from Drosophila and C. elegans to mammals. There are two main branches 
of Wnt signalling – the canonical and non-canonical pathways. All Wnt signalling involves 
binding of an extracellular secreted Wnt ligand to a Frizzled cell-surface receptor, and can 
change the behaviour and fate of cells in a multicellular organism. Wnt signalling often acts 
over a short distance, such as between neighbouring cells, but is also able to act as a longer 
range morphogen (Clevers and Nusse, 2012; Tabata and Takei, 2004). 
Canonical Wnt signalling involves the protein β-catenin (Figure 1.7). In the absence of Wnt 
ligand, β-catenin is sequestered by a protein complex called the destruction complex, whose 
components include Axin, Adenomatous polyposis coli (APC), Glycogen synthase kinase-3β 
(GSK3β), and Dishevelled (Dvl) (see section 1.6.2). The β-catenin protein is then 
phosphorylated, ubiquitinated, and targeted for degradation by the proteosome. 
When Wnt ligand is present, the Wnt receptors sequester the components of the destruction 
complex. This process requires the protein Dishevelled (Dvl). This sequestration enables β-
catenin to build up in the cytoplasm of the cell without being targeted for degradation. β-
catenin is then transported to the nucleus, where, in combination with other transcription 
factors and cofactors, including T-cell-specific transcription factor (TCF)/lymphoid enhancing 
binding factor (LEF), it is able to initiate the transcription of certain Wnt-responsive genes, 
including transcription factors important during embryonic development (MacDonald et al., 
2009). 
1.6.1    Wnt ligands and receptors 
Humans and most other mammals have 19 Wnt genes, which form 12 subfamilies. The Wnt 
proteins are hydrophobic, cysteine-rich secreted glycoproteins of around 40 kDa in size 
(Clevers and Nusse, 2012). 
In canonical Wnt signalling the Wnt ligands bind to a heterodimeric receptor, consisting of a 
Frizzled (Fz) protein and an LRP5/6 protein. There are 10 mammalian Fz proteins, which are 7-
membrane pass proteins with a cysteine-rich N-terminal domain (CRD) (Bhanot et al., 1996). 
LRP5 and LRP6 are low-density lipoprotein receptor-related proteins. They are both  
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Figure 1.7: Canonical Wnt signalling in the absence (A) or presence (B) of a Wnt ligand. 
Canonical Wnt signalling alters the fate and activity of the β-catenin protein. When Wnt ligand is 
absent (A) the destruction complex forms in the cytoplasm. This protein complex consists of a number 
of molecules, including Axin, APC, GSK3, and CK1. The destruction complex binds cytoplasmic β-
catenin, and phosphorylates it. This targets the β-catenin for degradation by the proteasome, and it 
becomes scarce within the cell. Absence of β-catenin in the nucleus results in the binding of 
repressors to the promoters of the Wnt-responsive genes, and transcription is inhibited. 
When Wnt ligand is present (B) it binds to the cell surface receptors Frizzled and LRP5/6. The 
intracellular regions of these receptors sequester components of the destruction complex, and 
prevent it from forming. β-catenin is not targeted for degradation, and its concentration within the 
cytoplasm increases. β-catenin translocate to the nucleus, where it displaces repressors on the 
promoters of Wnt responsive genes. In combination with a number of co-factors, β-catenin recruits 
components of the cell’s transcriptional machinery, and activates transcription of these genes. 
Figure modified from (MacDonald et al., 2009). 
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approximately 180 kDa in size, and have single-pass transmembrane domains (Brown et al., 
1998; Kim et al., 1998; Wehrli et al., 2000). 
1.6.1.1    Synthesis and secretion of the Wnt ligand 
Wnt ligands are synthesised in the endoplasmic reticulum (ER). They undergo a number of post 
translational modifications in the ER, including protein folding, glycosylation and acylation.  
Folding is enabled through interactions with molecular chaperones, such as GRP78, which 
binds Wnt3a (Verras et al., 2008). Wnts are cysteine rich, which supports evidence that 
disulphide bonds are an important part of Wnt folding (Mason et al., 1992). 
In Drosophila the transmembrane protein Porcupine (Porc) is necessary for N-glycosylation of 
the Wnt1 homologue Wingless (Wg) at multiple sites. It acts by anchoring Wg at the ER 
membrane (Tanaka et al., 2002). The role of glycosylation of Wnt ligands is controversial; some 
research has shown that prevention of Wnt3a glycosylation inhibits secretion and signalling 
(Komekado et al., 2007). However, alternative research suggests that lack of Wnt glycosylation 
has no effect on either secretion or signalling abilities of the ligand (Tang et al., 2012). 
Wnt ligands, including Wnt3a, have been shown to bind the lipid group palmitic acid at a 
conserved cysteine residue (Cys77 in murine Wnt3a). The lipid imparts hydrophobic properties 
on the protein, and removal results in a loss of signalling ability of the ligand (Willert et al., 
2003). Wnt3a is also modified at Ser209 with the monounsaturated fatty acid palmitoleic acid. 
This Ser209 palmitoylation has been found to be essential for secretion of the ligand. In cells 
lacking the Ser209 acylation, Wnt3a is retained in the endoplasmic reticulum (ER) and is not 
transported for secretion (Takada et al., 2006). For example, the enzyme stearoyl desaturase 
(SCD) generates monounsaturated fatty acids, which are then attached to Wnt ligands as the 
palmitic and palmitoleic acids described above (Rios-Esteves and Resh, 2013). Porc acts as an 
acyltransferase for this attachment, and is thus necessary for the secretion of Wnt3a in mice 
(Hofmann, 2000; Takada et al., 2006). In the absence of either of these proteins Wnt ligands, 
such as Wnt3a, show reduced secretion and signalling. 
Additionally, the seven-pass membrane protein Wntless (Wls) is essential for Wnt ligand 
secretion (Banziger et al., 2006; Bartscherer et al., 2006). Wls is a putative orphan G protein 
coupled receptor (Jin et al., 2010) which is found in the ER (Coombs et al., 2010). The protein is 
able to bind to the hydrophobic palmitoleic acid group at Ser209 of Wnt ligands to enable 
release from the ER and secretion from the cell (Das et al., 2012). 
The protein Oto is able to promote the anchorage of Wnt ligands to the membrane of the ER 
through the addition of the phospholipid glycosylphosphatidylinositol (GPI), thus preventing 
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secretion. Cleavage of the GPI anchor allows secretion of the Wnt ligand. In this way, Wnt 
ligand may be accumulated and then secreted in a burst (Zoltewicz et al., 2009). Additionally, 
accumulation of the Wnt ligand may be achieved through the use of cholesterol- and 
glycosphingolipid-rich domains of the plasma membrane known as lipid rafts; acylation of 
Wnt1 by Porc results in the targeting of the ligand to lipid rafts, which enables accumulation 
for secretion (Zhai et al., 2004). 
1.6.1.2    Transport through the extracellular matrix 
Cell surface proteins and the ECM play important roles in transduction of the secreted Wnt 
signal between cells. 
The proteoglycans (PGs) are protein components of the cell surface and the ECM which play 
important roles in cell adhesion and the regulation of intercellular signalling (Reichsman et al., 
1996). They consist of a core protein bound by covalently linked glycosaminoglycan chains. 
These chains may be chondroitin sulphate (CS), heparin sulphate (HS), dermatan sulphate or 
keratin sulphate. Some PGs, such as glypicans and syndecans, are found at the cell surface, 
whereas others, such as versican and perlecan, tend to be associated with the ECM 
(Theocharis et al., 2010). The cell surface PGs in particular bind to a large number of molecules 
involved in cell signalling, and can influence processes such as proliferation and migration 
(Theocharis et al., 2010). Heparin sulphate proteoglycans (HSPGs) are PGs which are 
commonly found on the surface of cells. They are able to act as cofactors in a number of 
interactions between proteins, such as between growth factors and their receptors, and 
between various enzymes and structural proteins (David, 1993). 
Wnt ligand is found mostly associated with components of the matrix; around 50% at the cell 
surface, 33% with the ECM, and only around 17% in solution surrounding the cells (Reichsman 
et al., 1996). Drosophila Wg has been found to be released from the cell surface and the ECM 
by the addition of small amounts of exogenous glycosaminoglycan chains, such as heparin, HS, 
and CS. Thus it was discovered that Wg is bound by the HS and CS components of the 
proteoglycans, and that this binding promotes signalling by Wg (Reichsman et al., 1996). 
Furthermore, research suggests that the Drosophila HSPGs dally and dally-like potentiate Wg 
signalling by acting in combination with the Wnt receptor Dfz2 (Baeg et al., 2001; Lin and 
Perrimon, 1999). This mechanism probably acts through the sequestration and stabilisation of 
Wg at the cell surface, which makes the ligands more available for receptor binding (Baeg et 
al., 2004). 
Wnt ligands are known to be hydrophobic, and yet they are able to move through the ECM – 
sometimes long distances – in order to bind receptors. Wg ligands in Drosophila have been 
61 
 
found to co-localise with extracellular lipoprotein particles called argosomes, which appear to 
aid movement of Wg through the ECM (Panakova et al., 2005). The HSPGs dally and dally-like 
may stabilise the ligands during transport (Mikels and Nusse, 2006). 
1.6.1.3    The Wnt receptors 
The Wnt ligands bind to a heterodimer consisting of the Fz and LRP5/6 Wnt receptors (Mao et 
al., 2001; Tamai et al., 2000). Wnts induce co-clustering of the Wnt receptors, thus increasing 
the likelihood of a response to further Wnt signalling (Bilic et al., 2007). 
The CRD of Fz plays an important role in the binding of Wnt to its receptor (Bourhis et al., 
2010; Dann et al., 2001; Hsieh et al., 1999; Janda et al., 2012). It is thought that binding of the 
site shields Wnt lipid groups from the aqueous environment (Janda et al., 2012). In Xenopus, 
the Fz8-CRD binds the Xwnt8 ligand in a doughnut shape, with two binding domains. In the 
first binding domain, a palmitoleic acid group at Ser187 of Xwnt8 (the equivalent of S209 of 
Wnt3a) binds into a hydrophobic groove in the Fz8-CRD. The second site consists of a rigid β-
strand on the Xwnt8 protein, which enables hydrophobic interactions with residues in a pocket 
of the Fz8-CRD (Bienz and He, 2012; Janda et al., 2012). 
The extracellular domain of LRP6 has been shown to bind Wnt1 and Wnt3a, and – when bound 
to a Wnt ligand – the CRD of Fz8 (Bourhis et al., 2010; Tamai et al., 2000). However, LRP6 
appears to have multiple binding sites for different Wnt ligands, and indeed may bind multiple 
Wnt ligands simultaneously (Bourhis et al., 2010). 
Binding strength differs greatly between the different Wnt ligands and the different receptors. 
For example, Wnt3a binds more tightly to the Fz8-CRD than Wnt5a and Wnt5b, and much 
more tightly than Wnt9b. However, Wnt9b binds very tightly to LRP6, whereas Wnt5a and 
Wnt5b appear not to interact with LRP6 at all (Bourhis et al., 2010). 
It has been shown that the C-terminal cytoplasmic domain of LRP6 is necessary for transducing 
the Wnt signal (Tamai et al., 2000). Following Wnt signalling the intracellular domain of LRP6 is 
phosphorylated by CK1 (casein kinase 1). This activates LRP6 and induces Axin recruitment 
(Bilic et al., 2007; Tamai et al., 2004). Similarly, Fz proteins are able to recruit and directly bind 
Dishevelled (Dvl) at the cell surface in response to Wnt ligand binding (Chen et al., 2003). 
Dishevelled is able to bind Axin, and so this reinforces – or possibly enables – the recruitment 
of Axin at the cell surface during Wnt signalling, and facilitates clustering of the Wnt receptors 
(Angers and Moon, 2009; Choi et al., 2010). 
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1.6.2    The destruction complex 
The destruction complex is a cytoplasmic protein complex including the proteins Axin, APC, 
GSK3β, and Dvl. The purpose of the destruction complex is to bind β-catenin in the absence of 
Wnt ligand, and phosphorylate β-catenin for targeting to proteosomal degradation. In the 
absence of Wnt ligand components of the destruction complex are sequestered at the cell 
membrane by the Wnt receptors, thus stabilising β-catenin for transcriptional activity 
(MacDonald et al., 2009). 
1.6.2.1    Axin 
The protein Axin acts as a molecular scaffold to which the other components of the 
destruction complex can bind. It significantly downregulates β-catenin when overexpressed, 
such as in cancer (Hart et al., 1998). Axin has several binding domains; an N-terminal Regulator 
of G-protein signalling (RGS) domain, a GSK3β-binding domain, and a C-terminal DIX 
(Dishevelled and Axin) domain (Behrens et al., 1998; Fagotto et al., 1999; Kishida et al., 1999). 
The N-terminal half of Axin has been found to bind to GSK3β, β-catenin, and the central region 
of APC (Hart et al., 1998). The RGS domain directly binds APC (Behrens et al., 1998; Hart et al., 
1998), and the DIX domain is able to bind other DIX domains, forming either a homodimer or a 
heterodimer with molecules such as Dvl (Choi et al., 2010). In binding β-catenin and GSK3β in 
close proximity, Axin promotes phosphorylation of β-catenin by GSK3β, thus targeting β-
catenin for degradation (Ikeda et al., 1998). 
The C-terminal region of Axin has been found to bind to the intracellular domain of LRP5 as a 
result of canonical Wnt signalling (Cliffe et al., 2003; Mao et al., 2001). The RGS, DIX and GSK3β 
binding domains are all thought to be important for this interaction (Mao et al., 2001). The 
binding is also facilitated by the presence of the Wnt ligand and by GSK3β (Mao et al., 2001). 
The interaction between Axin and LRP5 prevents the formation of the destruction complex, 
and thus β-catenin is stabilised. 
Additionally, GSK3β is able to phosphorylate the Axin protein, resulting in a more stable form 
which binds β-catenin with higher affinity (Willert et al., 1999; Yamamoto et al., 1999). In the 
presence of the Wnt ligand Wnt3a the phosphorylation of Axin by GSK3β is suppressed, 
resulting in Axin protein with a shorter half-life, and a reduction in overall Axin levels within 
the cell (Yamamoto et al., 1999). This aids the increase in intracellular β-catenin seen following 
canonical Wnt signalling. In addition, Axin is dephosphorylated in response to Wnt signalling, 
causing it to bind β-catenin with lower affinity, also increasing the concentration of free β-
catenin within the cell (Willert et al., 1999). 
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1.6.2.2    APC 
Adenomatous polyposis coli (APC) is a large protein of around 311.8 kDa (Groden et al., 1991). 
It has numerous domains and motifs, including armadillo repeats, a basic domain, an 
oligomerisation domain, and 15 and 20 amino acid repeats (Polakis, 1997). These domains 
facilitate interactions with a number of proteins, including itself (Joslyn et al., 1993), GSK3β 
(Rubinfeld et al., 1996), β-catenin (Rubinfeld et al., 1993), and microtubules (Smith et al., 
1994). The Armadillo repeats are necessary for association of APC with the plasma membrane 
during active canonical Wnt signalling (Cliffe et al., 2003). APC also binds Axin in a region 
between residues 1554 and 1698, near the C-terminal region (Hart et al., 1998). Many cancers 
have a mutation in APC, which results in the aberrant stabilisation of β-catenin (Peifer and 
Polakis, 2000). 
A region of 15 amino acid repeats acts as a binding site for β-catenin (Su et al., 1993). 
Additionally the protein contains a series of 7 repeats of 20 amino acids (Groden et al., 1991). 
These repeats contain some sequence similarity to the 15 amino acid repeats, and may also 
bind β-catenin (Rubinfeld et al., 1995). 
APC is phosphorylated by GSK3β in the 20 amino acid repeat region, which allows this region 
to bind β-catenin (Hart et al., 1998; Rubinfeld et al., 1993; Rubinfeld et al., 1997; Su et al., 
1993). This phosphorylation is promoted by Axin, which binds GSK3β and APC in close 
proximity (Hart et al., 1998). 
1.6.2.3    GSK3β 
Glycogen synthase kinase-3β (GSK3β) is a serine/threonine kinase which can phosphorylate 
multiple proteins, including many of those involved in the canonical Wnt signalling pathway. 
The GSK3β protein consists of an N-terminal β-sheet, which forms a barrel shape, and a C-
terminal α-helical domain (Dajani et al., 2001). 
GSK3β is able to phosphorylate several of the proteins involved in the destruction complex, 
including APC, Axin, and β-catenin. The binding of these proteins to the Axin scaffold brings 
them into close proximity, which promotes their GSK3β-mediated phosphorylation (Ikeda et 
al., 1998; Rubinfeld et al., 1996; Yamamoto et al., 1999). GSK3β binds to Axin via a 
hydrophobic groove in the α-helical region (Dajani et al., 2003). 
GSK3β activity needs to be inhibited in order for canonical Wnt signalling to occur, and this can 
be achieved through a number of mechanisms. For example, the protein FRAT (frequently 
rearranged in advanced T-cell lymphomas) is able to bind to a region overlapping the binding 
site of Axin. Thus it acts as an inhibitor of GSK3β activity by competing with Axin for occupation 
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of the site (Dajani et al., 2003). The activity of GSK3β can also be inhibited by phosphorylation 
of the serine-9 residue (Sutherland et al., 1993). This can be induced by Wnt and FGF2 
signalling (Shimizu et al., 2008). Additionally, endocytosis of GSK3β is induced by Wnt 
signalling. This results in a decrease in GSK3β activity in the cell, and also sequestration of 
GSK3β into multivesicular bodies (Taelman et al., 2010). 
1.6.2.4    Dvl 
Dvl has three main signalling domains; an N-terminal DIX domain, a central PDZ (post-synaptic 
density protein 95, Drosophila disc large tumour suppressor 1, zonula occludens 1) domain, 
and a more C-terminal DEP (Dishevelled, Egl-10, and Pleckstrin) domain (Kishida et al., 1999; Li 
et al., 1999). All three domains are necessary for the upregulation of β-catenin protein levels 
during Wnt signalling (Li et al., 1999; Yanagawa et al., 1995). The DIX domain allows Dvl, like 
Axin, to form either a homodimer or a heterodimer (Kishida et al., 1999). 
Dvl plays a role in Wnt signal transduction at the cell surface. When Wnt ligand is present the 
PDZ domain of Dvl binds to Fz (Wong et al., 2003). This interaction is stabilised by association 
between the DEP domain of Dvl and the plasma membrane (Simons et al., 2009). The receptor 
aggregation results in the accumulation of other proteins, including the Axin-GSK3β complex at 
the cell surface, which appears to enable GSK3β- and then CK1-dependent phosphorylation of 
LRP6 (Bilic et al., 2007; Davidson et al., 2005; Julius et al., 2000; Zeng et al., 2005; Zeng et al., 
2008). 
Dvl is phosphorylated by kinases such as CK1 or CK2 in response to Wnt signalling (Bryja et al., 
2007; Willert et al., 1997; Yanagawa et al., 1995), and it acts as an antagonist of Axin through 
multiple methods; it is not able to directly bind GSK3β, but through its interaction with Axin, 
Dvl is able to inhibit the Axin-mediated, GSK3β-dependent phosphorylation of both β-catenin 
and APC (Kishida et al., 1999). Additionally, as described above, Dvl aids recruitment of Axin to 
the cellular membrane through DIX-domain binding in response to canonical Wnt signalling 
(Bilic et al., 2007; Cliffe et al., 2003; Julius et al., 2000; Zeng et al., 2008). Dvl also inhibits the 
GSK3β-mediated phosphorylation of Axin, preventing the formation of its more stable form. 
The PDZ domain is necessary for this role (Yamamoto et al., 1999). Through these multiple 
mechanisms, Dvl is able to agonise canonical Wnt signalling, and increase the intracellular 
concentration of β-catenin. 
Dvl also plays a role in the activity of β-catenin as a transcription factor. Nuclear localisation of 
Dvl was found to occur following Wnt stimulation, and this was essential for its function in 
canonical Wnt signalling (Itoh et al., 2005). Additionally, Dvl was found to upregulate 
transcription of a reporter gene when co-transfected with LEF-1, compared to transfection of 
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LEF-1 alone (Li et al., 1999). These results are explained by the discovery that Dvl forms a 
complex with c-Jun, TCF and β-catenin, which stabilises the formation of the β-catenin-TCF 
complex at the promoters of Wnt-responsive genes (Gan et al., 2008). 
1.6.3    β-catenin 
β-catenin has functions in both the canonical Wnt signalling pathway and in adherens 
junctions between cells in epithelia. The balance between these different roles can affect 
availability of cytoplasmic β-catenin for canonical Wnt signalling. The structure of β-catenin is 
vital for interaction with other proteins, including those of the adherens junction, components 
of the destruction complex, and cofactors for the control of downstream gene transcription. 
1.6.3.1    Structure 
The β-catenin protein consists of 781 amino acids. Residues 138-671 form a compact central 
domain containing 12 armadillo repeats (Figure 1.8). Each repeat contains three α-helices, and 
the armadillo repeat region consists of a right-handed superhelix of these α-helices. The 
superhelix has a hydrophobic core and an external positively charged groove, which acts as an 
active site for a number of interactions. It also has a slight bend around the region of repeats 
9-10 (Huber et al., 1997). 
The N- and C-terminal domains are smaller and less organised when compared to the central 
domain. However, they too play roles in interactions with proteins. The C-terminal domain is 
involved in both the stabilisation of β-catenin in response to a canonical Wnt signal, and in the 
transcriptional activity of β-catenin (Cox et al., 1999). It was found that the C-terminal region 
may stabilise the protein by interacting with the β-catenin armadillo repeats, shielding this 
region from the destruction complex (Mo et al., 2009). This also shields the domain from 
binding E-cadherin in the adherens junction complex (Piedra et al., 2001). 
The N-terminal domain of β-catenin is also able to interact with the armadillo repeat region, 
although not as strongly as the C-terminal domain. The C-terminal region potentiates this 
interaction, but the binding of the N-terminal to the armadillo repeats hinders the binding of 
the C-terminal (Castano et al., 2002). Interaction of the terminal regions with the armadillo 
domain alters the specificity of the armadillo domain for various ligands and cofactors, 
including TBP (TATA binding protein), Tcf-4 and E-cadherin (Solanas et al., 2004). 
The C-terminal domain is necessary for the transcriptional activity of β-catenin because it binds 
to the transcription factors TBP (Hecht et al., 1999), and TCF/LEF (Solanas et al., 2004), 
enabling recruitment of transcription machinery to Wnt-target genes. This interaction is 
facilitated by the N-terminal region (Castano et al., 2002; Xing et al., 2008). 
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The N-terminal region of β-catenin also binds to α-catenin in the adherens junction (Aberle et 
al., 1996), and deletion of the N-terminal region prevents binding to α-catenin. However, 
deletion of the C-terminal domain increases binding, which suggests that the C-terminal 
inhibits interaction between the N-terminal domain of β-catenin and α-catenin (Castano et al., 
2002). 
1.6.3.2    β-catenin and adherens junctions 
Adherens junctions are found in epithelial and endothelial tissue, and form between the lateral 
surfaces of neighbouring cells. They consist of E-cadherin bound to p20, α-catenin, β-catenin 
and γ-catenin (plakoglobin) and are known to interact with the actin network (Capaldo et al., 
2014; Knudsen and Wheelock, 1992). 
Figure 1.8: The structures of the β-catenin gene (A) and protein (B). β-catenin has a number 
of domains which enable it to interact with other proteins. The Armadillo repeats facilitate binding 
with proteins such as Axin and APC, and the GSK3β phosphorylation domain enables degradation by 
the proteosome. The transactivation domain recruits components of the transcriptional machinery, 
thus supporting the activity of β-catenin as a transcription factor. 
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The N terminal region of β-catenin is known to be important for adherens junction formation 
as it binds to α-catenin (Aberle et al., 1996). Additionally, the armadillo repeats 3-8 are 
required for binding to E-cadherin (Graham et al., 2000). 
The protein Bcl9-2 appears to act as a molecular switch between the translation and adhesion 
roles of β-catenin; Bcl9-2 expression causes EMT and translocation of β-catenin to the nucleus 
for signalling. Reduction in Bcl2-9 results in membrane localisation of β-catenin, where it 
functions in adherens junctions (Brembeck et al., 2004). Additionally, phosphorylation of β-
catenin at Tyr-86 and Tyr-654 by tyrosine kinases inhibits the formation of the β-catenin/E-
cadherin complex at the adherens junction, and thus is another level of control (Roura et al., 
1999). The level of E-cadherin expression is usually the rate limiting factor for the formation of 
adherens junctions, and so controlling E-cadherin expression can alter the rate of junction 
formation, and thus β-catenin sequestration (Heasman et al., 1994). 
β-catenin which functions in adherens junctions and that which functions in canonical Wnt 
signalling come from the same pool. Therefore, changes in one mechanism may alter the 
other. For example, an increase in canonical Wnt signalling in mammalian cell culture through 
transfection of Wnt1 cDNA resulted in an increase in cytoplasmic β-catenin. This in turn caused 
saturation of β-catenin binding cadherin at the adherens junctions, and increased cell-cell 
adhesion (Hinck et al., 1994). Research has shown that even very low levels of β-catenin 
expression (around 12.5% of wild type) are sufficient to maintain adherens junctions, whereas 
higher levels (more than 25%) are required for canonical Wnt signalling and the maintenance 
of downstream gene expression (Rudloff and Kemler, 2012). This suggests that E-cadherin is 
able to outcompete components of the canonical Wnt signalling pathway for the binding of β-
catenin. 
Experiments which manipulate canonical Wnt signalling and β-catenin expression in the NT 
have demonstrated that this can affect the formation of the adherens junctions. For example, 
it was found that conditional null β-catenin disrupted the formation of the adherens junctions 
in the dorsal NT (Valenta et al., 2011). In addition, conditional mutation of β-catenin in the 
posterior region of the embryo reduced formation of adherens junctions (Hierholzer and 
Kemler, 2010). On the other hand, an increase in Wnt7a expression in neural progenitors 
through use of a transgene in mice also reduced the formation of adherens junctions in these 
cells (Shariatmadari et al., 2005). However, given that Wnt7a functions in both canonical and 
non-canonical Wnt signalling, this defect could be due to abnormalities in cell polarity caused 
by alterations in non-canonical Wnt signalling. 
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Plakoglobin and β-catenin demonstrate some functional redundancy. Plakoglobin functions in 
both the adherens junction, and another cell-cell junction called the desmosome. In 
plakoglobin mutant mouse embryos, β-catenin is able to replace plakoglobin in the 
desmosome, and thus was able to partially compensate for the loss of plakoglobin (Bierkamp 
et al., 1999). Additionally, plakoglobin was upregulated and partially compensated for 
conditional β-catenin deletion in the mouse heart (Zhou et al., 2007) and liver (Wickline et al., 
2011; Wickline et al., 2013). Plakoglobin appears able to replace β-catenin in the adherens 
junction, but is not able to compensate for its role in canonical Wnt signalling (Wickline et al., 
2013). 
1.6.3.3    β-catenin and the destruction complex 
Multiple components of the destruction complex are able to directly interact with β-catenin. 
The armadillo repeats of β-catenin bind to Axin (Ikeda et al., 1998). More specifically, 
Armadillo repeats 3-7 have been found to be responsible for binding the Axin homologue 
Conductin (Behrens et al., 1998). β-catenin also binds directly to APC via the central Armadillo 
repeats (Rubinfeld et al., 1995). β-catenin is phosphorylated by both CK1α and GSK3β. 
Phosphorylation by CK1α at residue Ser45 primes β-catenin for phosphorylation by GSK3β in 
the N-terminal region, at residues Ser29, Ser33, Ser37, and Thr41 (Amit et al., 2002; Liu et al., 
2002; Yost et al., 1996). 
Phosphorylation of β-catenin is crucial for its degradation. β-catenin which has been 
phosphorylated by GSK3β is recognised by the E3 ubiquitin ligase β-TrCP (β-transducin repeat-
containing protein), and only phosphorylated β-catenin is recognised (Hart et al., 1999). Once 
bound to β-catenin, β-TrCP recruits the ubiquitination complex protein Skp1 (Liu et al., 1999), 
which poly-ubiquitinates the β-catenin protein. This ubiquitination targets the β-catenin 
protein for degradation by the proteasome (Aberle et al., 1997; Orford et al., 1997). 
1.6.3.4    Translocation to the nucleus 
If β-catenin accumulates in the cytoplasm, it is transported to the nucleus via mechanisms 
which are not well understood. However, a number of proteins have been identified which 
modify the cellular response to canonical Wnt signalling by controlling either the influx or 
efflux of β-catenin from the nucleus. 
It is known that Rac1 activation is necessary for the translocation of β-catenin; activated Rac1 
is able to activate KNK2, which phosphorylates β-catenin at residues Ser191 and Ser605. This 
phosphorylation is necessary for the translocation of β-catenin, and its ablation reduces Wnt-
induced nuclear localisation of β-catenin (Wu et al., 2008). 
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Additionally, Armadillo repeats 1-12 of β-catenin have been found to interact with the 
Forkhead box domain of FoxM1 (Forkhead box M1). The cytoplasmic concentration of FoxM1 
increases in response to canonical Wnt signalling, and the interaction between β-catenin and 
FoxM1 has been shown to be necessary for the Wnt-dependent nuclear translocation of β-
catenin (Zhang et al., 2011). 
Other proteins promote the nuclear export of β-catenin. Axin and APC have both nuclear 
localisation sequences (NLS) and nuclear export sequences (NES), which allow them move in 
and out of the nucleus (Henderson, 2000; Wiechens et al., 2004). Therefore they are able to 
shuttle β-catenin into the cytoplasm from the nucleus (Cong and Varmus, 2004; Henderson, 
2000). Additionally, the proteins RanBP3 (Ran binding protein 3) and Menin directly bind β-
catenin and facilitate its transport from the nucleus into the cytoplasm (Cao et al., 2009; 
Hendriksen et al., 2005). 
1.6.3.5    Transcription factor activity 
Nuclear β-catenin is able to act as a transcription factor alongside numerous cofactors. 
Transcriptional repressors inhibit this activity. 
The transcription factors TCF and LEF are closely related proteins of the High Mobility Group-
box transcription factor family. They play an important role in the transcriptional activity of β-
catenin, and in the transcription of Wnt-responsive genes. LEF-1 is able to create bends of 130° 
in DNA by binding and widening the minor groove. This change in shape allows binding and 
interaction between DNA-bound proteins which would otherwise be too distant to interact 
(Giese et al., 1992; Giese et al., 1995). 
In the absence of canonical Wnt signalling, nuclear β-catenin is very low, and TCF/LEF acts as a 
transcriptional repressor in combination with the proteins of the Groucho-related genes (Grg) 
(Cavallo et al., 1998). Grg is able to recruit proteins to aid repression of the transcriptional 
activity. For example, Grg can recruit the HDAC Rpd3 (Chen et al., 1999), which compacts local 
chromatin structure, making the DNA less available to the core transcriptional machinery of 
the cell (Braunstein et al., 1993). 
When canonical Wnt signalling is active, and β-catenin nuclear concentration increases, Grg is 
displaced by β-catenin, which allows TCF/LEF to function as a transcriptional activator (Brantjes 
et al., 2001; Cavallo et al., 1998). Armadillo repeats 1-7 of β-catenin bind to the N-terminal 
domain of LEF-1 in a yeast 2-hybrid screen (Behrens et al., 1996). Likewise, the N-terminal 
region of Xtcf-3 has been found to bind the armadillo repeats of β-catenin in Xenopus 
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(Molenaar et al., 1996), and the N-terminal region of Drosophila dTCF binds to the armadillo 
repeats of the Drosophila β-catenin, Armadillo (van de Wetering et al., 1997). 
The interactions between TCF/LEF and β-catenin result in transcription of the Wnt-responsive 
genes, including cyclin-D1 (Tetsu and McCormick, 1999), siamois (Brannon et al., 1997), Xnr3 
(McKendry et al., 1997), and c-MYC (He et al., 1998). One mechanism by which this occurs is 
the recruitment of histone acetyltransferases (HATs), such as p300 and CBP (CREB binding 
protein) (Hecht et al., 2000). These proteins are able to induce transcription in two ways: 
acetylation of the surrounding histones, and recruitment of the transcriptional machinery, 
such as the protein TBP (Hecht et al., 2000). Histone acetylation produces a more open 
structure in the chromatin. This allows the core transcriptional machinery to access the DNA 
(Hebbes et al., 1988). 
HATs are able to recruit the core transcriptional machinery to Wnt-responsive genes during 
canonical Wnt signalling. The acetyltransferases of the p300/CBP family bind TBP and TFIIB 
(Kwok et al., 1994; Yuan et al., 1996). Additionally, the protein complex formed by β-catenin 
and TCF/LEF is able to recruit transcriptional machinery to DNA. β-catenin supplies a 
transactivation domain (TAD) to the complex, which is able to recruit proteins such as TBP to 
induce transcription of the region (Hecht et al., 1999; Willert and Nusse, 1998). 
As well as binding histone acetyltransferases, β-catenin binds a variety of other transcriptional 
coactivators. Many of these proteins – like the HATs – play a role in restructuring the local 
chromatin (Mosimann et al., 2009). For example, TRRAP (transcription/transformation domain 
associated protein), MLL (mixed lineage leukaemia) proteins, and ISW1 (imitation switch 1) are 
all able to bind β-catenin, and all play roles in the dynamics of chromatin structure (Sierra et 
al., 2006). 
1.6.4    Roles of canonical Wnt signalling during development 
Canonical Wnt signalling plays a vital role in the patterning and development of a wide variety 
of embryonic tissues. It is usually associated with the maintenance of stem cell fate and 
multipotency, and the inhibition of differentiation. Complete deletion of β-catenin in mouse 
embryos causes developmental arrest at gastrulation (Haegel et al., 1995). 
Canonical Wnt signalling plays important roles in a number of morphogenetic events during 
development. For example, it is necessary for the partitioning of the somites, and posterior 
extension of the body axis (Agathon et al., 2003; Aulehla et al., 2008; Takada et al., 1994) 
One of the more well-known Wnt assays involves duplication of the Xenopus antero-posterior 
body axis as a result of ectopic Xwnt1 expression (McMahon and Moon, 1989). This result is 
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reproducible using a number of different components of the canonical Wnt pathway, including 
β-catenin, Dvl, and dominant-negative GSK3β (Guger and Gumbiner, 1995; He et al., 1995; 
Sokol et al., 1995). Additionally, ectopic expression of Axin in Xenopus inhibits canonical Wnt 
signalling, and therefore also inhibits formation of the body axis (Zeng et al., 1997). These 
results verify the role of active canonical Wnt signalling in the formation and patterning of the 
embryonic antero-posterior axis (Kiecker and Niehrs, 2001). 
In this project, the research was focussed on the role of canonical Wnt signalling after 
gastrulation and the determination of the axes. On a tissue and cellular level, canonical Wnt 
signalling has numerous roles in patterning and differentiation of the developing CNS. It 
appears to largely be involved in the maintenance of multipotent, proliferating cells. For 
example, β-catenin is able to promote neural precursor cell proliferation when it binds to 
TCF/LEF proteins. It activates transcription of cyclin-D1, which allows the cell to pass from G1 
into S phase in the cell cycle (Arber et al., 1997; Tetsu and McCormick, 1999). Furthermore, 
canonical Wnt signalling increases expression of the ID, MSX and REST/NRSF proteins, which 
are all able to repress neuronal differentiation (Chong et al., 1995; Odelberg et al., 2000; 
Rockman et al., 2001; Schoenherr and Anderson, 1995; Willert et al., 2002). β-catenin is also 
able to interact with the Notch intracellular domain (NIC), and thus contribute towards the 
expression of the antineurogenic hes1 and hes5 genes by binding to the promoter (Shimizu et 
al., 2008). 
Publications suggest that canonical Wnt signalling is necessary for CNS angiogenesis, but not 
non-CNS angiogenesis. Canonical Wnt-related genes are expressed in the CNS, and loss of 
expression of these genes results in reduced angiogenesis and poor blood-brain barrier 
formation (Daneman et al., 2009). Additionally, an increase in β-catenin causes upregulation of 
the Notch signalling pathway and abnormalities in the development of the vessels, including 
the formation of blind-ended tubes, and elongation and branching defects (Corada et al., 
2010). 
Although canonical Wnt mutations commonly cause CNS defects, NTDs appear to be rarer, and 
the link between canonical Wnt signalling and NT development is not well understood. 
However, several studies suggest that such a link exists. For example, LRP6 mutant mouse 
embryos have a number of neural defects, including exencephaly and/or spina bifida with 
approximately 50% penetrance (Pinson et al., 2000), although it is possible that this effect is 
mediated through the non-canonical Wnt signalling pathway (Gray et al., 2013). Recent 
research indicates that β-catenin mutation may cause NTDs through the influence of canonical 
Wnt signalling on NT genes, including Pax3 (Zhao et al., 2014). 
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Canonical Wnt signalling is also involved in the development of the PNS. The role of Wnt 
signalling in early NC specification is discussed in section 1.3. However, it also appears to have 
a role in NC differentiation; mice with a conditional deletion of β-catenin in the NC fail to 
develop sensory neurons in the DRG (Hari et al., 2002). On the other hand, overexpression of 
β-catenin in the NC results in the almost complete differentiation of sensory neurons at the 
expense of other NC-derived tissue types (Lee et al., 2004). Thus β-catenin appears to promote 
sensory neuronal fate in the NC. Pax3 is also known to be important in the development of the 
NC and sensory neuronal fate (Auerbach, 1954; Nakazaki et al., 2008). Therefore, this evidence 
may support an interaction between the canonical Wnt signalling pathway and Pax3. 
1.6.5    Canonical Wnt signalling and cancer 
As discussed above, canonical Wnt signalling is associated with the maintenance of 
multipotency and proliferation, and the inhibition of differentiation. Cancer occurs when cells 
become proliferative, and often migratory, in inappropriate contexts. It is a disease caused by 
imbalance between proliferation, differentiation and apoptosis, and abnormal canonical Wnt 
signalling is often implicated. 
Cancers are usually associated with inappropriately activated canonical Wnt signalling. For 
example, stabilisation of β-catenin has previously been shown to induce transformation of 
mammary epithelial cells to a cancer-like state (Shimizu et al., 1997). Additionally, β-catenin 
stabilisation in the epidermis of mice was reported to cause hair follicle tumours (Gat et al., 
1998). 
Loss of components of the destruction complex may lead to accumulation of β-catenin in the 
absence of Wnt ligand. This can lead to constitutively active canonical Wnt signalling, and thus 
cancerous transformation. For example, loss of APC is a common cause of colon cancer 
(Nakamura et al., 1992), and loss of Axin2 has also been associated with the development of 
colorectal cancer (Lammi et al., 2004). 
Canonical Wnt signalling may also affect the ability of cancer cells to metastasise; metastatic 
cells have been reported to exhibit hyperactive canonical Wnt signalling, and reduction of TCF 
activity reduced the ability of the cancerous cells to metastasise (Nguyen et al., 2009). 
 
1.7    Aims and Hypotheses 
In this thesis I aim to use Pax3 mutant mice to observe why and how these embryos develop 
NTDs. This will include study of the Splotch-2H mutant mouse and the cellular and 
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morphological effects of the mutation. I will also study the potential interaction between Pax3 
and canonical Wnt signalling using the development of NTDs and NC defects in β-catenin loss- 
and gain-of-function embryos. 
In the first results chapter (Chapter 3) I intend to study the development of NTDs in Pax3-
mutant Splotch mice in detail, and identify abnormal cellular processes which could be causing 
the NTDs in these embryos. I will also compare morphology of the NT between genotypes to 
attempt to elucidate if the cellular defects result in a physical defect which could prevent NT 
closure. 
Hypothesis 1: Premature neuronal differentiation and reduced proliferation in the NT of the 
Splotch embryo cause spina bifida. 
In the second results chapter (Chapter 4) I will study the effects of β-catenin gain-of-function 
(GOF) on the development of the NT and NC in combination with Pax3 mutation. I will use a 
conditional β-catenin GOF allele in combination with a Pax3Cre allele to increase canonical Wnt 
signalling in Pax3-expressing tissues, including the NC and the dorsal region of the NT. I will 
then study NT and NC development in embryos with a variety of allele combinations to 
observe if any defects occur due to interaction between the pathways. 
In the third results chapter (Chapter 5) I will study the effects of β-catenin loss-of-function 
(LOF) on the development of the NT and NC in combination with Pax3 mutation. I will use a 
conditional β-catenin LOF allele in combination with a Pax3Cre allele to reduce canonical Wnt 
signalling in Pax3-expressing tissues. Again, I will study the development of the NT and NC in 
embryos with a variety of allele combinations to observe if any defects occur due to 
interaction between the pathways. The results using both β-catenin GOF and LOF may be 
clearer than using either GOF or LOF alone. 
Hypothesis 2: Interaction between Pax3 and the canonical Wnt signalling pathway reduces 
proliferation and induces premature neuronal differentiation in the NT and NC, resulting in 
NTDs and NC defects. 
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2    Materials and Methods 
2.1    Equipment and Software 
2.1.1    Laboratory equipment 
Microscopes used for dissection were Zeiss (Oberkochen) Stemi SV11 and Zeiss (Oberkochen) 
Stemi SV6. Microscopes used for whole mount bright field micrographs were the Zeiss 
(Oberkochen) Stemi SV11 microscope connected to a Leica (Wetzlar) DFC 490 camera, or the 
Leica (Wetzlar) MZ FLIII microscope connected to a Leica (Wetzlar) DC500 camera. The 
microscope used for whole mount fluorescent micrographs was the Leica (Wetzlar) MZ FLIII 
microscope connected to a Leica (Wetzlar) DC500 camera. The microscope used for bright field 
histology and micrographs was the Zeiss (Oberkochen) Axioplan 2 microscope connected to a 
Zeiss (Oberkochen) AxioCam HRc camera. The microscope used for fluorescent 
immunohistochemistry and micrographs was the Zeiss (Oberkochen) Axiophot microscope 
connected to a Leica (Wetzlar) DC500 camera. 
Room temperature centrifuging was carried out in the Fisher Scientific (New Hampshire) 
Accuspin Micro centrifuge. Cold centrifuging (at 4°C) was carried out in the Thermo Scientific 
(Massachusetts) Heraeus Fresco 21 centrifuge. Thermal cyclers used were the Techne 
(Staffordshire) TC-512 and MJ Research (Quebec) PTC-200. The Sonics (Connecticut) Vibra Cell 
sonicator was used. Spectrophotometers used were the Shimadzu (Kyoto) UV mini 1240 and 
the NanoDrop (Massachusetts) ND-1000. 
The microtomes Microm (Bicester) HM325 and Microm (Bicester) HM330 were used for wax 
sectioning, and the vibratome Leica (Wetzlar) VT 1000S was used for gelatin-albumin 
sectioning. 
2.1.2    Software 
Adobe Photoshop CS3 and Adobe Photoshop Lightroom 2 were used to process images. 
SigmaPlot 2001 was used to create graphs and charts. SigmaStat 3.5 was used for statistical 
analysis. 
 
2.2    Statistics 
SigmaStat 3.5 was used for all statistics described in this thesis. The statistical tests carried out 
for each experiment are described in figure legends. The t-test was used to compare two 
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groups of data. One-way ANOVA was used to compare for more than two groups, as this 
corrects for multiple comparisons; false positives are more likely when carrying out multiple 
comparisons between groups. A power calculation was used to estimate required sample size. 
The Chi Square and Fisher Exact Tests were used to compare proportions and assess for 
significance. If the sample size of at least 20% of the groups was greater than 5 then the Chi 
Square Test was used. If not, then the Chi Square test loses accuracy, and so the Fisher Exact 
Test was used instead. Where advised by the software, additional tests were carried out in 
order to confirm results. These are described in the figure legends. 
 
2.3    Solutions 
Regularly used solutions are described here. More specific solutions are described in the 
relevant sections. 
10x Phosphate-buffered saline (PBS, 1000 ml) 
100x PBS tablets (Oxoid, Cheshire) 
1000 ml Milli-Q water 
Stir until fully dissolved. Autoclave. 
 
1x PBS (1000 ml) 
100 ml 10x PBS 
900 ml Milli-Q water 
1 ml Diethyl pyrocarbonate (DEPC, Sigma, Missouri) 
Stir for several hours. Autoclave. 
PBT (1000 ml) 
1000 ml PBS 
1 ml Tween-20 
4% Paraformaldehyde (PFA, 500 ml) 
20 g PFA (Sigma, Missouri) 
500 ml PBS 
Dissolve at 60-65°C. 
DEPC-treated water (1000 ml) 
1000 ml Milli-Q water 
1 ml DEPC 
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Stir for several hours. Autoclave. 
10x Tris-buffered saline (TBS, 1000 ml) 
250 ml 1M Tris-HCl (pH 7.5) 
80 g NaCl (Fisher Scientific, New Hampshire) 
2 g KCl (Sigma, Missouri) 
Milli-Q water to 1000 ml 
Autoclave. 
TBST (1000 ml) 
100 ml 10x TBS 
1 ml Triton X-100 (Sigma, Missouri) 
Milli-Q water to 1000 ml 
 
2.4    Mouse methods, dissection and histology 
2.4.1    Mouse husbandry 
The mice used in this project were housed According to the Home Office Code of Practise. 
Ambient temperature was maintained between 19°C and 23°C, and humidity was kept 
between 40% and 70%. A 24 hour diurnal cycle of 12 hours light and 12 hours dark was used. 
Food and water were freely available. 
A standard pellet feed was used for most of the mice (Harlan breeding diet). Some of the mice 
were given a folate deficient (FD) diet for experimental purposes. This feed was produced in 
Harlan Laboratories, and contained no folate and 1% succinyl sulfathiazole (Burren et al., 
2008). Female mice were maintained on the folate deficient diet for at least 3 weeks prior to 
mating. 
Males were housed with other male littermates until sexual maturity, after which they were 
housed individually for studding. Females were housed in groups with other females. Mice 
were mated from sexual maturity at 6 weeks of age. 
A single male was housed with one or more females for breeding. A vaginal plug was taken as a 
sign of pregnancy. Pregnant females were housed individually, or with other pregnant females 
from the same group. 
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2.4.2    Mutations 
Several mutations will be referred to frequently in this thesis. These mutations are described in 
detail below. 
2.4.2.1    The Pax3Sp2H allele 
The Pax3Sp2H allele (also referred to in this thesis as Sp2H) was generated through X-ray 
irradiation (Beechey and Searle, 1986). The allele has a 32 bp deletion from the region of the 
Figure 2.1: Structures of the Sp2H allele and protein of Pax3. The structures of the wild type 
Pax3 gene (A) and protein (B) are provided for reference. The Sp
2H
 allele has a 32 bp deletion (shown 
in red) in the paired-type homeodomain region of exon 5 (C). This deletion causes a frame shift, and 
creates a stop codon. This results in the formation of a truncated, functionally null Pax3 protein (D). 
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gene which encodes the HD (Figure 2.1). The deletion results in creation of a stop codon. 
Therefore, the Sp2H protein is truncated and functionally null. 
2.4.2.2    The Pax3Cre allele 
The Pax3Cre allele used in this research was generated in 2005 (Engleka et al., 2005). It is a 
knock-in gene, in which the first exon of Pax3 is replaced with a Cre-recombinase (Cre) gene 
(Figure 2.2). The Pax3 gene is functionally null, and embryos which are homozygous for Pax3Cre 
have the same phenotype as other Pax3-null mice, including those homozygous for Pax3Sp2H. 
They display loss of Pax3 protein expression, and mouse reporter lines demonstrate effective 
Cre-dependent recombination in the appropriate tissues (Engleka et al., 2005). 
 
 
 
 
 
 
Figure 2.2: Structure of the Pax3Cre allele. The structure of the wild type Pax3 gene is provided 
for reference. The Pax3-Cre allele has exon 1 replaced with the Cre gene. Expression of this allele 
results in a functional Cre protein, but no functional Pax3 protein. 
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Figure 2.3: Structures of the β-cateninGOF allele and protein. The wild type β-catenin allele (A) 
and protein (B) are shown for reference. In the intact β-catenin
GOF
 allele loxP sites surround exon 3, 
which contains the GSK3β phosphorylation domain (C). When the Cre allele – and thus the Cre 
recombinase enzyme –  is present, exon 3 is removed from the allele (D). This results in a protein 
lacking the GSK3β phosphorylation domain (E). 
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2.4.2.3    The β-catenin Gain-Of-Function allele 
The β-catenin allele used in the research described in this thesis was developed in 1999. The 
Pax3GOF mouse was generated through the development of chimaeric mice and germline 
transmission (Harada et al., 1999). LoxP sites are positioned on either end of exon 3 along with 
a neo selection cassette. This results in the deletion of 76 amino acids from the protein, 
including the phosphorylation sites targeted by GSK3β (Figure 2.3). Thus, when a Cre is present 
and the region between the LoxP sites excised the β-catenin protein is no longer able to be 
phosphorylated by GSK3β. This reduces the targeting of β-catenin for ubiquitination and 
degradation, and the protein is stabilised (Harada et al., 1999). 
The β-catenin GOF allele was originally created to study the effects of Wnt signalling activation 
in the gut (Harada et al., 1999). The allele was used in combination with a cytokeratin-19 Cre 
allele, which allowed the β-cateninGOF allele to be expressed in the gut epithelium from early in 
development. Mice carrying the cytokeratin-19 Cre and β-cateninGOF alleles developed 
intestinal polyposis shortly after birth (Harada et al., 1999). 
Since the original research, this β-cateninGOF allele has been used in combination with a large 
number of different Cre recombinase-expressing alleles for expression in a wide variety of 
tissues. A selection of these studies are summarised in Table 2.1. 
2.4.2.4    β-catenin-null allele 
The β-catenin-null (β-catenin--) allele was developed in 1995. The mice were generated 
through creation of a chimaeric germline mutant (Haegel et al., 1995). The allele contains an 
IRES-βgeo cassette in place of exon 2 and part of exon 3 (Figure 2.4). A stop codon prevents 
translation of the remaining β-catenin allele (Haegel et al., 1995). Murine embryos which are 
homozygous for the β-catenin— allele die around the time of gastrulation (Haegel et al., 1995). 
2.4.2.5    β-catenin Loss-Of-Function allele 
The β-catenin loss-of-function (β-cateninLOF) allele contains loxP sites flanking exons 2-6, which 
are thus removed in the presence of Cre recombinase enzyme (Brault et al., 2001). Exons 2-6 
contain a number of important regions, including the ATG translation start site, the GSK3β 
phosphorylation domain, and part of the armadillo repeat domain (Figure 2.5). Its deletion 
prevents the production of a functional β-catenin protein (Brault et al., 2001). 
The mice were generated through creation of a chimaeric germline mutant (Brault et al., 
2001). The β-cateninLOF allele was originally used in combination with Wnt1-Cre to study β-
catenin LOF in the CNS. Wnt1Cre/+ β-cateninLOF/LOF embryos developed a number of CNS defects, 
including failure to develop regions of the midbrain and hindbrain, and lack of craniofacial  
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Figure 2.4: Structure of the β-catenin— allele. The wild type β-catenin allele (A) and protein (B) 
are shown for reference. In the β-catenin
—
 allele the IRES-βgeo cassette replaces exon 2 and part of 
exon 3 (C). A stop codon in the IRES-βgeo cassette prevents translation of the remaining β-catenin 
protein. This results in a null allele. 
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Figure 2.5: Structures of the β-cateninLOF allele and protein. The wild type β-catenin allele (A) 
and protein (B) are shown for reference. In the intact LOF allele loxP sites flank exons 2-6, which 
encode the GSK3β phosphorylation domain and part of the armadillo repeat domain (C). When the 
Cre recombinase enzyme is present the region is removed (D). This results in a functionally null 
protein (E). 
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structures (Brault et al., 2001). This latter aspect indicated a role for canonical Wnt signalling in 
the specification and/or differentiation of the NC. 
Since its generation, the β-cateninLOF allele has been used to study the role of canonical Wnt 
signalling in a number of different tissues and organ systems. Several examples of its use are 
summarised in Table 2.2. 
2.4.3    Mouse lines 
The mice described have been used for experiments discussed in this thesis. 
2.4.3.1    Pax3Sp2H/+  
The Splotch-2H mutation is carried on a mixed background which includes CBA/Ca, 101 and 
C3H/He. The heterozygous colony is maintained through the cross Pax3Sp2H/+ x Pax3+/+. 
2.4.3.2    Pax3Cre/+  
The Pax3Cre allele (Engleka et al., 2005) is carried on a C57BL/6 background. The heterozygous 
colony is maintained through the cross Pax3Cre/+ x Pax3+/+. 
2.4.3.3    β-cateninGOF/GOF 
The Pax3GOF allele is carried on a C57BL/6 background, and the homozygous colony is 
maintained through the cross β-cateninGOF/GOF x β-cateninGOF/GOF.  
2.4.3.4    β-cateninLOF/+ 
The β-cateninLOF allele is carried on a C57BL/6 background, and the heterozygous colony is 
maintained through the cross β-cateninLOF/+ x β-catenin+/+.  
2.4.3.5    β-catenin+/- 
This allele is carried on a C57BL/6 background, and the heterozygous colony is maintained 
through the cross β-catenin+/- x β-catenin+/+. 
2.4.3.6    BatGal/+ 
These mice were generated through DNA microinjection into the pronuclei of single-cell 
embryos (Maretto et al., 2003). The allele is carried on a C57BL/6 background, and the 
heterozygous colony is maintained through the cross BatGal/+ x +/+. 
2.4.3.7    p53+/- 
This allele was originally conditional, and the mice were generated by the production of 
germline chimaeras (Jonkers et al., 2001). The mutation is carried on a mixed CBA/101 
background. Embryos carrying the conditional allele were first bred to β-actinCre/+ embryos to 
remove p53 expression ubiquitously, including the germ cells. These animals were then  
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interbred to remove the β-actinCre allele. The heterozygous colony is maintained through the 
cross p53+/- x p53+/+. 
2.4.3.8    Sox1Cre/+ 
The mice were generated through homologous recombination in ES cells, followed by the 
generation of germline mutant mice (Takashima et al., 2007). The allele is carried on a C57BL/6 
background, and the heterozygous colony is maintained through the cross Sox1Cre/+ x Sox1+/+. 
2.4.3.9    Compound mutant mouse lines 
Some of the genetic crosses carried out require breeding with mice carrying more than one 
mutation. Compound mutants are generated only for experimental breeding. The crosses 
required to generate the compound mutants are described in Table 2.3. 
2.4.3.10    Mouse genetic crosses 
The following crosses were carried out in the research described in this thesis. 
 Pax3Sp2H/+ x Pax3Sp2H/+ 
 Pax3Sp2H/+ p53+/- x Pax3Sp2H/+ p53+/- 
 Pax3Sp2H/+ BatGal/+ x Pax3Sp2H/+ 
 Pax3Sp2H/+ β-cateninGOF/+ x Pax3Cre/+ β-catenin+/+ 
 Pax3Sp2H/+ β-cateninLOF/+ x Pax3Cre/+ β-catenin+/- 
 Pax3Sp2H/+ β-cateninLOF/+ x Pax3Cre/+ β-cateninLOF/+ 
 Pax3Sp2H/+ β-cateninGOF/+ x Sox1Cre/+ 
2.4.4    Embryo dissection 
Litters were obtained from timed matings. The matings were carried out either overnight or 
during the day, and the time of plug detection was designated embryonic day (E) 0.5. Females 
were killed using cervical dislocation, and the embryos were removed from the female through 
hysterectomy. Dissection of the embryos from the uterus was carried out in Dulbecco’s 
Modified Eagle’s Medium (DMEM, Invitrogen, Massachusetts) containing 10% heat-inactivated 
fetal bovine serum (FBS, Invitrogen, Massachusetts), which was pre-warmed to 37°C. 
Dissection was carried out using a dissection microscope. 
2.4.4.1    Dissection for tissue collection 
The decidua was removed from the uterus, and then placed in fresh DMEM and FBS. Embryos 
were removed from the decidua, the trophoblast, and Reichert’s membrane. The yolk sac was 
usually collected for genotyping by PCR (see section 2.5.2). The embryo was then finally 
removed from the chorion. Measurements were taken using an eyepiece graticule. The  
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Compound Mutant Genotype Genetic Cross 
Pax3Sp2H/+ p53+/- Pax3Sp2H/+ x p53+/- 
Pax3Sp2H/+ BatGal/+ Pax3Sp2H/+ x BatGal/+ 
Pax3Sp2H/+ β-cateninGOF/+ Pax3Sp2H/+ x β-cateninGOF/GOF 
Pax3Sp2H/+ β-cateninLOF/+ Pax3Sp2H/+ x β-cateninLOF/+ 
Pax3Cre/+ β-cateninLOF/+ Pax3Cre/+ x β-cateninLOF/+ 
Pax3Cre/+ β-catenin+/- Pax3Cre/+ x β-catenin+/- 
 
 
 
 
 
embryo was then washed in PBS, and either immediately frozen at -80°C without liquid, or 
fixed and dehydrated (see section 2.4.6). 
2.4.4.2    Dissection for embryo culture 
Embryos for culture were dissected late on day E8.5. The decidua was removed from the 
uterus, and then placed in fresh DMEM and FBS. Embryos were removed from the decidua, the 
trophoblast, and Reichert’s membrane without puncturing the yolk sac or damaging the 
ectoplacental cone. The embryo in the yolk sac was then removed to fresh DMEM and FBS for 
a short time until culture. 
2.4.5    Embryo Culture 
Prior to embryo culture rat blood was collected, and the serum separated and heat-treated for 
30 minutes at 56°C. This rat serum was stored at -20°C until use. 
Embryos were dissected down to the yolk sac and ectoplacental cone as described previously 
(section 2.3.3.2). Rat serum was defrosted and warmed to 37°C, and then syringed through a 
0.45 µm filter. 0.5-1.0 ml rat serum was allowed per embryo. The rat serum was separated into 
culture tubes, no more than 3 ml per tube, and the top of the tube was greased to seal the lid 
against gas exchange. Gas containing 5% CO2 and 5% O2 was gently blown onto the surface of 
the rat serum for 1 minute. The embryos were added, no more than 4 to a tube, and then 
gassed again, before being placed in a 37°C incubator on a roller to keep the fluid moving. 
Table 2.3: Compound mutant genotypes and the genetic crosses required to produce 
them. 
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Cultures were carried out for approximately 42 hours. The tubes were gassed approximately 
every 12 hours, and the composition of the gas changed with embryonic age: E8.5 embryos 
were gassed with 5% O2 and 5% CO2, E9.5 embryos with 20% O2 and 5% CO2, and E10.5 
embryos with 40% O2 and 5% CO2. 
Some cultures included the canonical Wnt inhibitor XAV939 (Sigma, Missouri). In these 
cultures, XAV939 was first mixed with dimethyl sulfoxide (DMSO) to give a suspension at a 
concentration of 125 mM. A 1 in 50 dilution of the XAV939 suspension was made using PBS-
DEPC, to give a working solution at a concentration of 2.5 mM. This working solution was 
diluted into the rat serum at the desired concentration.  
Once the culture was complete the embryos were removed from the culture tubes into DMEM 
and FBS, and then dissected as in section 2.4.4.1. The embryos were either frozen at -80°C 
without liquid, or fixed and dehydrated (see section 2.4.6). 
2.4.6    Tissue fixation and dehydration 
Fresh tissue was fixed by placing it immediately in cold paraformaldehyde (PFA), and 
incubating overnight at 4°C. 
The fixed tissue was dehydrated on ice using cold solutions. It was first washed twice for 15 
minutes in PBS to removed PFA, and then incubated in increasing concentrations of methanol 
in DEPC-treated water. Once the tissue was in 100% methanol, it was stored at -20°C. 
2.4.7    Tissue sections 
2.4.7.1    Paraffin wax sections 
Embryos were previously fixed and dehydrated (see section 2.4.6), and then stored in 100% 
methanol at -20°C prior to embedding. 
Embryos were incubated in 100% ethanol through two 30 minute washes, and then incubated 
twice in a glass embedding mould in Histoclear (National Diagnostics, Georgia) – once at room 
temperature and once at 60°C. The length of the Histoclear washes was dependent on the 
stage of the embryo; 15 minutes for E8.5, 20 minutes for E9.5, and 30 minutes for E10.5. The 
embryos were then incubated in the embedding moulds in molten wax at 60°C for three hours, 
with fresh wax every 45 minutes. 
Following the incubations, the moulds were moved to room temperature, and the embryo 
positioned for sectioning as the wax set. The wax was left to set in the moulds for at least 24 
hours at room temperature prior to sectioning. Brief incubations at -20°C allowed the wax-
embedded embryos to be removed from the moulds. 
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Wax blocks were shaped to a cube containing the embryo, and then mounted onto wooden 
blocks using molten wax. Sections were cut to a thickness of 7 µm, and then incubated on a 
water-covered slide over a heater for a few minutes to smooth out wrinkles in the wax. The 
water was then removed, and the slides were left to dry at 37°C for at least 24 hours. 
2.4.7.2    Vibratome sections 
Embryos were fixed prior to embedding (see section 2.4.6), and then washed in PBS. If they 
were also dehydrated for storage at -20°C, they were then rehydrated through a series of 
incubations in decreasing concentrations of methanol in PBS, and then washed twice in PBS. 
Embryos (or pieces of embryo) were incubated overnight in a gelatin-albumin mix (0.45% 
gelatin, 27% albumin, 18% sucrose in PBS) at 4°C. The following day, 200 µl gelatin-albumin 
mix was pipetted into a mould. 20 µl glutaraldehyde (Sigma, Missouri) was then added and 
very quickly mixed before the embryo was placed and positioned in the mould. The block set 
at room temperature for 30 minutes, and was then removed from the mould and stored in PBS 
at 4°C. 
The gelatin-albumin blocks were incubated in PBS at 4°C for at least 1 hour prior to sectioning. 
Blocks were trimmed and mounted, and sectioned using a vibratome at a thickness of 40µm 
(frequency 8, speed 7). Sections were mounted in 50% glycerol in distilled water. 
2.4.7.3    Eosin staining of tissue sections 
Embryos were first embedded and sectioned in wax (see section 2.4.7.1), and mounted onto 
glass slides. The slides were dewaxed by incubating them twice in Histoclear for 10 minutes 
per wash, and then rehydrated by incubating them briefly in decreasing concentrations of 
ethanol in water. They were then washed twice in water. 
To develop the colour, the sections were incubated in 1% eosin Y (Acros Organics, Geel) in 
distilled water for 3-5 minutes. They were then washed twice very briefly in water and checked 
under a microscope. If the colour needed further development they were again incubated in 
eosin. Once the colour was a little darker than desired the sections were dehydrated by 
incubating them for 10 seconds per step in increasing concentrations of ethanol in distilled 
water, until they were in 100% ethanol. This step fades the colour a little. The sections were 
then transferred briefly to Histoclear, before being washed in fresh Histoclear for 5-10 
minutes. The slides were mounted using di-n-butyl phthalate (DPX, BDH). 
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2.5    DNA Methods 
2.5.1    DNA Extraction 
DNA was extracted from yolk sac tissue collected during dissection of embryos. A Lysis mixture 
was made using 1 in 5 DNAreleasy (Anachem, Luton) in PBS, and 20 µl of this mixture was 
added to each yolk sac, covering the tissue. The mixture and yolk sac were then put into a 
thermal cycler, and the appropriate program was run. 
2.5.2    PCR 
PCR was used to genotype embryos. DNA extracted from the yolk sac was used for the 
reaction. 
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2.5.2.1    PCR Cycles 
 
Program 
No. 
Start Cycle 
No. of 
Cycles 
Finish 
Temp 
(°C) 
Time 
(mins) 
Temp 
(°C) 
Time 
(s) 
Temp 
(°C) 
Time 
(mins) 
1 94 2 
94 
60 
72 
30 
30 
45 
32 72 5 
2 94 4 
96 
62 
72 
20 
20 
30 
40 72 10 
3  94 1.5 
94 
60 
72 
30 
60 
60 
35 72 2 
4  94 2 
94 
60 
72 
30 
30 
150 
31 72 10 
5 94 2 
94 
58 
72 
30 
30 
45 
35 72 5 
6 94 5 
94 
60 
72 
60 
60 
60 
35 72 5 
7  94 2 
94 
63 
72 
30 
30 
45 
29 72 5 
8  65 15 
96 
65 
96 
65 
96 
120 
240 
60 
60 
30 
1 - - 
 
 
Table 2.4: PCR cycles. 
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2.5.2.2    PCR Primers 
 
Allele Primer Primer Sequence 
Wild Type 
band size 
(bp) 
Mutant 
band size 
(bp) 
Cycle 
Sp2H 
Forward CCTCGGTAAGCTTCGCCCTCTG 
122 90 1 
Reverse 
CAGCGCAGGAGCAGAACCACCT
TC 
Pax3-Cre 
1 CTGCACTCGGTGTCACG 
~300 ~600 1 
2 AAGCGAGCACAGTGCGGC 
3 
GAAACAGCATTGCTGTCACTTG
GTCGTGGC 
β-catenin 
GOF 
Forward 
AGAATCACGGTGACCTGGGTTA
AA 
600 
800 (550 
when 
floxed) 
2 
Reverse 
CATTCATAAAGGACTTGGGAGG
TGT 
β-catenin 
LOF 
Forward AAGGTAGAGTGATGAAAGTTGTT 
221 324 3 
Reverse CACCATGTCCTCTGTCTATTC 
p53 
deleted 
Forward CACAAAAACAGGTTAAACCCAG 
None ~600 1 
Reverse GAAGACAGAAAAGGGGAGGG 
p53 wild 
type 
Forward CACAAAAACAGGTTAAACCCAG 
300 None 1 
Reverse AGCACATAGGAGGCAGAGAC 
β-catenin 
null 
1 CATGGACAGGGGTGGCCTGA 
220 150 4 2 TGTTTTTCGAGCTTCAAGGTTCAT 
3 AGAATCACGGTGACCTGGGTTAAA 
BatGal 
Forward TTATCGATGAGCGTGGTGGTTATGC 
None 400 5 
Reverse GCGCGTACATCGGGCAAATAATATC 
GAPDH 
Forward ATGACATCAAGAAGGTGGTG 
177 NA 6 
Reverse CATACCAGGAAATGAGCTTG 
Cre 
A 
ACCCTGATCCTGGCAATTTCGG
C 
None 500 7 
B 
GATGCAACGAGTGATGAGGTTC
GC 
 
 
Table 2.5: PCR primers. All primers are from Sigma, Missouri. 
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2.5.2.3    Method 
The following PCR mixture was used.  
 PCR mixture (50 µl) 
 2 µl DNA 
 5 µl 10x PCR Rxn buffer (Invitrogen, Massachusetts) 
 1.5 µl 1.5 mM MgCl2 (45 µM, Invitrogen, Massachusetts) 
 5 µl 2mM dNTP mix (dATP, dCTP, dGTP and dTTP, all Promega, Wisconsin)(0.2 mM) 
 0.3 µl 40 µM Forward primer (0.24 µM) 
 0.3 µl 40 µM Reverse primer (0.24 µM) 
 0.25 µl 5 U/µl Taq DNA polymerase (0.025 U/µl, Invitrogen, Massachusetts) 
 Milli-Q water to 50 µl 
Distilled water was used as a negative control. The tubes containing the mixture were placed in 
a thermal cycler, and an appropriate PCR program was run. 2.5% agarose gels were made by 
heating together 2.5 g agarose powder per 100 ml TAE buffer until the agarose was fully 
dissolved. Once it had cooled slightly 6 μl ethidium bromide (Sigma, Missouri) was added per 
100 ml agarose mixture. This was left to cool until solid with a comb to form wells. The PCR 
samples were then loaded onto the 2.5% agarose gel for electrophoresis, and imaged under 
ultraviolet (UV) light. 
2.5.3    Transformation 
20-100ng target plasmid was added to the bottom of a chilled 1.5 ml tube. Competent cells 
(DH5α) were thawed on ice, and then a 50 µl aliquot was added to the plasmid and gently 
mixed. The tube containing plasmid and competent cells was incubated on ice for 20 minutes, 
heat shocked at 42°C for 45 seconds, and then returned to ice for at least 2 minutes. 950 µl LB 
broth (2.5% LB Broth, Invitrogen, Massachusetts, in Milli-Q water) was added to the tube, and 
the mixture was incubated with shaking at 37°C for 1 hour. The cells were then ready to be 
plated. 
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2.5.4    Plasmid extraction 
Transformed cells were plated under sterile conditions onto LB agar plates (32% LB agar, 
Invitrogen, in Milli-Q water) containing an appropriate antibiotic, and allowed to grow 
overnight at 37°C. Individual white colonies from the plates were picked into 5 ml LB broth 
containing the same antibiotic, and incubated overnight in a 37°C shaker. Around 3 ml of the 
resulting mixture was treated using the Qiagen (Venlo) QIAprep Spin Miniprep Kit (following 
the kit protocol), and the concentration of DNA in the final elution was estimated using a 
NanoDrop. The plasmid was stored at -20°C. 
2.5.5    Plasmid linearisation 
An appropriate restriction enzyme was chosen, and the following restriction digest set up. 
Restriction digest (200 µl) 
5 – 10 μg Plasmid DNA 
1 x Restriction Enzyme Buffer (Promega (Wisconsin), Fermentas (Massachusetts) or 
New England Biolabs (Massachusetts)) 
20 - 50 U Restriction Enzyme (Promega (Wisconsin), Fermentas (Massachusetts) or 
New England Biolabs (Massachusetts)) 
1 x Bovine serum albumin (if recommended by manufacturer) 
Milli-Q water to 200 μl 
The digest was incubated for 2 – 4 hours at the optimal temperature for the restriction 
enzyme, as recommended by the manufacturer. The plasmid was either cleaned immediately, 
or stored at -20°C until it was cleaned. The plasmid was cleaned using the QIAquick PCR 
Purification kit, following the recommended protocol. The concentration of the cleaned 
plasmid could be estimated using a NanoDrop. 
2.5.6    Whole mount TUNEL staining 
TUNEL staining was carried out using the Millipore (Massachusetts) ApopTag Peroxidase in situ 
Apoptosis Detection Kit. Prior to this assay, embryos were fixed in 4% PFA, dehydrated into 
100% methanol, and stored at -20°C. 
2.5.6.1    Day 1: Permeabilisation and TdT enzyme incubation 
Embryos were rehydrated into PBT using decreasing concentrations of methanol. They were 
then incubated in 10 µg/ml proteinase K diluted in PBT. The length of the incubation was 
dependent on the developmental stage of the embryo, as shown below. 
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 E8.5: 1 minute 
 E9.5: 4 minutes 
E10.5: 8 minutes 
The embryos were washed in 2 mg/ml glycine in PBT immediately following the proteinase K 
incubation. This ensures cessation of the proteinase K reaction. The embryos were then 
incubated for 20 minutes in 4% PFA, washed, and then fixed in an ice-cold 2:1 mixture of 
ethanol and ascetic acid on ice for 10 minutes. Following further washing, the embryos were 
incubated in equilibration buffer from the kit for 1 hour at room temperature, and then left 
overnight at 37°C in working strength TdT enzyme, also from the kit. 
2.5.6.2    Day 2: Washing, blocking, and antibody incubation 
The TdT enzyme reaction was halted by washing the embryos in working strength stop/wash 
buffer from the kit for 3 hours with several changes of solution. They were then blocked for at 
least 1 hour in a blocking solution containing 5% heat-treated sheep serum and 2 mg/ml 
bovine serum albumin (BSA) in PBT. 
After blocking, the embryos were incubated in 0.5 µl/ml Anti-digoxigenin AP-conjugated Fab 
Fragments (Roche, Penzberg) in a blocking solution containing 1% heat-treated sheep serum 
and 2 mg/ml BSA in PBT. This incubation was carried out for 2 hours at room temperature. 
They were then washed in 2 mg/ml BSA in PBT overnight at 4°C with multiple changes of 
solution. 
2.5.6.3    Day 3: Developing 
Embryos were equilibrated in NTMT by washing three times for 5 minutes. They were then 
incubated in the dark in a developing solution containing NBT/BCIP in NTMT for around 10 
minutes, or until the stain had developed sufficiently, and then the reaction was stopped using 
washes in PBT. 
NTMT (50 ml) 
1 ml 5M NaCl (100 mM, Fisher Scientific, New Hampshire) 
2.5 ml 2M Tris HCl pH 9.5 (100 mM) 
1.25 ml 2M MgCl2 (50 mM, Fluka Analytical, Buchs) 
0.5 ml Tween-20 (Sigma, Missouri) 
DEPC-treated water to 50 ml 
Developing solution (5 ml) 
 5 ml NTMT 
 85 µl NBT/BCIP (0.32 µg/µl NBT, 0.16 µg/µl BCIP, Roche, Penzberg) 
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Finally, the embryos were fixed for 30 minutes at room temperature in 4% PFA, and then 
washed in PBT. 
 
2.6    RNA methods 
2.6.1    Whole mount in situ hybridisation 
Prior to whole mount in situ hybridisation embryos were fixed in 4% PFA, dehydrated into 
100% methanol, and stored at -20°C. 
2.6.1.1    Day 1: Embryo pre-treatment and hybridisation 
Embryos were rehydrated on ice into PBT using decreasing concentrations of methanol in PBT. 
They were then bleached in 6% hydrogen peroxide (Sigma, Missouri) in PBT on ice for 1 hour, 
and washed in PBT. The embryos were then treated with 5 µg/ml proteinase K depending on 
their developmental stage, as shown below. 
 E8.5: 1 minute 
 E9.5: 2 minutes 
 E10.5: 7 minutes 
The embryos were washed in glycine solution (Fisher Scientific, New Hampshire, 2 mg/ml in 
PBT) to stop the proteinase K reaction, and then in PBT. They were then fixed in 4% PFA 
containing 0.2% glutaraldehyde (Sigma, Missouri) for 20 minutes at room temperature, and 
then again washed in PBT. 
Embryos were pre-hybridised in hybridisation mixture at 70°C for at least 2 hours. 
Hybridisation mixture containing the RNA probe was then applied to the embryos, and they 
were incubated overnight at 70°C. Sense probe was used as a negative control where 
necessary. 
Hybridisation Mixture (50 ml) 
25 ml Formamide (Sigma, Missouri) 
12.5 ml 20x SSC pH 4.5 
5 ml 10% SDS  
25 μl 10 mg/ml Yeast RNA (50 μg/ml) 
100 μl 25 mg/ml Heparin (50 μg/ml) 
DEPC-treated water to 50 ml 
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20x SSC pH 4.5 (500 ml) 
87.7 g NaCl 
44.1 g Sodium Citrate (Fluka Analytical, Buchs) 
500 ml DEPC-treated water 
Adjust to pH 4.5 using hydrochloric acid. Autoclave. 
10% Sodium dodecyl sulfate (SDS, 500 ml) 
50 g SDS (Sigma, Missouri) 
500 ml DEPC-treated water 
2.6.1.2    Day 2: Post-hybridisation 
The following solutions were made and heated to hybridisation temperature. 
 Solution 1 (50 ml) 
 25 ml Formamide 
 12.5 ml 20x SSC 
5 ml 10% SDS 
DEPC-treated water to 50 ml 
 Solution 2 (50 ml) 
 25 ml Formamide 
 5 ml 20x SSC 
 5 ml 10% SDS 
 DEPC-treated water to 50 ml 
The probe-hybridisation mixture was removed from the embryos for storage at -20°C and 
future use, and solution 1 was applied to the embryos for a 15 minute wash at hybridisation 
temperature. This is followed by two further washes in solution 1 for 30 minutes each at 
hybridisation temperature, and then two 30 minute washes in solution 2 at a temperature 5° 
lower than hybridisation temperature. 
Embryos were washed in TBST, and then blocked for at least 1 hour at room temperature in 
10% heat-treated sheep serum in TBST. They were then incubated overnight at 4°C in a 1:2000 
concentration Anti-digoxigenin AP-conjugated Fab Fragments (Roche, Penzberg) in TBST 
containing 1% heat-treated sheep serum. 
2.6.1.3    Day 3: Washing 
The embryos were washed several times briefly, and then for longer incubations, all in TBST, 
and all at room temperature. They were then washed overnight in TBST at 4°C. 
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2.6.1.4    Day 4: Developing 
Embryos were equilibrated in NTMT. They were then incubated in developing solution, 
described below. 
NTMT (50 ml) 
1 ml 5M NaCl (100 mM) 
2.5 ml 2M Tris HCl pH 9.5 (100 mM) 
1.25 ml 2M MgCl2 (50 mM) 
0.5 ml Tween-20 
DEPC-treated water to 50 ml 
Developing solution (5 ml) 
 5 ml NTMT 
 22.5 µl NBT (4.5 µl/ml, Roche, Penzberg) 
 17.5 µl BCIP (3.5 µl/ml, Roche, Penzberg) 
The embryos were incubated in this solution protected from light. 
2.6.2    RNA extraction 
Tissue was previously stored without liquid at -80°C. It was kept on ice throughout RNA 
extraction (unless otherwise stated) to minimise RNA degradation. 
Frozen tissue (from dry ice) was homogenised in 500 µl Trizol (Ambion, Massachusetts) 
through vigorous pipetting in a fine pipette tip, and the sample was then incubated at room 
temperature for 5 minutes. 100 µl chloroform was added, and the tube was shaken vigorously 
for 15 seconds. The sample was then incubated at room temperature for a further 2-3 
minutes, before being centrifuged at 12000 x g for 15 minutes at 4°C.  Following centrifugation 
the upper aqueous phase contained the RNA and was removed to a fresh tube. 
In order to precipitate the RNA from the solution, 250 µl isopropyl alcohol was added to the 
sample. The mixture was vortexed and incubated for 10 minutes at room temperature, and 
then centrifuged at 14000 x g for 10 minutes at 4°C to pellet the RNA. The supernatant was 
removed, and the pellet washed using 500 µl 75% methanol (in DEPC-treated water).  The RNA 
was pelleted again by centrifugation at 12000 x g for 5 minutes at 4°C. The supernatant was 
removed, and the pellet left to air-dry for around 15 minutes, before being resuspended in 20 
µl RNase-free water. 
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The sample was then DNase-treated using the Ambion (Massachusetts) DNAfree kit, following 
the protocol given by the manufacturer, and the resulting elution was analysed with a 
NanoDrop to estimate the concentration of the RNA. 
2.6.3    RNA purification 
2.6.3.1    Using the ChromaSpin-100 DEPC-H2O Columns (Clontech, California) 
The manufacturer recommended protocol was used. Then 40 μl formamide and 1 μl RNase 
inhibitor (Roche, Penzberg) were added to the cleaned RNA, and the probe was stored at -
20°C. 
2.6.3.2    Using precipitation 
4 µl 0.2M EDTA (Sigma, Missouri) was added to stop the transcription, then the RNA was 
precipitated using 4 µl 4M lithium chloride (Sigma, Missouri), 1 µl tRNA (Sigma, Missouri) and 
100 µl 100% ethanol, and overnight incubation at -20°C. The precipitated RNA was pelleted by 
centrifugation at 13000 rpm for 10 minutes at 4°C. The pellet was washed first with 70% 
ethanol, and then with 100% ethanol, centrifuging the pellet as described above, and 
discarding the supernatant for each step. The pellet was dissolved in a suitable volume of 
RNase-free water for 15 minutes at 65°C. 1 µl RNase Inhibitor (Roche, Penzberg) was added, 
and the RNA was stored at -20°C. 
2.6.4    Real time quantitative PCR 
2.6.4.1    First strand cDNA synthesis 
The VILO Superscript cDNA Synthesis Kit (Invitrogen, Massachusetts) was used for this 
reaction, and the manufacturer recommended protocol was used. The following reaction 
mixture was made. 
 cDNA Synthesis (20 µl) 
 2 µg RNA 
 4 µl 5x VILO Reaction mix (Invitrogen, Massachusetts) 
 2 µl 10x SuperScript enzyme mix (Invitrogen, Massachusetts) 
 Nuclease-free water to 20 µl 
The reaction was incubated at room temperature for 10 minutes, and then put into a thermal 
cycler. The cycler held the reaction at 42°C for 1 hour, and then terminated the reaction by 
incubating it at 85°C for 5 minutes. Samples were stored at -80°C. 
The quality of the resulting cDNA was tested using PCR for the gene GAPDH. See section 2.5.2    
for details. 
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2.6.4.2    RT-qPCR reaction 
The real time quantitative PCR (RT-qPCR) was carried out using the following mixture per well. 
12.5 μl RealTime PCR Mesa Blue qPCR Master Mix Plus for SYBR Assay 
1.5 μl Forward primer (10 μM stock solution) 
1.5 μl Reverse primer (10 μM stock solution) 
2 μl cDNA 
7.5 μl DEPC-treated water 
DEPC-treated water was used as a negative control for each primer pair. The following thermal 
cycle was used for the reaction. Primers were designed to function at the following 
temperatures, and were tested before use. 
2 minutes at 50°C 
5 minutes at 95°C 
15 seconds at 95°C 
1 minute at 60°C 
1 minute at 60°C 
The gene GAPDH (glyceraldehyde 3-phosphate dehydrogenase) was used as a house-keeping 
gene for normalisation of expression of the genes. β-Actin was used as a second house-keeping 
gene for Axin2 to verify the results. See Table 2.7 for information about the primer pairs used. 
Each reaction was carried out in triplicate. A dissociation curve was also observed for each 
reaction to check for primer dimerization or other failure of the experiment. Any reaction in 
which the qPCR result for CT differed from the other repeats by 0.2 or more was not included 
in the data. An RQ was calculated for each embryo by averaging the RQs for the replicates 
included in the data (discussed with individual experiments, at least 2 replicates per condition). 
An RQ was then calculated for each genotype or group by taking the average of the embryos in 
the group. All results were normalised to the average RQ for the control group, which was 
given the value 1. 
 
 
 
 
 
x 40 
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Gene 
Forward primer 
sequence (5’ – 3’) 
Reverse primer 
sequence (5’ – 3’) 
Region 
Amplified (bp) 
Reference 
GAPDH 
ATGACATCAAGAAGGT
GGTG 
CATACCAGGAAATGA
GCTTG 
1001-1177 (Gustavsson et 
al., 2007) 
Axin1 
CCTCTACCTCACATTCC
TCGCACTT 
TCAACCGTTCCTCCAA
CTTTTCT 
1534-1676 (Sun et al., 
2012) 
Axin2 
AAGCCTGGCTCCAGAA
GATCACAA 
TTTGAGCCTTCAGCA
TCCTCCTGT 
2560-2694 
 
Cdx2 
TCCTGCTGACTGCTTTC
TGA 
CCCTTCCTGATTTGTG
GAGA 
1639-1802 (Koch et al., 
2012) 
Fzd6 
GCGGCGTTTGCTTCGT
T 
CACAGAGGCAGAAG
GACGAAGT 
1380-1454 (Hayashi et al., 
2009) 
Sfrp4 
ATCCTGGCCATCGAAC
AGTATGAA 
GCACCATCATATCTG
GTGTGAT 
421-742 (Johnston et 
al., 2010) 
Dll1 
GGATCTGAACTACTGC
ACTC 
GAGCACACTCACTAC
CTC 
1594-1733 Designed by 
Nick Greene 
Fos1 
GTCGACCTAGGGAGGA
CCTTAC 
CATCTCTGGAAGAGG
TGAGGAC 
1391-1498 (Watanabe et 
al., 2009) 
Pax3: 1 
GGCTTTCGAGAGAACC
CACT 
AGGTCTCCGACAGCT
GGTAT 
1093-1316 
 
Pax3: 2 
GTGCTCGCTTTTTCGTC
TCG 
CAGAGGCCTGCCGTT
GATAA 
325-538 
 
 
 
 
 
 
 
Table 2.7: RT-qPCR primers. All primers are from Sigma (Missouri). Pax3: 1 and Pax3: 2 primers 
were designed using Primer-BLAST online software (http://www.ncbi.nlm.nih.gov/tools/primer-
blast/). Primers were designed to work using the thermal cycle described above. 
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2.6.5    Transcription for in situ probes 
The following transcription reaction was set up. 
 Transcription (20 µl) 
1 μg Linearised DNA 
2 μl DIG labelling mix (Roche, Penzberg) 
2 µl 10x Transcription buffer (Roche, Penzberg) 
0.5 μl RNase inhibitor (Roche, Penzberg) 
2 μl relevant polymerase (Roche, Penzberg) 
Nuclease-free water to 20 μl 
The reaction was incubated at 37°C for 2-4 hours. The RNA was either cleaned immediately 
following transcription, or stored at -20°C until it could be cleaned. 
 
2.7    Protein Methods 
2.7.1    Whole mount antibody staining 
The embryos were fixed in 4% PFA, dehydrated (see section 2.1.4) and stored at -20°C prior to 
use. They were fixed again in DMSO (Sigma, Missouri) + methanol (in a 1:4 ratio) at 4°C 
overnight the evening before the antibody staining. The embryos were then incubated for 2 x 2 
hours in a 1:1:4 ratio of DMSO + H2O2 + methanol at room temperature, followed by 2 x 2 
hours in PBXMS at room temperature. An appropriate concentration of primary antibody was 
added to PBXMS (Tuj1 was used at a dilution of 1:1000), and the embryos were incubated in 1 
ml or less of this primary antibody solution overnight at 4°C. They were washed for 3 x 10 
minutes followed by 3 x 1 hour in PBX at room temperature, and then 2 x 1 hour in PBXMS, 
also at room temperature. An appropriate concentration of secondary antibody was added to 
PBXMS and the embryos were incubated in 1 ml or less of this secondary antibody solution 
overnight at 4°C. They were then washed for 3 x 10 minutes followed by 3 x 1 hour in PBX at 
room temperature. Finally, the embryos were washed for 3 x 10 minutes in PBS at room 
temperature. 
PBXMS (50ml) 
45 ml PBS 
5 ml Heat Treated Sheep Serum (10% final volume) 
1 g Fat-free Dried Milk (2% final volume, Premier Foods, St. Albans) 
0.25 ml Triton X-100 (0.5% final volume, Sigma, Missouri) 
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PBX (100 ml) 
100 ml PBS 
0.5 ml Triton X-100 
2.7.2    Antibody staining of wax sections 
2.7.2.1    Day 1: Slide preparation and primary antibody incubation 
Sections were first dewaxed and rehydrated, and the antigens were unmasked. This was done 
using either Declere (Cell Marque, California) (see section 2.7.2.1.1) or Histoclear, methanol 
and citrate buffer (see section 2.7.2.1.2). The method depended on the primary antibody 
being used. The antibody anti-phospho-histone H3 (rabbit, Millipore, Massachusetts) requires 
the Declere method, and the antibody Tuj1 (Neuronal class III β-tubulin rabbit polyclonal 
antibody, Covance, New Jersey) requires the citrate buffer method. 
Sections were washed in TBST, and incubated in blocking solution for at least 1 hour at room 
temperature. 
 Blocking solution (50 ml) 
 5 ml 20 mg/ml BSA in MilliQ water (2 mg/ml, Sigma, Missouri) 
 5 ml 1.5% Glycine in MilliQ water (0.15%) 
 5 ml 10x TBS 
50 µl Triton X-100 
2.5 ml Heat-inactivated sheep serum 
Milli-Q water to 50 ml 
To conserve blocking solution a humidity chamber was used for the incubation; 200 µl blocking 
solution was added to each slide, and a Parafilm coverslip applied. This method was also used 
for the antibody incubations. 
Following the blocking procedure, the slides were incubated in an appropriate concentration 
of the primary antibody in blocking solution overnight at 4°C. Tuj1 was used at a concentration 
of 1:1000, and anti-phospho-histone H3 was used at a concentration of 1:250. When testing 
the antibodies the negative control was incubated overnight in blocking solution without 
primary antibody. 
2.7.2.1.1    Declere method 
Declere was diluted 1:20 in distilled water prior to use. Slides were placed in the diluted 
Declere at room temperature, and then heated in a steamer for 50 minutes. 10 minutes prior 
to the end of the incubation fresh Declere was placed in the steamer to heat. The slides were 
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then removed from the steamer and placed in the fresh, heated Declere, then left to cool to 
room temperature. The Declere dewaxes the slides, rehydrates the sections, and unmasks 
antigens. 
2.7.2.1.2    Citrate buffer method 
Slides were dewaxed by two 10 minutes incubations in Histoclear. They were then rehydrated 
by a series of 2 minute incubations in decreasing concentrations of ethanol in distilled water 
(two incubations in 100% ethanol, followed by 90%, 70%, 50%, and 25%, and two washes in 
distilled water). Slides were then moved to cold citrate buffer, and microwaved on medium 
power for 3 minutes. Slides were left to cool for 1 minute, then again microwaved on medium 
power for 3 minutes. Finally, slides were left to cool for 1 minute, microwaved on high power 
for 3 minutes, and left to cool to room temperature. 
Citrate Buffer (1000 ml) 
2.1 g Citric Acid (11 mM, Sigma, Missouri) 
1000 ml MilliQ water 
Use NaOH to alter the pH to 6.0. 
2.7.2.2    Day 2: Secondary antibody incubation and slide mounting 
Slides were washed in TBST, and then incubated in the dark in a 1:500 concentration of the 
secondary antibody, Invitrogen (Massachusetts) Alexa Fluor 488 Goat anti-Rabbit IgG. This 
incubation was carried out for 1 hour at room temperature. The slides were then washed again 
in TBST, still protected from light, and mounted using Vectashield Mounting medium for 
Fluorescence with DAPI (Vector Laboratories, California). They were stored at 4°C protected 
from light. 
2.7.2.3    Analysis of antibody staining of slides 
Antibody staining of slides was carried out using sections of different orientations and regions 
for various experiments. Some analysis was centred on the closure point of the PNP, using 
transverse caudal sections. In this analysis, the first section (in a rostro-caudal direction) which 
showed an open NT was designated section 0. Contiguous sections positioned more rostrally, 
in the closed region, were designated -1, -2, -3, etc. Contiguous sections positioned more 
caudally, in the open region, were designated 1, 2, 3 etc. Analysis of the hinge points used at 
least 4 sections out of sections 0, 1, 2, 3, 4 and 5. Sections 0, 1 and 2 were classed as proximal 
sections, and sections 3, 4 and 5 were classed as distal sections. These positions were relative 
to the closure point of the PNP. All other analysis of this region used at least 4 sections out of 
sections -6, -4, -2, 0, 2 and 4. 
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Other analysis used sections from the cranial region of the embryo using coronal sections. In 
these sections, the first section (in a dorso-ventral direction) in which the lumen of the optic 
vesicle is visible on both sides was designated section 0. Contiguous sections positioned more 
ventrally were designated sections 1, 2, 3, etc. Analysis was carried out on at least 4 sections 
out of sections 0, 2, 4, 6 and 8. 
Analysis involving cell counting or measurements was carried out on between 4 and 6 sections 
per embryo. Cell counts were carried out individually for each section, and then an average 
figure per section was calculated for each embryo, thus accounting for differences in the 
number of sections used per embryo. Likewise, measurements were taken for each section, 
and then an average per section was calculated for each embryo. Analysis for genotypes or 
groups of embryos used an average of the embryos in the group, giving each embryo equal 
weight, regardless of the number of sections included. 
2.7.3    Protein extraction and quantification 
Protein was extracted from whole embryos which had previously been stored without liquid at 
-80°C. Embryos were kept on dry ice throughout protein extraction. 
Around 50 µl RIPA buffer was added to E9.5 embryos, and then the frozen samples were 
homogenised using a sonicator. Homogenates were stored at -80°C. 
RIPA Buffer 
50mM Tris pH 7 - 8  
150 mM NaCl  
0.1% SDS  
0.5% sodium deoxycholate  
1% Triton X-100 
Protease inhibitors 
The protein in the samples was quantified using the Pierce (Massachusetts) Bicinchoninic acid 
(BCA) Kit. Standard solutions of a known protein concentration were made using BSA, and 
small samples of the extractions were mixed with the reagents using the protocol 
recommended by the manufacturer’s instructions. The samples and standards were incubated 
at 60°C for 3 minutes, and then the absorption was measured at 562 nm using a 
spectrophotometer. 
2.7.4    Western blot 
Protein extractions were previously stored at -80°C. 
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2.7.4.1    Day 1 
Protein extractions were prepared for the Western blot gel by mixing a known quantity of 
protein in the extract with 0.5 µl β-mercaptoethanol and loading buffer (BioRad, California, 
Laemmli sample buffer) to a final volume of 25 µl. These mixtures were then incubated at 
100°C for 2-3 minutes to denature the proteins. 
Western blots were carried out using Invitrogen (Massachusetts) NuPage system Bis-Tris gels 
with a 4-12% gradient, and either 10 or 15 wells. A working solution of NuPage MOPS running 
buffer (Invitrogen, Massachusetts) was made as follows: 
 NuPage MOPS Running Buffer (500 ml) 
25 ml NuPage 20x running buffer (Invitrogen, Massachusetts) 
475 ml MilliQ water 
The gel was loaded with 5 µl protein marker (BioRad, California, Precision Plus Protein 
Standard) and the samples. Distilled water was used as a negative control in place of the 
protein. Other possible negative controls which could be used are a p53-negative protein 
sample, or a separate blot minus the antibody. Positive controls could include a sample of p53 
protein. The gel was run under the following conditions. 
20 minutes: 100 volts, 120 mA, 25 W. 
1 hour: 150 volts, 120 mA, 25 W. 
A 1 hour wet transfer was carried out to transfer proteins to the membrane. The following 
transfer buffer was used. 
20x Transfer buffer (125 ml) 
10.2 g Bicine (25 mM) 
13.1 g Bis-Tris (25 mM, Sigma, Missouri) 
0.75 g EDTA (1 mM, Sigma, Missouri) 
Milli-Q water to 125 ml. 
pH adjusted to 7.2. 
1x Transfer buffer (1000 ml)  1 gel (10% methanol)  2 gels (20% methanol) 
20x Transfer buffer   50 ml    50 ml 
Methanol    100 ml    200 ml 
Milli-Q water    850 ml    750 ml 
Following transfer, the membrane was blocked at room temperature for at least 1 hour in 
blocking solution containing TBST with 5% dried milk powder. The membrane was then 
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incubated overnight at 4°C in blocking solution containing primary antibody (1:1000 
concentration of Santa Cruz anti-p53 rabbit polyclonal antibody). 
2.7.4.2    Day 2 
The membrane was washed in TBST and then incubated for 1 hour at room temperature in 
blocking solution containing secondary antibody (1:50 000 concentration of Roche, Penzberg, 
goat anti-rabbit HRP-conjugated antibody). 
The membrane was again washed in TBST, and then incubated for 5 minutes at room 
temperature in chemiluminescent solution (Amersham ECL Prime Western blotting detection 
reagents, GE Healthcare, Little Chalfont). The membrane was imaged using 
chemiluminescence-sensitive film (Kodak, New York, Standard chemiluminescent BioMax light 
film) and an X-ray developer.  
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3    Causes of neural tube defects in Pax3 mutant 
embryos 
3.1    Results 
In this chapter, the Splotch-2H mouse will be studied during embryonic development. The 
work is based on the following hypothesis: premature neuronal differentiation and reduced 
proliferation in the NT of the Splotch embryo cause spina bifida. 
The aim of this research is to ascertain the cellular mechanism or mechanisms which are 
defective in the Splotch embryo, and possibly result in the development of NTDs. Based on 
previous research (see section 1.4.5) it appears likely that excess apoptosis, premature 
neuronal differentiation or reduced proliferation in the NT could occur in these embryos, and 
potentially cause NTDs. Therefore, in this chapter each process will be studied to identify 
abnormalities in the Splotch mutant embryos in comparison to wild type embryos. Previous 
research on the cranial region of Splotch embryos and the development of exencephaly 
(Nicholas Greene, unpublished data) found that there was no difference in the rate of 
apoptosis between wild type and Splotch mutant embryos, but that premature neuronal 
differentiation and reduced proliferation were both present in the cranial NT of Splotch 
mutant embryos. Therefore, the hypothesis above assumes that the mechanism is the same in 
the spinal region. 
Morphological differences are also studied in this chapter in the spinal NT of Splotch mutant 
embryos compared to wild type embryos. The aim of this is to identify any morphological 
changes in the NT caused by the cellular defects which could prevent closure of the NT. 
In addition, other pathways are briefly studied in relation to the Pax3 mutation. Folic acid has 
previously been reported to rescue exencephaly, but not spina bifida in Splotch mutant 
embryos (Burren et al., 2008). This is confirmed here. The Notch and canonical Wnt signalling 
pathways have also been linked to Pax3 (Ma et al., 1996; Megason and McMahon, 2002; 
Nakazaki et al., 2008; Zhao et al., 2014), and so qualitative studies are used to assess if these 
pathways are affected by the Pax3 mutation in Splotch embryos. 
3.1.1    Neural tube defects in Splotch mutant embryos 
The Pax3 mutation found in Splotch mice results in partial penetrance of exencephaly and 
complete penetrance of spina bifida (Auerbach, 1954) (Figure 3.1). These NTDs were studied 
for frequency, and also for cellular defects which could be causal. 
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Figure 3.1: The Splotch phenotype. +/+ (A and B) and Sp2H/Sp2H (C and D) embryos are shown at 
E9.5 and E10.5. The PNP is shown between white arrowheads and the open cranial region is shown 
between white arrows. Scale bars represent 500 μm. 
At E9.5, +/+ embryos have a closed cranial region, and a relatively small PNP (A). However, Sp
2H
/Sp
2H
 
embryos at the same stage often have an open cranial NT, and the PNP is significantly larger (C). At 
E10.5, +/+ embryos have a completely closed NT (B). However, Sp
2H
/Sp
2H
 embryos at the same stage 
usually display an open spinal region, referred to as spina bifida at E10.5, and also frequently have 
an open cranial NT (D). 
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3.1.1.1    The stage of onset of spinal NTDs in Splotch mutant embryos 
In order to study the molecular mechanisms which are abnormal in NTD development in 
Sp2H/Sp2H embryos, it was important to determine the period of time during NT development 
in which the mechanism is abnormal. The longer the NT is exposed to the intrauterine 
environment, the greater the potential for secondary effects leading to differences in the 
cellular processes of the tissue when compared to wild type (+/+) NT. Therefore, it is important 
to study the tissue before it has been affected by the exposure, but when the cellular defect is 
present. Thus, embryos were studied to identify the somite stage at which phenotypic 
differences are first apparent between Sp2H/Sp2H and +/+ embryos. 
Spinal NT closure occurs prior to cranial NT closure, and spina bifida occurs when the spinal NT 
fails to fully close (Greene et al., 2009). Therefore, the earliest observable difference between 
+/+ and Sp2H/Sp2H embryos is an increase in the length of the PNP in the Sp2H/Sp2H embryos 
(unpublished observations). The PNP eventually closes in +/+ embryos, but remains open in 
the Sp2H/Sp2H embryo, and develops into spina bifida. 
Due to these observations, differences in PNP length were used to estimate the stage at which 
progression of closure in Sp2H/Sp2H embryos begins to diverge from that observed among +/+ 
embryos. Experimental litters containing embryos of each genotype were generated through 
intercross of Splotch heterozygous (Sp2H/+) mice. The number of somites and the length of PNP 
were recorded for each embryo, and then analysed according to genotype. The embryos were 
also grouped according to number of somites (8-9 somites, 10-11 somites, etc.), and the PNP 
sizes were plotted for each genotype within the group (Figure 3.2). This allowed statistical 
analysis to be carried out to compare PNP sizes between genotypes. 
A significant difference in PNP size is first seen between wild type and Sp2H/Sp2H embryos at 
the 10-11 somite stage, although a trend toward a larger PNP in mutant embryos is seen even 
earlier than this. The results suggest that the cause of the NTD is present from very early 
during NT closure, possibly from soon after the initiation of closure at approximately 7 
somites. 
A significant increase in PNP size is seen between wild type and Sp2H/+ embryos from the 12-13 
somite stage. This difference is consistently smaller than that between +/+ and Sp2H/Sp2H 
embryos, but is present and significant until the 20-21 somite stage, which is the latest stage 
that was measured. 
NTDs are rare in Sp2H/+ embryos (Auerbach, 1954). Therefore the results suggest that the 
progression of neurulation may be slightly delayed in Sp2H/+ compared to +/+ embryos, but is  
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Figure 3.2: Closure of the posterior neuropore in the Splotch mouse. Experimental litters 
were generated containing a mixture of genotypes by intercrossing Sp
2H
/+ mice. The graph 
demonstrates the length of the PNP (as shown in Figure 3.1, the distance between the white 
arrowheads) of embryos of different genotypes at different somite stages during development, 
between 8 and 23 somites. The graph begins in A and continues in B. Asterisks indicate significant 
difference from +/+ embryos of the same somite stage. The first significant difference between +/+ 
and Sp
2H
/Sp
2H
 embryos is seen at the 10-11 somite stage. The first significant difference between +/+ 
and Sp
2H
/+ embryos is seen at the 12-13 somite stage. The size of the PNP decreases as the NT closes 
in +/+ and Sp
2H
/+ embryos between 8 and 23 somites. However, the PNP slightly increases in size 
between these time points in Sp
2H
/Sp
2H
 embryos. 
Error bars indicate standard error. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001. One-way ANOVA was used 
to test for significant difference.  
8-9 somites – +/+: n = 2. Sp
2H
/+: n = 8. Sp
2H
/Sp
2H
: n = 6. 
10-11 somites – +/+: n = 9. Sp
2H
/+: n = 21. Sp
2H
/Sp
2H
: n = 12. 
12-13 somites – +/+: n = 17. Sp
2H
/+: n = 30. Sp
2H
/Sp
2H
: n = 8. 
14-15 somites – +/+: n = 23. Sp
2H
/+: n = 58. Sp
2H
/Sp
2H
: n = 29. 
16-17 somites – +/+: n = 27. Sp
2H
/+: n = 34. Sp
2H
/Sp
2H
: n = 20. 
18-19 somites – +/+: n = 26. Sp
2H
/+: n = 50. Sp
2H
/Sp
2H
: n = 30. 
20-21 somites – +/+: n = 20. Sp
2H
/+: n = 34. Sp
2H
/Sp
2H
: n = 14. 
22-23 somites – +/+: n = 6. Sp
2H
/+: n = 4. Sp
2H
/Sp
2H
: n = 1. 
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Figure 3.3: The frequency of exencephaly in the Splotch mouse. Experimental litters were 
generated containing a mixture of genotypes by intercrossing Sp
2H
/+ mice.  Exencephaly was defined 
as an open cranial NT at the 18 somite stage or later. 
The graph describes the rate of exencephaly in embryos from these litters, with the different 
genotypes analysed separately. Exencephaly does not occur in +/+ embryos, but a small percentage 
of Sp
2H
/+ embryos develop the NTD (9.0%), although this difference is not significant. However, a 
significantly higher percentage of Sp
2H
/Sp
2H
 embryos develop exencephaly (66.7%). 
* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001. The chi-square was used to test for significant difference. +/+: 
n = 54. Sp
2H
/+: n = 94. Sp
2H
/Sp
2H
: n = 46. 
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still completed. However, flexion defects have not been reported in Sp2H/+ mice, which 
suggests that closure itself is not overtly delayed. On the other hand Sp2H/Sp2H embryos have 
nearly complete penetrance of spina bifida (Auerbach, 1954; Greene et al., 2009), so NT 
closure is not completed. 
3.1.1.2    Splotch mutant embryos have an increased frequency of exencephaly 
Although Sp2H/+ embryos have a slightly higher frequency of exencephaly than +/+ embryos, 
this difference does not reach significance (Figure 3.3). This could be due to sample size, and it 
is possible that with higher numbers of embryos the difference would become significant. 
However, Sp2H/Sp2H embryos have a significantly higher frequency of exencephaly than +/+ 
embryos. These results suggest that the presence of the Sp2H allele – particularly when in 
homozygous form – predisposes the mouse embryo to develop exencephaly. 
3.1.2    Cellular defects during spinal neurulation in Splotch mutant embryos. 
As discussed in section 1.4.5, a number of theories have been suggested to explain the 
development of NTDs in Sp2H/Sp2H mice. Some of these theories have been tested in the cranial 
region, but the research described here focusses on cellular defects observed in the spinal 
region as potential causes of spina bifida. 
3.1.2.1    Pax3 expression in the neural tube 
In order to study the effects of Pax3 mutation in these mice, the region in which Pax3 is 
expressed in wild type embryos must be defined. Whole mount in situ hybridisation was 
carried out on +/+ embryos at E9.5 to identify the region of Pax3 expression (Figure 3.4). 
Expression was detected in the NT and the segmented mesoderm. 
Embryos were sectioned in transverse or coronal orientation, and Pax3 expression was 
observed in the dorsal region of both the caudal and cranial NT. A small area of expression was 
also observed in the ventral region of the cranial NT (Figure 3.4C). However, due to the angle 
of the section this most likely represents the dorsal region of the NT which curves back 
underneath the forebrain. Therefore the dorsal region of the NT was studied as the Pax3 
expressing region. 
3.1.2.2    Neuronal differentiation is normal in the spinal neural tube of Splotch mutant 
embryos 
Premature neuronal differentiation has been suggested as a potential cause of NTDs in 
Sp2H/Sp2H embryos (see section 1.4.5.2). Cells exit the cell cycle upon differentiation, and also 
exhibit differences in cell properties, such as cell-cell adhesion and communication, from the 
precursor cells of the neurepithelium (Yamashita, 2013). These changes could modify the  
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properties of the NT, either through a reduction in cell number, or through alteration of the 
cell types within the tissue. 
Neuronal differentiation in the NT was examined using whole mount in situ hybridisation with 
a probe to identify the Ngn2 gene. This is a proneural gene, and acts as marker for 
differentiating neurons. It is also downstream of Pax3 signalling (Nakazaki et al., 2008). 
Therefore, changes in Ngn2 expression could be due solely to Pax3 mutation, and will not 
necessarily indicate neuronal defects. However, alterations in the expression pattern of Ngn2 
at this stage could be an early indicator of the kind of Pax3-related neuronal defects which 
might be present at later stages of development.  
Figure 3.4: Region of Pax3 expression. A shows a wild type embryo at E9.5 which has undergone 
whole mount in situ hybridisation for Pax3. Expression can be seen in the NT (white arrowheads) and 
the segmented mesoderm (white arrow). The white scale bar represents 250 μm. 
B and C show eosin-stained wax sections taken from the embryo. B shows a caudal section through 
the neural tube, at the level indicated by the red line in A. Pax3 expression can be seen in the dorsal 
region of the NT (black arrowhead), and in the paraxial mesoderm (black arrow). C shows a section 
through the cranial region. The position of the section is indicated by the blue line in A. Pax3 
expression can be seen in the dorsal midbrain region of the NT (black arrowhead), and also in a small 
area of the ventral forebrain region (blue arrowhead). The black scale bars represent 50 μm. 
117 
 
 
 
 
 
 
 
Ngn2 expression is studied at the 13-15 somite stage. At this stage neuronal specification is 
beginning to occur in the cranial and spinal regions of the NT. At the time of study, statistics 
showed 14-15 somites to be the stage at which the PNPs of Sp2H/Sp2H embryos were first 
statistically larger than those of their wild type counterparts. Therefore many of the studies 
described in this thesis use the same somite stage. Later statistical analysis showed the 
divergence between genotype to be earlier, at the 10-11 somite stage (Figure 3.2). Although 
the 14-15 somite stage is less than ideal for the studies, it is likely that any cellular defects will 
still be present and identifiable at this stage. 
Figure 3.5: Comparing Ngn2 expression between +/+ and Sp2H/Sp2H embryos. Experimental 
litters were generated containing a mixture of genotypes by intercrossing Sp
2H
/+ mice. 13-15 somite 
stage embryos underwent whole mount in situ hybridisation for Ngn2. The embryos shown are at 
the 15 somite stage. The scale bars represent 250 μm. n = 3 for each genotype. 
Ngn2 expression can be seen in the spinal region and the midbrain, and a small patch of surface-
level cells near the branchial arches (arrowhead). There are no differences between the genotypes in 
the spinal expression pattern of Ngn2. There is possibly excess cranial expression of Ngn2 in 
Pax3
Sp2H/Sp2H
 embryos. Sections of this region could provide more information. However, this study 
focusses on the development of the spinal NT. 
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Expression in +/+ embryos is seen in the spinal region and the midbrain, as well as a small 
subset of surface-level cells near the branchial arches (Figure 3.5). No difference is seen in the 
pattern of Ngn2 expression between the wild type and Splotch mutant embryos at this stage. 
Notch signalling is important in controlling the timing of neuronal differentiation (de la Pompa 
et al., 1997). Pax3 and Ngn2 act upstream of the Notch pathway during neuronal 
differentiation (Ma et al., 1996). Additionally, deletion of Notch in mouse has been found to 
exacerbate the Splotch phenotype (Nicholas Greene, unpublished data). Therefore the relative 
expression levels of two Notch target genes – Dll1 and Fos1 – were compared between +/+ 
and Sp2H/Cre embryos. The expression of these genes was previously identified as potentially 
altered in Sp2H/Sp2H embryos (Nicholas Greene, unpublished data). Sp2H/Cre embryos were 
used as these were generated using an alternative genetic cross (explained in Figure 3.6). This 
cross is used mostly in Chapter 4, but the embryos were also used for RT-qPCR data in this 
chapter. The genetic crosses used each experiment are described in the figure legends. 
Expression levels of Dll1 and Fos1 were studied using real time quantitative PCR (RT-qPCR), 
comparing between the genotypes at the 23-24 somite stage (Figure 3.6). No significant 
differences were found in relative expression levels of these genes when comparing 
genotypes. However, the original study was carried out using 14-15 somite stage embryos. 
Therefore it could be interesting to repeat the study at multiple stages, as the expression 
differences between genotypes could change with developmental stage. 
Additionally, immunohistochemistry was used on both whole mount embryos and transverse 
sections to study neuronal differentiation in +/+ and Sp2H/Sp2H embryos (Figure 3.7). The 
antibody Tuj1 binds βIII-tubulin, and was used to identify differentiated neurons. 
Whole mount immunohistochemistry was used to compare neuronal differentiation between 
+/+ and Sp2H/Sp2H embryos at 23-24 somite stage. This developmental stage was use due to 
availability of somite stage matched embryos. Although the defect is well established at this 
stage, it may be easier to identify differences in the extent of the spinal neuronal 
differentiation between genotypes, as differentiation has extended further along the axis, and 
differences may be more exaggerated or more quantifiable. βIII-tubulin expression was studied 
in both the cranial and spinal regions of the embryos. No differences were seen in either the 
pattern or the extent of cranial expression (Figure 3.7). 
Neuronal differentiation in the spinal region progresses in a rostral-to-caudal wave. Therefore 
the extent of the differentiation was quantified by observing the furthest somite level which  
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Figure 3.6: Comparing expression levels of Notch genes between +/+ and Sp2H/Cre 
embryos. Experimental litters were generated containing a mixture of genotypes through the cross 
Pax3
Sp2H/+
 β-catenin
GOF/+
 x Pax3
Cre/+
 β-catenin
+/+
. This cross was used for the experiments described in 
Chapter 4. Sp
2H
/Cre embryos are – like Sp
2H
/Sp
2H
 embryos – Pax3-null. Relative expression levels are 
normalised to wild type embryos. 
The expression levels of Dll1 (A) and Fos1 (B) were compared using whole embryo RNA extractions 
and RT-qPCR analysis. GAPDH was used as the housekeeping gene. No significance was seen in gene 
expression between the genotypes for either Dll1 or Fos1. 
The t-test was used to test for significant difference. n = 4 for each genotype. Error bars show 
standard error. 
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Figure 3.7: Comparing neuronal differentiation between +/+ and Sp2H/Cre embryos. 
Experimental litters were generated containing a mixture of genotypes through the cross Pax3
Sp2H/+
 β-
catenin
GOF/+
 x Pax3
Cre/+
 β-catenin
+/+
. This cross was used for the experiments described in Chapter 4. 
Sp
2H
/Cre embryos are – like Sp
2H
/Sp
2H
 embryos – Pax3-null. 
A and B are 24 somite stage embryos which have undergone whole mount immunohistochemistry 
with the antibody Tuj1, a neuronal marker. Scale bars in A and B represent 500 µm. The pattern and 
extent of neuronal differentiation do not differ greatly between +/+ (A) and Sp
2H
/Cre (B) embryos. 
Embryos used were 23-24 somite stage, embryos shown are 24 somite stage. n = 2 per genotype. 
Neuronal differentiation in the spinal region develops in a rostro-caudal direction. Therefore, the 
extent to which neuronal differentiation had progressed was examined (marked by arrowheads in A 
and B). The most caudal somite level which displayed robust Tuj1 staining was compared between the 
genotypes at the 23-24 somite stage. The results are shown in C. No significant difference was seen 
between the genotypes in the extent of the neuronal differentiation. Student t-test was used to test 
for significant difference. n = 4 for each genotype. 
Immunohistochemistry using Tuj1 was also carried out on sections of the NT of 17-21 somite stage 
embryos (D-E). The region surrounding the rostral limit of the PNP was examined for neuronal 
differentiation. Scale bars in D-F represent 50 µm. The positive control (D) is a section from the cranial 
NT of a +/+ embryo, and Tuj1 staining is seen particularly in neuronal cell bodies around the basal 
surface of the NT. However, no neuronal differentiation is seen in the sections around the PNP in 
either +/+ (E) or Sp
2H
/Sp
2H
 (F) embryos. +/+: n = 2. Sp2H/Sp2H: n = 3. 
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demonstrated βIII-tubulin expression. No significant difference was seen when comparing +/+ 
and Sp2H/Sp2H embryos (Figure 3.7C). 
The embryos were sectioned in a transverse orientation through the region surrounding the 
rostral limit of the PNP. Tuj1 was used for immunohistochemistry of this region. If neuronal 
differentiation were seen in this region it could potentially affect NT closure. However, no β-
tubulin expression was seen in the region for either the +/+ or Sp2H/Sp2H embryos (Figure 3.7D-
F). 
3.1.2.3    Apoptosis does not cause spina bifida in Splotch mutant embryos 
As described in section 1.4.5.1, excess apoptosis in the spinal NT has been suggested as a 
cause of NTDs in Splotch mutant embryos. 
Whole mount TUNEL stains were carried out on whole mount embryos at the 15-16 somite 
stage in order to compare levels of apoptosis in the spinal neural tube of +/+ and Sp2H/Sp2H 
embryos (Figure 3.8). This stage was chosen as it is reasonably early in the development and 
closure of the spinal NT, and embryos were available to allow the developmental stages to be 
matched. Although the TUNEL assay showed variation in the staining – particularly regarding 
the wild type embryos – the results were consistent; no excess apoptosis was observed in 
Sp2H/Sp2H embryos. 
A genetic cross was carried out similar to that published previously (Pani et al., 2002) 
combining the Sp2H allele with a p53 mutant allele. If excess apoptosis were causing the 
development of NTDs in Sp2H/Sp2H embryos it would be expected that the reduction in 
apoptosis caused by the p53 mutation would rescue the NTDs in Sp2H/Sp2H embryos. However, 
such a rescue was not seen (Figure 3.9). On the other hand, the p53 mutation did not appear 
to greatly reduce apoptosis in wild type embryos (Figure 3.10). 
3.1.2.4    Proliferation is reduced in the spinal neural tube of Splotch mutant embryos 
Research has suggested that Pax3 may have a role in regulation of proliferation (see section 
1.4.5.3). Therefore, proliferation in the Pax3-expressing dorsal region of the caudal NT was 
studied to observe if a change in proliferation could be involved in the development of spina 
bifida in Sp2H/Sp2H mice. 
Two different developmental stages were studied; the 14-15 somite stage and the 19-20 
somite stage. As mentioned earlier, the 14-15 somite stage was initially chosen as at the time 
experiment commenced, this was the stage at which a significantly bigger PNP was first seen in 
the Sp2H/Sp2H embryos compared to the wild type embryos. At 14-15 somite stage the PNP is 
significantly bigger in Sp2H/Sp2H compared to +/+ embryos. However, as this is reasonably early  
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 Figure 3.8: Comparing levels of apoptosis in +/+ and Sp2H/Sp2H embryos. Experimental litters 
were generated containing a mixture of genotypes by intercrossing Sp
2H
/+ mice. TUNEL staining has 
been used to observe apoptosis in 15-16 somite stage embryos. A and B show examples of wild type 
embryos, and C and D show examples of Splotch mutant embryos. A’, B’, C’ and D’ show close-up 
images of the caudal region and PNP. Scale bars represent 250 µm. n = 4 per genotype. 
Apoptosis in the cranial region may be slightly increased in Sp
2H
/Sp
2H
 (C and D) embryos compared to 
+/+ (A and B) embryos, but this result is inconsistent between embryos. In addition, although there 
is a great deal of variation between embryos, there does not appear to be a consistent difference in 
the levels of apoptosis in the spinal regions and PNPs of Sp
2H
/Sp
2H
 embryos (C, C’, D and D’) and +/+ 
embryos (A, A’, B and B’). 
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Figure 3.9: Phenotypes of embryos from a Pax3Sp2H/+ p53+/- x Pax3Sp2H/+ p53+/- cross. 
Exencephaly is defined as an open cranial NT at the 18 somite stage or older. Spina bifida is defined as 
an open spinal NT at the 30 somite stage or older. 
Graph A displays the frequency of exencephaly in the embryos of different genotypes from this cross. 
Significance was analysed between embryos of the equivalent Pax3 genotype, but with different p53 
genotypes. Although significance was only seen in the Sp
2H
/+ embryos, it appears that a decrease in 
p53 expression increases the frequency of exencephaly. 
Graph B displays the frequency of spina bifida in the embryos of different genotypes from this cross. 
Significance was analysed between embryos of the equivalent Splotch genotype, but with different 
p53 status. Very little difference was seen that could be attributed to the presence or absence of p53. 
Therefore, p53 expression appears to have no effect on the development of spina bifida. 
*** p ≤ 0.001. The Fisher Exact Test was used to test for significant difference. 
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Figure 3.10: Comparing levels of apoptosis in Pax3+/+ p53+/+ and Pax3+/+ p53-/- embryos. 
Experimental litters were generated containing a mixture of genotypes by intercrossing Pax3
Sp2H/+
 
p53
+/-
 mice. TUNEL staining has been used to observe apoptosis in 21-24 somite stage embryos. A 
and C show Pax3
+/+
 p53
+/+
 embryos, and B and D show Pax3
+/+
 p53
-/-
 embryos. Scale bars represent 
250 µm. It is clear that the levels of apoptosis are highly variable between embryos, but do not 
appear to differ between Pax3
+/+
 p53
+/+
 embryos and Pax3
+/+
 p53
-/-
 embryos. 
Pax3
+/+
 p53
+/+
: n = 2. Pax3
+/+
 p53
-/-
: n = 3. 
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in NT closure secondary effects in the NT of Sp2H/Sp2H embryos caused by exposure to the 
intrauterine environment are unlikely. At 19-20 somite stage the PNP is considerably larger in 
Sp2H/Sp2H embryos, and the cellular defect has been present for some time, and therefore may 
be more apparent. 
Sections were taken of the region surrounding the rostral limit of the PNP in mouse embryos 
of the appropriate ages and genotypes (See section 2.7.2.3 for more information). 
Immunohistochemistry was carried out on these sections to identify cells positive for phospho-
histone H3 (PH3). This protein marks late G2 and M phase cells, and is often used to calculate 
mitotic index (Colman et al., 2006). 
The dorsal-most 25% of each section was designated the Pax3-expressing region, and the 
ventral-most 33% was used as a Pax3-negative control region. For each region a count was 
taken for the total number of cells (using DAPI) and the number of PH3-positive cells. The 
results for the sections were totalled to give a percentage of PH3-positive cells for each 
embryo, referred to from now on as the mitotic index. 
At 14-15 somite stage, +/+ embryos showed a significantly higher mitotic index in the Pax3-
expressing dorsal region than in the Pax3-negative ventral region. However, this proliferation 
gradient appears to be lacking in Sp2H/Sp2H embryos (Figure 3.11C, E and G). The dorsal index 
for Sp2H/Sp2H embryos resembled the ventral region, with no significant difference in mitotic 
index between the two regions in these embryos (Figure 3.11E). 
Mitotic index for 14-15 somite stage Pax3-negative ventral control regions showed no 
significant difference between +/+ and Sp2H/Sp2H embryos. However the rate of proliferation in 
the Sp2H/Sp2H embryos was significantly reduced compared to wild type in the Pax3 expression 
domain (Figure 3.11C). 
At the 19-20 somite stage, analysis of +/+ embryos shows that the proliferation gradient 
present in the younger 14-15 somite stage +/+ embryos is no longer present (Figure 3.11D, F 
and H). In the 19-20 somite stage +/+ embryos there was no significant difference between the 
mitotic indices of the Pax3-positive dorsal and Pax3-negative ventral regions. Likewise, no such 
difference was seen in the 19-20 somite stage Sp2H/Sp2H embryos (Figure 3.11F). 
3.1.2.5    Morphological differences between the neural tubes of wild type and Splotch 
mutant embryos 
The neural tube cross sections of +/+ and Sp2H/Sp2H embryos were analysed further. This was in 
order to examine any morphological effects of reduced proliferation on the Sp2H/Sp2H NTs, and  
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Figure 3.11: Proliferation rates in the neural tubes of +/+ and Sp2H/Sp2H embryos – 1. A 
shows the region of the embryo studied. Transverse sections were taken from the region surrounding 
and including the closure point of the PNP (n = 4-6 per embryo). B shows one such section, and 
demonstrates how the section was divided for the study. The total dorso-ventral ‘height’ of the NT 
was measured (x). The ‘Dorsal’ region was taken as the dorsal-most quarter of the NT (x/4), and the 
‘Ventral’ region was taken as the ventral-most third of the NT (x/3). The proliferation studies were 
carried out in these regions. Scale bar represents 50 μm. PH3 is phospho-histone H3 staining. Data is 
replicated in C-D, E-F and G-H to show different genotype and stage comparisons. 
C and D compare the compare the rates of proliferation between +/+ and Sp
2H
/Sp
2H
 embryos in the 
dorsal and ventral regions at the 14-15 somite stage (C) and 19-20 somite stage (D). A significant 
difference is only seen in the dorsal region at the 14-15 somite stage (C) – the Sp
2H
/Sp
2H
 embryos 
show a reduction in the rate of proliferation. 
E and F compare the rates of proliferation between the dorsal and ventral regions in +/+ and 
Sp
2H
/Sp
2H
 embryos at the 14-15 somite stage (E) and 19-20 somite stage (F). +/+ embryos show a 
significant reduction in proliferation in the ventral region at the 14-15 somite stage. No other 
significant differences were seen between regions. 
G and H compare the rates of proliferation between the two time points in the dorsal and ventral 
regions in the +/+ (G) and Sp
2H
/Sp
2H
 embryos (H). +/+ embryos show a reduction in proliferation in 
the dorsal region of 19-20 somite stage embryos compared to 14-15 somite stage embryos. No other 
significant differences were seen. 
* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001. NS: no significance. n = 6 for each genotype within each time 
point (n = 24 in total). Error bars show standard error. The t-test was used to test for significant 
difference. This data follows a Gaussian distribution apart from dorsal data in the 19-20 somite stage 
Sp
2H
/Sp
2H
 embryos. 
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Figure 3.12: Proliferation rates in the neural tubes of +/+ and Sp2H/Sp2H embryos – 2. 
Experimental litters were generated containing a mixture of genotypes by intercrossing Sp
2H
/+ mice 
Scale bars represent 50 µm. Cell nuclei are stained with DAPI and show as blue. The Phospho histone 
H3 antibody marks proliferating cells and shows as green. 
A and B show examples of the NTs of wild type and Splotch mutant embryos respectively. The NT is 
outlined in white for clarity. Splotch mutant embryos (B) have a reduced mitotic index (proportion of 
green cells compared to blue cells) in the dorsal NT compared to wild type embryos (A) at the 14-15 
somite stage. 
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Figure 3.13: Comparing the morphology of +/+ and Sp2H/Sp2H embryos – 1. Experimental 
litters were generated containing a mixture of genotypes by intercrossing Sp
2H
/+ mice. The numbers 
of cells in neural tube cross sections were analysed using the DAPI antibody as a nuclear marker. 
Results were compared between +/+ and Sp
2H
/Sp
2H
 embryos. 
A and B show the regions studied. A delineates the area of the entire NT. Graphs shown in green 
pertain to this area. B demonstrates the dorsal and ventral regions, as described in Figure 3.13C. 
Graphs shown in red pertain to these areas. PH3 is phospho-histone H3 staining. Scale bars 
represent 50 µm. 
C shows the results for cell numbers in the whole NT. Cell numbers are significantly lower in 
Sp
2H
/Sp
2H
  embryos compared to +/+ embryos at both the 14-15 and 19-20 somite stages. 
D and E show the results for the cell numbers in the specified region of the NT at the 14-15 somite 
stage (D) and the 19-20 somite stage (E). Cell numbers are significantly reduced in Sp
2H
/Sp
2H
 embryos 
in both the dorsal and ventral regions, and at both the 14-15 and 19-20 somite stages. 
* p ≤ 0.05, ** p ≤ 0.01. NS: no significance. n = 6 for each genotype within each time point (n = 24 in 
total). Error bars show standard error. The t-test was used to test for significant difference. This data 
follows a Gaussian distribution. 
133 
 
to potentially identify any abnormalities which could contribute to the development of spina 
bifida. 
3.1.2.5.1    Cross sectional cell number 
If cell proliferation is reduced in the dorsal region of the NT in Sp2H/Sp2H embryos, it seems 
likely that these embryos may have fewer cells in the NT. DAPI staining was used to enable cell 
counts for cross sections of the NT (Figure 3.13). 
Sp2H/Sp2H embryos show a significant reduction in the total number of cells in the cross section 
of the NT. This difference is seen at both the 14-15 and 19-20 somite stages (Figure 3.13C). 
Therefore it appears that a reduction in cell number occurs in the younger embryos, but 
continues into the older embryos, even once the difference in proliferation is no longer 
present. 
Previously the sections had been divided into dorsal and ventral regions for the proliferation 
counts. Cell counts were taken for each of these regions separately, and compared between 
+/+ and Sp2H/Sp2H embryos in order to determine if the proliferation defect affected cell 
numbers in just the Pax3-positive dorsal region, or throughout the NT. 
Statistically significant reductions in cell number are seen in both the dorsal and ventral 
regions of 14-15 and 19-20 somite stage embryos (Figure 3.13D-E). These results suggest that 
cell number is reduced not just in the Pax3-positive dorsal region of the NT, but throughout 
the NT of Sp2H/Sp2H embryos. The reduction in cell number is likely to be caused by the reduced 
dorsal cell proliferation in these embryos. It could result in either a reduction in cell density, or 
a smaller NT, or both. 
3.1.2.5.2    Neural tube size 
Dorso-ventral height and left-right width of the NT were compared between +/+ and Sp2H/Sp2H 
embryos. The measurements were taken from the cross sections. Height was measured down 
the centre line of the NT, through the MHP. Width was measured at the widest point of the NT 
cross section, perpendicular to the centre line (Figure 3.14). 
At the 14-15 somite stage, both height and width were significantly reduced in Sp2H/Sp2H 
embryos compared to +/+ embryos (Figure 3.14D-E). At the 19-20 somite stage the height of 
the NT was significantly reduced, but not the reduction in width does not reach significance 
(Figure 3.14D-E). Possibly this difference would be significant with larger sample sizes. 
The ratio of height to width was analysed to determine if the proportions of the NT were 
changed in any way in the Sp2H/Sp2H embryos. However no statistically significant differences  
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Figure 3.14: Comparing the morphology of +/+ and Sp2H/Sp2H embryos – 2. A-C show 
measurements and regions which were compared. The scale bar represents 50 μm. PH3 is phospho-
histone H3 staining.  A shows the lengths which were taken for height and width. Height was 
measured from the MHP along the dorso-ventral axis. Width was taken at the widest point of the NT 
perpendicular to the height measurement. All graphs shown in yellow pertain to these measurements. 
B shows the total area of the NT. Graphs shown in green pertain to this area. C shows the partial 
regions measured; the dorsal-most 25% and the ventral-most 33%. Graphs shown in red pertain to 
these areas. 
D compares height and width of the NTs between +/+ and Sp
2H
/Sp
2H
 embryos at the 14-15 and 19-20 
somite stages. A significant reduction in height is seen in Sp
2H
/Sp
2H
 embryos at both somite stages. E 
compares the width at both somite stages. A reduction in width is seen in the mutants at both stages, 
but the difference is only significant at the 14-15 somite stage. F looks at the height/width ratio, 
comparing the genotypes at the two time points. No significant difference is seen in the height/width 
ratios, which suggests that although the NTs are smaller in Sp
2H
/Sp
2H
 embryos, they are similarly 
proportioned. 
G compares the total area of the NTs between the genotypes at both time points. Sp
2H
/Sp
2H
 embryos 
have a significantly reduced surface area at both time points. H and I compare the partial areas – 
dorsal and ventral – between the genotypes at the 14-15 somite stage (H) and the 19-20 somite stage 
(I). Sp
2H
/Sp
2H
 embryos show significantly reduced area in both the dorsal and ventral regions at 14-15 
somite stage. However, although both regions are reduced in area at the 19-20 somite stage, the 
differences are not significant. 
J-L: Cell density is measured as the number of cells contained within a region/area of that region. 
There are no significant differences in cell density between the genotypes at either time point (J). K 
and L compare cell density between the genotypes in the partial regions at the 14-15 somite stage (K) 
and the 19-20 somite stage (L). K shows that there is an increase in cell density in Sp
2H
/Sp
2H
 embryos at 
the 14-15 somite stage, although this difference is only significant in the dorsal region. However this 
difference is no longer present at the 19-20 somite stage (L). 
* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001. NS: no significance. n = 6 for each genotype within each time 
point (n = 24 in total). Error bars show standard error. The t-test was used to test for significant 
difference. All data follows a Gaussian distribution except for the total area of 14-15 somite stage 
Sp
2H
/Sp
2H
 embryos, and the total cell density of 19-20 somite stage Sp
2H
/Sp
2H
 embryos. 
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were seen in this ratio for either the 14-15 or 19-20 somite stages, suggesting that the overall 
shape of the NT remains in proportion, although it is reduced in size in the Sp2H/Sp2H embryos 
(Figure 3.14F). 
The area of the NT was also measured. A statistically significant reduction was seen in the 
cross sectional area of the NT of Sp2H/Sp2H embryos at both the 14-15 and 19-20 somite stages 
compared to +/+ embryos (Figure 3.14G-I). This is consistent with a smaller NT. 
3.1.2.5.3    Cell density 
Cell density was measured as  
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠
𝑐𝑟𝑜𝑠𝑠 𝑠𝑒𝑐𝑡𝑖𝑜𝑛𝑎𝑙 𝑎𝑟𝑒𝑎
 . First the overall density of the cross section 
was analysed, using the total cell count and the total area of the cross section. There is no 
significant difference between the +/+ overall density and the Sp2H/Sp2H overall density at 
either the 14-15 or 19-20 somite stages (Figure 3.14J). 
Next the regional densities of the NT were analysed, considering the dorsal region and the 
ventral region separately. Cell counts and area measurements were taken for these regions. At 
the 14-15 somite stage there is a statistically significant increase in cell density in the Pax3-
expressing dorsal region of the neural tube in Sp2H/Sp2H embryos compared to the dorsal 
region of the NT in +/+ embryos (Figure 3.14K). Although the cell density in the Pax3-negative 
control domains of these embryos appears to also be increased, the data does not reach 
significance. Therefore the mutation appears to increase the cell density in the NT at this stage 
in development, but it appears to affect the dorsal region more than the ventral region. 
Regional cell density in 19-20 somite stage embryos appears to be more equal across the 
genotypes compared to 14-15 somite stage embryos (Figure 3.14L). There is no statistically 
significant difference in cell density in either the dorsal or ventral regions. 
3.1.2.5.4    Thickness of the neural folds 
Another property of the NT which was analysed was the thickness of the neural folds. This was 
measured on both folds using the cross sections at three different points on the dorso-ventral 
axis; at the boundary of the dorsal region (25% total height from the dorsal-most point), at the 
midpoint (50% total height from the dorsal-most point), and at the boundary of the ventral 
region (33% total height from the ventral-most point). These will be referred to as the dorsal, 
mid, and ventral measurements respectively. See Figure 3.15A-B for illustration. 
At the 14-15 somite stage there is a strong trend for Sp2H/Sp2H embryos to have thinner neural 
folds at all three measurement points. However, the difference narrowly fails to reach  
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Figure 3.15: Comparing the morphology of +/+ and Sp2H/Sp2H embryos – 3. A demonstrates 
how the NT was divided up for the thickness studies. The scale bars represent 50 μm. The total 
height of the NT was measured (white double-ended arrow), and lines were drawn perpendicular to 
this, across the width of the NT; one below the dorsal quarter (x), one at midway (y), and one above 
the ventral third (z). Measurements were taken perpendicular to the neural folds, from the points 
where the lines met the basal surface of the NT (B) – dorsal, midpoint and ventral measurements. 
C and D compare thickness measurements between +/+ and Sp
2H
/Sp
2H
 embryos at the 14-15 somite 
stage (C) and the 19-20 somite stage (D). Comparisons were made for each of the three 
measurements points. No significant differences were seen between the genotypes. 
E compares the ratio of dorsal thickness to total NT area between genotypes. Comparisons were 
made for each of the time points. A significantly increased ratio is seen at both the 14-15 and 19-20 
somite stages in Sp
2H
/Sp
2H
 embryos compared to +/+ embryos. 
* p ≤ 0.05, ** p ≤ 0.01. NS: no significance. n = 6 for each genotype within each time point (n = 24 in 
total). Error bars show standard error. Student t-test was used to test for significant difference. This 
data follows a Gaussian distribution. 
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Figure 3.16: Comparing the morphology of +/+ and Sp2H/Sp2H embryos – 4. Experimental 
litters were generated containing a mixture of genotypes by intercrossing Sp
2H
/+ mice Scale bars 
represent 50 µm. Cell nuclei are stained with DAPI and show as blue. The Phospho histone H3 
antibody marks proliferating cells and shows as green. A and B show examples of the NTs of wild 
type and Splotch mutant embryos respectively. The NT is outlined in white for clarity. 
Splotch mutant embryos (B) have reduced numbers of cells in cross section, and a smaller cross-
sectional area in the NT compared to wild type embryos (A). In addition, the density of cells in the 
dorsal region of the NT is reduced in Splotch embryos (B) at the 14-15 somite stage compared to 
wild type embryos (A). 
The height and width of the NTs are shown in red. Splotch mutant embryos have reduced height at 
both 14-15 and 19-20 somite stages, and reduced width at the 14-15 somite stage compared to wild 
type embryos (A). The thickness of the NT (shown in pink) is also reduced at the 14-15 somite stage 
in Splotch mutant embryos (B) compared to wild type embryos (A). 
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statistical significance for the dorsal, mid, and ventral measurements (Figure 3.15C). Possibly 
the differences would be statistically significant with larger sample sizes. 
By the 19-20 somite stage the difference has decreased, and there are no significant 
differences in the thickness of the neural folds between +/+ and Sp2H/Sp2H embryos for the 
dorsal, mid, or ventral measurements (Figure 3.15D). 
Although the NT was found to be significantly smaller in Sp2H/Sp2H embryos at both the 14-15 
and 19-20 somite stages, the neural folds of these embryos are not significantly thinner. 
Therefore, the thickness of the neural folds was analysed in relation to the size of the NT for 
+/+ and Sp2H/Sp2H embryos. 
𝐷𝑜𝑟𝑠𝑎𝑙 𝑡ℎ𝑖𝑐𝑘𝑛𝑒𝑠𝑠
𝑇𝑜𝑡𝑎𝑙 𝑎𝑟𝑒𝑎
 was calculated for each embryo, and the results 
were compared between the genotypes. Dorsal area was chosen as the thickness 
measurement most likely to be affected by the presence of the Sp2H allele, as this involves the 
region of the NT which expresses Pax3 in wild type embryos. 
Analysis showed a statistically significant increase in the dorsal thickness to area ratio for both 
the 14-15 and 19-20 somite stage Sp2H/Sp2H embryos (Figure 3.15E). This suggests that the 
neural folds are proportionally thicker for their size in the NTs of Sp2H/Sp2H embryos when 
compared to +/+ embryos, and that this difference is present at the 14-15 somite stage, and 
continues to be present at the 19-20 somite stage. 
3.1.2.5.5    Bending and positions of the hinge points 
As the neural folds are proportionally thicker in Sp2H/Sp2H embryos compared to +/+ embryos, 
it is possible that this affects the bending of the hinge points; thicker neural folds may exhibit a 
lower degree of bending, thus resulting in failure of the NT to close. In this way, the change in 
proportions of the neural folds of Sp2H/Sp2H embryos compared to +/+ embryos may cause the 
higher frequency of spina bifida seen in these mice. In order to examine if this may be the 
case, the angles of the MHPs were measured, along with the angles and positions of the 
DLHPs, in the open region of the spinal NT. 
In order to calculate the angle of the MHP, several points were defined in the neural folds. The 
thicknesses of the neural folds were calculated halfway along the dorso-ventral axis, and the 
midpoint of each fold was marked at this point. Likewise, the midpoint of the neural folds was 
calculated at the MHP.  The angle of the MHP was calculated by measuring the angle between 
these three points (Figure 3.17A-B). 
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Figure 3.17: Comparing the angles of the medial hinge points between +/+ and Sp2H/Sp2H 
embryos. A and B show how the MHP angle was defined. The scale bar represents 50 μm. Blue 
staining is DAPI. Green staining is anti-phospho histone H3. A shows how the length of the NT is 
measured along the midline, and then the NT is bisected halfway along this midline (yellow lines). The 
thickness of the neural folds is measured at the MHP and the bisection points (red lines), and then the 
centres of the neural folds are calculated in these regions (blue circles). The MHP is measured as an 
angle between these points (B, blue circles, red lines and yellow angle). 
The angles of the MHPs have been compared between +/+ and Sp
2H
/Sp
2H
 embryos at the 14-15 (C) and 
19-20 (D) somite stages. No significant differences in angle are present between the genotypes at 
either somite stage. 
In E-H the MHPs have been analysed separately according to whether they are proximal or distal to 
the closure point of the PNP (see section 2.7.2.3 for more details). E and F show that there are no 
significant differences between the MHP angle of proximal or distal sections in either +/+ or Sp
2H
/Sp
2H
 
embryos at the 14-15 (E) or 19-20 (F) somite stages. G and H show that there are no significant 
differences in MHP angle between the genotypes at either the 14-15 (G) or 19-20 (H) somite stages 
when comparing proximal and distal sections separately. 
NS: no significance. Error bars show standard error. The t-test was used to test for significant 
difference. This data follows a Gaussian distribution, apart from the unseparated MHP angles of 14-15 
somite stage +/+ embryos. 
+/+ 14-15 somite stage: n = 6. 
Sp
2H
/Sp
2H
 14-15 somite stage: n = 5. 
+/+ 19-20 somite stage: n = 5. 
Sp
2H
/Sp
2H
 19-20 somite stage: n = 5. 
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The angle of the MHP was compared between Sp2H/Sp2H and +/+ embryos at both the 14-15 
and 19-20 somite stages. At both of these somite stages, there were no significant differences 
in MHP angle between Sp2H/Sp2H and +/+ embryos (Figure 3.17C and D). 
Additionally, the angle of the MHP was compared between sections proximal and distal to the 
closure point of the PNP. Within each genotype, no significant differences were observed 
between the angles of the MHPs in proximal or distal sections in either 14-15 or 19-20 somite 
stage embryos (Figure 3.17E and F). Additionally, no differences were found between 
genotypes when comparing either proximal or distal sections separately (Figure 3.17G and H). 
The DLHP angle was calculated by marking the midpoint of the neural fold at the DLHP, and 
finding the angle between lines which are parallel to the neural folds around the DLHP and 
meet at this point (Figure 3.18A and B). The DLHPs are not always present in the NT at the 
level of the PNP closure point in 14-15 somite stage embryos, so this analysis was only carried 
out on 19-20 somite stage embryos. It was found that the angles of the DLHPs are significantly 
smaller in Sp2H/Sp2H embryos compared to +/+ embryos, indicating greater bending in the 
Splotch mutant embryos. (Figure 3.18C) However, these differences between the genotypes 
do not reach significance when considering proximal and distal sections separately, although 
this could possibly be overcome by greater sample sizes as there appears to be a trend, despite 
the absence of statistical significance (Figure 3.18E). 
The dorso-ventral position of the DLHPs was calculated by connecting a line between the 
outermost points of the DLHPs, at the basal edge of the NT. The distance was then measured 
between the ventral-most point of the NT and the intersection of this line with the midline. 
This distance was calculated as a proportion of the total length of the NT (Figure 3.20A and B). 
It was found that the DLHPs of Sp2H/Sp2H embryos are located significantly more dorsally when 
compared to those of +/+ embryos (Figure 3.20C). No significant differences were seen within 
genotypes when comparing proximal and distal sections (Figure 3.20D). However, significant 
differences are present between the genotypes when comparing proximal and distal sections 
separately (Figure 3.20E). 
3.1.3    The effects of folate deficiency on neural tube closure in Splotch mutant 
embryos 
Folate levels are known to affect the closure of the NT in Sp2H/Sp2H embryos (Burren et al., 
2008; Fleming and Copp, 1998). Folate deficient embryos were generated by feeding a folate 
deficient diet (FD) to the mother for three weeks before mating, and during gestation. The 
effects of folate deficiency on NTD development were studied in these embryos. 
143 
 
 
 
 
 
Figure 3.18: Comparing the angles of the dorsolateral hinge points between +/+ and 
Sp2H/Sp2H embryos – 1. A and B show how the DLHP angles were defined. The scale bar represents 
50 μm. Blue staining is DAPI. Green staining is anti-phospho histone H3. A shows how the thicknesses 
of the neural folds were measured at the DLHPs (yellow lines) and the midpoints of the neural folds 
were calculated at these points (blue circles). B shows how lines were drawn centred on these 
midpoints (blue circles) lying parallel with the neural folds dorsal and ventral to the DLHPs (red lines). 
The angles between these lines were calculated to give a value for the DLHPs (yellow angles). 
The angles of the DLHPs at the 19-20 somite stage have been compared between +/+ and Sp
2H
/Sp
2H
 
embryos (C). Sp
2H
/Sp
2H
 embryos have significantly smaller DLHP angles when compared to +/+ 
embryos. 
In D and E the DLHPs have been analysed separately according to whether they are proximal or distal 
to the closure point of the PNP (see section 2.7.2.3 for more details). D shows that there are no 
significant differences between the DLHP angles of proximal or distal sections in either +/+ or 
Sp
2H
/Sp
2H
 embryos at the 19-20 somite stage. E shows that there are no significant differences in DLHP 
angle between the genotypes when comparing proximal and distal sections separately. 
* p ≤ 0.05. NS: no significance. Error bars show standard error. The t-test was used to test for 
significant difference. This data follows a Gaussian distribution. 
+/+: n = 4. 
Sp
2H
/Sp
2H
: n = 3. 
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Figure 3.19: Comparing the angles of the dorsolateral hinge points between +/+ and 
Sp2H/Sp2H embryos – 2. Experimental litters were generated containing a mixture of genotypes by 
intercrossing Sp
2H
/+ mice Scale bars represent 50 µm. Cell nuclei are stained with DAPI and show as 
blue. The Phospho histone H3 antibody marks proliferating cells and shows as green. A and B show 
examples of the NTs of wild type and Splotch mutant embryos respectively. The NT is outlined in 
white for clarity. 
The positions of the DLHPs are shown in yellow, and the measured angles are shown in pink. The 
average DLHP angles of Splotch mutant embryos (B) are smaller than those of wild type embryos (A). 
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Figure 3.20: Comparing the positions of the dorsolateral hinge points between +/+ and 
Sp2H/Sp2H embryos. A and B show how the DLHP positions were defined. The scale bar represents 50 
μm. Blue staining is DAPI. Green staining is anti-phospho histone H3. A shows how the thicknesses of 
the neural folds were measured at the DLHPs (yellow lines) and the midpoints of the neural folds were 
calculated at these points (blue circles). B shows how these points were joined (blue circles, red line). 
The midline of the NT was measured (yellow line), and the distance from the ventral limit of the NT to 
the line joining the DLHP midpoints was also measured (blue line). The position of the DLHPs was 
calculated as   
𝑏𝑙𝑢𝑒 𝑙𝑖𝑛𝑒
𝑦𝑒𝑙𝑙𝑜𝑤 𝑙𝑖𝑛𝑒
 . 
The positions of the DLHPs at the 19-20 somite stage have been compared between +/+ and Sp
2H
/Sp
2H
 
embryos (C). Sp
2H
/Sp
2H
 embryos have significantly more dorsal DLHPs when compared to +/+ embryos. 
In D and E the DLHPs have been analysed separately according to whether they are proximal or distal 
to the closure point of the PNP (see section 2.7.2.3 for more details). D shows that there are no 
significant differences between the DLHP positions of proximal or distal sections in either +/+ or 
Sp
2H
/Sp
2H
 embryos at the 19-20 somite stage. E shows that the DLHPs are significantly more dorsal in 
Sp2H/Sp2H embryos compared to +/+ embryos when considering proximal and distal sections 
separately. 
** p ≤ 0.01. NS: no significance. Error bars show standard error. The t-test was used to test for 
significant difference. n = 3 per genotype. This data follows a Gaussian distribution. 
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Figure 3.21: Exencephaly in folate-deficient embryos. Experimental litters containing multiple 
genotypes were generating through intercross of Sp
2H
/+ mice.  
The graph shows frequency of exencephaly in the different genotypes from this cross. Exencephaly is 
defined as an open cranial NT at the 18 somite stage or older. Sp
2H
/Sp
2H
 embryos have a significantly 
higher frequency of exencephaly when compared to +/+ embryos. The frequency in Sp
2H
/+ embryos 
also appears to be higher, but the difference has not reached significance. The Fisher Exact Test was 
used to test for significant difference. *** p < 0.001. +/+: n = 10. Sp
2H
/+: n = 28. Sp
2H
/Sp
2H
: n = 16.  
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Figure 3.22: Comparing the frequency of exencephaly in embryos of different genotypes 
with either normal or folate deficient status. Experimental litters were generated through 
intercross of Sp
2H
/+ embryos. Progeny of the resulting genotypes were compared to embryos of 
equivalent genotype with folate deficiency. FD and ND embryos were collected concurrently, 
although ND embryos were collected for a longer period of time. 
+/+ and Sp
2H
/Sp
2H
 embryos showed an increase in the frequency of exencephaly in the FD embryos 
when compared to the ND embryos of the equivalent genotype. However, this difference was not 
significant. Sp
2H
/+ embryos, on the other hand, show a significant increase in exencephaly in the FD 
embryos. 
* p < 0.05. The Fisher Exact Test (+/+ and Sp2H/Sp2H) or the Chi-Square Test (Sp2H/+) were used to 
test for significant difference. 
Normal folate status - +/+: n = 54. Sp
2H
/+: n = 94. Sp
2H
/Sp
2H
: n = 46. 
Folate deficient - +/+: n = 10. Sp
2H
/+: n = 28. Sp
2H
/Sp
2H
: n = 16. 
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3.1.3.1    Folate deficiency increases the rate of exencephaly in Splotch heterozygous 
embryos 
FD embryos were monitored for exencephaly. A significant increase in the frequency of 
exencephaly is seen when comparing Sp2H/Sp2H embryos to +/+ (Figure 3.21). An increase is 
also seen in Sp2H/+ embryos compared to +/+, but this difference does not reach significance. 
The frequency of exencephaly within genotypes was compared between normal diet (ND) and 
FD embryos to observe the effect of the folate deficiency on exencephaly development. An 
increase was seen in the frequency of exencephaly in +/+ and Sp2H/Sp2H FD embryos, although 
these differences did not reach significance. However, a significant increase in the frequency of 
exencephaly was seen in Sp2H/+ FD embryos when compared to the ND embryos of the same 
genotype (Figure 3.22). This data validates previous findings (Burren et al., 2008). 
3.1.3.2    Folate deficiency slightly affects spinal neurulation in Splotch heterozygous 
embryos 
The effect of FD on spinal neurulation has not previously been studied. The PNP was measured 
for each embryo, and the embryos were grouped according to somite stage (6-8, 9-11, etc.) 
(Figure 3.23). The PNP sizes of +/+ embryos on ND and FD were compared to examine whether 
the FD may have an effect on NT closure without any influence of the Pax3 mutation.  
The PNP sizes were also compared within the genotypes between embryos on ND or FD. No 
significant differences in PNP size were found between +/+ ND or FD embryos (Figure 3.24A). 
However, a significant reduction in PNP size was found in Sp2H/+ FD embryos at the 15-17 and 
18-20 somite stages (Figure 3.24B). FD Sp2H/Sp2H embryos also showed a significant reduction 
in PNP size at the 9-11 somite stage when compared to ND embryos (Figure 3.24C). 
3.1.4    Canonical Wnt signalling in Splotch mutant embryos 
It is possible that canonical Wnt signalling is disrupted in Sp2H/Sp2H embryos (see section 1.4.7 
for more information). Therefore, canonical Wnt signalling levels, and expression of related 
genes, were studied in Sp2H/Sp2H mice. 
3.1.4.1    LacZ RT-qPCR of BatGal embryos 
Embryos were collected at the 18-19 somite stage from a Pax3Sp2H/+ LacZBatGal/+ x Pax3Sp2H/+ 
cross. The BatGal allele is a LacZ-expressing gene under the control of β-catenin responsive 
elements (Maretto et al., 2003). Therefore, the β-galactosidase gene is expressed in regions of 
canonical Wnt signalling, and the amount expressed should indicate the level of canonical Wnt 
signalling. 
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Figure 3.23: Posterior neuropore closure in folate deficient embryos. Experimental litters 
containing multiple genotypes were generated through intercross of Sp
2H
/+ mice. 
The graph shows PNP length in embryos of the different genotypes in grouped somite stages. 
Although the Sp
2H
/Sp
2H
 embryos appear to have a larger PNP at the 12-14 somite stage, a significant 
increase in size is first seen at the 15-17 somite stage. No significant difference is seen in PNP size 
between +/+ and Sp
2H
/+ embryos. One-way ANOVA was used to test for significant difference. Error 
bars show standard error. * p < 0.05.  
9-11 somites – +/+: n = 1. Sp
2H
/+: n = 8. Sp
2H
/Sp
2H
: n = 2. 
12-14 somites – +/+: n = 12. Sp
2H
/+: n = 24. Sp
2H
/Sp
2H
: n = 2. 
15-17 somites – +/+: n = 14. Sp
2H
/+: n = 26. Sp
2H
/Sp
2H
: n = 8. 
18-20 somites – +/+: n = 6. Sp
2H
/+: n = 20. Sp
2H
/Sp
2H
: n = 14. 
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 Figure 3.24: Comparison of posterior neuropore size in embryos of different genotypes 
with either normal or folate deficient status. Experimental litters were generated through 
intercross between Sp
2H
/+ embryos. FD and ND embryos were collected concurrently, although ND 
embryos were collected for a longer period of time. The graphs show data for the resulting 
genotypes – +/+ (A), Sp
2H
/+ (B), and Sp
2H
/Sp
2H
 (C). Data has been grouped according to the somite 
stage of the embryo. 
+/+ embryos show no significant differences in PNP size between the two different folate statuses. 
However the Sp
2H
/+ and Sp
2H
/Sp
2H
 embryos both show significant differences at certain somite 
stages when compared to the ND embryos. A significant reduction in PNP size is seen in the FD 
embryos at the 15-17 and 18-20 somite stages in the Sp
2H
/+ embryos, and at the 9-11 somite stage 
in the Sp
2H
/Sp
2H
 embryos. 
* p ≤ 0.05, ** p ≤ 0.01. Error bars show standard error. The t-test was used to test for significant 
difference. 
A – 9-11 somites – ND: n = 10. FD: n = 1.  
12-14 somites – ND: n = 29. FD: n = 12. 
15-17 somites – ND: n = 38. FD: n = 14. 
18-20 somites – ND: n = 40. FD: n = 6. 
21-23 somites – ND: n = 12. FD: n = 4. 
B – 6-8 somites – ND: n = 4. FD: n = 3.  
9-11 somites – ND: n = 26. FD: n = 8. 
12-14 somites – ND: n = 59. FD: n = 24. 
15-17 somites – ND: n = 63. FD: n = 26. 
18-20 somites – ND: n = 66. FD: n = 20. 
21-23 somites – ND: n = 22. FD: n = 7. 
C – 6-8 somites – ND: n = 2. FD: n = 2.  
9-11 somites – ND: n = 16. FD: n = 2. 
12-14 somites – ND: n = 25. FD: n = 2. 
15-17 somites – ND: n = 32. FD: n = 8. 
18-20 somites – ND: n = 39. FD: n = 14. 
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RNA was extracted from whole embryos of genotypes Pax3+/+ BatGal/+ and Pax3Sp2H/Sp2H 
BatGal/+. RT-qPCR was used to compare the relative expressions of LacZ in these embryos, to 
observe if Pax3 expression affects levels of canonical Wnt signalling in the embryos as a whole. 
No significant difference was seen in the levels of LacZ expression between these genotypes 
(Figure 3.25). 
3.1.4.2    Wnt RT-qPCR plate 
RT-qPCR was carried out using the RT2 ProfilerTM PCR Array Plate for the mouse Wnt signalling 
pathway from SABiosciences. This array allowed a broad readout of the expression of genes  
Figure 3.25: Comparing Wnt signalling levels between +/+ and Sp2H/Sp2H embryos. 
Experimental litters were generated containing a mixture of genotypes by crossing Sp
2H
/+ +/+ mice 
to Sp
2H
/+ BatGal/+ mice. RT-qPCR was carried out on whole embryo RNA extractions from 18-19 
somite stage +/+ and Sp
2H
/Sp
2H
 embryos carrying the BatGal Wnt reporter allele. No significant 
difference in LacZ expression was seen between the genotypes. 
The t-test was used to test for significant difference. n = 3 for each genotype. Error bars show 
standard error. 
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implicated in or downstream of Wnt signalling in the Splotch embryo. The array does not allow 
for replicates, and thus is simply used to indicate genes which may be worth further study. The 
RT-qPCR was carried out using RNA extracted from 14 somite stage embryo heads, and +/+ 
embryos were compared to Sp2H/Sp2H embryos. The 14 somite stage was used as this was the 
main stage of interest (as discussed previously), and the cranial region was used as this is what 
was available at the 14 somite stage. Although the spinal region is the main area of study in 
the Splotch embryos in this thesis, it is possible that using the cranial region could also give 
insight into gene expression in the embryo as a whole, including the spinal region. 
 
 
 
Gene Relative Expression 
Axin1 0.60 
Fgf4 0.69 
Fosl1 5.28 
Foxn1 1.74 
Fshb 1.47 
Fzd6 0.68 
Sfrp4 1.44 
Wnt2 0.24 
Wnt6 0.71 
Wnt7a 1.73 
Wnt8a 1.72 
Wnt9a 0.51 
 
 
Table 3.1: Genes which passed the threshold of 1.4-fold difference in the RT2 ProfilerTM 
PCR Array Plate for the mouse Wnt signalling pathway from SABiosciences. Experimental 
litters were generated by intercrossing Sp
2H
/+ embryos. Sp
2H
/Sp
2H
 embryos were compared to 
control embryos, which had the genotype +/+. n = 3 per genotype. 
RNA was extracted from the cranial regions of 14 somite stage embryos, and then pooled according 
to genotype. The threshold was a 1.4-fold difference, which is equivalent to relative expression levels 
of 1.4 (upregulated gene) or 0.71 (downregulated gene). 
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A threshold of 1.4-fold difference was chosen to define genes with differences in relative 
expression levels. This should allow dismissal of genes which are exhibiting small natural 
fluctuations in expression. Several genes passed the set threshold of 1.4-fold difference (see 
Table 3.1 for a list of these genes), and some of these were studied further (see section 
below). However, Wnt-related gene expression appeared largely very similar between +/+ and 
Sp2H/Sp2H embryos. 
3.1.4.3    RT-qPCR of Wnt genes in Splotch mutant embryos 
A number of canonical Wnt-related genes were chosen from amongst those which appeared to 
be disrupted on the Wnt RT-qPCR plate (see section above). The potential genes were 
narrowed down by choosing those which were related to canonical Wnt signalling specifically, 
and which appeared to show an expression pattern which could overlap with that of Pax3. The 
genes Axin1, Sfrp4, and Fzd6 were chosen to study, and the genes Axin2 and Cdx2 were chosen 
to monitor the overall levels of Wnt signalling, as these are established measures of canonical 
Wnt signalling levels; Cdx2 is known to be downstream of canonical Wnt signalling, and Axin2 
has been shown to be downregulated in the NTs of embryos with β-catenin loss-of-function 
(Benahmed et al., 2008; Hart et al., 1998; Wang and Shashikant, 2007; Zechner et al., 2003). 
Axin2 is commonly used to monitor levels of canonical Wnt signalling, as expression of Axin2 is 
induced by canonical Wnt signalling. This is supported by the identification of TCF/LEF binding 
sites in the Axin2 promoter region (Jho et al., 2002). Although several genes showed greater 
fold changes in the Wnt RT-qPCR plate study these were not examined further due to lack of 
connection to the canonical Wnt signalling pathway or due to differences in expression pattern 
between the gene and Pax3. 
RNA was extracted from whole embryos of 23-24 somite stage and genotypes +/+ and 
Sp2H/Cre, and RT-qPCR was used to compare relative expressions of the chosen genes (Figure 
3.26). Although embryos at approximately the same somite stage as used previously (14 
somites) would be ideal for carrying out the validation, these were not available in sufficient 
numbers to allow comparison between the genotypes. 23-24 somite stage embryos were 
available in numbers which enabled comparison. However, no significant differences were 
seen in the gene expressions when compared between the genotypes. 
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Figure 3.26: Comparing expressions of Wnt-related genes in +/+ and Sp2H/Cre embryos. 
Experimental litters were generated containing a mixture of genotypes through the cross Pax3
Sp2H/+
 
β-catenin
GOF/+
 x Pax3
Cre/+
 β-catenin
+/+
. This cross was used for the experiments described in Chapter 
4. Sp
2H
/Cre embryos are – like Sp
2H
/Sp
2H
 embryos – Pax3-null. 
Gene expression was analysed using RT-qPCR on whole embryo (23-24 somite stage) RNA 
extractions. The gene expressions analysed were Axin1 (A), Axin2 (B), Cdx2 (C), Fzd6 (D), and Sfrp4 
(E). No significant differences were seen in expression between the genotypes for any of the genes 
studied. 
n = 4 for each genotype. Error bars show standard error. The t-test was used to test for significant 
difference. 
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3.2    Discussion 
3.2.1    Cellular defects during spinal neurulation in Splotch mutant embryos 
Three main theories have been put forward as potential cellular mechanisms which could 
cause exencephaly in Sp2H/Sp2H embryos; increased apoptosis, premature neuronal 
differentiation, and reduced proliferation in the NT. This study analysed each of these cellular 
processes in the spinal region of Sp2H/Sp2H embryos during neurulation to investigate whether 
they could possibly they play a causal role in the development of spina bifida. 
Apoptosis was studied using both observational and experimental methods. TUNEL staining 
detected no increase in apoptosis in the PNP of Sp2H/Sp2H embryos, although quantification of 
apoptosis in the spinal region by cell counting using sections could confirm this more 
definitively. Additionally, higher sample numbers could help to clarify the results, as apoptosis 
is highly variable, even within a genotype. It is possible that higher levels of apoptosis occur in 
the cranial region of Sp2H/Sp2H embryos compared to +/+ embryos. However this result was 
inconsistent, and would require quantitation of apoptotic cells and larger sample sizes to 
confirm. 
If excess apoptosis was present in the caudal NT of Sp2H/Sp2H embryos, then experimentally 
reducing apoptosis may have constituted a rescue effect. This effect has been previously 
reported through use of a p53-null allele (Pani et al., 2002). However, attempts to replicate 
these results proved unsuccessful; Sp2H/Sp2H embryos developed both spina bifida and 
exencephaly regardless of p53 expression levels. This suggested that the p53-null allele used in 
these crosses had no rescuing effect on NTDs in Sp2H/Sp2H mice. 
However, p53 has additional functions unrelated to apoptosis, including cell cycle arrest, 
induction of senescence, and regulation of metabolism (Chen et al., 2005; el-Deiry, 1998; Hu et 
al., 2010; Matoba et al., 2006). Therefore, p53 mutation will have effects on other cellular 
processes in addition to apoptosis, and any of these may have contributed to NTD rescue in 
Sp/Sp embryos. Inhibitors which target apoptosis specifically, such as Z-VAD-FMK, may provide 
information on the role of apoptosis in NTD development in Splotch embryos, while leaving 
other p53-mediated processes intact. 
There are several reasons why the research described here could disagree with that reported 
previously (Pani et al., 2002). For example, the original research used mice carrying the Pax3Sp 
allele, whereas the mice used in the research described here carry the Pax3Sp2H allele. 
Differences in Pax3 protein activity or severity of NTDs could affect the results. Additionally, 
the mice in the original research had a C57 genetic background, whereas those used in the 
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research described here had a mixed CBA/101 background. As discussed previously (Section 
1.2.2.1) differences in genetic background can alter the effects of mutations due to the 
presence of different modifier genes (Davidson et al., 2007; Finnell et al., 1986; Finnell et al., 
1988; Fleming and Copp, 2000). Therefore, it is possible that any rescue effects caused by the 
p53 mutation in Splotch embryos are more prominent on particular genetic backgrounds. 
Following these results, attempts were made to verify the knock-down of the p53 protein in 
the mice used in the study. However, endogenous p53 protein present at a concentration 
which was too low to detect using Western blot, despite attempts to concentrate the protein. 
Additionally, no reduction in apoptosis was noted in Pax+/+ p53-/- embryos compared to Pax3+/+ 
p53+/+ embryos, so verification was not possible. Immunohistochemistry to detect the p53 
protein in whole embryos or sections could possibly be used to verify p53 knockdown in the 
mutant embryos. 
Neuronal differentiation in the neural tube was compared in +/+ and Sp2H/Sp2H embryos during 
neurulation. Theoretically premature neuronal differentiation in the spinal region of Sp2H/Sp2H 
mice could interfere with the closure of the PNP and cause spina bifida. Indeed, premature 
neuronal differentiation in the cranial region has been previously found in Splotch embryos 
(Nicholas Greene, unpublished data). However, no differentiating cells were observed in the 
region surrounding the closure point of the PNP, either in +/+ or Sp2H/Sp2H embryos. Therefore, 
even if premature neuronal differentiation were present in the spinal NT of Sp2H/Sp2H embryos 
it would be unlikely to be causal for spina bifida. 
Sp2H/Sp2H embryos were assessed for the presence of premature neuronal differentiation in 
the spinal region. The extent of the differentiation was measured by observing the somite level 
at which neuronal differentiation was visible through immunohistochemistry. However, no 
significant difference was seen when comparing this between the +/+ and Sp2H/Sp2H embryos. 
This makes it unlikely that there is premature neuronal differentiation in the spinal region of 
Sp2H/Sp2H embryos. 
Finally, proliferation of the cells in the spinal NT was compared between +/+ and Sp2H/Sp2H 
embryos during neurulation. Reduced proliferation has been previously found in the cranial NT 
of Splotch embryos (Nicholas Greene, unpublished data). A gradient of proliferation was 
observed in the cells of the spinal NT in +/+ embryos at the 14-15 somite stage; proliferation 
was high in the dorsal Pax3-expression region, and lower in the ventral Pax3-negative region. 
However, this gradient is lost by the 19-20 somite stage; embryos demonstrate a uniform rate 
of proliferation throughout the NT, equivalent to the lower ventral rate of proliferation in 14-
15 somite stage +/+ embryos. The proliferation gradient is absent in 14-15 somite stage 
160 
 
Sp2H/Sp2H embryos – the mutant NT has a uniform rate of proliferation throughout, which is 
equivalent to the lower ventral rate of proliferation in +/+ embryos. There were no significant 
differences in proliferation between +/+ and Sp2H/Sp2H embryos at 19-20 somite stage; 
proliferation is uniform throughout the NT in both genotypes at this stage of development.  
As mentioned previously, experiments to study proliferation and differentiation in the Splotch 
embryos were carried out the 14-15 somite stage and 13-15 somite stage respectively, as this 
originally appeared to be the developmental stage at which significant differences in the size 
of the PNPs were first seen between genotypes. As more data was collected this point during 
development was found to be earlier than originally thought, at the 10-11 somite stage. 
Ideally, the experiment quantifying proliferation in the spinal region of the NT would be 
repeated using embryos at the 8-9 somite stage, prior to the onset of the defect. At this stage 
during development there are no significant differences in the size of the PNP between +/+ 
and Sp2H/Sp2H embryos. The defect must be present prior to the detection of the 
morphological defect. Therefore, at the 8-9 somite stage the cellular defect would likely be 
present, but there would be no morphological differences to potentially affect the results. 
However, the data presented in this thesis has merit, as it demonstrates cellular differences in 
the NT soon after the onset of the morphological defect. 
It would be interesting to carry out the proliferation experiments using 13-15 and 19-20 somite 
stage embryos, and sections a fixed distance from the caudal extremity. In the experiments 
described in this thesis the focus of study was the closure point of the PNP. However, due to 
the differences in the size of the PNP between genotypes this point will be in a different 
position on the rostro-caudal axis depending on genotype. Therefore, it could be informative 
to observe proliferation in the NT a set distance from the caudal tip of the embryo. This would 
eliminate the possibility that the position of the sections on the rostro-caudal axis causes 
changes in proliferation between genotypes, as opposed to the genotypes themselves. 
However, the method used in this thesis is useful, as it enables direct comparison between 
genotypes of proliferation in the actively closing regions of the PNP. This is essential, as the 
closure appears to be slowed in Sp2H/Sp2H embryos, and so this is a critical region. 
It would also be interesting to study whether the proliferation defect seen in Sp2H/Sp2H 
embryos causes the NTDs in these embryos, or whether it is an unrelated additional defect. A 
reduction in proliferation could prevent NT closure through a wide range of mechanisms. For 
example, it could alter the morphology of the NT (as was studied), thus mechanically 
preventing closure. Alternatively, the rate of proliferation could be coupled with another 
cellular mechanism, such as differentiation, apoptosis, or migration (such as that of the NC). 
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Alteration of proliferation could alter the activity of other mechanisms, which could affect the 
behaviour or proportions of cell types, or the properties of the tissue. Any of these alterations 
could potentially prevent closure of the NT. Experiments to observe the expression of genes, 
such as those expressed in the NC, those related to migration, or those expressed in the ECM 
for example, could provide more information about other disrupted mechanisms in the NT and 
surrounding tissues of Splotch mutant embryos. Alternatively, the proliferation defect seen in 
the Splotch mutant embryos may not be limited to the NT. Proliferation studies of surrounding 
tissue, such as the notochord or the gut, could show if these tissues may also have altered 
proliferation in the mutant embryos. For example, reduced proliferation in the gut of ct 
embryos causes spina bifida (Copp et al., 1988a). Therefore, it is possible that proliferation 
defects in tissues other than the NT in the Splotch embryos may cause NTDs.  
Reducing proliferation in embryos at the critical stages of NT closure could mimic the defect 
seen in the Sp2H/Sp2H mice, and it would be interesting to observe if NTDs develop. For 
example, culture of embryos in an anti-mitotic agent, such as Mitomycin, would reduce 
proliferation. However, this reduction might be seen in all tissues, and could potentially cause 
a large number of defects. Therefore, NTDs would not necessarily be indicative of causation by 
reduced proliferation in the NT specifically. Alternatively, an interesting experiment could be 
to slightly reduce proliferation in Sp2H/+ embryos; these embryos are more susceptible to NTDs 
than +/+ embryos. Therefore, if reduced proliferation were causative of NTDs, then a small 
reduction in proliferation may be sufficient to induce development of the defects in Sp2H/+ 
embryos. If anti-mitotic agents are capable of inducing NTDs in Sp2H/+ embryos, it could be an 
indication that the reduction in proliferation is causative of NTDs. 
The Pax3 gene encodes a transcription factor. Research has identified a number of Pax3 target 
genes involved in proliferation, differentiation and apoptosis  which could provide information 
on how it is able to regulate these processes (Wang et al., 2007). This could also indicate which 
pathways are being affected by Pax3 mutation, and why proliferation is downregulated in the 
NTs of Sp2H/Sp2H embryos. 
The expressions of several Cyclin proteins are upregulated by Pax3 (Wang et al., 2007). These 
include Cyclin A and Cyclin E, which promote transition into S phase and DNA replication 
(Ohtsubo et al., 1995; Zindy et al., 1992), and Cyclin I, which is required for progression 
through S and G2/M phases (Nagano et al., 2013). Pax3 may increase cell proliferation through 
activation of genes such as the Cyclins, and promotion of progress through the cell cycle. 
Additionally, Pax3 increases expression of other genes which promote proliferation, such as 
protein kinase C-γ, and Ybx1, thus acting in a less direct manner (Feng et al., 2009; Wouters et 
162 
 
al., 2009). This suggests that Pax3 acts through multiple pathways in order to robustly promote 
proliferation. 
3.2.2    Consequences of the reduction in proliferation in the neural tube 
The finding that proliferation is reduced in the neural folds of Sp2H/Sp2H embryos is supported 
by previously published research. For example, lower numbers of cells in sections of neural 
tube from Sp2H/Sp2H embryos compared to +/+ embryos has been reported (Kapron-Bras and 
Trasler, 1988). In addition, lower proliferation rates have been described in NTs from Sp2H/Sp2H 
embryos compared to +/+ embryos at certain stages of development (Keller-Peck and Mullen, 
1997). Research appears to show that this defect in Splotch embryos is due to lengthening of 
the cell cycle comparative to wild type; previous work shows that neurepithelial cells from 
Sp2H/Sp2H embryos have extended cell cycles in comparison to wild type embryos (Wilson, 
1974). Additionally, Pax3 protein has been found to upregulate expression of a number of 
Cyclin genes, which are known to aid progression through the cell cycle (Wang et al., 2007). 
Therefore, it seems likely that Pax3 increases proliferation through cell cycle regulation. 
The reduction of proliferation in the neural folds of Sp2H/Sp2H embryos would be predicted to 
cause a reduction in cell number in the NT. This was found to be true; data showed a 
significant reduction in cell number in the NT as a whole in 14-15 somite stage Sp2H/Sp2H 
embryos, but also interestingly in both the dorsal and ventral regions separately. This shows 
that although the proliferation defect is only present in the dorsal region of the NT the effects 
are present throughout. This could suggest that either cells are translocating dorsally in the 
neural folds, or the dorsal region comprises a smaller proportion of the NT. This could be 
analysed using a dorsal NT marker, such as Wnt1 or Wnt3a, to observe the relative size of the 
dorsal region. Additionally, the reduction in cell number is still present in 19-20 somite stage 
embryos, when the proliferation is comparable in +/+ and Sp2H/Sp2H embryos. This suggests 
that at this stage, the embryos have been unable to compensate for the reduced proliferation 
through alternative mechanisms, such as reduced apoptosis. The reduction in cell number 
could result in morphological changes in the NT. For example, it could reduce the size of the 
NT, or it could alter the cell density of the tissue. 
Measurements showed that the height and width of the NT are significantly reduced in the 14-
15 somite stage Sp2H/Sp2H embryos. At the 19-20 somite stage the differences in height and 
width are less pronounced when comparing between the genotypes, and only the height is 
significantly reduced in Sp2H/Sp2H embryos. This suggests that the NT may be able to 
compensate to a small degree to recover size once the proliferation defect is no longer 
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present. The height/width ratio is comparable between the genotypes, which suggests that the 
size proportions of the NT are unchanged in Sp2H/Sp2H embryos. 
The overall cross sectional area of the NT is reduced in Sp2H/Sp2H embryos at both the 14-15 
and 19-20 somite stages. This is consistent with a smaller size. Likewise, the dorsal and ventral 
areas of the NT are smaller at the 14-15 somite stage, although this was expected since the 
height and width are reduced. Again, the difference in size is less pronounced at the 19-20 
somite stage, as the dorsal and ventral surface areas demonstrate no significant differences 
between +/+ and Sp2H/Sp2H embryos, although Sp2H/Sp2H embryos show a trend towards a 
smaller NT size when compared to +/+ embryos. 
A small increase in cell density in the NT is seen at the 14-15 somite stage. However, this 
difference only reaches significance in the dorsal region, where the reduction in proliferation is 
located. At the 19-20 somite stage no difference in cell density is seen either in the whole NT 
cross section, or in the dorsal and ventral regions considered separately. These results suggest 
that the reduction in cell number is likely to contribute to the reduction in NT size in Sp2H/Sp2H 
embryos, but a defect may also be present in the mechanisms controlling the dorso-ventral 
and lateral size of the NT. At the 14-15 somite stage, the cells are more densely packed into 
the smaller NT, but by the 19-20 somite stage the issue has been partially rectified, and both 
the size and cell density appear closer to wild type levels. 
Another potential explanation for the size and cell density defects seen in Sp2H/Sp2H NTs 
involves cell-cell adhesion in the neurepithelium, which is known to require Pax3 signalling 
(Wiggan et al., 2002; Wiggan and Hamel, 2002). If the cells are somehow more tightly adhered 
in Sp2H/Sp2H NT then there would be less interstitial space, and the cells would be more densely 
packed. Additionally, the size of the NT would be reduced. If this were partially rectified before 
the 19-20 somite stage then the tissue would become less dense, and the size of the NT may 
more closely resemble that of +/+ embryos. This theory is supported by the fact that the defect 
is more pronounced in the dorsal Pax3-expression region, and also becomes less pronounced 
at the 19-20 somite stage in comparison to the 14-15 somite stage. However, Pax3 is 
associated with maintenance and formation of epithelia, and ectopic Pax3 expression in vitro is 
associated with formation of epithelial structure and increased cell-cell adhesion (Wiggan et 
al., 2002). Additionally, Pax3 mutation in vivo causes loss of epithelial structure in the 
dermomyotome (Mansouri et al., 2001). Also, expression of the gene Cyclin A2 is upregulated 
by Pax3, and the Cyclin A2 protein promotes epithelial formation and cell-cell adhesion 
(Bendris et al., 2014; Wang et al., 2007). Therefore, increased cell density in the NT of 
Sp2H/Sp2H embryos was unexpected. Nonetheless, the NT itself retains epithelial integrity in 
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Sp2H/Sp2H embryos, and previous research does not exclude the possibility that Pax3 protein 
could function to decrease cell-cell adhesion in the NT. 
The thickness of the NT was compared between +/+ and Sp2H/Sp2H embryos. A trend towards a 
thinner NT was apparent in 14-15 somite stage Sp2H/Sp2H embryos, although this data does not 
reach significance. As the NT is only a single cell in thickness this would suggest a potential 
defect in the mechanisms controlling the apico-basal length of the cells. Larger sample sizes 
could clarify if this is the case. Again, this defect appears to resolve by the 19-20 somite stage. 
Sp2H/Sp2H embryos show a significant reduction in NT size, but no significant reduction in the 
thickness of the NT when compared to +/+ embryos. Therefore the ratio between dorsal 
thickness and NT area was compared between genotypes to observe any changes in 
proportions of the NT. This ratio was significantly increased in Sp2H/Sp2H embryos at both the 
14-15 and 19-20 somite stages. This shows that the thickness of the NT is increased relative to 
NT size in Sp2H/Sp2H embryos compared to +/+ embryos, and that this defect is present during 
both early and late PNP closure. An increase in NT thickness may affect the mechanical 
properties of the NT during neurulation, potentially making it more resistant to bending and 
closure, and may contribute to the development of spina bifida in Sp2H/Sp2H embryos. 
This theory was examined further through examination of the hinge points in +/+ and 
Sp2H/Sp2H embryos. No differences were observed in the angle of the MHP between +/+ and 
Sp2H/Sp2H embryos, but some differences were identified between the genotypes in the DLHPs. 
Greater bending is seen in the DLHPs of Sp2H/Sp2H embryos, and they are also positioned more 
dorsally in these embryos. These two observations could be linked, as the greater bending in 
the DLHPs could reduce the distance between these hinge points and the dorsal-most point of 
the NT, thus affecting their proportional position along the dorso-ventral axis. 
This was an unexpected result. I hypothesised that the increase in the thickness of the neural 
folds in Sp2H/Sp2H embryos could reduce hinge point bending, and thus prevent NT closure. 
However, this is not what was observed. It is possible that the increased bending could prevent 
NT closure in Sp2H/Sp2H embryos, possibly by preventing the neural folds from making contact, 
and thus fusing correctly. This may or may not be linked to the relative thickening of the neural 
folds. Alternatively, it could be linked to the fact that the neural folds are actually slightly 
thinner in mutant neural folds compared to those of the wild type embryos, even though they 
are proportionally thicker. For example, the shorter cells could be more greatly affected by the 
basal positioning of the nucleus, making apical constriction more extreme. This could increase 
the bending of the hinge points. However, as this data did not reach significance more studies 
would need to be carried out to prove or disprove this theory. On the other hand, the 
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increased bending of the neural folds could be an artefact of the fixing and sectioning process, 
or alternatively the morphology of the neural tube could be unrelated to the failure of NT 
closure in Sp2H/Sp2H embryos. 
Sections were compared proximal and more distal to the closure point of the PNP, but no 
differences were observed in the hinge points between these positions. However, the most 
distal sections studied were a maximum of 42 μm caudal of the closure point. It is possible that 
sections a greater distance caudally from the closure point could identify differences between 
the genotypes which could suggest a morphological mechanism for the development of spina 
bifida in Sp2H/Sp2H embryos. 
3.2.3    The effects of folate deficiency on neural tube closure in Splotch mutant 
embryos 
Sp2H/Sp2H embryos are responsive to folate deficiency in the frequency of NTD development; 
frequency of exencephaly is increased and the size of the PNP is reduced. The rescue of PNP 
closure was an unexpected result, and has not previously been reported. However, it is likely 
that the rescue was temporary, as previous research has reported no difference in the 
frequency of spina bifida in Sp2H/Sp2H or Sp2H/+ embryos fed either ND or FD (Burren et al., 
2008). 
The folate deficiency could be acting on the embryo through either of two mechanisms; 
disruption in the donation of methyl groups to macromolecules, or the synthesis of 
pyrimidines and purines. It has previously been reported that folate supplementation rescued 
defective epigenetic marking in the Sp2H/Sp2H genome (Ichi et al., 2010). Therefore it is possible 
that folate deficiency worsens the epigenetic defects seen in these embryos. However, it is 
more likely that folate affects NTD development in Sp2H/Sp2H embryos through defective 
pyrimidine and purine synthesis. 
It has been shown in this project that Sp2H/Sp2H embryos have reduced proliferation in the 
dorsal region of the spinal NT. If folate deficiency is reducing pyrimidine and purine synthesis, 
then this could further reduce the rate of proliferation, and potentially prolong the time the 
embryo has reduced proliferation. Assuming that the reduction in proliferation is causative of 
NTDs, this could worsen the NTDs, and induce NTDs in embryos which may not otherwise have 
developed them, including Sp2H/+ embryos. This would explain the increase in exencephaly 
observed in the FD embryos. Furthermore, it could also explain research which has shown 
rescue of NTDs by folic acid in Sp2H/Sp2H embryos, as folate supplementation could increase 
purine and pyrimidine synthesis, and potentially increase proliferation in the Pax3-deficient 
regions of the NT. 
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The effects of folate deficiency on the rate of proliferation in the NT could be studied as 
described previously, using sections and an antibody against the proliferation marker phospho-
histone H3. It would be informative to observe the effects of folate deficiency – and also 
potentially folate supplementation – on the rates of proliferation in the dorsal Pax3-expressing 
regions of the NT of Sp2H/Sp2H embryos. If folic acid does indeed rescue NTDs through rescue of 
the proliferation defect it would be expected that folate supplementation would increase 
proliferation in the NTs of Sp2H/Sp2H embryos to levels resembling those of wild type embryos. 
On the other hand, it would be expected that folate deficiency would further reduce 
proliferation in the NTs of Sp2H/Sp2H embryos, and would also reduce proliferation in the NTs of 
Sp2H/+ embryos to levels resembling those of Sp2H/Sp2H embryos. It could also be interesting to 
repeat the apoptosis and neuronal differentiation experiments carried out in this chapter using 
folate deficient or folate supplemented embryos. This could be informative if folate is involved 
in either of these processes during embryonic development, possibly through epigenetic 
mechanisms. 
On the other hand, folate deficiency may have effects on the mother which could affect 
embryonic development independently of effects on proliferation and epigenetics. For 
example, FD mothers tend to eat less and be more slender than their ND counterparts. This 
does not cause serious malnutrition or starvation as they are able to be on the diet for long 
periods of time without serious effects. However, it is possible that the small reduction in 
calorific or nutritional intake could affect embryonic development during gestation. 
This folate deficient mouse model is not directly comparable to a human model. Minor 
reductions in folate intake, such as those seen in humans, have no effect on the folate levels in 
the mouse embryo (Burren et al., 2008). Additionally, in humans, although maternal folate 
deficiency is a risk factor in the development of NTDs, most mothers experiencing NTD 
pregnancies have folate levels within a healthy range (Kirke et al., 1993). It is highly unlikely 
that any human would be folate deficient to the degree induced in the mouse model described 
here. However, this model could be useful in deducing the mode of action of NTD rescue 
through folic acid supplementation, and thus could be useful in understanding why some NTDs 
are unaffected by folic acid. 
3.2.4    The Splotch mutation and canonical Wnt signalling 
Both Pax3 signalling and canonical Wnt signalling are known to be important in the balance of 
proliferation and differentiation in the NT (Keller-Peck and Mullen, 1997; Megason and 
McMahon, 2002). Therefore it is likely that the two pathways are interlinked. Previous 
research appears to support this theory; it has been shown that canonical Wnt signalling acts 
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upstream of Pax3, and also that Pax3 induces expression of Wnt1 (Fenby et al., 2008; Zhao et 
al., 2014). Therefore, Splotch mice were studied to determine if Pax3 acts upstream of 
canonical Wnt signalling. 
Comparisons in Wnt gene expression were made between +/+ and Sp2H/Sp2H samples using the 
SABiosciences RT2 ProfilerTM PCR Array Plate for the mouse Wnt signalling pathway. A number 
of genes demonstrated small differences in expression between the genotypes, and several of 
these were tested individually using RT-qPCR. However, none of the differences could be 
verified. Expression levels of the canonical Wnt signalling-related genes Axin1, Axin2, Cdx2, 
Fzd6, and Sfrp4 were compared between +/+ and Sp2H/Sp2H whole embryos, but no significant 
differences were identified. Likewise, LacZ RT-qPCR of +/+ and Sp2H/Sp2H embryos carrying the 
BatGal allele identified no significant difference in canonical Wnt signalling between the 
genotypes. 
Taken together, these results suggest that canonical Wnt signalling does not act downstream 
of Pax3 signalling in the NT. This hypothesis could be verified using Sp2H/Sp2H embryos through 
study of more of the genes involved in canonical Wnt signalling, as only a small selection were 
studied. However, none of the data shown here suggests otherwise. 
Additionally, it would be interesting to study the expression of these genes at an earlier stage 
in development, for example the 8-9 somite stage, prior to the onset of the morphological 
defect. It is possible that changes in gene expression which are causative for NTDs in Splotch 
mice are no longer detectable in the 23-24 somite stage embryos which were tested. 
Alternatively, different Wnt-related genes in addition to Axin2 and Cdx2 could be used to 
quantify the levels of canonical Wnt signalling in the embryos. For example, Cyclin-D1 or c-Myc 
could also be used in this way, as they are targets of β-catenin transcription (He et al., 1998; 
Tetsu and McCormick, 1999). The combination of several genes could give a more accurate 
reading of canonical Wnt signalling levels in the different genotypes. 
It is also possible that although whole embryos of different genotypes had similar expression 
of the genes tested, certain regions of the embryos may express them differently. A good way 
to examine this would be to carry out whole mount in situ hybridisation of the embryos using 
probes to detect the genes tested. This could show differences in the patterns of gene 
expression between genotypes. Additionally, RT-qPCR of select regions of the embryos – for 
example the NT – could identify differences in the levels of gene expression. 
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3.2.5    Conclusions 
Splotch embryos have been found to have a significant reduction in proliferation in the Pax3-
expressing dorsal region of the spinal NT. This appears to cause a number of morphological 
defects in the NT itself, although it is currently uncertain whether or not this is causative of the 
spinal NTDs seen in these embryos. In addition folate deficiency has been shown to worsen 
cranial NTDs in the Splotch mutants. This is likely to be through further reduction in 
proliferation in the T, but more studies are needed to confirm this. 
Although a cellular defect has been identified in the Splotch mouse, it is also important to 
identify the molecular defects responsible for the development of NTDs. Evidence in the 
literature suggests that there could be interaction between the Pax3 and canonical Wnt 
signalling pathways. Given the involvement of canonical Wnt signalling in the regulation of 
proliferation and differentiation, this could suggest a mechanism by which Pax3 mutation 
causes reduced proliferation in the NT. 
Initial studies described in this chapter suggest that Pax3 mutation does not cause changes in 
the expression levels of the canonical Wnt-related genes tested. However, other Wnt genes 
may be affected, or alternatively protein levels or expression patterns of the Wnt components 
could be altered. It is also possible that canonical Wnt signalling acts upstream of Pax3. 
Therefore, in Chapters 4 and 5 of this thesis I will be investigating the potential interaction 
between Pax3 and canonical Wnt signalling, and observing the effects this interaction has on 
NT and NC development. 
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4    Pax3 and β-Catenin Gain-of-Function 
4.1    Results 
The experiments described in this chapter aim to use the β-catenin gain-of-function (β-
cateninGOF) allele to determine if an interaction exists between Pax3 and the canonical Wnt 
signalling pathway, and which cellular mechanisms may be involved in this interaction. They 
also attempt to elucidate the developmental processes which are affected by the interaction, 
and to describe the defects present in double mutant embryos. The research is based on the 
hypothesis: interaction between Pax3 and the canonical Wnt signalling pathway reduces 
proliferation and induces premature neuronal differentiation in the NT and NC, resulting in 
NTDs and NC defects. 
Although data from the previous chapter suggests that canonical Wnt signalling is not 
disrupted in Splotch mutant embryos, this will be examined in more detail, looking at the 
mutant phenotype as well as gene expression, and using a β-catenin mutant allele to examine 
the effects of compound mutation. Evidence from the literature strongly suggests that there is 
an interaction between Pax3 and the canonical Wnt signalling pathway, and so this will be 
examined further. The link with NTDs will be studied through compound mutant embryos, and 
through cellular processes which are affected by the interaction between Pax3 and the 
canonical Wnt signalling pathway. 
Previous publications indicate an interaction between canonical Wnt signalling and Pax3. The 
two pathways show overlapping function; Pax3 is important in the regulation of proliferation 
and differentiation, and canonical Wnt signalling is also known to play a role in the regulation 
of these processes (Keller-Peck and Mullen, 1997; Megason and McMahon, 2002). This 
interaction could either be direct communication between Pax3 and the canonical Wnt 
signalling pathway, or convergence of the processes on the same developmental pathway. For 
example, both Pax3 and canonical Wnt signalling act through the Notch pathway to regulate 
development of the NC and the nervous system (De Bellard et al., 2002; Ma et al., 1996; 
Nakazaki et al., 2008; Shimizu et al., 2008; Yun et al., 2002). Therefore, observed effects of 
interaction could be a summation of the effects of both Pax3 and canonical Wnt signalling on 
the Notch pathway. 
Both canonical Wnt signalling and Pax3 are important for the development of the NC cells. 
Wnt1 and Wnt3a play a role in the induction and proliferation of the NC (Dickinson et al., 
1994; Ikeya et al., 1997; Saint-Jeannet et al., 1997). In addition, Pax3 is necessary for NC  
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specification, migration and differentiation; Pax3 mutant mice have a reduced NC population 
and reduced NC-derivative tissues (Auerbach, 1954; Conway et al., 1997a; Lang et al., 2000; 
Moase and Trasler, 1989). Interestingly, Pax3-induced NC development appears to be Wnt-
dependent (Monsoro-Burq et al., 2005; Sato et al., 2005). 
Several publications also indicate interaction between the canonical Wnt signalling pathway 
and Pax3 through the influence of one on the other. Evidence has been published which 
suggests that canonical Wnt signalling may act both upstream and downstream of Pax3 (Fenby 
et al., 2008; Zhao et al., 2014). Additionally, Pax3 may directly regulate expression of several 
components of the canonical Wnt signalling pathway (Wang et al., 2007). 
Most of the experimental litters used in this chapter are generated using the cross Pax3Sp2H/+ β-
cateninGOF/+ x Pax3Cre/+ β-catenin+/+ (Figure 4.1). Comparisons are drawn between different 
Figure 4.1: A punnet square demonstrating the progeny from the cross Pax3Sp2H/+ β-
cateninGOF/+ x Pax3Cre/+ β-catenin+/+. The key represents the five genotype groups used in the 
experiments described in this chapter. Colour coding demonstrates how the genotypes are 
distributed among the groups, as several genotypes have been pooled into the same genotype 
group (see also Figure 4.2). 
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genotypes, including Pax3 heterozygous embryos, with or without β-catenin gain-of-function 
(GOF). As the β-cateninGOF allele is conditional, and the ‘floxed’ region must be excised by Cre 
recombinase to become active, Pax3 heterozygotes with β-catenin GOF are always of the 
genotype Pax3Cre/+ β-cateninGOF/+. However, Pax3 heterozygote embryos without β-catenin GOF 
may be of the genotypes Pax3Cre/+ β-catenin+/+, Pax3Sp2H/+ β-catenin+/+ or Pax3Sp2H/+ β-
cateninGOF/+, as none of these genotypes have a floxed β-cateninGOF allele. These three 
genotypes show no significant differences in rates of exencephaly or spina bifida (Figure 4.2B 
and D), therefore they will be pooled throughout the results, and referred to as Pax3+/- β-
catenin+/+. 
Likewise, neither Pax3+/+ β-catenin+/+ nor Pax3+/+ β-cateninGOF/+ embryos have a floxed β-
cateninGOF allele. They show no significant differences in rates of exencephaly or spina bifida, 
and so have been pooled as ‘wild type’ embryos (Figure 4.2A and C). They will be referred to as 
Pax3+/+ β-catenin+/+ embryos in these results. 
4.1.1    Verification of the increase in canonical Wnt signalling in embryos carrying 
the β-catenin gain-of-function allele 
The β-cateninGOF allele has previously been generated and tested for effectiveness (Harada et 
al., 1999). However, it was important to check that the allele effectively increases canonical 
Wnt signalling in the mice being used for this research. Therefore, the levels of canonical Wnt 
signalling were evaluated in embryos carrying the β-cateninGOF allele by analysing expression of 
downstream target genes, Axin2 and Cdx2. 
A probe which identifies the mRNA for Axin2 was used in whole mount in situ hybridisations to 
compare levels of canonical Wnt signalling between embryos carrying the Pax3 mutations, and 
embryos of the equivalent Pax3 genotype also exhibiting β-catenin GOF (Figure 4.3). Axin2 is a 
component of the destruction complex (Hart et al., 1998). 
The in situ hybridisation was carried out on all embryos at the same time, and the colour 
development reaction had equal timings for all embryos. However, a darker staining is visible 
in embryos with β-catenin GOF. This is true when comparing the Pax3+/- embryos with and 
without β-catenin GOF, and also when comparing the Pax3Sp2H/Cre mutant embryos with and 
without β-catenin GOF (Figure 4.3). These results are relatively consistent. Therefore, in situ 
hybridisation suggests higher levels of Axin2 expression, and thus higher levels of canonical 
Wnt signalling in embryos with β-catenin GOF. Sections of these embryos could have indicated 
the structures which show differences in Axin2 expression, and negative controls could have 
demonstrated background staining. 
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Figure 4.2: Pooling of embryo genotypes from the cross Pax3Sp2H/+ β-cateninGOF/+ x Pax3Cre/+ 
β-catenin+/+. Several genotypes were pooled in experiments due to similar expression levels of wild 
type Pax3 and β-catenin, and to similar frequencies of exencephaly and spina bifida. Experimental 
litters were generated containing a mixture of genotypes through the cross Pax3
Sp2H/+
 β-catenin
GOF/+
 x 
Pax3
Cre/+
 β-catenin
+/+
. Exencephaly was defined as an open cranial NT at the 18 somite stage or later. 
Spina bifida was defined as an open spinal NT at the 30 somite stage or later. 
The frequencies of exencephaly and spina bifida were compared between Pax3
+/+
 β-catenin
+/+
 and 
Pax3
+/+
 β-catenin
GOF/+
 embryos (A and C), as these embryos have wild type Pax3 and wild type or 
unfloxed β-catenin. No significant differences were found in the frequencies of the NTDs, so these 
embryos are pooled in experiments as Pax3
+/+
 β-catenin
+/+
 embryos. 
The frequencies of exencephaly and spina bifida were compared between Pax3
Sp2H/+
 β-catenin
+/+
, 
Pax3
Sp2H/+
 β-catenin
GOF/+
, and Pax3
Cre/+
 β-catenin
+/+
 embryos (B and D), as these embryos have 
heterozygous expression of Pax3, and wild type or unfloxed β-catenin. No significant differences were 
found in the frequencies of the NTDs, so these embryos are pooled in experiments as Pax3
+/-
 β-
catenin
+/+
 embryos. 
Significance was assessed using the Chi-Square Test (A) or the Fisher Exact Test (B). 
A - Pax3+/+ β-catenin+/+: n = 98. Pax3+/+ β-cateninGOF/+: n = 72. B – Pax3Sp2H/+ β-catenin+/+: n = 
130. Pax3Sp2H/+ β-cateninGOF/+: n = 87. Pax3Cre/+ β-catenin+/+: n = 101. C – Pax3+/+ β-catenin+/+: n 
= 21. Pax3+/+ β-cateninGOF/+: n = 9. D – Pax3Sp2H/+ β-catenin+/+: n = 34. Pax3Sp2H/+ β-cateninGOF/+: 
n = 16. Pax3Cre/+ β-catenin+/+: n = 26. 
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However, whole mount in situ hybridisation is not a quantitative method of gene expression 
analysis. Therefore, RT-qPCR was used to quantify levels of canonical Wnt signalling in the 
embryos used for this research (Figure 4.4). 
The genes Axin2 and Cdx2 were used as an indirect read-out of canonical Wnt signalling in the 
embryos of different genotypes. Cdx2 is downstream of canonical Wnt signalling, and the gene 
may be a direct target of the β-catenin transcription complex (Benahmed et al., 2008; Wang 
and Shashikant, 2007). Embryos at the 22-24 somite stage were used for analysis; Pax3 is still 
expressed at this stage, and so the canonical Wnt signalling GOF should still be in effect, and 
sufficient embryos were available at this stage to allow for replicates. 
No significant differences were seen in the relative levels of Cdx2 expression between embryos 
of differing genotypes (Figure 4.4A). However, a significant increase in relative Axin2 
expression was seen when comparing Pax3+/- embryos with and without β-catenin GOF, and 
when comparing Pax3Sp2H/Cre mutant embryos with and without β-catenin GOF. This was seen 
when using both GAPDH and β-actin as housekeeping genes for normalisation of expression 
(Figure 4.4B and C). These results suggest that β-catenin GOF does indeed increase levels of 
canonical Wnt signalling. 
4.1.2    β-catenin gain-of-function alone is not able to induce neural tube defects 
The β-cateninGOF allele is conditional, and therefore requires a Cre recombinase enzyme to 
become ‘floxed’ and demonstrate β-catenin GOF. In the absence of Cre recombinase, the GOF 
protein functions as wild type β-catenin. The Pax3Cre allele used in this study is a null Pax3 
allele. It is possible that the phenotypes observed represent a summation or interaction of the 
effects of Pax3 mutation and β-catenin GOF. Alternatively, phenotypes may simply reflect an 
effect of β-catenin GOF. In order to distinguish these possibilities the effect of β-catenin GOF 
with wild type levels of Pax3 was examined using a different Cre allele. 
The allele used as a replacement was a Sox-1Cre allele (Takashima et al., 2007). Sox-1 is 
expressed throughout the neurepithelium from the specification of the neural plate (Pevny et 
al., 1998; Takashima et al., 2007). NTDs have not been reported in mice which are 
heterozygous or homozygous for Sox-1 mutation (Nishiguchi et al., 1998). 
Experimental litters were generated though the cross Pax3Sp2H/+ β-cateninGOF/+ x Sox-1Cre/+, and 
the rates of spina bifida and exencephaly were analysed (Figure 4.5). Comparisons were drawn 
between embryos with and without β-catenin GOF in the NT, and with or without Pax3 
heterozygosity. 
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 Figure 4.4: β-catenin gain-of-function increases the expression of Wnt markers. Experimental 
litters were generated containing a mixture of genotypes through the cross Pax3
Sp2H/+
 β-catenin
GOF/+
 x 
Pax3
Cre/+
 β-catenin
+/+
. RT-qPCR was carried out using RNA prepared from whole embryos at the 22-24 
somite stage. 
Expression levels of two different genes were used to assess the level of canonical Wnt signalling – 
Cdx2 (A) and Axin2 (B and C). Cdx2 was assessed using GAPDH as a housekeeping gene for 
normalisation (A). Axin2 was assessed using GAPDH (B) and β-actin (C) for normalisation. β-actin was 
used for normalisation in addition to GAPDH to ensure that differences in expression levels of Axin2 
expression were not due to differences inexpression levels of GAPDH between genotypes. 
Graph A shows no significant differences in Cdx2 expression between the genotypes. Graphs B and C 
show very similar results. Pax3
Cre/+
 β-catenin
GOF/+
 embryos show a significant increase in Axin2 
expression compared to Pax3
+/-
 β-catenin
+/+
 embryos, and Pax3
Sp2H/Cre
 β-catenin
GOF/+
 embryos show a 
significant increase compared to Pax3
Sp2H/Cre
 β-catenin
+/+
 embryos. 
* p < 0.05. Significance was assessed using one way ANOVA. Only relevant differences have been 
labelled on the graphs. Error bars indicate standard error. 
Pax3
+/+
 β-catenin
+/+
: n = 4. Pax3
+/-
 β-catenin
+/+
: n = 4 (n = 3 in C). Pax3
Cre/+
 β-catenin
GOF/+
: n = 3. 
Pax3
Sp2H/Cre
 β-catenin
+/+
: n = 4. Pax3
Sp2H/Cre
 β-catenin
GOF/+
: n = 3. 
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Figure 4.5: The effect of β-catenin gain-of-function on the development of neural tube 
defects in the absence of Pax3 mutation. Experimental litters were generated though the cross 
Pax3
Sp2H/+
 β-catenin
GOF/+
 Sox-1
+/+
 x Pax3
+/+
 β-catenin
+/+
 Sox-1
Cre/+
, and were collected at E10.5. Rates of 
spina bifida (A) and exencephaly (B) were analysed in each genotype in the offspring. Exencephaly has 
been defined as an open cranial region at the 18 somite stage or later. Spina bifida has been defined 
as an open spinal region at the 30 somite stage or later. Significance was assessed between genotypes 
with equivalent Pax3 and Sox1 status, but with different β-catenin genotypes. 
No significant differences were seen between genotypes in the frequency of spina bifida. This 
suggests that β-catenin GOF – with or without Pax3 heterozygosity – does not induce spinal NTDs. 
There are no significant differences observed in the frequency of exencephaly in the genotypes which 
do not include the Pax3
Sp2H
 allele (B). However, an increased frequency is seen between Pax3
+/+
 β-
catenin
GOF/+
 Sox-1
+/+
 (0%) and Pax3
+/+
 β-catenin
GOF/+
 Sox-1
Cre/+
 (25%) embryos. This could suggest a 
slightly increased risk of exencephaly caused by β-catenin GOF independent of Pax3 mutation. 
When the embryos are heterozygous for Pax3
Sp2H
 the β-catenin GOF induces exencephaly. A 
significant increase in the rate of exencephaly in seen in Pax3
Sp2H/+
 β-catenin
GOF/+
 Sox-1
Cre/+
 embryos 
compared to Pax3
Sp2H/+
 β-catenin
+/+
 Sox-1
Cre/+
 embryos. These genotypes differ only in the presence or 
absence of β-catenin GOF. 
* p < 0.01. Significance was assessed using the Fisher Exact Test. 
Pax3
+/+
 β-catenin
+/+
 Sox-1
+/+
: n = 10. Pax3
+/+
 β-catenin
+/+
 Sox-1
Cre/+
: n = 15. Pax3
+/+
 β-catenin
GOF/+
 Sox-
1
+/+
: n = 3. Pax3
+/+
 β-catenin
GOF/+
 Sox-1
Cre/+
: n = 4.  Pax3
Sp2H/+
 β-catenin
+/+
 Sox-1
+/+
: n = 6. Pax3
Sp2H/+
 β-
catenin
+/+
 Sox-1
Cre/+
: n = 13. Pax3
Sp2H/+
 β-catenin
GOF/+
 Sox-1
+/+
: n =1 . Pax3
Sp2H/+
 β-catenin
GOF/+
 Sox-1
Cre/+
: 
n = 2. 
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Rates of spina bifida were very low in all the genotypes studied, suggesting that defective Wnt 
signalling alone, or with Pax3 heterozygosity, is not able to affect spinal NT closure. 
Additionally, the rates of exencephaly development were low in embryos with no Pax3 
mutation, but with β-catenin GOF in the NT. However, a small increase was observed in the 
frequency of exencephaly between Pax3+/+ β-cateninGOF/+ Sox1+/+ and Pax3+/+ β-cateninGOF/+ 
Sox1Cre/+ embryos. This difference did not reach significance, and more samples would be 
needed to confirm, but this could suggest that β-catenin GOF may slightly increase the risk of 
developing exencephaly independent of Pax3 mutation. On the other hand, in combination 
with Pax3 heterozygosity β-catenin GOF significantly increased the rate of exencephaly 
development in the embryos. 
4.1.3    The effect of β-catenin gain-of-function on the development of neural tube 
defects in Pax3Sp2H/Cre embryos 
The effect of the Pax3Sp2H allele on NT closure was studied in the previous chapter. Here the 
effect of the β-cateninGOF allele on NT closure is studied, and in particular how it interacts with 
the mutant Pax3 alleles Pax3Sp2H and Pax3Cre to influence the closure of the PNP and the cranial 
NT. Data regarding spina bifida and exencephaly in embryos of different genotypes are 
summarised in Table 4.1. 
4.1.3.1    β-catenin gain-of-function affects spinal neurulation in Pax3Sp2H/Cre and Pax3+/- 
embryos, but does not cause spina bifida 
Spinal neurulation was studied in the early stages of NT closure by measuring the size of the 
PNP. Additionally, the outcome of spinal neurulation is studied through analysis of the 
frequency of spina bifida in the embryos. 
In order to assess the effects of β-catenin GOF on the caudal closure of the NT the closure rate 
of the PNP was studied in the same way as previously described for Sp2H/Sp2H embryos (see 
section 3.1.1.1). The size of the PNP was measured and plotted against the somite stage of the 
embryo (Figure 4.6). 
In order to study the effects of β-catenin GOF on PNP closure Pax3+/- β-catenin+/+ embryos 
were compared to Pax3Cre/+ β-cateninGOF/+ embryos, and also Pax3Sp2H/Cre β-catenin+/+ embryos 
were compared to Pax3Sp2H/Cre β-cateninGOF/+ embryos. 
A significant increase in PNP size was seen in Pax3Cre/+ β-cateninGOF/+ embryos when compared 
to Pax3+/- β-catenin+/+ embryos at the 12-13 somite stage, but the difference was then 
insignificant until the 20-21 somite stage. A significant increase in PNP size was seen in  
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Genotype 
Number of embryos 
for exencephaly 
analysis 
% embryos 
with 
exencephaly 
Number of 
embryos for spina 
bifida analysis 
% embryos 
with spina 
bifida 
Pax3+/+  
β-catenin+/+  
178 1.7 34 0.0 
Pax3+/-  
β-catenin+/+  
322 9.6 77 5.2 
Pax3Cre/+  
β-cateninGOF/+  
82 80.5 9 11.1 
Pax3Sp2H/Cre 
β-catenin+/+  
112 58.9 31 83.9 
Pax3Sp2H/Cre  
β-cateninGOF/+  
82 98.8 17 88.2 
 
 
 
 
 
Pax3Sp2H/Cre β-cateninGOF/+ compared to Pax3Sp2H/Cre β-catenin+/+ embryos at the 18-19 somite 
stage. 
Spina bifida was significantly increased in frequency in Pax3Sp2H/Cre β-catenin+/+ embryos 
compared to Pax3+/+ β-catenin+/+ embryos (Figure 4.7B). However, there appears to be no 
significant difference in spina bifida frequency when comparing Pax3+/- β-catenin+/+ and 
Pax3Cre/+ β-cateninGOF/+ embryos, and also when comparing Pax3Sp2H/Cre β-catenin+/+ and 
Pax3Sp2H/Cre β-cateninGOF/+ embryos. 
Table 4.1: The frequency of neural tube defects in embryos of different genotypes. 
Exencephaly is defined as an open cranial NT at the 18 somite stage or later. Spina bifida is defined as 
an open spinal NT at the 30 somite stage or later. 
The genotypes are seen in the expected ratios (see Figure 4.1 for information) except for embryos of 
the genotype Pax3
Cre/+
 β-catenin
GOF/+
 at the 30+ somite stage (the spina bifida column), which are 
present at a lower frequency than would be expected. This could be due to partial embryonic 
lethality between the 18 and 30 somite stages. However, as this reduction in frequency is not seen in 
the more severely affected Pax3
Sp2H/Cre
 β-catenin
GOF/+
 embryos, this result could be spurious. 
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Figure 4.7: β-catenin gain-of-function increases the frequency of exencephaly but not spina 
bifida in Pax3 mutant and heterozygous embryos. Experimental litters were generated 
containing a mixture of genotypes through the cross Pax3
Sp2H/+
 β-catenin
GOF/+
 x Pax3
Cre/+
 β-catenin
+/+
. 
Exencephaly is defined as an open cranial NT at the 18 somite stage or later. Spina bifida is defined as 
an open spinal NT at the 30 somite stage or later.  
β-catenin GOF dramatically increases the frequency of exencephaly (A); Pax3
Cre/+
 β-catenin
GOF/+
  
embryos have a significantly higher frequency of exencephaly than Pax3
+/-
 β-catenin
+/+
 embryos, and 
Pax3
Sp2H/Cre
 β-catenin
GOF/+
 have a significantly higher frequency than Pax3
Sp2H/Cre
 β-catenin
+/+
 embryos. 
B compares the frequency of spina bifida in embryos of different genotypes from the same cross, as 
described for A. No significant difference in the frequencies of spina bifida are seen between Pax3
+/-
 β-
catenin
+/+
 and Pax3
Cre/+
 β-catenin
GOF/+
 embryos, or between Pax3
Sp2H/Cre
 β-catenin
+/+
 and Pax3
Sp2H/Cre
 β-
catenin
GOF/+
 embryos. 
*** p < 0.001. Significance was assessed using the Chi-Square Test (A) or the Fisher Exact Test (B). 
Only relevant significant differences are shown. 
A – Pax3
+/+
 β-catenin
+/+
: n = 178. Pax3
+/-
 β-catenin
+/+
: n = 322. Pax3
Cre/+
 β-catenin
GOF/+
: n = 82. 
Pax3
Sp2H/Cre
 β-catenin
+/+
: n = 112. Pax3
Sp2H/Cre
 β-catenin
GOF/+
: n = 82. 
B – Pax3
+/+
 β-catenin
+/+
: n = 34. Pax3
+/-
 β-catenin
+/+
: n = 77. Pax3
Cre/+
 β-catenin
GOF/+
: n = 9. Pax3
Sp2H/Cre
 β-
catenin
+/+
: n = 31. Pax3
Sp2H/Cre
 β-catenin
GOF/+
: n = 17. 
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4.1.3.2    β-catenin gain-of-function increases the rate of exencephaly in both Pax3Sp2H/Cre and 
Pax3+/- mutant embryos 
In order to analyse the effect of β-catenin GOF on NTD development the frequency of 
exencephaly was compared between Pax3+/- β-catenin+/+ and Pax3Cre/+ β-cateninGOF/+ embryos, 
and also between Pax3Sp2H/Cre β-catenin+/+ and Pax3Sp2H/Cre β-cateninGOF/+ embryos (Figure 4.7A). 
Pax3Cre/+ β-cateninGOF/+ embryos demonstrated a highly significant increase in the rate of 
exencephaly compared to Pax3+/- β-catenin+/+ embryos. Likewise, Pax3Sp2H/Cre β-cateninGOF/+ 
embryos showed a highly significant increase in the rate of exencephaly compared to 
Pax3Sp2H/Cre β-catenin+/+ embryos. 
As an aside, the results of this analysis support the findings previously described in section 
3.1.1.2; there is a highly significant increase in the rate of exencephaly in Pax3Sp2H/Cre mutant 
embryos when compared to the Pax3+/+ embryos. Interestingly, there is a significant increase 
in the rate of exencephaly in Pax3+/- embryos compared to Pax3+/+. This is in contrast to the 
results from section 3.1.1.2. This difference could be due to higher numbers of embryos, or to 
the involvement of the Pax3Cre allele in addition to the Pax3Sp2H allele. 
4.1.4    Phenotypes resulting from β-catenin gain-of-function 
β-catenin GOF alters the phenotype of the embryo; Pax3Sp2H/Cre β-catenin+/+ embryos have a 
frequency of 84% spina bifida and 59% exencephaly (Figure 4.7 and Table 4.1). However, at 
E9.5 the exencephaly affects the midbrain and hindbrain, and the neural folds are usually fairly 
closely apposed. However, Pax3Sp2H/Cre β-cateninGOF/+ embryos have a different appearance 
(Figure 4.8). They too demonstrate high frequencies of spina bifida (88%), which is very similar 
in appearance to that seen in Pax3Sp2H/Cre β-catenin+/+ embryos, but also have exencephaly at a 
frequency of 99% (Figure 4.7 and Table 4.1). At E9.5 the exencephaly almost always appears 
very different; the open region of the neural folds is more extensive, and often affects the 
forebrain in addition to the midbrain and hindbrain. The neural folds are widely splayed open, 
and the edges of the open region are more rippled in appearance compared to open neural 
folds in Pax3Sp2H/Cre β-catenin+/+ embryos. Haemorrhage is frequently seen in the region of the 
developing CNS, often in the cranial region, but also sometimes in the spinal region. This can 
affect both open and closed regions of the NT, and is seen in approximately 23% of Pax3Sp2H/Cre 
β-cateninGOF/+ embryos (Figure 4.8E). This represents a significant increase in frequency when 
compared to Pax3Sp2H/Cre β-catenin+/+ embryos, which develop CNS haemorrhage at a frequency 
of around 7% (p < 0.001, assessed using the Chi Square Test). 
At E10.5 the difference is still apparent between Pax3Sp2H/Cre genotypes. The neural folds of 
Pax3Sp2H/Cre β-catenin+/+ embryos have usually taken on a more rippled appearance (Figure  
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Figure 4.8: Phenotype of Pax3Sp2H/Cre β-cateninGOF/+ embryos. Experimental litters were 
generated through the cross Pax3
Sp2H/+
 β-catenin
GOF/+
 x Pax3
Cre/+
 β-catenin
+/+
. The scale bars 
represent 500 µm. White arrowheads indicate the open regions of the cranial NT, and the white 
arrows indicate the open region of the spinal NT. 
A and B show embryos at E9.5 and E10.5 respectively with the genotype Pax3
+/+
 β-catenin
+/+
 for 
comparison. Embryos at both of these stages have a closed cranial region, although at E9.5 (A) wild 
type embryos still have an open PNP. C and D show embryos with the genotype Pax3
Sp2H/Cre
 β-
catenin
+/+
 at E9.5 and E10.5 respectively. These embryos demonstrate open PNPs at both stages, and 
often have open cranial regions. E and F show embryos with the genotype Pax3
Sp2H/Cre
 β-catenin
GOF/+
 
at E9.5 and E10.5 respectively. These embryos have open cranial NTs and open spinal NTs at both 
stages. The black arrow in E indicates cranial haemorrhage. Note the flattened shape of the 
forebrain in F, and the more abnormal appearance of the open cranial region in F compared to D. 
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4.8D), much like those in Pax3Sp2H/Cre β-cateninGOF/+ embryos. Pax3Sp2H/Cre β-catenin+/+ embryos 
also occasionally develop haemorrhage in the NT, with a frequency of around 13%. However 
exencephaly seen in Pax3Sp2H/Cre β-cateninGOF/+ embryos is usually much larger and causes the 
cranial region to be very misshapen. Haemorrhage is also usually more extensive (Figure 4.8F). 
A difference in phenotype is also often seen when comparing Pax3+/- embryos with and 
without β-catenin GOF. Pax3+/- β-catenin+/+ embryos have a wild type phenotype in respect to 
NT closure, rarely developing either spina bifida or exencephaly. However, Pax3+/- β-
cateninGOF/+ embryos have a high frequency of exencephaly (80%, see Figure 4.7 and Table 
4.1), although they too rarely develop spina bifida. The exencephaly seen in Pax3+/- β-
cateninGOF/+ embryos resembles that seen in Pax3Sp2H/Cre β-cateninGOF/+ embryos; the opening is 
large, often affecting the forebrain and midbrain as well as the hindbrain, and the neural fold 
edges in the open region are rippled in appearance. Haemorrhage in the region of the NT is 
also seen in 13% of Pax3Cre/+ β-cateninGOF/+ embryos (compared to 5% of Pax3Cre/+ β-catenin+/+ 
embryos), although this is usually less severe than in Pax3Sp2H/Cre β-cateninGOF/+ embryos. 
There are multiple possible causes for these differences in phenotype. It is possible that the 
phenotypes are simply a summation of the individual phenotypes caused by β-catenin and 
Pax3 mutations. The mutations may affect different cellular or morphological mechanisms, 
which affect NT closure in different ways, and produce a compound phenotype. 
Alternatively, the differences between phenotypes in Pax3Sp2H/Cre β-catenin+/+ and Pax3Sp2H/Cre β-
cateninGOF/+ embryos could be caused by an interaction between Pax3 and canonical Wnt 
signalling. This is discussed in more detail in section 1.4.7. The pathways could interact 
directly, or they could both act on a single cellular mechanism which affects NT closure, such 
as proliferation or neuronal differentiation. 
Reduced canonical Wnt signalling in the CNS has been reported to cause abnormalities in 
angiogenesis and haemorrhage (Daneman et al., 2009). Although the embryos described here 
have an increase in canonical Wnt signalling, it is possible that the haemorrhage seen in 
Pax3Cre/+ β-cateninGOF/+ and Pax3Sp2H/Cre β-cateninGOF/+ embryos could be due to disruption of the 
canonical Wnt signalling pathway, rather than an interaction between Pax3 and the canonical 
Wnt signalling pathway. 
4.1.5    β-catenin gain-of-function does not affect proliferation during cranial 
neurulation 
As shown previously (section 3.1.2.4) a decrease in proliferation may be a causative element of 
spina bifida development in the Sp2H/Sp2H mouse. If canonical Wnt signalling acted directly on 
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Pax3 signalling it may also have an effect on proliferation of cells in the NT. Alternatively, 
canonical Wnt signalling may worsen NTDs in Pax3 mutant embryos by acting further on an 
already defective cellular mechanism. The main effect of canonical Wnt signalling on NT 
closure appears to be in the cranial region. Therefore, proliferation in the cranial NT was 
analysed. 
Embryos of multiple genotypes for study were generated from the cross Pax3Sp2H/+ β-
cateninGOF/+ x Pax3Cre/+ β-catenin+/+. They were collected at the  13-15 somite stage, as at this 
stage the cranial NT would be in the process of closing in Pax3+/+ β-catenin+/+ embryos. 
Therefore, the cranial tissue in mutant embryos which would go on to develop exencephaly 
will not yet show secondary effects resulting from exposure to the intra-uterine environment. 
The anti-phospho histone H3 antibody stains cells in G2/M phase, and so was used as a marker 
for proliferating cells, as described in section 3.1.2.4. Coronal sections were taken of the 
cranial NT, and the dorsal 25% of the cranial NT was studied as the Pax3-positive region (see 
section 3.1.2.1 for cranial Pax3 expression). 
The mitotic index was calculated for Pax3-positive region of the cranial NT for the embryos of 
each genotype (Table 4.2 and Figure 4.9). Data shows that there are no significant differences 
in the rate of proliferation between the genotypes. 
4.1.6    β-catenin gain-of-function does not affect neuronal differentiation during 
neurulation 
It has been suggested previously that premature neuronal differentiation may contribute to 
the development of NTDs in Pax3 mutant embryos (section 3.1.2.2). Although this was found 
not to be the case in Sp2H/Sp2H spinal neurulation, it is potentially true for the cranial region. 
Canonical Wnt signalling is known to be important in the initiation and timing of differentiation 
of many cell types during development. Therefore β-catenin GOF may worsen cranial NTDs in 
the Pax3Sp2H/Cre embryos by acting through this mechanism. 
Spinal neuronal differentiation is normal in Sp2H/Sp2H embryos. However, β-catenin GOF 
appears to slow closure of the PNP, although it doesn’t increase the frequency of spina bifida. 
Therefore, β-catenin GOF may have this effect in the Pax3 mutant homozygous and 
heterozygous embryos through causing premature neuronal differentiation in the spinal 
region. 
4.1.6.1    Spinal neuronal differentiation in embryos with β-catenin gain-of-function 
Whole mount antibody staining using the neuronal marker Tuj1 was used to detect neuronal 
differentiation in the spinal region as previously described in section 3.1.2.2; spinal neuronal  
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Genotype 
Average number 
of cells per 
section 
Average number 
of proliferating 
cells per section 
% cells which are 
proliferating 
(mitotic index) 
Pax3+/+ β-catenin+/+  65.0 3.35 5.13 
Pax3+/- β-catenin+/+  99.8 4.77 4.85 
Pax3Cre/+ β-cateninGOF/+  87.8 5.52 6.04 
Pax3Sp2H/Cre β-catenin+/+  107.9 5.13 4.86 
Pax3Sp2H/Cre β-cateninGOF/+  143.7 7.44 5.19 
 
 
 
 
 
differentiation extends in a rostral-to-caudal manner. Therefore the caudal-most somite level 
which has robust Tuj1 staining was analysed for the embryos of each genotype (Figure 4.10).  
No significant differences were found in the extent of spinal neuronal differentiation between 
the genotypes studied. 
4.1.6.2    Cranial neuronal differentiation in embryos with β-catenin gain-of-function 
Neuronal differentiation was studied in embryos at the 13-15 somite stage, when the cranial 
NT is closing, and the tissue will not yet show secondary damage due to exposure to the intra-
uterine environment. Coronal sections were taken of the cranial NT, and the antibody Tuj1, 
which binds βIII-tubulin, was used to mark differentiating neurons. The dorsal half of the NT 
was defined as the experimental region, and counts were taken of the number of Tuj1-positive 
cells in this region (Table 4.3 and Figure 4.11). No significant differences were found in the 
number of Tuj1-positive cells in the dorsal half of the cranial NT. 
Table 4.2: The number of proliferating cells in the dorsal region of the neural tube. The 
number of cells was calculated for the dorsal region of the NT by counting DAPI-stained nuclei in this 
region. The number of neurons was calculated by counting phospho-histone H3-positive cells in the 
same region. The antibody against phospho-histone H3 stains cells in G2 and M phase, and thus is 
used as a marker for proliferating cells. An average was calculated by totalling the number of cells 
and the number of proliferating cells per embryo, calculating the percentage of proliferating cells for 
each embryo, and then averaging this percentage between embryos of each genotype. 
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Figure 4.9: β-catenin gain-of-function does not affect proliferation in the cranial neural 
tube. Experimental litters were generated containing a mixture of genotypes through the cross 
Pax3
Sp2H/+
 β-catenin
GOF/+
 x Pax3
Cre/+
 β-catenin
+/+
. Immunohistochemistry of sections using an antibody 
against phospho histone H3 was carried out on embryos of multiple genotypes. This antibody 
identifies cells in G2 and M phase, and therefore is used as a marker for proliferating cells. The scale 
bar represents 100 μm.  
A demonstrates how the NT section was divided for proliferation cell counts. The height of the NT was 
measured (x), and then the dorsal-most quarter was demarcated (x/4). Phospho histone H3-positive 
cells were counted within this dorsal region. DAPI was used to mark all cells in the NT section. No 
significant differences were found between genotypes for the number of PH3-positive cells (B). 
One way ANOVA was used to assess significance. Error bars indicate standard error. 
4-6 sections per embryo. Number of embryos – Pax3
+/+
 β-catenin
+/+
: n = 6. Pax3
+/-
 β-catenin
+/+
: n = 6. 
Pax3
Cre/+
 β-catenin
GOF/+
: n = 3. Pax3
Sp2H/Cre
 β-catenin
+/+
: n = 4. Pax3
Sp2H/Cre
 β-catenin
GOF/+
: n = 7. 
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Figure 4.10: β-catenin gain-of-function does not affect the rostro-causal progression of 
spinal neuronal differentiation in Pax3Cre/+ or Pax3Sp2H/Cre embryos. Experimental litters 
containing a mixture of the genotypes for study were generated using the cross Pax3
Sp2H/+
 β-
catenin
GOF/+
 x Pax3
Cre/+
 β-catenin
+/+
. Embryos were studied at the 23 somite stage. n = 4 for each 
genotype. The antibody Tuj1 was used to mark neurons, as it binds βIII-tubulin. 
Neuronal differentiation in the spinal region develops in a rostro-caudal direction. Therefore, the 
extent to which neuronal differentiation had progressed was examined. The most caudal somite 
level which displayed robust Tuj1 staining was compared between the genotypes. No significant 
difference was seen between the genotypes in the extent of the neuronal differentiation.  
Significance was calculated using one-way ANOVA. Error bars indicate standard error. 
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Figure 4.11: β-catenin gain-of-function does not affect neuronal differentiation in the 
cranial neural tube. Experimental litters were generated containing a mixture of genotypes through 
the cross Pax3
Sp2H/+
 β-catenin
GOF/+
 x Pax3
Cre/+
 β-catenin
+/+
. Immunohistochemistry of sections using the 
Tuj1 antibody was carried out on progeny of multiple genotypes at the 13-15 somite stage. This 
antibody binds βIII-tubulin, and marks differentiated neurons. The scale bar represents 100 μm.  
A demonstrates how the NT section was divided for differentiation cell counts. The height of the NT 
was measured (x), and then the dorsal-most half was demarcated (x/2). Tuj1-positive cells were 
counted within this dorsal region. DAPI was used to mark all cells in the NT section. No significant 
differences were found between genotypes for the number of PH3-positive cells (B). 
One way ANOVA was used to assess significance. Error bars indicate standard error. 
4-6 sections per embryo. Number of embryos – Pax3
+/+
 β-catenin
+/+
: n = 4. Pax3
+/-
 β-catenin
+/+
: n = 6. 
Pax3
Cre/+
 β-catenin
GOF/+
: n = 2. Pax3
Sp2H/Cre
 β-catenin
+/+
: n = 3. Pax3
Sp2H/Cre
 β-catenin
GOF/+
: n = 5. 
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Genotype 
Average number 
of cells per section 
Average number of 
neurons per section 
% cells which 
are neurons 
Pax3+/+ β-catenin+/+  173.2 6.10 3.21 
Pax3+/- β-catenin+/+  185.3 4.77 2.70 
Pax3Cre/+ β-cateninGOF/+  174.8 5.22 2.94 
Pax3Sp2H/Cre β-catenin+/+  204.2 7.72 3.13 
Pax3Sp2H/Cre β-cateninGOF/+  272.4 8.55 3.10 
 
 
 
 
 
4.1.7    The effects of β-catenin gain-of-function on the development of the neural 
crest 
The data presented above analyse the effects of β-catenin GOF on the closure of the NT. 
However, Sp2H/Sp2H embryos have several additional abnormalities involving the limb 
musculature and the NC (Auerbach, 1954; Bober et al., 1994; Goulding et al., 1994). 
The specification and migration of the NC, and the development of the subsequent NC-derived 
tissues were studied in mouse embryos carrying various combinations of Pax3 and β-catenin 
mutations. The aim of this study was to determine if canonical Wnt signalling interacts with 
Pax3 in the development and differentiation of the NC. 
4.1.7.1    β-catenin gain-of-function causes abnormalities in the neural crest 
Whole mount in situ hybridisation for the gene ErbB3, a marker for NC, was used to study NC 
in multiple genotypes, and from the 18 to 30+ somite stages (Figure 4.12). Embryos within a  
Table 4.3: The number of neurons in the dorsal region of the neural tube. The number of 
cells was calculated for the dorsal region of the NT by counting DAPI-stained nuclei in this region. 
The number of neurons was calculated by counting Tuj1-positive cells in the same region. Tuj1 stains 
βIII-tubulin and is used as a marker for neurons. An average was calculated by totalling the number 
of cells and the number of neurons per embryo, calculating the percentage of neurons for each 
embryo, and then averaging this percentage between embryos of each genotype. 
4-6 sections per embryo. Number of embryos – Pax3
+/+
 β-catenin
+/+
: n = 4. Pax3
+/-
 β-catenin
+/+
: n = 6. 
Pax3
Cre/+
 β-catenin
GOF/+
: n = 2. Pax3
Sp2H/Cre
 β-catenin
+/+
: n = 3. Pax3
Sp2H/Cre
 β-catenin
GOF/+
: n = 5. 
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genotype and somite stage show a high degree of consistency in the pattern of ErbB3 
expression. 
Little difference is apparent in ErbB3 expression between Pax3+/+ β-catenin+/+ and Pax3+/- β-
catenin+/+ embryos at any of the stages studied. Loss of Pax3 expression results in reduced 
ErbB3 expression in the DRG of Pax3Sp2H/Cre β-catenin+/+ embryos. However, rudimentary DRG 
still form, and segmentation is clearly visible. 
The addition of β-catenin GOF either to the Pax3 heterozygous or homozygous mutant 
embryos has a profound effect on the expression of ErbB3. Both Pax3Cre/+ β-cateninGOF/+ and 
Pax3Sp2H/Cre β-cateninGOF/+ embryos completely lack expression in the trigeminal ganglia, and 
both lack staining in the DRG by 30+ somite stage, although Pax3Cre/+ β-cateninGOF/+ embryos 
form rudimentary, badly segmented DRG at earlier stages. Additionally, ErbB3 expression in 
the vagus nerve is affected; both genotypes lack staining in the vagus nerve at the 30+ somite 
stage. However, Pax3Sp2H/Cre β-cateninGOF/+ embryos fail to express ErbB3 in the vagus nerve 
throughout development, whereas Pax3Cre/+ β-cateninGOF/+ embryos first overexpress ErbB3 in 
the developing vagus nerve, and then lose expression by 30+ somite stage. Both Pax3Cre/+ β-
cateninGOF/+ and Pax3Sp2H/Cre β-cateninGOF/+ embryos quickly developed dark, but seemingly non-
specific staining in the cranial regions and the trunk. This makes it difficult to observe the 
expression pattern of ErbB3. Alternatively, the consistency of this staining across samples may 
suggest a defect in ErbB3 expression. Sectioning through this region could help to identify 
stained tissues and clarify why this staining occurs. 
In addition to studying the NC population, the antibody Tuj1 – a neuronal marker – was used 
to study the development of the PNS, which is largely NC-derived. Pax3+/+ β-catenin+/+ and 
Pax3+/- β-catenin+/+ embryos show similar patterns of Tuj1 staining (Figure 4.13). Pax3Sp2H/Cre β-
catenin+/+ embryos also show similar patterning, but the DRG are not quite so clearly defined. 
Comparable to the ErbB3 expression patterns, the presence of β-catenin GOF severely disrupts 
the patterning of nerve differentiation in Pax3 homozygous and heterozygous embryos. In 
both Pax3Cre/+ β-cateninGOF/+ and Pax3Sp2H/Cre β-cateninGOF/+ embryos, the nerves in the cranial 
meshwork appear to clump into foci, and the vagus nerve shows disrupted patterning. The 
spinal DRG show very disrupted patterning, and segmentation is poorly defined. 
These abnormalities in the spinal NC could be caused by failure of NC specification, 
differentiation, apoptosis of specified NC, or failure of NC migration. Presence of ErbB3 
expression in the spinal region of each of the genotypes at the 24-26 somite stage suggests  
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that migration still occurs. Therefore, studies were carried out to observe apoptosis, and NC 
specification and differentiation in the embryos of different genotypes. 
4.1.7.2    β-catenin gain-of-function causes an increase in apoptosis in the neural crest 
Whole mount TUNEL stains were carried out to compare the pattern and frequency of 
apoptotic cells in embryos of different genotypes. The purpose of this is to ascertain if β-
catenin has any effect on apoptosis, in particular focussing on the NC. in situ hybridisation 
against the ErbB3 gene has shown that NC cells are present at the 24-26 somite stage, but not 
at 30+ somites in Pax3Cre/+ β-cateninGOF/+ and Pax3Sp2H/Cre β-cateninGOF/+ embryos. In order to 
determine if the NC are undergoing apoptosis between the 26 and 30 somite stage, TUNEL 
stains were carried out shortly prior to and during these stages, from 22 to 30+ somites. The 
results of these TUNEL stainings gave variable results, even within somite stages and 
genotypes. No common patterns have been discussed unless they are present on all embryos 
of a particular somite stage and genotype which have been tested. However, larger sample 
sizes and quantification through sectioning could further clarify the results. It is also assumed 
that TUNEL staining in regions known to contain NC cells mark apoptosing NC cells. However, 
the TUNEL staining also marks apoptotic cells of other tissues. TUNEL staining in combination 
with NC markers could further clarify the cell types undergoing apoptosis. In addition, negative 
controls could show background staining which occurs during TUNEL staining. 
Apoptosis shows a similar pattern in Pax3+/+ β-catenin+/+ and Pax3+/- β-catenin+/+ embryos; at 
the 22-24 somite stage (Figure 4.14) apoptosis is most obvious in a stream of migrating NC. At 
the 27-29 somite stage (Figure 4.15) this stream of apoptotic NC is still visible, and apoptosing 
NC-derived cells are visible in the DRG in a segmented pattern. Additionally, a clearly-defined 
line of apoptotic cells is visible in the midline of the forebrain NT. At the 30+ somite stage 
(Figure 4.16), the migrating stream of NC is less visible, but apoptotic cells in the DRG form the 
same segmented patterning seen at the 27-29 somite stage. However, even between embryos 
of the same genotype there is variation. 
The pattern of apoptosis in Pax3Sp2H/Cre β-catenin+/+ embryos does not appear to differ greatly 
from that of Pax3+/+ β-catenin+/+ embryos; at the 22-24 and 27-29 somite stages (Figures 4.14 
and 4.15). Apoptosis in Pax3Sp2H/Cre β-catenin+/+ embryos is indistinguishable from Pax3+/+ β-
catenin+/+ embryos, apart from possibly a small increase in apoptosis at the cervical-hindbrain 
boundary (Figure 4.14), and a reduction in apoptotic cells at the midline of the forebrain NT 
(Figure 4.15). However, by the 30+ somite stage (Figure 4.16) apoptosis appears to be 
reduced. This is particularly obvious in the DRG. 
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Pax3Cre/+ β-cateninGOF/+ embryos show a largely wild type pattern of apoptosis at the 22-24 
somite stage, but with possibly a small increase in apoptosis at the cervical-hindbrain 
boundary (Figure 4.14). However, at the 27-29 somite stage (Figure 4.15) the segmentation of 
apoptotic cells in the DRG begins to appear less defined. Furthermore, no apoptosis is seen in 
the midline of the forebrain NT. Apoptosis in the migrating NC appears to be normal. At the 
30+ somite stage (Figure 4.16) the segmentation of the apoptotic DRG cells has reduced 
further, and overall apoptosis appears to be slightly increased when compared to both Pax3+/+ 
β-catenin+/+ and Pax3+/- β-catenin+/+ embryos. 
Apoptosis in Pax3Sp2H/Cre β-cateninGOF/+ embryos is increased at the cervical-hindbrain 
boundary, and may be slightly increased overall at the 22-24 somite stage (Figure 4.14). At the 
27-29 somite stage (Figure 4.15) apoptosis at the midline of the forebrain NT is absent. In 
addition, apoptosis in the DRG appears to be reduced compared to both Pax3+/+ β-catenin+/+ 
and Pax3Sp2H/Cre β-catenin+/+ embryos. However, at the 30+ somite stage (Figure 4.16) apoptosis 
is increased in the DRG compared to Pax3+/+ β-catenin+/+ embryos, and very much compared to 
Pax3Sp2H/Cre β-catenin+/+ embryos. Furthermore, the segmental pattern of apoptosis in the 
spinal region is lost. 
A summary of the apoptosis data is given in Table 4.4. 
4.1.7.3    β-catenin gain-of-function causes a slight decrease in neural crest specification 
The gene FoxD3 is an early marker for NC specification (Dottori et al., 2001). The expression 
pattern of FoxD3 was studied through whole mount in situ hybridisation in embryos with and 
without β-catenin GOF at early stages of NC specification (Figure 4.17). The purpose of this is 
to determine whether β-catenin GOF affects the specification of the NC. 
Embryos were analysed at the 7-9 and 10-12 somite stages, early in the specification of the NC, 
in order to observe the initial development of these cells. Pax3+/+ β-catenin+/+ and Pax3+/- β-
catenin+/+ embryos show similar FoxD3 expression patterns. Pax3Cre/+ β-cateninGOF/+ embryos 
have a more broken pattern of FoxD3 expression in the spinal region of the NT, suggesting that 
NC specification may not be continuous along the length of the NT. This is more apparent at 
the 7-9 somite stage than the 10-12 somite stage. 
Pax3Sp2H/Cre β-catenin+/+ and Pax3Sp2H/Cre β-cateninGOF/+ embryos show similar patterns of FoxD3 
expression; expression in the cranial region and rhombomere 4 is unchanged from the wild 
type, but expression in the spinal NT is absent at both the 7-9 and 10-12 somite stages. 
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Genotype Somite Stage 
Change from Pax3+/+ β-catenin+/+ TUNEL 
Staining 
Pax3+/- β-catenin+/+ 
22-24 None. 
27-29 None. 
30+ None. 
Pax3Cre/+ β-cateninGOF/+ 
22-24 
Small increase at the cervical-hindbrain 
boundary. 
27-29 
Reduced DRG segmentation. No apoptosis in 
the midline of the forebrain. 
30+ 
Reduced DRG segmentation. Slightly 
increased overall apoptosis. 
Pax3Sp2H/Cre β-catenin+/+ 
22-24 None. 
27-29 Reduction at the midline of the forebrain. 
30+ Reduced. 
Pax3Sp2H/Cre β-cateninGOF/+ 
22-24 
Increased at the cervical-hindbrain 
boundary. Possibly slight overall increase. 
27-29 
No apoptosis in the midline of the forebrain. 
Reduced apoptosis in the DRG. 
30+ 
Increased in the DRG. No segmentation in 
DRG. 
 
 
 
 
 
 
 
 
 
 
Table 4.4: Summary of apoptosis data between the 22 and 30+ somite stages. The data given 
is a comparison to the pattern of TUNEL staining seen in Pax3
+/+
 β-catenin
+/+
 embryos at each given 
somite stage. 
22-24 somite stage – n = 2 for each genotype. 
27-29 somite stage – β-catenin
+/+
: n = 2. Pax3
+/-
 β-catenin
+/+
: n = 3. Pax3
Cre/+
 β-catenin
GOF/+
: n = 2. 
Pax3
Sp2H/Cre
 β-catenin
+/+
: n = 3. Pax3
Sp2H/Cre
 β-catenin
GOF/+
: n = 2. 
30+ somite stage – Pax3
+/+
 β-catenin
+/+
: n = 2. Pax3
+/-
 β-catenin
+/+
: n = 2. Pax3
Cre/+
 β-catenin
GOF/+
: n = 1. 
Pax3
Sp2H/Cre
 β-catenin
+/+
: n = 2. Pax3
Sp2H/Cre
 β-catenin
GOF/+
: n = 2. 
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(C
).
 
B
o
th
 P
a
x3
Sp
2
H
/C
re
 β
-c
a
te
n
in
+/
+
 a
n
d
 P
a
x3
Sp
2H
/C
re
 β
-c
a
te
n
in
G
O
F/
+  
em
b
ry
o
s 
ap
p
ea
r 
to
 h
av
e
 n
o
rm
al
 F
o
xD
3
 e
xp
re
ss
io
n
 i
n
 t
h
e 
cr
an
ia
l 
re
gi
o
n
 a
n
d
 r
h
o
m
b
o
m
er
e
 4
. 
H
o
w
ev
er
, 
th
es
e 
em
b
ry
o
s 
h
av
e 
n
o
 e
xp
re
ss
io
n
 in
 t
h
e 
sp
in
al
 N
T 
at
 t
h
e 
7
-9
 o
r 
1
0
-1
2
 s
o
m
it
e 
st
ag
es
. 
7
-9
 s
o
m
it
e 
st
ag
e 
– 
P
ax
3
+
/+
 β
-c
at
en
in
+
/+
: n
 =
 4
. P
ax
3
+/
-  β
-c
at
e
n
in
+
/+
: n
 =
 2
. P
ax
3
C
re
/+
 β
-c
at
en
in
G
O
F/
+
: n
 =
 2
. P
ax
3
Sp
2
H
/C
re
 β
-c
at
en
in
+
/+
: n
 =
 2
. P
ax
3
Sp
2H
/C
re
 β
-c
at
en
in
G
O
F/
+
: n
 =
 3
. 
1
0
-1
2
 s
o
m
it
e 
st
ag
e 
– 
P
ax
3
+
/+
 β
-c
at
en
in
+/
+
: n
 =
 4
. P
ax
3
+
/-
 β
-c
at
en
in
+
/+
: n
 =
 3
. P
ax
3
C
re
/+
 β
-c
at
e
n
in
G
O
F/
+ :
 n
 =
 3
. P
ax
3
Sp
2H
/C
re
 β
-c
at
en
in
+
/+
: n
 =
 2
. P
ax
3
Sp
2H
/C
re
 β
-c
at
en
in
G
O
F/
+
: n
 =
 2
. 
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β
-c
at
e
n
in
 g
ai
n
-o
f-
fu
n
ct
io
n
 d
o
es
 n
o
t 
af
fe
ct
 e
xp
re
ss
io
n
 o
f 
N
g
n
2
. 
Ex
p
er
im
en
ta
l 
lit
te
rs
 w
er
e 
ge
n
er
at
ed
 c
o
n
ta
in
in
g 
a 
m
ix
tu
re
 o
f 
ge
n
o
ty
p
es
 t
h
ro
u
gh
 t
h
e 
cr
o
ss
 
P
a
x3
Sp
2H
/+
 β
-c
a
te
n
in
G
O
F/
+
 x
 P
a
x3
C
re
/+
 β
-c
a
te
n
in
+
/+
. W
h
o
le
 m
o
u
n
t 
in
 s
it
u
 h
yb
ri
d
is
at
io
n
 f
o
r 
N
g
n
2
 w
as
 c
ar
ri
ed
 o
u
t 
o
n
 1
6
-1
8
 s
o
m
it
e 
st
ag
e 
em
b
ry
o
s 
o
f 
va
ri
o
u
s 
ge
n
o
ty
p
es
. S
e
ct
io
n
s 
w
er
e 
th
en
 t
ak
en
 o
f 
th
e 
ca
u
d
al
 (
A
’-
E
’)
 a
n
d
 c
ra
n
ia
l r
eg
io
n
s 
(A
’’
-E
’’
) 
o
f 
th
e 
N
T.
 T
h
e 
d
as
h
ed
 li
n
e
s 
sh
o
w
 t
h
e 
p
o
si
ti
o
n
 o
f 
th
e 
N
T 
in
 t
h
e 
se
ct
io
n
s.
 S
ca
le
 b
ar
s 
re
p
re
se
n
t 
2
5
0
 µ
m
. 
P
a
x3
+
/+
 β
-c
a
te
n
in
+
/+
 e
m
b
ry
o
s 
(A
, 
A
’,
 a
n
d
 A
’’
) 
sh
o
w
s 
ex
p
re
ss
io
n
 o
f 
N
g
n
2
 i
n
 t
h
e 
m
id
 r
eg
io
n
 o
f 
th
e 
N
T 
o
n
 t
h
e 
d
o
rs
o
-v
en
tr
al
 a
xi
s.
 T
h
er
e 
is
 a
 s
m
al
l 
ve
n
tr
al
 r
eg
io
n
 o
f 
n
o
 e
xp
re
ss
io
n
, 
an
d
 a
 la
rg
er
 d
o
rs
al
 r
eg
io
n
 o
f 
lo
w
 e
xp
re
ss
io
n
. 
So
m
e 
ex
p
re
ss
io
n
 is
 a
ls
o
 s
ee
n
 in
 t
h
e 
la
te
ra
l m
e
so
d
er
m
 d
ir
ec
tl
y 
ad
ja
ce
n
t 
to
 t
h
e 
d
o
rs
al
 r
eg
io
n
 o
f 
th
e 
N
T.
 
Th
er
e 
ap
p
ea
r 
to
 b
e 
n
o
 m
aj
o
r 
d
if
fe
re
n
ce
s 
in
 N
g
n
2
 e
xp
re
ss
io
n
 b
et
w
ee
n
 t
h
e 
ge
n
o
ty
p
es
 a
t 
th
e 
1
6
-1
8
 s
o
m
it
e 
st
ag
e.
 T
h
e 
P
a
x3
 h
et
er
o
zy
go
u
s 
an
d
 h
o
m
o
zy
go
u
s 
m
u
ta
n
t 
em
b
ry
o
s,
 w
it
h
 
an
d
 w
it
h
o
u
t 
β
-c
at
en
in
 G
O
F,
 a
p
p
ea
r 
to
 s
h
o
w
 v
er
y 
si
m
ila
r 
ex
p
re
ss
io
n
 p
at
te
rn
s 
o
f 
N
g
n
2
. 
P
ax
3
+
/+
 β
-c
at
en
in
+
/+
: n
 =
 3
. P
ax
3
+
/-
 β
-c
at
en
in
+
/+
: n
 =
 3
. P
ax
3
C
re
/+
 β
-c
at
en
in
G
O
F/
+
: n
 =
 2
. P
ax
3
Sp
2
H
/C
re
 β
-c
at
en
in
G
O
F/
+
: n
 =
 3
. P
ax
3
Sp
2H
/C
re
 β
-c
at
en
in
G
O
F/
+
: n
 =
 3
. 
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β
-c
at
e
n
in
 g
ai
n
-o
f-
fu
n
ct
io
n
 r
ed
u
ce
s 
ex
p
re
ss
io
n
 o
f 
B
rn
3
a
 i
n
 t
h
e
 s
p
in
al
 r
e
gi
o
n
. 
Ex
p
er
im
en
ta
l 
lit
te
rs
 w
e
re
 g
en
er
at
ed
 c
o
n
ta
in
in
g 
a 
m
ix
tu
re
 o
f 
ge
n
o
ty
p
es
 
th
ro
u
gh
 t
h
e 
cr
o
ss
 P
a
x3
Sp
2H
/+
 β
-c
a
te
n
in
G
O
F/
+
 x
 P
a
x3
C
re
/+
 β
-c
a
te
n
in
+
/+
. i
n
 s
it
u
 h
yb
ri
d
is
at
io
n
 f
o
r 
B
rn
3
a
 w
as
 c
ar
ri
ed
 o
u
t 
o
n
 e
m
b
ry
o
s 
o
f 
m
u
lt
ip
le
 g
en
o
ty
p
es
. 
W
h
it
e 
sc
al
e 
b
ar
s 
re
p
re
se
n
t 
5
0
0
 μ
m
, 
an
d
 b
la
ck
 s
ca
le
 b
ar
s 
re
p
re
se
n
t 
1
0
0
 µ
m
. 
F’
-J
’ 
an
d
 F
’’
-J
’’
 s
h
o
w
 t
ra
n
sv
er
se
 s
ec
ti
o
n
s 
th
ro
u
gh
 3
0
+ 
so
m
it
e 
st
ag
e 
em
b
ry
o
s.
 F
’-
J’
 s
h
o
w
 c
ra
n
ia
l s
ec
ti
o
n
s,
 a
n
d
 F
’’
-J
’’
 s
h
o
w
 s
p
in
al
 
se
ct
io
n
s.
 D
o
tt
ed
 li
n
e
s 
d
el
in
ea
te
 t
h
e 
N
T 
w
it
h
in
 s
ec
ti
o
n
s.
 
P
a
x3
+
/+
 β
-c
a
te
n
in
+
/+
 e
m
b
ry
o
s 
at
 t
h
e 
2
3
-2
4
 a
n
d
 3
0
+ 
so
m
it
e 
st
ag
e
s 
(A
 a
n
d
 F
 r
e
sp
ec
ti
ve
ly
) 
sh
o
w
 s
tr
o
n
g 
B
rn
3
a
 e
xp
re
ss
io
n
 i
n
 t
h
e 
N
T 
(b
la
ck
 a
rr
o
w
h
ea
d
s)
 a
n
d
 i
n
 t
h
e 
so
m
it
e
s 
(w
h
it
e
 
ar
ro
w
h
ea
d
s)
, 
sh
o
w
in
g 
cl
ea
rl
y 
d
ef
in
ed
 s
eg
m
en
ta
ti
o
n
. 
B
rn
3
a
 e
xp
re
ss
io
n
 a
p
p
ea
rs
 t
o
 b
e 
ex
p
re
ss
ed
 in
 t
h
e 
so
m
it
es
 a
lo
n
g 
th
e 
fu
ll 
le
n
gt
h
 o
f 
th
e 
b
o
d
y 
in
 2
3
-2
4
 s
o
m
it
e 
st
ag
e 
e
m
b
ry
o
s 
(A
),
 b
u
t 
in
 3
0
+ 
so
m
it
e 
st
ag
e
 e
m
b
ry
o
s 
is
 r
ed
u
ce
d
 i
n
 t
h
e
 r
o
st
ra
l-
m
o
st
 s
o
m
it
e
s 
an
d
 m
o
re
 s
tr
o
n
gl
y 
ex
p
re
ss
ed
 i
n
 t
h
e
 c
au
d
al
 s
o
m
it
e
s 
(F
).
 B
rn
3
a
 i
s 
ex
p
re
ss
ed
 i
n
 a
p
p
ro
xi
m
at
el
y 
th
e 
d
o
rs
al
 h
al
f 
o
f 
th
e 
cr
an
ia
l 
N
T 
(F
’)
 a
n
d
 t
h
e 
d
o
rs
al
 t
h
ir
d
 i
n
 t
h
e 
sp
in
al
 N
T 
(F
’’
).
 S
o
m
it
ic
 B
rn
3
a
 i
s 
cl
ea
rl
y 
vi
si
b
le
 i
n
 t
h
e 
sp
in
al
 r
eg
io
n
, 
an
d
 i
s 
e
xp
re
ss
e
d
 i
n
 a
 d
ef
in
ed
 s
tr
ip
e 
in
 t
h
e
 
d
er
m
o
m
yo
to
m
e 
(F
’’
, a
rr
o
w
s)
. B
rn
3
a
 e
xp
re
ss
io
n
 is
 P
a
x3
+
/-
 β
-c
a
te
n
in
+
/+
 e
m
b
ry
o
s 
(B
, G
, G
’ a
n
d
 G
’’
) 
is
 id
en
ti
ca
l t
o
 P
a
x3
+
/+
 β
-c
a
te
n
in
+
/+
. 
B
rn
3
a
 e
xp
re
ss
io
n
 in
 2
3
-2
4
 s
o
m
it
e
 s
ta
ge
 P
a
x3
Sp
2H
/C
re
 β
-c
a
te
n
in
+
/+
 e
m
b
ry
o
s 
(D
) 
ap
p
ea
rs
 t
o
 b
e 
re
d
u
ce
d
 c
o
m
p
ar
ed
 t
o
 P
a
x3
+
/+
 β
-c
a
te
n
in
+
/+
 e
m
b
ry
o
s.
 T
h
e
 s
ta
in
in
g 
is
 b
ar
el
y 
vi
si
b
le
 in
 
th
e 
so
m
it
e
s 
o
r 
th
e 
N
T.
 E
xp
re
ss
io
n
 is
 s
lig
h
tl
y 
m
o
re
 v
is
ib
le
 in
 3
0
+ 
so
m
it
e 
st
ag
e 
P
a
x3
Sp
2
H
/C
re
 β
-c
a
te
n
in
+
/+
 e
m
b
ry
o
s 
(I
),
 b
u
t 
st
ill
 a
p
p
ea
rs
 t
o
 b
e
 r
ed
u
ce
d
, 
p
ar
ti
cu
la
rl
y 
in
 t
h
e 
ca
u
d
al
 N
T 
an
d
 t
h
e 
so
m
it
e
s,
 w
h
er
e 
st
ai
n
in
g 
is
 o
n
ly
 f
ai
n
tl
y 
vi
si
b
le
. 
Ex
p
re
ss
io
n
 i
n
 t
h
e 
se
ct
io
n
s 
(I
’ 
an
d
 I
’’
) 
co
rr
o
b
o
ra
te
s 
th
e
se
 o
b
se
rv
at
io
n
s;
 t
h
e 
st
ai
n
in
g 
is
 p
re
se
n
t 
in
 t
h
e 
sa
m
e 
re
gi
o
n
s 
as
 i
n
 
P
a
x3
+
/+
 β
-c
a
te
n
in
+
/+
 e
m
b
ry
o
s,
 b
u
t 
ap
p
ea
rs
 m
u
ch
 f
ai
n
te
r.
 
Sp
in
al
 N
T 
ex
p
re
ss
io
n
 o
f 
B
rn
3
a
 a
p
p
ea
rs
 t
o
 b
e 
re
d
u
ce
d
 i
n
 P
a
x3
C
re
/+
 β
-c
a
te
n
in
G
O
F/
+  
em
b
ry
o
s 
at
 b
o
th
 t
h
e 
2
3
-2
4
 s
o
m
it
e 
st
ag
e 
(C
) 
an
d
 t
h
e 
3
0
+ 
so
m
it
e 
st
ag
e 
(H
).
 T
h
e 
cr
an
ia
l 
re
gi
o
n
, 
h
o
w
ev
er
, 
ap
p
ea
rs
 t
o
 b
e 
le
ss
 s
tr
o
n
gl
y 
af
fe
ct
ed
. 
Th
es
e 
re
su
lt
s 
ar
e 
ve
ri
fi
ed
 b
y 
th
e 
se
ct
io
n
s;
 t
h
e 
cr
an
ia
l 
re
gi
o
n
 (
H
’)
 s
h
o
w
s 
B
rn
3
a
 N
T 
e
xp
re
ss
io
n
 s
im
ila
r 
to
 P
a
x3
+
/+
 β
-c
a
te
n
in
+
/+
 
em
b
ry
o
s,
 b
u
t 
th
e 
sp
in
al
 s
ec
ti
o
n
 s
h
o
w
s 
re
d
u
ce
d
 N
T 
ex
p
re
ss
io
n
 (
H
’’
).
 B
rn
3
a
 e
xp
re
ss
io
n
 i
n
 t
h
e 
so
m
it
es
 o
f 
P
a
x3
C
re
/+
 β
-c
a
te
n
in
G
O
F/
+  
em
b
ry
o
s 
ap
p
ea
rs
 s
im
ila
r 
to
 t
h
at
 i
n
 P
a
x3
+
/+
 β
-
ca
te
n
in
+
/+
 e
m
b
ry
o
s,
 o
r 
p
o
ss
ib
ly
 s
lig
h
tl
y 
re
d
u
ce
d
 (
C
 a
n
d
 H
).
 H
o
w
ev
er
, t
h
e 
se
ct
io
n
s 
(H
’ 
an
d
 H
’’
) 
sh
o
w
 t
h
at
 t
h
e 
so
m
it
ic
 r
eg
io
n
 o
f 
B
rn
3
a
 e
xp
re
ss
io
n
 is
 e
xp
an
d
ed
 v
en
tr
al
ly
 c
o
m
p
ar
ed
 
to
 P
a
x3
+/
+  
β
-c
a
te
n
in
+/
+  
em
b
ry
o
s.
 T
h
er
e 
is
 a
n
 a
d
d
it
io
n
al
 r
e
gi
o
n
 o
f 
B
rn
3
a
 e
xp
re
ss
io
n
 i
n
 t
h
e 
cr
an
ia
l 
re
gi
o
n
 o
f 
2
3
-2
4
 s
o
m
it
e 
st
ag
e 
P
a
x3
C
re
/+
 β
-c
a
te
n
in
G
O
F/
+  
em
b
ry
o
s,
 a
b
o
ve
 t
h
e 
p
h
ar
yn
ge
al
 a
rc
h
es
 a
n
d
 in
to
 t
h
e 
fo
re
b
ra
in
 (
C
, w
h
it
e 
as
te
ri
sk
).
 T
h
is
 a
b
er
ra
n
t 
ex
p
re
ss
io
n
 a
p
p
ea
rs
 t
o
 c
o
n
ti
n
u
e 
in
to
 3
0
+ 
so
m
it
e 
st
ag
e 
(H
).
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β
-c
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e
n
in
 
ga
in
-o
f-
fu
n
ct
io
n
 
re
d
u
ce
s 
ex
p
re
ss
io
n
 o
f 
B
rn
3
a
 i
n
 t
h
e 
sp
in
al
 
re
gi
o
n
, c
o
n
ti
n
u
ed
. 
B
rn
3
a
 e
xp
re
ss
io
n
 is
 g
re
at
ly
 r
e
d
u
ce
d
 in
 t
h
e 
sp
in
al
 
N
T 
an
d
 
so
m
it
es
 
o
f 
P
a
x3
Sp
2
H
/C
re
 
β
-c
a
te
n
in
G
O
F/
+  
em
b
ry
o
s 
at
 2
3
-2
4
 (
E)
 a
n
d
 3
0
+ 
(J
) 
so
m
it
e 
st
ag
e
s.
 
Sp
in
al
 s
ec
ti
o
n
s 
al
so
 s
h
o
w
 t
h
is
 (
J’
’)
. 
Th
e 
ab
er
ra
n
t 
cr
an
ia
l e
xp
re
ss
io
n
 s
e
en
 in
 P
a
x3
C
re
/+
 β
-c
a
te
n
in
G
O
F/
+  
em
b
ry
o
s 
(C
 a
n
d
 H
) 
is
 a
ls
o
 p
re
se
n
t 
in
 P
a
x3
Sp
2H
/C
re
 
β
-c
a
te
n
in
G
O
F/
+  
em
b
ry
o
s 
(E
 
an
d
 
J)
. 
H
o
w
ev
er
, 
cr
an
ia
l 
se
ct
io
n
s 
(J
’)
 s
h
o
w
 t
h
at
 B
rn
3
a
 e
xp
re
ss
io
n
 
is
 n
o
t 
p
re
se
n
t 
in
 t
h
e 
N
T.
 
2
3
-2
4
 s
o
m
it
e 
st
ag
e:
 P
ax
3
+
/+
 β
-c
at
en
in
+
/+
: 
n
 =
 3
. 
P
ax
3
+
/-
 
β
-c
at
en
in
+
/+
: 
n
 
=
 
2
. 
P
ax
3
C
re
/+
 
β
-
ca
te
n
in
G
O
F/
+
: n
 =
 2
. P
ax
3
Sp
2H
/C
re
 β
-c
at
en
in
+
/+
: n
 =
 1
. 
P
ax
3
Sp
2H
/C
re
 β
-c
at
en
in
G
O
F/
+
: n
 =
 1
. 
3
0
+ 
so
m
it
e 
st
ag
e:
 
P
ax
3
+
/+
 
β
-c
at
en
in
+
/+
: 
n
 
= 
4
. 
P
ax
3
+
/-
 
β
-c
at
en
in
+
/+
: 
n
 
=
 
2
. 
P
ax
3
C
re
/+
 
β
-
ca
te
n
in
G
O
F/
+
: n
 =
 2
. P
ax
3
Sp
2H
/C
re
 β
-c
at
en
in
+
/+
: n
 =
 2
. 
P
ax
3
Sp
2H
/C
re
 β
-c
at
en
in
G
O
F/
+
: n
 =
 3
. 
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4.1.7.4    Development of the peripheral nervous system 
Expression of the genes Ngn2 and Brn3a were used to study the development of the PNS. 
Ngn2 is a proneural gene, and Brn3a is expressed in sensory neurons (Ninkina et al., 1993; 
Sommer et al., 1996). Ngn2 expression was studied early in the development of the PNS, at the 
16-18 somite stage (Figure 4.18). β-catenin GOF appears to have no effect on Ngn2 expression 
at this stage. 
Brn3a expression was studied at a slightly later stage of PNS development, at the 23-24 and 
30+ somite stages (Figure 4.19). Pax3 mutation appears to cause a general reduction in Brn3a 
expression. However, β-catenin GOF appears to slightly reduce spinal NT Brn3a expression, but 
expand the region of cranial expression beyond the NT, such that staining was evident above 
the pharyngeal arches and in the forebrain. Additionally, β-catenin GOF expands the region of 
Brn3a expression in the somites ventrally, below the dermomyotome and into the sclerotome. 
4.1.8    β-catenin gain-of-function does not affect Pax3 expression 
Evidence has suggested that canonical Wnt signalling may act upstream of Pax3 signalling 
(Zhao et al., 2014). Therefore, the expression level of Pax3 was studied to test whether it is 
influenced by β-catenin GOF. RT-qPCR was carried out using two different Pax3 primers. Only 
Pax3Cre/+ β-catenin+/+ embryos were used as Pax3 heterozygotes to eliminate the chance of 
error caused by possible differences in expression between the Pax3Cre and Pax3Sp2H alleles, 
and because the primer pairs used are only able to detect one of the two alleles. 
Pax3 primer pair 1 is positioned to overlap the 32bp region which is deleted in exon 5 of the 
Pax3Sp2H allele (Figure 4.20A-C), so it detects Pax3+ and Pax3Cre, but not Pax3Sp2H. This primer 
pair detected no significant difference in Pax3 expression between Pax3Cre/+ β-catenin+/+ and 
Pax3Cre/+ β-cateninGOF/+ embryos, or between Pax3Sp2H/Cre β-catenin+/+ and Pax3Sp2H/Cre β-
cateninGOF/+ embryos (Figure 4.21A). 
Pax3 primer 2 is positioned to amplify the region from exon 1 to exon 2 of Pax3 , with the 
forward primer binding in exon 1, and the reverse primer in exon 2 (Figure 4.20D-F). Therefore 
it detects Pax3+ and Pax3Sp2H, but not Pax3Cre. This primer pair detected no significant 
difference in Pax3 expression between Pax3Cre/+ β-catenin+/+ and Pax3Cre/+ β-cateninGOF/+ 
embryos, or between Pax3Sp2H/Cre β-catenin+/+ and Pax3Sp2H/Cre β-cateninGOF/+ embryos (Figure 
4.21B). 
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Figure 4.20: Positions of primer pairs 1 and 2 within the Pax3 gene. The positions of the 
primer pairs are demonstrated by half arrows in the Pax3
+
 (A and D), Pax3
Sp2H
 (B and E) and Pax3
Cre
 
(C and F) alleles. 
Amplification by primer pair 1 occurs in the Pax3
+
 (A) and Pax3
Cre
 (C) alleles, but not the Pax3
Sp2H
 
allele (B) as the forward primer binding site is positioned in the deleted region. Amplification by 
primer pair 2 occurs in the Pax3
+
 (D) and Pax3
Sp2H
 (E) alleles, but not the Pax3
Cre
 allele (F) as the 
forward primer binding site is positioned in exon 1, which is replaced by a Cre recombinase gene in 
this allele. 
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Figure 4.21: β-catenin gain-of-function does not affect Pax3 expression levels. Experimental 
litters were generated containing a mixture of genotypes through the cross Pax3
Sp2H/+
 β-catenin
GOF/+
 x 
Pax3
Cre/+
 β-catenin
+/+
. RT-qPCR was carried out on embryos of multiple genotypes at the 23-24 somite 
stage. * indicates significant difference from Pax3
+/+
 β-catenin
+/+
. # indicates significant difference 
from Pax3
Cre/+
 β-catenin
+/+
. 
Graph A shows RT-qPCR results using Pax3 primer pair 1. This primer pair detects Pax3
+
 and Pax3
Cre
, 
but not Pax3
Sp2H
. A significant reduction in Pax3 expression is seen between Pax3
+/+
 β-catenin
+/+
 and 
Pax3
Sp2H/Cre
 β-catenin
+/+
 embryos, and between Pax3
+/+
 β-catenin
+/+
 and Pax3
Sp2H/Cre
 β-catenin
GOF/+
 
embryos. However, no significant differences are seen between Pax3
+/-
 β-catenin
+/+
 and Pax3
Cre/+
 β-
catenin
GOF/+
 embryos, or between Pax3
Sp2H/Cre
 β-catenin
+/+
 and Pax3
Sp2H/Cre
 β-catenin
GOF/+
 embryos. 
Graph B shows RT-qPCR results using Pax3 primer pair 2. This primer pair detects Pax3
+
 and Pax3
Sp2H
, 
but not Pax3
Cre
. A significant reduction in Pax3 expression is seen between Pax3
+/+
 β-catenin
+/+
 and 
both Pax3
Cre/+
 β-catenin
+/+
 and Pax3
Sp2H/Cre
 β-catenin
+/+
 embryos. However, no significant differences 
are seen between Pax3
+/-
 β-catenin
+/+
 and Pax3
Cre/+
 β-catenin
GOF/+
 embryos, or between Pax3
Sp2H/Cre
 β-
catenin
+/+
 and Pax3
Sp2H/Cre
 β-catenin
GOF/+
 embryos. Additionally, Pax3 expression is significantly 
reduced in Pax3
Sp2H/Cre
 β-catenin
+/+
 embryos compared to Pax3
Cre/+
 β-catenin
+/+
 embryos. 
*/# p < 0.05. Significance compared to Pax3
+/+
 β-catenin
+/+
 was determined using one way ANOVA 
followed by the Holm Sidak test (A), or by one way ANOVA on ranks followed by Dunn’s test (B). 
Pairwise significance was determined using the t-test. Only significance between relevant data is 
shown. Error bars show standard error. 
For both A and B – Pax3
+/+
 β-catenin
+/+
: n = 4. Pax3
Cre/+
 β-catenin
+/+
: n = 3. Pax3
Cre/+
 β-catenin
GOF/+
: n = 
3. Pax3
Sp2H/Cre
 β-catenin
+/+
: n = 4. Pax3
Sp2H/Cre
 β-catenin
GOF/+
: n = 3. 
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4.2    Discussion 
4.2.1    The β-catenin gain-of-function allele 
The β-catenin GOF allele used in this research was first developed and described by the Taketo 
lab (Harada et al., 1999). 
β-catenin is known to play a role in adherens junctions in addition to canonical Wnt signalling. 
Therefore it is possible that the mutation affects both functions, and not just the canonical 
Wnt signalling pathway. In the original paper describing this mutation (Harada et al., 1999) this 
is mentioned as a possibility, although it is also stated that the mutation does not appear to 
affect the interaction with adherens junctions. However, there remains a possibility that some 
of the effects of the mutation described in this thesis could be due to alterations in the 
adherens junctions. This could be further examined through study of the adherens junctions 
themselves in tissues affected by the mutation (i.e. Pax3-expressing tissues) in the different 
genotypes. For example, use of antibodies against components of the adherens junction, such 
as α-catenin, γ-catenin or E-cadherin could provide some insight into the integrity and density 
of adherens junctions within mutant tissue, including the neural tube. 
For the purpose of this thesis several genotypes were pooled during analysis (see introduction 
to Chapter 4 Results, section 4.1). These pooled genotypes contained functionally equivalent 
combinations of alleles, and provided higher numbers of embryos for experiments and 
analysis. However, genotypes would have ideally been kept separate, as there is a chance that 
differences in the mutations could cause differences in the results. Analysis of the pooled 
genotypes showed no significant differences in the frequencies of spina bifida and 
exencephaly, but this does not completely rule out the possibility of differences between the 
genotypes, especially as sample numbers were often low. 
As an example of potential differences, previous publications report different frequencies of 
exencephaly in Pax3Cre/Cre and Pax3Sp2H/Sp2H embryos, despite both mutations resulting in 
functionally null Pax3 protein; Pax3Cre/Cre embryos have a frequency of 20-30% exencephaly, 
(Nick Greene, unpublished observations) compared to around 80% in Pax3Sp2H/Sp2H embryos 
(Fleming and Copp, 2000). However, it has also been found that the frequency of exencephaly 
within Pax3Sp2H/Sp2H embryos may vary considerably with time, despite all other factors being 
equal (Greene et al., 2009). Therefore, a certain amount of variability, even within a strain, is 
to be expected. 
An additional issue is that the Pax3Cre allele and the Pax3Sp2H allele are carried on different 
genetic backgrounds. The effect of this during development is discussed in more detail in 
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section 1.2.2.1. The combination of genetic backgrounds in the cross could create variations in 
modifier genes in the offspring, and it is possible that this could affect the results of the study. 
Ideally, the Pax3Sp2H allele would have been backcrossed onto the C57BL/6 background, which 
is the background of the Pax3Cre allele. Analysis of the embryos throughout the experiments 
described in this chapter showed fairly consistent results, which suggests that the difference in 
genetic background is not affecting the results to a large degree. However, this caveat should 
be taken into consideration for the results. Both alleles were used in the cross because, 
although the frequency of spina bifida was close to 100% in both genotypes, Pax3Sp2H/Sp2H 
embryos have a higher frequency of exencephaly than Pax3Cre/Cre embryos. At least one copy of 
the Pax3Cre allele was necessary to flox conditional alleles in the experiments, but combining 
this allele with the Pax3Sp2H allele increased the rate of exencephaly; Pax3Sp2H/Cre embryos 
have a higher frequency of exencephaly than Pax3Cre/Cre embryos. This made it easier and more 
efficient to study the development of exencephaly in the experiments. 
4.2.2    β-catenin gain-of-function and neural tube defects 
It was discussed in Chapter 3 that Sp2H/Sp2H embryos exhibit a reduction in proliferation in the 
neural tube, and that this may be the cause of NTDs in these embryos. Evidence suggests a 
potential link between Pax3 and canonical Wnt signalling (see section 1.4.7). Canonical Wnt 
signalling is associated with the maintenance of a proliferative, multipotent state (Megason 
and McMahon, 2002), and so it was hypothesised that an increase in canonical Wnt signalling 
levels may rescue NTDs in Sp2H/Sp2H embryos. However, this was not found to be the case. 
β-catenin GOF appears to greatly affect the closure of the cranial NT. The resulting increase in 
canonical Wnt signalling causes a visible difference in the cranial neural folds of Pax3Sp2H/Cre β-
cateninGOF/+ embryos compared to Pax3Sp2H/Cre β-catenin+/+ embryos (Figure 4.8). β-catenin GOF 
induced by Sox-1Cre does not appear to increase NTDs to the same degree as when induced by 
Pax3Cre (Sox1 is reported to be expressed in the NT, although this could be confirmed in the 
experimental mice through in situ hybridisation). The Pax3+/+ β-cateninGOF/+ Sox-1Cre/+ genotype 
causes exencephaly in 25% of embryos (Figure 4.5), Pax3Sp2H/Cre β-catenin+/+ in 59% of embryos, 
and Pax3Sp2H/Cre β-cateninGOF/+ in 99% of embryos (Figure 4.7). In addition, β-catenin GOF 
induces exencephaly in Pax3 heterozygous embryos, as Pax3+/- β-catenin+/+ embryos have 
exencephaly at a rate of 10%, whereas Pax3Cre/+ β-cateninGOF/+ embryos have exencephaly at a 
rate of 80% (Figure 4.7). Therefore, it is likely that the increase in the frequency of 
exencephaly is due to genetic interaction between the Pax3 and canonical Wnt signalling 
pathways, rather than an additive effect of the phenotypes. 
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Previously, neuronal differentiation and proliferation in the NT were studied in Splotch mice, 
as Pax3 mutation was reported to affect the proliferation-differentiation balance (Keller-Peck 
and Mullen, 1997). Canonical Wnt signalling is reported as having a similar role (Miyake et al., 
2012; Xie et al., 2011), so it is possible that the effects of β-catenin GOF are mediated through 
these same processes. It would be expected that β-catenin GOF-mediated upregulation of 
canonical Wnt signalling could therefore increase proliferation and decrease differentiation, as 
this effect has been reported previously (Miyake et al., 2012; Xie et al., 2011). However, spina 
bifida, and potentially exencephaly in Sp2H/Sp2H embryos is likely to be caused by a reduction in 
proliferation in the NT (Chapter 3), and β-catenin GOF worsens NTDs in Pax3 mutant embryos 
(Figures  4.7 and 4.8). Therefore, it appears likely that β-catenin GOF is not rescuing the 
proliferation defect in the NTs of Pax3 mutant embryos, but may still affect it.  
Proliferation was studied in the Pax3-expressing dorsal regions of the cranial NT. Results were 
compared between Pax3+/- β-catenin+/+ and Pax3Cre/+ β-cateninGOF/+ embryos, and between 
Pax3Sp2H/Cre β-catenin+/+ and Pax3Sp2H/Cre β-cateninGOF/+ embryos in order to determine how β-
catenin GOF affects NT proliferation (Figure 4.9). However, no significant differences in the 
rates of proliferation were seen between any of the genotypes, including Pax3+/+ β-catenin+/+ 
and Pax3Sp2H/Cre β-catenin+/+ embryos. 
A significant difference in proliferation in the dorsal spinal NT was observed when comparing 
+/+ and Sp2H/Sp2H embryos, as the dorso-ventral gradient of proliferation is lost in Sp2H/Sp2H 
embryos at the 14-15 somite stage (see section 3.1.2.4, Figure 3.11). Therefore, it is possible 
that a similar difference exists between genotypes in the cranial region, but that higher 
numbers of samples would be needed to detect differences in the rate of proliferation 
between genotypes. Alternatively, the differences between the results could be due to 
differences in the genetic background of the mice used in the study – embryos used in the 
study described in section 3.1.2.4 were generated through a Sp2H/+ x Sp2H/+ cross, and were on 
a CBA genetic background. On the other hand, embryos used in the cranial proliferation study 
described in this chapter were generating using the cross Pax3Sp2H/+ β-cateninGOF/+ x Pax3Cre/+ β-
catenin+/+, and were on a C57 genetic background. The different genetic backgrounds may 
affect the rate of proliferation observed in mutant embryos. It is also possible that the lack of 
difference between proliferation in Pax3+/+ β-catenin+/+ and Pax3Sp2H/Cre β-catenin+/+ embryos 
suggests that although proliferation is abnormal and may underlie NTDs in the spinal NT, it 
might not be a factor in the cranial region. 
On the other hand, β-catenin GOF has only a minor exacerbating effect on the closure of the 
PNP in Pax3+/- or Pax3Sp2H/Cre embryos. β-catenin GOF causes a significant increase in the size of 
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the PNP when compared to embryos of equivalent Pax3 genotype but without β-catenin GOF 
(Figure 4.6). However, this difference does not occur until a slightly later stage of NT closure – 
the 18-19 or 20-21 somite stages for Pax3Sp2H/Cre and Pax3+/- respectively – when PNP closure is 
already delayed in embryos carrying the Pax3 mutation compared with wild type embryos. 
Additionally, there are no significant differences in the frequency of spina bifida when 
comparing Pax3+/- β-catenin+/+ to Pax3Cre/+ β-cateninGOF/+ embryos, and Pax3Sp2H/Cre β-catenin+/+ 
to Pax3Sp2H/Cre β-cateninGOF/+ embryos (Figure 4.7). This suggests that β-catenin GOF may delay 
closure, but does not prevent it from occurring. 
Premature neuronal differentiation is not present in the spinal NT of Sp2H/Sp2H embryos. 
However, this does not preclude the phenotype being present in embryos with β-catenin GOF, 
and potentially contributing to NTD development. Nonetheless, no significant differences were 
seen in the level of neuronal differentiation between genotypes (Figure 4.10 and 4.11). 
Therefore it appears unlikely that β-catenin GOF induces neuronal differentiation, and such a 
mechanism is unlikely to cause spinal NTDs. 
The data in Tables 4.2 and 4.3 suggest that Pax3Sp2H/Cre β-cateninGOF/+ embryos have higher 
numbers of cells in cross-sections of the NT compared to Pax3+/+ β-catenin+/+ embryos. 
However, since this is also apparent in Pax3Sp2H/Cre β-catenin+/+ embryos, which do not carry the 
β-cateninGOF allele, this is unlikely to be due to abnormalities in canonical Wnt signalling. It is 
possible that this is an artefact of sectioning, and differences in the angle of sectioning affect 
the size of the NT and number of cells observed in each section. No differences were observed 
in mitotic index in the cranial region between genotypes. Nonetheless, the antibody used to 
calculate mitotic index – against phospho histone h3 – labels cells in G2/M phase. This 
indicates that the proportion of cells in G2/M phase is unchanged in mutant embryos. 
However, it is possible that proliferation could be increased by a reduction in the length of S or 
G2 phase during the cell cycle. This could be studied using immunohistochemistry with both 
anti-phospho histone H3 and the antibody Ki-67, which labels cells in all active phases of the 
cell cycle. Therefore, cells in S or G2 phase would be Ki-67 positive, but phospho histone H3 
negative. It is also possible that proliferation was increased in the mutant embryos prior to the 
stage of study, but had reduced to normal levels by the 13-15 somite stage. Proliferation 
studies using embryos from earlier stages of development, such as the 9-11 somite stage, 
could provide more information about this. 
4.2.3    β-catenin gain-of-function and neural crest defects 
Although this research initially focussed on the development of NTDs, a secondary aim was to 
determine whether there may be an interaction between Pax3 and canonical Wnt signalling. 
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Given the observed effects of β-catenin GOF on NTDs, there are two possible explanations; 
firstly, β-catenin GOF in the NT may exacerbate the deleterious effect of Pax3 mutation. This 
could be due to interaction in a downstream mechanism, or possibly more than one, which 
summate to give the observed phenotype. Secondly, there may be a more direct interaction in 
which of the pathways is able to influence the activity of the other. To aid in determining the 
nature of the interaction, the effect of β-catenin GOF was studied in another Pax3-positive 
tissue in addition to the NT – the NC. 
A more severe phenotype was observed in the NTs of Pax3Sp2H/Cre β-cateninGOF/+ embryos when 
compared to Pax3Sp2H/Cre β-catenin+/+ embryos, and in Pax3Cre/+ β-cateninGOF/+ embryos when 
compared to Pax3+/- β-catenin+/+ embryos (Figures 4.7 and 4.8). Therefore, the NC were 
studied to determine what effect Pax3 and β-catenin mutations have on the developing NC 
and the NC derivatives in compound mutant embryos. 
ErbB3 was used as a marker for NC, and its expression was studied in embryos of different 
genotypes between 18 and 30+ somites (Figure 4.12). The Tuj1 antibody was also used as a 
neuronal marker in embryos of a similar somite stage to study the effect of β-catenin GOF on 
the development of the NC-derived PNS (Figure 4.13). In combination these assays provide 
information about the neuronal specification of the NC. 
Pax3Sp2H/Cre β-catenin+/+ embryos show weaker ErbB3 expression. However, expression is 
present in all the appropriate tissues, and rudimentary DRG are present. This result is 
corroborated by Tuj1 immunohistochemistry. However, when comparing Pax3+/- β-catenin+/+ 
to Pax3Cre/+ β-cateninGOF/+ embryos, and Pax3Sp2H/Cre β-catenin+/+ to Pax3Sp2H/Cre β-cateninGOF/+ 
embryos, differences are apparent, which are due to β-catenin GOF. 
Both Pax3Cre/+ β-cateninGOF/+ and Pax3Sp2H/Cre β-cateninGOF/+ embryos show some ErbB3 
expression in developing DRG until the 24-26 somite stage. However, in Pax3Sp2H/Cre β-
cateninGOF/+ embryos the segmental pattern of expression is less well defined, and expression 
is much fainter than in wild type embryos. Tuj1 immunohistochemistry suggests that neuronal 
differentiation in the spinal region at this stage resembles wild type, although the vagus nerve 
is less developed in both genotypes. Unlike the other genotypes, at the 30+ somite stage ErbB3 
expression is no longer visible in the spinal region of Pax3Cre/+ β-cateninGOF/+ and Pax3Sp2H/Cre β-
cateninGOF/+ embryos. Tuj1 immunohistochemistry shows that some neurons differentiate in 
this region, but are less numerous than in wild types, and segmentation of the DRG is less 
clear. Additionally, these genotypes continue to show abnormalities in the developing vagus 
nerve, and absent expression of ErbB3 in the trigeminal ganglia. Evidence suggests that these 
abnormalities are due to β-catenin GOF, rather than the Pax3 mutation alone. However, the 
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phenotype of Pax3Sp2H/Cre β-cateninGOF/+ embryos is consistently more abnormal than Pax3Cre/+ 
β-cateninGOF/+ embryos, suggesting that Pax3 mutation still affects the phenotype in embryos 
with β-catenin GOF. 
The mutant phenotypes seen in Pax3Cre/+ β-cateninGOF/+ and Pax3Sp2H/Cre β-cateninGOF/+ embryos 
could potentially be caused by a number of abnormal mechanisms. The NC appear to migrate 
normally, as ErbB3 expression is present in the appropriate regions in embryos with β-catenin 
GOF at the 18-20 somite stage (Figure 4.12). However, compared to wild type, expression in 
Pax3Sp2H/Cre β-cateninGOF/+ embryos appears to be weaker and both Pax3Cre/+ β-cateninGOF/+ and 
Pax3Sp2H/Cre β-cateninGOF/+ embryos appear to form fewer neurons in the DRG, which could 
suggest that fewer NC cells have been specified. This theory is supported by the abnormal 
development of the vagus nerve, and the failure of ErbB3 expression in the trigeminal ganglia, 
as it is possible that both of these abnormalities could be caused by insufficient population of 
the appropriate regions by NC. 
Alternatively, the mutant phenotypes seen in embryos with β-catenin GOF could be caused by 
excess apoptosis of the NC following migration. This could explain the progressive loss of ErbB3 
expression, and also the reduction in neuronal differentiation observed in Pax3Cre/+ β-
cateninGOF/+ and Pax3Sp2H/Cre β-cateninGOF/+ embryos. 
Another possible explanation could be premature differentiation of the spinal NC in embryos 
with β-catenin GOF. This would cause the cells to stop expressing ErbB3, and could also explain 
the lower numbers of differentiating neurons in Pax3Cre/+ β-cateninGOF/+ and Pax3Sp2H/Cre β-
cateninGOF/+ embryos, as early differentiation would prematurely halt proliferation. 
Pax3+/+ β-catenin+/+ and Pax3+/- β-catenin+/+ embryos show an unbroken line of spinal NC 
specification delineated by FoxD3 expression at the 7-9 and 10-11 somite stages (Figure 4.17). 
In contrast, FoxD3 expression was not detectable in the spinal region of Pax3Sp2H/Cre β-catenin+/+ 
embryos at these stages. As ErbB3 expression is seen at later stages of development, this 
would suggest that NC specification is delayed in these mutant embryos, which may result in 
fewer NC cells being specified. Pax3Cre/+ β-cateninGOF/+ embryos show a broken line of FoxD3 
expression. This suggests that although the initial specification does not appear to be delayed, 
the process may occur at a slower rate in these embryos. Therefore, fewer NC cells may be 
specified, as the environment may not be as conducive to specification at the later stage. For 
example, the morphogen gradients may change, resulting in altered environmental cues, or 
expression of ECM proteins may be less favourable to NC specification at the slightly later 
stages. Pax3Sp2H/Cre β-cateninGOF/+ embryos also show reduced FoxD3 expression in the spine 
between the 7 and 11 somite stages, which again suggests a delay and/or failure of 
229 
 
specification. On the other hand, fewer cells may be competent to respond to specification 
signals, and thus fewer NC cells are specified. It would be interesting to observe NC 
specification through FoxD3 in situ hybridisation in embryos of a lower somite stage, for 
example the 5-6 somite stage. This would enable observation of the initial specification of the 
NC in Pax3+/+ β-catenin+/+ embryos, and would allow comparison of this point between the 
genotypes.  
It is well documented that Splotch mice have a reduced population of NC, and it has often 
been attributed to a failure of NC migration, either through intrinsic or environmental 
mechanisms (Auerbach, 1954; Chan et al., 2004; Conway et al., 1997b; Henderson et al., 1997; 
Serbedzija and McMahon, 1997). It is likely that a NC migration defect is present in the Splotch 
mouse. Research has indicated that Pax3 may influence expression of both ECM proteins, such 
as Matrix metalloproteinase 14, Fibronectin, and Laminin A, and also intracellular proteins, 
such as Doublecortin and Claudin13, which act on cell migration and adhesion (Wang et al., 
2007). Therefore, Pax3 is likely to play a role in both intracellular and environmental control of 
NC migration. However, research has shown that migration defects are unlikely to be the sole 
cause of NC defects seen in Sp2H/Sp2H mice. For example, other studies have suggested that 
reduced expansion of the NC population prior to migration is the cause of the defects (Conway 
et al., 2000). This data fits the findings of this study, but could potentially also be interpreted 
as a reduction in NC specification. Therefore it seems likely that NC cells in Sp2H/Sp2H mice 
either fail to proliferate pre-migration, or that fewer are initially specified. This may be due to 
a delay in the initiation of NC specification. 
On the other hand, NC in Pax3Cre/+ β-cateninGOF/+ embryos appear to be specified at the 
appropriate time, but in fewer numbers, or the expansion of the NC population is reduced 
(Figure 4.17). The lack of NC specification in Pax3Sp2H/Cre β-cateninGOF/+ embryos is likely to be 
caused by a combination of β-catenin GOF and Pax3 mutant NC defects; delayed specification, 
reduced specification, or a reduction in pre-migratory NC proliferation, or some combination 
of these. Study of NC specification at slightly older somite stages could indicate when it begins 
in Pax3Sp2H/Cre β-catenin+/+ and Pax3Sp2H/Cre β-cateninGOF/+ embryos; for example by in situ 
hybridisation for FoxD3 at the 13-15 and 16-18 somite stages. This could provide more 
information about the timing of specification and numbers of specified cells. 
Apoptosis was studied through TUNEL staining in embryos of various genotypes between 22 
and 30+ somites (Figures 4.14, 4.15 and 4.16). In Pax3Sp2H/Cre β-catenin+/+ at the 30+ somite 
stage, there is an apparent reduction in the characteristic pattern of apoptosis in regions 
containing high numbers of NC. This is interesting given the smaller population of NC in these 
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embryos. The reduction in apoptosis at the 30+ somite stage could be a reflection of the 
reduced abundance of NC. Alternatively, the TUNEL-positive cells may not be NC, and may be 
cells from other tissues. This could be assessed by using TUNEL staining in combination with an 
antibody to mark NC, such as anti-FoxD3 or anti-ErbB3. Sections of the NT following TUNEL 
staining could also be useful in quantifying the apoptosis present. It would also be interesting 
to study NC from Splotch embryos in vitro to observe rates and proportions of apoptosis. 
Pax3Cre/+ β-cateninGOF/+ embryos show similar patterns of apoptosis to wild type embryos at the  
22-24 and 27-29 somite stages, but by the 30+ somite stage they exhibit a generalised increase 
in apoptosis, in particular in a pattern  corresponding to the DRGs. At the 27-29 somite stage, 
Pax3Sp2H/Cre β-cateninGOF/+ embryos show a slight reduction in apoptosis, but by the 30+ somite 
stage, apoptosis is similar or slightly elevated compared with wild type levels. These results 
could provide an explanation for the lack of ErbB3 expression in the spinal region at the 30+ 
somite stage: higher rates of apoptosis in this region could further reduce the size of the NC 
population, which is already diminished prior to migration. However, Tuj1 
immunohistochemistry shows that some of the NC survive to form neurons in this region. 
Therefore, the lack of ErbB3 expression cannot be completely explained by excess apoptosis of 
the NC. 
Markers of PNS differentiation were analysed to indicate whether subsequent PNS 
differentiation is likely to be affected. Ngn2 expression was used to study general neuronal 
differentiation (Sommer et al., 1996), and Brn3a was used as marker for sensory neurons 
specifically (Ninkina et al., 1993). Research suggests that Pax3 mutation causes premature 
neuronal differentiation, but prevents the differentiation of sensory neurons (Dude et al., 
2009). Therefore, it was of interest to determine the effect of Pax3 mutation in combination 
with β-catenin GOF. 
Ngn2 expression was studied fairly early during NT closure, at the 16-18 somite stage (Figure 
4.18). There did not appear to be any difference in expression pattern between genotypes. 
This was surprising, as Ngn2 is known to act downstream of Pax3 (Nakazaki et al., 2008). 
However, research has shown that Pax3 mutation affects Ngn2 expression at later stages of 
development (Nakazaki et al., 2008). Therefore it is possible that both Pax3 and canonical Wnt 
signalling may affect neurogenesis and Ngn2 expression at a later stage, but that the 16-18 
somite stage is too early to detect a difference. 
Brn3a expression was studied at a slightly later stage in development, at the 23-24 and 30+ 
somite stages (Figure 4.19). Pax3Sp2H/Cre β-catenin+/+ embryos appear to show reduced Brn3a 
expression compared with wild type, particularly in the spinal region. This may indicate a 
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reduced potential for differentiation, but most likely reflects reduction in the NC cell number. 
Pax3Sp2H/Cre β-cateninGOF/+ and Pax3Cre/+ β-cateninGOF/+ embryos also show this reduction in 
Brn3a expression. 
An interesting Brn3a expression pattern was observed in the cranial region of Pax3Cre/+ β-
cateninGOF/+ and Pax3Sp2H/Cre β-cateninGOF/+ embryos. Expression is not reduced in the cranial 
region, and an additional region of expression was observed above the pharyngeal arches and 
in the forebrain (Figure 4.19). These results suggest that β-catenin GOF causes an expansion of 
Brn3a expression in the cranial region. It appears likely that canonical Wnt signalling induces 
Brn3a expression in this region, and that overexpression of β-catenin results in an expansion of 
the Brn3a expression domain. It is interesting that Brn3a expression in Pax3Cre/+ β-cateninGOF/+ 
embryos is downregulated in the spinal region, but not the cranial region. This suggests that 
the canonical Wnt signalling pathway influences the differentiation of the NC differently in the 
cranial and spinal regions. 
Additionally, the region of Brn3a expression in the somites is expanded ventrally in Pax3Cre/+ β-
cateninGOF/+ and Pax3Sp2H/Cre β-cateninGOF/+ embryos compared to wild type (Figure 4.19). This 
suggests that β-catenin GOF either causes an expansion of the expression domain of Brn3a, or 
interferes with the formation of the dermomyotome, thus causing a generalised expansion of 
dermomyotome markers, including Brn3a. Research suggests that Wnt1 and Wnt3a expression 
in the NT may affect dermomyotome formation (Fan et al., 1997), so the overexpression of β-
catenin may interfere with this process. On the other hand, Pax3 has also been implicated in 
development of the dermomyotome (Goulding et al., 1994), and yet the faint Brn3a expression 
seen in the somites of Pax3Sp2H/Cre β-catenin+/+ embryos suggests that it is localised to the 
dorsal region. Analysis with other markers of the dermomyotome, such as Sim1, could provide 
more information (Fan et al., 1997). 
It is difficult to conclude whether β-catenin GOF has any effect on the differentiation of the NC 
population, either in timing or cell type generated. Both β-cateninGOF and Pax3 mutant alleles 
reduced the expression of Brn3a in differentiating NC. However, as it is also likely that they 
both decrease the size of the NC population, it is difficult to determine what causes the defects 
seen in these mice. Ngn2 expression studies of embryos at similar somite stages could allow a 
comparison between the number of differentiating neurons and the number of differentiating 
sensory neurons, which would allow the sensory neuronal differentiation to be observed as a 
proportion of overall neuronal differentiation. 
The most prominent NC defect seen in the embryos with β-catenin GOF is the premature 
disappearance of ErbB3 expression at 30+ somite stage (Figure 4.12). There is evidence that 
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this defect could be caused by reduced specification of NC cells, increased apoptosis, or 
premature differentiation, or some combination of these. The in vivo experiments described 
here are important, as they allow the study of each of these processes in the presence of 
surrounding tissues and signals which are likely to influence them. However, the reduced 
populations of NC make analysis difficult, as the relative amounts of each of these processes 
are awkward to study in vivo. Therefore in vitro studies of NC could prove very useful, as it 
would be possible to quantify the processes as a function of the size of the NC population. 
These experiments would allow the study of the rates of apoptosis in the NC of the different 
genotypes, as well as research into the timing and cell types of neuronal differentiation in 
these embryos. 
4.2.4    The effect of β-catenin gain-of-function on Pax3 expression 
Recent research suggests that canonical Wnt signalling may act upstream of Pax3 signalling 
during NT closure (Zhao et al., 2014). Therefore, RT-qPCR was used to quantify Pax3 expression 
in embryos of different genotypes to determine whether it was affected by β-catenin GOF. 
Primers which detect expression from the Pax3+ (wild type) and Pax3Cre alleles but not the 
Pax3Sp2H allele showed a significant reduction of Pax3 expression in embryos carrying the 
Pax3Sp2H allele (Figure 4.21A). Thus, expression was lower in Pax3Sp2H/Cre β-catenin+/+ and 
Pax3Sp2H/Cre β-cateninGOF/+ embryos compared with Pax3+/+ β-catenin+/+, Pax3Cre/+ β-catenin+/+ 
and Pax3Cre/+ β-cateninGOF/+ embryos. This difference was predicted although the magnitude of 
the loss of expression was greater than expected; the Pax3 expression of Pax3Sp2H/Cre β-
catenin+/+ embryos would be expected to be around 0.5 of wild type, when it is actually 0.32. 
This could suggest that the Pax3Cre mRNA is expressed at a lower level than wild type. This idea 
is supported by the fact that, while not statistically significant, there appeared to be lower 
Pax3 expression in Pax3Cre/+ β-catenin+/+ than Pax3+/+ β-catenin+/+ embryos. 
A second set of primers which amplify DNA from wild type and Pax3Sp2H alleles, but not the 
Pax3Cre allele showed an expected significant reduction in Pax3 expression in Pax3Cre/+ β-
catenin+/+ embryos when compared to Pax3+/+ β-catenin+/+ embryos (Figure 4.21B). In addition, 
Pax3Sp2H/Cre β-catenin+/+ embryos exhibited significantly lower Pax3 expression than Pax3Cre/+ β-
catenin+/+. These data suggests that Pax3Sp2H mRNA is expressed at a lower level than wild type 
Pax3 mRNA. 
Neither set of primers detected any significant differences in Pax3 expression between 
Pax3Cre/+ β-catenin+/+ and Pax3Cre/+ β-cateninGOF/+ embryos, or between Pax3Sp2H/Cre β-catenin+/+ 
and Pax3Sp2H/Cre β-cateninGOF/+ embryos. Therefore, β-catenin GOF does not appear to affect 
expression of Pax3. 
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It has been previously reported that β-catenin loss-of-function is able to downregulate the 
expression of Pax3 (Zhao et al., 2014). Therefore, it might have been expected that β-catenin 
GOF could upregulate Pax3 expression. However, this does not appear to be the case. This may 
be because β-catenin is not the limiting factor in the level of Pax3 expression. If this was the 
case, then upregulating β-catenin would not increase the expression of Pax3. Alternatively, it 
could be because the β-catenin GOF is only present in certain tissues of the embryo. Therefore, 
any effect this mutation would have on Pax3 expression will also only occur in these certain 
tissues, and may be undetectable using qPCR of the whole embryo. 
4.2.5    Conclusions 
Evidence in this chapter suggests that an interaction occurs between the Pax3 and canonical 
Wnt signalling pathways which causes compound mutations to affect the embryos differently 
compared to Pax3 or canonical Wnt mutations alone. For example, the compound mutant 
embryos have much higher frequencies of NTDs in comparison to the separate mutations. 
However, the nature of this interaction remains uncertain. Proliferation and neuronal 
differentiation in the cranial NT appear unchanged by both the Pax3 and β-cateninGOF 
mutations. The development of the NC is severely affected by the combination of the 
mutations, but the processes behind the defects are currently unclear. However, evidence 
suggests that the interaction between the pathways may affect multiple cellular mechanisms 
in the NC, including specification, proliferation, apoptosis and migration. Further studies, 
should clarify which defects are present, and their relative contributions to the development 
of the NT and NC defects.  
It is also unclear how β-catenin GOF affects the expression of Pax3. Previously described 
literature suggests that β-catenin GOF might upregulate Pax3 expression, but this was not 
detected. However, this does not necessarily mean that a change in expression does not occur. 
In order to provide balance to these studies, and to further examine the interaction between 
the Pax3 and canonical Wnt signalling pathways, it is also important to observe the effects of 
β-catenin loss-of-function. Abnormally low levels of canonical Wnt signalling is likely to affect 
the embryo differently to abnormally high levels, and may interact with Pax3 differently. 
Therefore, complementary experiments using embryos with β-catenin loss-of-function are 
described in Chapter 5 of this thesis. 
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5    Pax3 and β-Catenin Loss-of-Function 
5.1    Results 
Previous research has indicated the possibility of an interaction between Pax3 and the 
canonical Wnt signalling pathway. The two pathways play overlapping roles during 
development, as both are important in maintaining cells in an undifferentiated, proliferative 
state (Keller-Peck and Mullen, 1997; Megason and McMahon, 2002). In addition, both 
pathways are involved in the specification and development of the NC and NC-derived tissues 
(Bondurand et al., 2000; Conway et al., 1997b; Nakazaki et al., 2008; Saint-Jeannet et al., 1997; 
Shimizu et al., 2008). 
The interaction between Pax3 and the canonical Wnt signalling pathway could be direct, with 
one pathway affecting the expression of components of the other pathway. Published research 
suggests that this is possible, as β-catenin LOF has been shown to reduce the expression of 
Pax3 in the NT (Zhao et al., 2014). Additionally, studies have shown several genes encoding 
components of the canonical Wnt signalling pathway to be direct targets of Pax3 (Fenby et al., 
2008; Wang et al., 2007). 
Alternatively, the interaction between Pax3 and the canonical Wnt signalling pathway could be 
indirect, with the processes converging on a common mechanism or pathway. For example, 
both Pax3 and the canonical Wnt signalling pathway are known to act on Notch signalling to 
regulate the development of the NC and nervous system (De Bellard et al., 2002; Ma et al., 
1996; Nakazaki et al., 2008; Shimizu et al., 2008; Yun et al., 2002). In this case, the interaction 
would reflect a summation of the effects of Pax3 and the canonical Wnt signalling pathway. 
Both Pax3 and canonical Wnt signalling have important roles in the specification and 
development of the NC. Wnt1 and Wnt3a are involved in specification and proliferation 
(Dickinson et al., 1994; Ikeya et al., 1997; Saint-Jeannet et al., 1997), and Pax3 is important for 
specification, migration and differentiation of the NC (Auerbach, 1954; Conway et al., 1997a; 
Lang et al., 2000; Moase and Trasler, 1989). Pax3-induced NC development appears to be Wnt-
dependent, which may suggest interaction between the pathways during NC development 
(Monsoro-Burq et al., 2005; Sato et al., 2005). 
The aim of this study is to determine whether an interaction exists between Pax3 and the 
canonical Wnt signalling pathway, and if so, to determine the nature of the interaction. The 
hypothesis being tested is the same as that described in Chapter 4: interaction between Pax3  
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Figure 5.1: Punnet square demonstrating genotypes and ratios of offspring from the cross 
Pax3Sp2H/+ β-cateninLOF/+ x Pax3Cre/+ β-catenin+/-. The key represents the genotype groups used 
in the experiments described in this chapter. Colour coding demonstrates how the genotypes are 
distributed among the groups, as several genotypes have been pooled into the same genotype 
group (see Figures 5.4 and 5.5). 
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the canonical Wnt signalling pathway reduces proliferation and induces premature neuronal 
differentiation in the NT and NC, resulting in NTDs and NC defects. Two different genetic 
crosses were carried out to generate the embryos used for these results. The initial cross was 
Pax3Sp2H/+ β-cateninLOF/+ x Pax3Cre/+ β-catenin+/- (Figure 5.1), but due to and breeding problems 
the experiments were continued using embryos from the cross Pax3Sp2H/+ β-cateninLOF/+ x 
Pax3Cre/+ β-cateninLOF/+ (Figure 5.2). Figures 5.1 and 5.2 also provide information on genotype 
Figure 5.2: Punnet square demonstrating genotypes and ratios of offspring from the cross 
Pax3Sp2H/+ β-cateninLOF/+ x Pax3Cre/+ β-cateninLOF/+. The key represents the genotype groups used 
in the experiments described in this chapter. Colour coding demonstrates how the genotypes are 
distributed among the groups, as several genotypes have been pooled into the same genotype 
group (see Figure 5.3). 
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pooling (described below). Information in figure legends states which cross was used for the 
experiment described. 
Pax3+/- β-catenin+/+ has been used to denote either Pax3Cre/+ β-catenin+/+, Pax3Sp2H/+ β-
catenin+/+, Pax3Sp2H/+ β-cateninLOF/+, or Pax3Sp2H/+ β-cateninLOF/LOF. In the absence of Cre 
recombinase the β-cateninLOF allele is not recombined, and acts as a wild type β-catenin allele. 
Thus the genotypes listed above are functionally equivalent, and there are no significant 
differences in the rates of spina bifida or exencephaly between these genotypes (Figures 5.3, 
5.4 and 5.5, and Table 5.1). 
In addition, β-catenin+/- may refer to a single copy of the β-catenin-null allele, or it may refer to 
β-cateninLOF/+ if Cre recombinase is expressed (the β-cateninLOF allele has been recombined) or 
to β-cateninLOF/- if Cre is not present (one copy of β-catenin--, one un-recombined β-cateninLOF 
allele). These alleles are functionally equivalent in the Cre-expressing regions, and there are no 
significant differences in the rates of spina bifida or exencephaly between the genotypes 
(Figures 5.3, 5.4 and 5.5, and Table 5.1). 
Likewise, neither Pax3+/+ β-catenin+/+, Pax3+/+ β-cateninLOF/+, nor Pax3+/+ β-cateninLOF/LOF 
embryos have recombined β-cateninLOF alleles. They show no significant differences in rates of 
exencephaly or spina bifida (Figures 5.3, 5.4 and 5.5, and Table 5.1), and so have been pooled 
as ‘wild type’ embryos. They will be referred to as Pax3+/+ β-catenin+/+ embryos in these results. 
5.1.1    Verification of the decrease in canonical Wnt signalling caused by the β-
catenin loss-of-function allele 
As with the β-cateninGOF allele, the β-cateninLOF allele has previously been generated and 
examined (Brault et al., 2001). However, the effects of this allele were further verified in the 
embryos used for this research. 
A probe which identified Axin2 mRNA was used in whole mount in situ hybridisation as a 
marker to indicate levels of canonical Wnt signalling. Embryos were compared with different 
Pax3 genotypes, and carrying two, one or no mutant copies of the β-catenin allele. 
Embryos which carried one or no β-catenin mutant alleles showed the same expression 
patterns of Axin2, suggesting a wild type level of canonical Wnt signalling. However, embryos 
with two mutant β-catenin alleles – Pax3Cre/+ β-cateninLOF/- and Pax3Sp2H/Cre β-cateninLOF/- 
embryos – show reduced expression of Axin2. This suggests reduced canonical Wnt signalling 
(Figure 5.6). 
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Figure 5.3: Pooling of embryo genotypes from the cross Pax3Sp2H/+ β-cateninLOF/+ x Pax3Cre/+ 
β-cateninLOF/+. Several genotypes were pooled in experiments due to similar expression levels of wild 
type Pax3 and β-catenin, and to similar frequencies of exencephaly and spina bifida. Experimental 
litters were generated containing a mixture of genotypes through the cross Pax3
Sp2H/+
 β-catenin
LOF/+
 x 
Pax3
Cre/+
 β-catenin
LOF/+
. Exencephaly was defined as an open cranial NT at the 18 somite stage or later. 
Spina bifida was defined as an open spinal NT at the 30 somite stage or later. 
The frequencies of exencephaly and spina bifida were compared between Pax3
+/+
 β-catenin
+/+
, Pax3
+/+
 
β-catenin
LOF/+
 and Pax3
+/+
 β-catenin
LOF/LOF
 embryos (A and C), as these embryos have wild type Pax3 
and wild type or unfloxed β-catenin. No significant differences were found in the frequencies of the 
NTDs, so these embryos are pooled in experiments as Pax3
+/+
 β-catenin
+/+
 embryos. 
The frequencies of exencephaly and spina bifida were compared between Pax3
Sp2H/+
 β-catenin
+/+
, 
Pax3
Sp2H/+
 β-catenin
LOF/+
, Pax3
Sp2H/+
 β-catenin
LOF/LOF
, and Pax3
Cre/+
 β-catenin
+/+
 embryos (B and D), as 
these embryos have heterozygous expression of Pax3, and wild type or unfloxed β-catenin. No 
significant differences were found in the frequencies of the NTDs, so these embryos are pooled in 
experiments as Pax3
+/-
 β-catenin
+/+
 embryos. 
Significance was assessed using the Fisher Exact Test. 
A – Pax3
+/+
 β-catenin
+/+
  : n = 16. Pax3
+/+
 β-catenin
LOF/+
 : n = 38. Pax3
+/+
 β-catenin
LOF/LOF
 : n = 13. B – 
Pax3
Sp2H/+
 β-catenin
+/+
 : n = 25. Pax3
Sp2H/+
 β-catenin
LOF/+
 : n = 34. Pax3
Sp2H/+
 β-catenin
LOF/LOF
 : n = 14. 
Pax3
Cre/+
 β-catenin
+/+
 : n = 9. C – Pax3
+/+
 β-catenin
+/+
  : n = 9. Pax3
+/+
 β-catenin
LOF/+
 : n = 19. Pax3
+/+
 β-
catenin
LOF/LOF
 : n = 7. D – Pax3
Sp2H/+
 β-catenin
+/+
 : n = 12. Pax3
Sp2H/+
 β-catenin
LOF/+
 : n = 22. Pax3
Sp2H/+
 β-
catenin
LOF/LOF
 : n = 4. Pax3
Cre/+
 β-catenin
+/+
 : n = 4. 
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Figure 5.4: Pooling of embryo genotypes from the cross Pax3Sp2H/+ β-cateninLOF/+ x Pax3Cre/+ 
β-catenin+/- - exencephaly. Several genotypes were pooled in experiments due to similar 
expression levels of wild type Pax3 and β-catenin, and to similar frequencies of exencephaly and spina 
bifida. Experimental litters were generated containing a mixture of genotypes through the cross 
Pax3
Sp2H/+
 β-catenin
LOF/+
 x Pax3
Cre/+
 β-catenin
+/-
. Exencephaly was defined as an open cranial NT at the 
18 somite stage or later. 
The frequency of exencephaly was compared between Pax3
+/+
 β-catenin
+/+
 and Pax3
+/+
 β-catenin
LOF/+
 
embryos (A), as these embryos have wild type Pax3 and wild type or unfloxed β-catenin. No significant 
differences were found in the frequencies of the NTD, so these embryos are pooled in experiments as 
Pax3
+/+
 β-catenin
+/+
 embryos. The frequency of exencephaly was also compared between Pax3
+/+
 β-
catenin
+/-
 and Pax3
+/+
 β-catenin
LOF/-
 embryos (B), as these genotypes have wild type expression of Pax3 
and one null allele of β-catenin. No significant differences were found in the frequencies of the NTD, 
so these embryos are pooled in experiments as Pax3
+/+
 β-catenin
+/-
 embryos. 
The frequency of exencephaly was compared between Pax3
Sp2H/+
 β-catenin
+/+
, Pax3
Sp2H/+
 β-catenin
LOF/+
, 
and Pax3
Cre/+
 β-catenin
+/+
 embryos (C), as these embryos have heterozygous expression of Pax3, and 
wild type or unfloxed β-catenin. No significant differences were found in the frequencies of the NTD, 
so these embryos are pooled in experiments as Pax3
+/-
 β-catenin
+/+
 embryos. The frequency of 
exencephaly was also compared between Pax3
Cre/+
 β-catenin
LOF/+
, Pax3
Cre/+
 β-catenin
+/-
, Pax3
Sp2H/+
 β-
catenin
+/-
, and Pax3
Sp2H/+
 β-catenin
LOF/-
 embryos (D), as these genotypes have one mutant allele of 
Pax3 and one null allele of β-catenin. No significant differences were found in the frequencies of the 
NTD, so these embryos are pooled in experiments as Pax3
+/-
 β-catenin
+/-
 embryos. 
Significance was assessed using the Fisher Exact Test. 
A - Pax3
+/+
 β-catenin
+/+
: n = 19. Pax3
+/+
 β-catenin
LOF/+
: n = 15. B – Pax3
+/+
 β-catenin
+/-
: n = 19. Pax3
+/+
 β-
catenin
LOF/-
: n = 15. C – Pax3
Cre/+
 β-catenin
+/+
: n = 14. Pax3
Sp2H/+
 β-catenin
+/+
: n = 11. Pax3
Sp2H/+
 β-
catenin
LOF/+
: n = 17. D – Pax3
Cre/+
 β-catenin
LOF/+
: n = 10. Pax3
Cre/+
 β-catenin
+/-
: n = 15. Pax3
Sp2H/+
 β-
catenin
+/-
: n = 17. Pax3
Sp2H/+
 β-catenin
LOF/-
: n = 19. 
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Figure 5.5: Pooling of embryo genotypes from the cross Pax3Sp2H/+ β-cateninLOF/+ x Pax3Cre/+ 
β-catenin+/- - spina bifida. Several genotypes were pooled in experiments due to similar expression 
levels of wild type Pax3 and β-catenin, and to similar frequencies of exencephaly and spina bifida. 
Experimental litters were generated containing a mixture of genotypes through the cross Pax3
Sp2H/+
 β-
catenin
LOF/+
 x Pax3
Cre/+
 β-catenin
+/-
. Spina bifida was defined as an open spinal NT at the 30 somite 
stage or later. 
The frequency of spina bifida was compared between Pax3
+/+
 β-catenin
+/+
 and Pax3
+/+
 β-catenin
LOF/+
 
embryos (A), as these embryos have wild type Pax3 and wild type or unfloxed β-catenin. No significant 
differences were found in the frequencies of the NTD, so these embryos are pooled in experiments as 
Pax3
+/+
 β-catenin
+/+
 embryos. The frequency of spina bifida was also compared between Pax3
+/+
 β-
catenin
+/-
 and Pax3
+/+
 β-catenin
LOF/-
 embryos (B), as these genotypes have wild type expression of Pax3 
and one null allele of β-catenin. No significant differences were found in the frequencies of the NTD, 
so these embryos are pooled in experiments as Pax3
+/+
 β-catenin
+/-
 embryos. 
The frequency of spina bifida was compared between Pax3
Sp2H/+
 β-catenin
+/+
, Pax3
Sp2H/+
 β-catenin
LOF/+
, 
and Pax3
Cre/+
 β-catenin
+/+
 embryos (C), as these embryos have heterozygous expression of Pax3, and 
wild type or unfloxed β-catenin. No significant differences were found in the frequencies of the NTD, 
so these embryos are pooled in experiments as Pax3
+/-
 β-catenin
+/+
 embryos. The frequency of spina 
bifida was also compared between Pax3
Cre/+
 β-catenin
LOF/+
, Pax3
Cre/+
 β-catenin
+/-
, Pax3
Sp2H/+
 β-catenin
+/-
, 
and Pax3
Sp2H/+
 β-catenin
LOF/-
 embryos (D), as these genotypes have one mutant allele of Pax3 and one 
null allele of β-catenin. No significant differences were found in the frequencies of the NTD, so these 
embryos are pooled in experiments as Pax3
+/-
 β-catenin
+/-
 embryos. 
Significance was assessed using the Fisher Exact Test. 
A - Pax3
+/+
 β-catenin
+/+
: n = 2. Pax3
+/+
 β-catenin
LOF/+
: n = 5. B – Pax3
+/+
 β-catenin
+/-
: n = 5. Pax3
+/+
 β-
catenin
LOF/-
: n = 6. C – Pax3
Cre/+
 β-catenin
+/+
: n = 4. Pax3
Sp2H/+
 β-catenin
+/+
: n = 6. Pax3
Sp2H/+
 β-
catenin
LOF/+
: n = 7. D – Pax3
Cre/+
 β-catenin
LOF/+
: n = 3. Pax3
Cre/+
 β-catenin
+/-
: n = 5. Pax3
Sp2H/+
 β-catenin
+/-
: 
n = 4. Pax3
Sp2H/+
 β-catenin
LOF/-
: n = 4. 
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RT-qPCR was used as a quantitative measure of downstream targets of canonical Wnt 
signalling in the embryos used for this research. The genes Cdx2 and Axin2 were used to 
measure the levels of canonical Wnt signalling. The gene GAPDH was used as a housekeeping 
gene for normalisation for both Cdx2 and Axin2. In addition, Axin2 expression was measured 
using β-actin as a housekeeping gene for normalisation to ensure that results were not due to 
differences in GAPDH expression between genotypes. 
No significant differences were seen in expression levels of Cdx2 or Axin2 between the 
genotypes (Figure 5.7). This does not necessarily show that β-catenin LOF does not cause 
reduced canonical Wnt signalling, as the β-cateninLOF allele is only recombined in Pax3-
expressing tissues. Therefore, the reduction in canonical Wnt signalling will only be present in 
certain tissues, including the NT and NC. RT-qPCR of whole embryos may not be sensitive 
enough to detect the reduction in expression of downstream targets. 
5.1.2    The effect of β-catenin loss-of-function on the development of neural tube 
defects in the Pax3 mutant embryo 
β-catenin GOF appears to have a significant effect on the development of NTDs in Pax3 
heterozygous and mutant mice (Chapter 4). Therefore, the effects of β-catenin LOF in Pax3 
mutant mice were also examined. 
5.1.2.1    β-catenin loss-of-function may delay spinal neurulation in Pax3 heterozygous 
mutant embryos 
The closure of the PNP was studied to observe whether β-catenin LOF has an effect on spinal 
neurulation. Data in this analysis has been pooled from two separate genetic crosses: 
Pax3Sp2H/+ β-cateninLOF/+ x Pax3Cre/+ β-catenin+/- and Pax3Sp2H/+ β-cateninLOF/+ x Pax3Cre/+ β-
cateninLOF/+ (Figure 5.8). In Figure 5.9, which displays this data, mutant Pax3 alleles have all 
been designated Pax3--, and mutant β-catenin alleles have all been designated β-catenin--. This 
is to demonstrate, in a simplified manner, how the data has been pooled. No significant 
differences in NTD frequency which could affect the data when pooled were detected between 
embryos of equivalent Pax3 and β-catenin genotype from different crosses (Table 5.1). 
As expected, significant differences were seen between embryos with equivalent β-catenin 
genotypes but different Pax3 genotypes; Pax3 mutant embryos have larger PNPs from an early 
somite stage, consistent with previous data (section 3.1.1.1). However, the β-catenin genotype 
appears to have little effect on PNP size in early somite stages; embryos with equivalent Pax3 
genotype but different β-catenin genotypes show similarly sized PNPs. However, a significant 
increase in PNP size is seen in Pax3+/- β-catenin-/- embryos in comparison to Pax3+/- β-catenin+/+  
248 
 
 Figure 5.7: RT-qPCR was unable to determine if β-catenin loss-of-function reduces the level 
of canonical Wnt signalling. Experimental litters were generated containing a mixture of genotypes 
through the cross Pax3
Sp2H/+
 β-catenin
LOF/+
 x Pax3
Cre/+
 β-catenin
LOF/+
. RT-qPCR was carried out using 
RNA prepared from whole embryos at the 23-24 somite stage. 
Graph A shows results for the gene Cdx2 using GAPDH as an endogenous gene. No significant 
differences are seen between genotypes. Graphs B and C show data for Axin2; graph B shows data 
using GAPDH as the endogenous gene, and graph C shows data using β-actin as the endogenous gene. 
No significant differences in gene expression are seen between the genotypes in either of these 
graphs. 
Significance was assessed using one-way ANOVA. Error bars indicate standard error. 
Pax3
+/+
 β-catenin
+/+
: n = 3. Pax3
Cre/+
 β-catenin
+/+
: n = 3. Pax3
Cre/+
 β-catenin
LOF/LOF
: n = 2. Pax3
Sp2H/Cre
 β-
catenin
+/+
: n = 3. Pax3
Sp2H/Cre
 β-catenin
LOF/+
: n = 3. Pax3
Sp2H/Cre
 β-catenin
LOF/LOF
: n = 3. 
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Figure 5.8: Punnet squares demonstrating the pooling of genotypes of offspring from the 
crosses Pax3Sp2H/+ β-cateninLOF/+ x Pax3Cre/+ β-cateninLOF/+ (A) and Pax3Sp2H/+ β-cateninLOF/+ x 
Pax3Cre/+ β-catenin+/- (B). The key represents the genotype groups used in Figure 5.11. Colour 
coding demonstrates how the genotypes are distributed among the groups, as several genotypes 
have been pooled into the same genotype group (see Table 5.1). 
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embryos at 24-26 somite stage (Figure 5.9). This could indicate that β-catenin LOF delays PNP 
closure in Pax3 heterozygous mutant embryos. 
The frequency of spina bifida has also been studied in embryos generated by the cross 
Pax3Sp2H/+ β-cateninLOF/+ x Pax3Cre/+ β-cateninLOF/+ (Figure 5.10). This allows observation of the 
long-term effects of β-catenin LOF on spinal neurulation. β-catenin LOF did not affect the 
frequency of spina bifida in Pax3 mutant embryos. However, a significant increase in the 
frequency of spina bifida is seen in Pax3Cre/+ β-cateninLOF/LOF embryos compared to Pax3+/- β-
catenin+/+ embryos, suggesting that β-catenin LOF affects spinal neurulation in Pax3 
heterozygous embryos. 
5.1.2.2    β-catenin loss-of-function may decrease the frequency of exencephaly in Pax3 
mutant embryos 
Cranial NT closure was studied to observe whether β-catenin LOF affects cranial neurulation 
(Figure 5.11). No significant differences in the frequency of exencephaly were observed 
between genotypes. However, the frequency in Pax3Sp2H/Cre β-cateninLOF/LOF embryos is 13%, 
compared to 45% in Pax3Sp2H/Cre β-catenin+/+ embryos. This reduction suggests that β-catenin 
LOF may rescue the exencephaly seen in Pax3 mutant mice. Proportion sample size calculation 
suggests that a sample size of 36 per genotype would be required to produce a significant 
difference. 
5.1.2.3    The β-catenin loss-of-function phenotype 
β-catenin LOF alters the phenotype of Pax3 mutant embryos (Figure 5.12). Pax3Sp2H/Cre β-
cateninLOF/LOF embryos frequently have spina bifida, but exencephaly appears to be less 
common in Pax3Sp2H/Cre β-cateninLOF/LOF embryos than in Pax3Sp2H/Cre β-catenin+/+ embryos. In 
Pax3Sp2H/Cre β-cateninLOF/LOF embryos which have a closed cranial NT, the cranial region may 
appear slightly misshapen, and haemorrhage is common in both the cranial NT and the spinal 
NT (Figure 5.12C). Reduced canonical Wnt signalling in the CNS has been previously shown to 
cause haemorrhage and abnormalities in angiogenesis (Daneman et al., 2009). Therefore, the 
haemorrhage seen in Pax3Sp2H/Cre β-cateninLOF/LOF may be due to the reduction in canonical Wnt 
signalling affecting angiogenesis, rather than an interaction between Pax3 and the canonical 
Wnt signalling pathway. 
The phenotype of Pax3Sp2H/Cre β-cateninLOF/+ embryos resembles that of Pax3Sp2H/Cre β-catenin+/+ 
embryos. This suggests that one copy of wild type β-catenin is able to compensate for β-
catenin LOF in the NT. 
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5.1.2.4    An inhibitor of Wnt signalling has no effect on the frequency of exencephaly in 
cultured Pax3 mutant embryos 
The aim of this experiment was to chemically inhibit canonical Wnt signalling to investigate 
whether reduced Wnt signalling has an effect on the development of exencephaly in Splotch 
embryos. The inhibitor XAV939 was used in embryo culture to achieve the knock-down of 
canonical Wnt signalling during NT closure. 
Xav939 inhibits canonical Wnt signalling through the stabilisation of Axin, which promotes β-
catenin degradation (see section 1.6.2). The enzymes tankyrase 1 and tankyrase 2 bind and 
promote the degradation of Axin. XAV939 stabilises Axin by inhibiting the activity of the 
tankyrase enzymes (Huang et al., 2009). 
Figure 5.12: Phenotype of a Pax3Sp2H/Cre β-cateninLOF/LOF embryo. This image shows a Pax3+/+ 
β-catenin
+/+
 embryo for reference (A), a typical Pax3
Sp2H/Cre
 β-catenin
+/+
 embryo (B), and a typical 
Pax3
Sp2H/Cre
 β-catenin
LOF/LOF
 embryo (C). All embryos are at E10.5 All genotypes were generated 
through the cross Pax3
Sp2H/+
 β-catenin
LOF/+
 x Pax3
Cre/+
 β-catenin
LOF/+
. Scale bars indicate 500 μm. 
The arrowhead indicates the cranial NT, which is open in the Pax3
Sp2H/Cre
 β-catenin
+/+
 embryo (B) and 
closed in the Pax3
+/+
 β-catenin
+/+
 (A) and Pax3
Sp2H/Cre
 β-catenin
LOF/LOF
 embryos (C). The arrow 
indicates the spinal NT, which is closed in the Pax3+/+ β-catenin+/+ embryo (A), but open in both the 
Pax3
Sp2H/Cre
 β-catenin
+/+
 (B) and Pax3
Sp2H/Cre
 β-catenin
LOF/LOF
 (C) embryos. The asterisk indicates 
haemorrhage in the hindbrain, forebrain and spinal NT of the Pax3
Sp2H/Cre
 β-catenin
LOF/LOF
 embryo (B). 
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Embryos were cultured in concentrations of 25 μM and 100 μM XAV939, to estimate a 
threshold concentration above which the inhibitor causes generalised toxic effects. These toxic 
effects included stunted growth of the tail bud, exencephaly, tailbud externalised from the 
yolk sac, reduced yolk sac circulation, small somites, and failure of the embryos to turn during 
development. Control embryos were cultured in an equivalent concentration of vehicle 
(DMSO). At 100 μM XAV939 all the embryos (9/9) showed severe abnormalities caused by 
generalised toxicity. At 25 μM XAV939 17/30 embryos still showed abnormalities due to 
generalised toxicity. Therefore, further tests were carried out to further refine the dose 
required. Cultures were carried out using doses of 5 μM, 10 μM, 15 μM and 20 μM XAV939. 
Abnormalities were seen in 2/3 embryos at 20 μM, 1/3 embryos at 15 μM, 0/4 at 10 μM, and 
2/4 embryos at 5 μM. Although abnormalities were seen at 5 μM Xav939, it is possible that 
these were due to suboptimal culture conditions, rather than toxic effects from the inhibitor. A 
concentration of 10 μM XAV939 was chosen for use in embryo culture, as this was the highest 
concentration tested which produced no generalised toxic effects. 
XAV939 had no effect on the development of exencephaly in Splotch embryos. A very similar 
proportion of Sp2H/Sp2H embryos developed exencephaly in inhibitor culture as in the control 
culture (Figure 5.13). 
In order to determine if the lack of phenotypic difference was a genuine effect or could be due 
to lack of Wnt inhibition, Sp2H/+ embryos were assessed for inhibition of canonical Wnt 
signalling as a result of culture in XAV939, compared to culture in vehicle. In situ hybridisation 
was used to detect Axin2 expression, but no differences were identified between culture 
conditions (Figure 5.14A and B). Relative expressions of the genes Axin2 and Cdx2 were also 
analysed by RT-qPCR, but there were no significant differences in the expression level of either 
gene when comparing culture conditions (Figure 5.14C and D). 
5.1.3    The effect of β-catenin loss-of-function on the development of the neural 
crest in Pax3 mutant embryos 
The effect of β-catenin GOF on NC development and differentiation was studied in detail in the 
previous chapter (see section 4.1.7). Therefore, study of β-catenin LOF was performed on the 
NC for comparison. The effects of β-catenin LOF have been reported previously in the NC using 
Wnt1-Cre (Brault et al., 2001). A study using Pax3-Cre could provide information about the 
effect of suppressing β-catenin function in the Pax3 expression domain in comparison to the 
Wnt1 expression domain, enabling comparison of the roles of β-catenin at different 
developmental times and in slightly different regions. It also enables study of potential 
interactions of β-catenin LOF with Pax3 heterozygosity. 
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Figure 5.13: Culture of Splotch embryos with XAV939 does not affect the frequency of 
exencephaly. Experimental litters were generated containing a mixture of genotypes through 
intercross of Sp
2H
/+ embryos. Embryos were cultured through the period of NT closure in the 
presence of either canonical Wnt inhibitor (XAV939) at 10μM concentration, or vehicle (DMSO) at an 
equivalent concentration. Exencephaly was defined as an open cranial NT at the 18 somite stage or 
later. 
No significant differences were observed in the frequency of exencephaly when comparing culture 
conditions within a genotype. None of the +/+ or Sp
2H
/+ embryos developed exencephaly in either 
culture condition, and very similar proportions of Sp
2H
/Sp
2H
 embryos developed exencephaly in 
vehicle and inhibitor culture conditions. 
Significance was assessed using the Fisher Exact Test. 
DMSO – +/+: n = 4. Sp
2H
/+: n = 11. Sp
2H
/Sp
2H
: n = 8. XAV939 – +/+: n = 3. Sp
2H
/+: n = 16. Sp
2H
/Sp
2H
: n = 
7. 
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Figure 5.14: Culture in 10 µM XAV939 has no detectable effect on canonical Wnt 
signalling. Experimental litters were generated containing a mixture of genotypes through the cross 
Sp
2H
/Sp
2H
 x Sp
2H
/Sp
2H
. Whole mount in situ hybridisation for Axin2 was carried out on Sp
2H
/+ 
embryos at the 21-26 somite stage (A and B). RT-qPCR was carried out on Sp
2H
/+ embryos at the 24-
28 somite stage (C and D). Scale bars represent 500 μm. 
No differences in the expression of Axin2 were detected using in situ hybridisation (A and B) when 
comparing embryos which have undergone treatment with vehicle (DMSO, A) or inhibitor (10 μM 
XAV939, B). DMSO: n = 3. XAV939: n = 4. 
RT-qPCR was carried out on whole embryo RNA preparations using the genes Axin2 and Cdx2 as 
indicators of canonical Wnt signalling levels (C and D) (n = 4). GAPDH was used as the housekeeping 
gene for normalisation. No significant differences were detected in relative expression levels of 
either Axin2 (C) or Cdx2 (D) between embryos which have undergone treatment with vehicle or 
inhibitor. n = 4 per condition. 
Significance was assessed using the t-test. Error bars indicate standard error. 
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ErbB3 expression was used as a marker for the NC (Figure 5.15). Study of embryos at the 30+ 
somite stage showed that Pax3Sp2H/Cre β-catenin+/+ embryos had weaker expression throughout 
the embryo compared to Pax3+/+ β-catenin+/+ embryos. However, β-catenin LOF resulted in the 
absence of ErbB3 expression in the trigeminal ganglia and the vagus nerve. Additionally, 
expression in the DRG was much reduced in Pax3Cre/+ β-cateninLOF/LOF embryos compared with 
Pax3+/+ β-catenin+/+ and Pax3Cre/+ β-catenin+/+ embryos, and was absent in Pax3Sp2H/Cre β-
cateninLOF/LOF embryos. 
5.1.4    Pax3 signalling is reduced by β-catenin loss-of-function 
As discussed in the previous chapter, evidence has suggested that canonical Wnt signalling 
may act upstream of Pax3 signalling (Zhao et al., 2014). Therefore, expression levels of Pax3 
were studied to determine whether they were influenced by β-catenin LOF (Figure 5.16). RT-
qPCR was carried out using two different sets of primers to amplify the Pax3 gene. Only 
Pax3Cre/+ β-catenin+/+ embryos were used as Pax3 heterozygotes to eliminate the chance of 
error caused by possible differences in expression between the Pax3Cre and Pax3Sp2H alleles, 
and because the primer pairs used are only able to detect one of the two alleles. 
Pax3 primer pair 1 detects Pax3+ and Pax3Cre, but not Pax3Sp2H (as previously described in 
section 4.1.8). As would be expected, there is no difference in Pax3 expression between 
Pax3+/+ β-catenin+/+ and Pax3Cre/+ β-catenin+/+ embryos, and Pax3Sp2H/Cre β-catenin+/+ embryos 
show a significant reduction in Pax3 expression when compared to Pax3+/+ β-catenin+/+ 
embryos (Figure 5.16A). However, there is also a significant reduction in Pax3 expression of 
Pax3Cre/+ β-cateninLOF/LOF embryos compared to Pax3Cre/+ β-catenin+/+ embryos, which is 
attributable to the presence of the β-cateninLOF allele. There is also a reduction in Pax3Sp2H/Cre β-
cateninLOF/LOF embryos compared to Pax3Sp2H/Cre β-catenin+/+ embryos, although this difference 
does not reach significance. Together these data suggest that β-catenin LOF causes 
downregulation of Pax3 expression. 
Pax3 primer pair 2 detects Pax3+ and Pax3Sp2H, but not Pax3Cre (as previously described in 
section 4.1.8). As would be expected, there is a significant reduction in Pax3 expression in 
Pax3Sp2H/Cre β-catenin+/+ embryos when compared to Pax3+/+ β-catenin+/+ embryos (Figure 
5.16B). However, a significant reduction in Pax3 expression would be expected in Pax3Cre/+ β-
catenin+/+ embryos compared to Pax3+/+ β-catenin+/+ embryos, but this was not observed, 
although a small reduction in expression is apparent. There is significantly decreased Pax3 
expression in Pax3Cre/+ β-cateninLOF/LOF embryos compared to Pax3Cre/+ β-catenin+/+ embryos. 
Interestingly, the data from the β-catenin GOF cross shows that Pax3Cre/+ β-catenin+/+ embryos 
have around half the Pax3 expression of Pax3+/+ β-catenin+/+ embryos shown by RT-qPCR with  
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Figure 5.16: β-catenin loss-of-function reduces Pax3 expression levels. Experimental litters 
were generated containing a mixture of genotypes through the cross Pax3
Sp2H/+
 β-catenin
LOF/+
 x 
Pax3
Cre/+
 β-catenin
LOF/+
. RT-qPCR was carried out on embryos of multiple genotypes at the 23-24 
somite stage. * indicates significant difference from Pax3
+/+
 β-catenin
+/+
, and # indicates statistical 
significance from Pax3
Cre/+
 β-catenin
+/+
. 
Graph A shows RT-qPCR results using Pax3 primer pair 1 which detects Pax3
+
 and Pax3
Cre
, but not 
Pax3
Sp2H
. A significant reduction in Pax3 expression is seen in Pax3
Cre/+
 β-catenin
LOF/LOF
, Pax3
Sp2H/Cre
 β-
catenin
+/+
, Pax3
Sp2H/Cre
 β-catenin
LOF/+
, and Pax3
Sp2H/Cre
 β-catenin
LOF/LOF
 embryos when compared to 
Pax3
+/+
 β-catenin
+/+
 embryos. A significant reduction is also seen in Pax3
Cre/+
 β-catenin
LOF/LOF
 embryos 
when compared to Pax3
Cre/+
 β-catenin
+/+
 embryos. There is also a reduction in Pax3 expression in 
Pax3
Sp2H/Cre
 β-catenin
LOF/LOF
 embryos when compared to Pax3
Sp2H/Cre
 β-catenin
+/+
 embryos, but this 
difference does not reach statistical significance. 
Graph B shows RT-qPCR results using Pax3 primer pair 2 which detects Pax3
+
 and Pax3
Sp2H
, but not 
Pax3
Cre
. A significant reduction in Pax3 expression is seen in Pax3
Cre/+
 β-catenin
LOF/LOF
, Pax3
Sp2H/Cre
 β-
catenin
+/+
, Pax3
Sp2H/Cre
 β-catenin
LOF/+
, and Pax3
Sp2H/Cre
 β-catenin
LOF/LOF
 embryos when compared to 
Pax3
+/+
 β-catenin
+/+
 embryos. A significant reduction is also seen in Pax3
Cre/+
 β-catenin
LOF/LOF
 embryos 
when compared to Pax3
Cre/+
 β-catenin
+/+
 embryos. There is a reduction in Pax3 expression in 
Pax3
Sp2H/Cre
 β-catenin
LOF/LOF
 embryos when compared to Pax3
Sp2H/Cre
 β-catenin
+/+
 embryos, but this 
difference does not reach statistical significance. 
*/# p < 0.05. Significance compared to Pax3
+/+
 β-catenin
+/+
 was determined using one way ANOVA 
followed by the Holm Sidak test. Pairwise significance was determined using the t-test. Only 
significance between relevant data is shown. Error bars show standard error. 
Pax3
+/+
 β-catenin
+/+
: n = 3. Pax3
Cre/+
 β-catenin
+/+
: n = 3. Pax3
Cre/+
 β-catenin
LOF/LOF
: n = 2. Pax3
Sp2H/Cre
 β-
catenin
+/+
: n = 3. Pax3
Sp2H/Cre
 β-catenin
LOF/+
: n = 3. Pax3
Sp2H/Cre
 β-catenin
LOF/LOF
: n = 3.  
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Pax3 primer pair 2. When the data is normalised to Pax3+/+ β-catenin+/+ embryos from the 
relevant genetic cross, comparing Pax3Cre/+ β-catenin+/+ embryos from the β-catenin GOF and 
LOF crosses shows a significant difference in Pax3 expression (Figure 5.17). This could be due 
to slight differences in genetic background, or could be due to random variation. 
 
Figure 5.17: Pax3Cre/+ β-catenin+/+ embryos from two different genetic crosses have 
significantly different expression levels of Pax3. GOF refers to embryos from the cross 
Pax3
Sp2H/+
 β-catenin
GOF/+
 x Pax3
Cre/+
 β-catenin
+/+
, and LOF refers to embryos from the cross Pax3
Sp2H/+
 
β-catenin
LOF/+
 x Pax3
Cre/+
 β-catenin
LOF/+
. RT-qPCR was carried out on 23-24 somite stage Pax3
Cre/+
 β-
catenin
+/+
 embryos using RNA prepared from whole embryos. GAPDH was used as a housekeeping 
gene for normalisation, and Pax3 primer pair 2 was used to determine relative Pax3 expression. 
Pax3 expression for embryos within each cross was normalised using Pax3 expression of wild type 
embryos from the same cross. n = 3 for each group. 
A significant decrease in Pax3 expression is seen when comparing Pax3
Cre/+
 β-catenin
+/+
 embryos 
from the cross Pax3
Sp2H/+
 β-catenin
GOF/+
 x Pax3
Cre/+
 β-catenin
+/+
 to embryos of the same genotype 
from the cross Pax3
Sp2H/+
 β-catenin
LOF/+
 x Pax3
Cre/+
 β-catenin
LOF/+
. 
** p < 0.01. Significance was calculated using the t-test. Error bars show standard error. 
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5.2    Discussion 
5.2.1    The β-catenin Loss-of-Function allele 
The β-catenin LOF allele used in this research was first developed and described by the Kemler 
lab (Brault et al., 2001). 
As discussed previously (see section 1.6.3.2) β-catenin is known to play a role in adherens 
junctions in addition to canonical Wnt signalling. Therefore it is possible that β-catenin LOF 
affects both functions, and not just the canonical Wnt signalling pathway. Again, study of the 
adherens junctions themselves could provide information about the integrity and density of 
the junctions in tissues with β-catenin LOF. 
Two different genetic crosses were used for study of embryos with β-catenin LOF. The initial 
cross carried out was Pax3Sp2H/+ β-cateninLOF/+ x Pax3Cre/+ β-catenin+/-. However, the mice used 
for this cross did not breed well, and had small litters. Therefore, the cross was changed to 
Pax3Sp2H/+ β-cateninLOF/+ x Pax3Cre/+ β-cateninLOF/+. The mice used for this cross bred better and 
had larger litters. Mice carrying the β-cateninLOF/+ allele had the same genetic background as 
mice carrying the β-catenin+/- allele (see section 2.4.2), so there was no change in genetic 
background in the new cross. However, it is possible that the difference in allele use could give 
slightly different results. Figure legends give information about which genetic cross was used 
for the experiments. The majority of the experiments use the second genetic cross described 
here. The embryos of both crosses were pooled for Figure 5.9, as analysis showed no 
significant differences in the rates of NTDs between embryos from the different crosses (see 
Table 5.1). However, sample numbers are relatively low, so it is possible that differences in the 
rates of NTDs would be evident with larger samples. This pooling was not ideal, but it allowed 
for more thorough analysis of the existing data. 
In addition, genotypes were pooled within the crosses for experiments (see introduction to 
Chapter 5 Results, section 5.1). Again, the data showed no significant differences between 
genotypes within the pooled groups, although again it is possible that differences would have 
been found with larger sample sizes. Ideally, pooling would not have been necessary. 
However, this pooling allowed for better analysis of existing data. On the other hand, it should 
be considered that the pooling could possibly affect the results seen in this thesis. 
As previously discussed in section 4.2.1, the Pax3Cre allele and the Pax3Sp2H allele are carried on 
different genetic backgrounds, which could create variations in modifier genes in the offspring. 
As mentioned, the consistency of the described results suggests that this isn’t having a 
significant effect, but it should be considered when interpreting the data. 
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5.2.2    β-catenin loss-of-function and neural tube defects 
The effect of β-catenin LOF has been previously studied in the neural tube using a Wnt1-Cre 
line (Brault et al., 2001). Wnt1 is expressed in a similar domain of the NT to Pax3; both are 
expressed in the dorsal region, although Pax3 expression may extend slightly more ventrally in 
the NT (Megason and McMahon, 2002). However, Wnt1Cre/+ β-cateninLOF/LOF embryos did not 
develop NTDs. This suggests that β-catenin LOF alone does not cause NTDs. Conversely, β-
catenin LOF appears to have an effect on NTD development when in combination with Pax3 
mutation. 
β-catenin LOF does not appear to affect the frequency of spinal NTDs in wild type or Pax3 
mutant embryos, but greatly increases the frequency of spina bifida in Pax3 heterozygous 
mutant embryos (Figure 5.10). Pax3 heterozygotes do not usually develop spina bifida, but 
have demonstrated vulnerability to cranial NTD development in comparison to wild type 
embryos. For example, folate deficiency increases the frequency of exencephaly in Pax3 
heterozygous embryos (see section 3.1.3.1) (Burren et al., 2008). Additionally, Pax3 
heterozygous embryos are highly susceptible to β-catenin GOF-induced exencephaly (see 
section 4.1.3.2). It appears that Pax3 heterozygous embryos are also vulnerable to spinal NTDs 
under specific conditions, such as β-catenin LOF. Pax3+/- β-catenin-/- embryos have significantly 
increased PNP size in comparison to Pax3+/- β-catenin+/+ embryos at the 24-26 somite stage, 
and a significantly higher proportion of these embryos develop spina bifida at later stages of 
development (Figures 5.9 and 5.10). Pax3+/+ and Pax3Sp2H/Cre embryos show no such increase in 
spinal NTD development in response to β-catenin LOF. However, Pax3Sp2H/Cre embryos have 
100% frequency of spina bifida without β-catenin LOF, so no further increase is possible. This 
data suggests that although β-catenin LOF in the NT does not in itself cause spina bifida, as 
demonstrated in Wnt1Cre/+ β-cateninLOF/LOF embryos (Megason and McMahon, 2002), it is able 
to induce spinal NTD development in embryos which are vulnerable due to Pax3 
heterozygosity. 
β-catenin LOF has a very different effect on closure of the cranial NT. Although the differences 
did not reach significance, a clear trend was visible which suggests that β-catenin LOF 
decreases the frequency of exencephaly in Pax3Sp2H/Cre embryos; Pax3Sp2H/Cre β-catenin+/+ 
embryos showed a frequency of 45%, whereas Pax3Sp2H/Cre β-cateninLOF/LOF embryos had a 
frequency of 13% (Figure 5.11). This is strong evidence for an interaction between Pax3 and 
canonical Wnt signalling; generalised developmental abnormalities may worsen an existing 
defect, but a rescue effect suggests a more specific interaction. 
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Evidence suggests that canonical Wnt signalling induces Pax3 expression (Zhao et al., 2014). 
Therefore, it would be logical to assume that β-catenin LOF would compromise expression of 
Pax3. However, Pax3Sp2H/Cre embryos are already Pax3-null. Therefore, it appears that β-catenin 
LOF is able to compensate for the loss of Pax3 in the cranial region. This could be through a 
mechanism such as increased proliferation, or delayed neuronal differentiation, which could 
offset defects previously observed in the cranial regions of Sp2H/Sp2H embryos (Greene et al., 
unpublished data). It is also possible that the deleterious effects of Pax3 mutation are 
dependent on an intact canonical Wnt signalling pathway. This would place Pax3 both up- and 
down-stream of the canonical Wnt signalling pathway. 
The aim of Splotch embryo culture with the canonical Wnt inhibitor XAV939 was to determine 
if chemically reducing canonical Wnt signalling could rescue exencephaly in the mutant 
embryos. The inhibitor was found to have no effect on the development of exencephaly in any 
of the genotypes studied (Figure 5.13). 
This lack of effect could be because the inhibitor did not affect NT closure, or it could be 
because the inhibitor failed to downregulate canonical Wnt signalling. Therefore, Sp2H/+ 
embryos were assessed for Axin2 expression using in situ hybridisation and RT-qPCR, and Cdx2 
expression was assessed using RT-qPCR (Figure 5.14). No differences were observed in the 
expression of either of these genes using any method. In the original paper it was reported 
that XAV939 increased the protein levels but not mRNA levels of Axin (Huang et al., 2009). This 
could explain why no difference was seen in Axin2 expression. However, if Axin2 protein was 
upregulated, a downregulation of Cdx2 would be expected. Cdx2 has not proven to be an 
especially good marker for canonical Wnt activity, but the embryo-wide downregulation 
should result in reduced Cdx2 expression. 
These results suggest that XAV939 did not successfully downregulate canonical Wnt signalling 
in Splotch embryos. This could be for a number of reasons. For example, the concentration 
used may have been too low. The 10 μM concentration was chosen for its lack of a generalised 
toxic effect, but this may have meant that the concentration was too low to sufficiently inhibit 
canonical Wnt signalling. Alternatively, the inhibitor may have degraded prior to use, or may 
degrade quickly in embryo culture. Therefore, XAV939 may not be the best choice of canonical 
Wnt signalling inhibitor for use in embryo culture. Better results may be gained by using an 
alternative inhibitor. For example PMED-1 inhibits canonical Wnt signalling by reducing β-
catenin binding to CREB (cAMP response element-binding protein), which is a component of 
the core transcriptional machinery of the cell. This has been used to inhibit signalling in 
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zebrafish embryos (Delgado et al., 2014). Alternatively, BASI alters the transcription of several 
microRNA molecules which mediate posttranscriptional β-catenin silencing (Shi et al., 2014). 
5.2.3    β-catenin loss-of-function and neural crest defects 
Given the rescue effect of β-catenin LOF on cranial NT closure in Splotch embryos, NC 
development was studied to observe if defects were also rescued in this system. However, β-
catenin LOF appeared to worsen the NC defects observed in Pax3Sp2H/Cre embryos. 
Pax3Sp2H/Cre β-catenin+/+ embryos show reduced ErbB3 expression throughout the embryos, but 
the vagus nerve, trigeminal ganglia and DRG all show expression, and appear to be developing 
to some degree (Figure 5.15). Pax3Sp2H/Cre β-cateninLOF/+ embryos show similar ErbB3 expression 
to Pax3Sp2H/Cre β-catenin+/+ embryos, which suggests that a single copy of wild type β-catenin is 
able to compensate for β-catenin LOF. However, both Pax3Cre/+ β-cateninLOF/LOF and Pax3Sp2H/Cre 
β-cateninLOF/LOF embryos appear to show severe NC defects; both genotypes lack ErbB3 
expression in the vagus nerve and the trigeminal ganglia, which could indicate that these 
structures are not developing. Additionally, Pax3Cre/+ β-cateninLOF/LOF embryos show weak spinal 
ErbB3 expression in the DRG (although segmentation is clearly evident), and Pax3Sp2H/Cre β-
cateninLOF/LOF embryos show no expression in the DRG. Again, this suggests that these 
structures may have formed improperly, or not at all. These data suggest that canonical Wnt 
signalling is necessary for correct development of several NC-derived tissues, including the 
DRG, trigeminal ganglia and the vagus nerve. 
Further research into the specification, migration and differentiation of the NC could provide a 
more complete picture of the role of β-catenin in the NC. FoxD3 in situ hybridisation early in 
NC specification could provide insight into its role in early NC development, and Tuj1 antibody 
staining alongside Brn3a and Ngn2 in situ hybridisation could give more information about the 
fate of these cells. Additionally, TUNEL staining would provide data on survival of the NC cells.  
Evidence so far suggests that deletion of genes involved in canonical Wnt signalling results in 
the specification of fewer NC cells, and thus abnormal development of NC derivatives (Ikeya et 
al., 1997). It would be interesting to observe the more localised effects of β-catenin 
downregulation in the NT and NC enabled by conditional LOF and Pax3Cre. 
As mentioned previously, research has previously been carried out in which the conditional β-
cateninLOF allele was combined with Wnt1Cre (Brault et al., 2001). Wnt1 has a similar expression 
pattern to Pax3 in the NT and NC (Brault et al., 2001; Megason and McMahon, 2002). 
Therefore, Wnt1Cre/+ β-cateninLOF/LOF embryos will have reduced β-catenin expression in a 
similar region to Pax3Cre/+ β-cateninLOF/LOF embryos. However, Wnt1Cre/+ β-cateninLOF/LOF embryos 
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have more severe CNS and NC defects in comparison to Pax3Cre/+ β-cateninLOF/LOF embryos 
described in this thesis. Wnt1Cre/+ β-cateninLOF/LOF embryos failed to develop craniofacial 
structures and the forebrain, midbrain and hindbrain were all grossly abnormal. Greatly 
increased apoptosis was also visible in the cranial region (Brault et al., 2001). On the other 
hand, Pax3Cre/+ β-cateninLOF/LOF embryos show far fewer cranial defects.  
These differences could be caused by a number of factors. For example, Wnt1 may be 
expressed slightly earlier in NC and NT development than Pax3, as canonical Wnt signalling is 
involved in the specification of these cells, whilst Pax3 is expressed in the specified cells 
(Monsoro-Burq et al., 2005; Saint-Jeannet et al., 1997; Wilson et al., 2001). A small change in 
the timing of expression could be crucial during NC specification. Additionally, small changes in 
the region or level of expression could also be crucial. Therefore, the differences in phenotype 
between Wnt1Cre/+ β-cateninLOF/LOF and Pax3Cre/+ β-cateninLOF/LOF embryos indicate a greater 
influence of Wnt1 than Pax3 in the development of the cranial NC, or it could indicate that 
slightly earlier canonical Wnt signalling has a greater effect on craniofacial development. 
5.2.4    The effects of β-catenin loss-of-function on Pax3 expression 
Recent research suggests that canonical Wnt signalling may act upstream of Pax3 signalling 
during NT closure (Zhao et al., 2014). RT-qPCR was used to quantify Pax3 expression in 
embryos of different genotypes to determine whether it was affected by β-catenin LOF (Figure 
5.16). 
Two different primer pairs were used which distinguished between the Pax3Cre and Pax3Sp2H 
alleles (see section 4.1.8). RT-qPCR using these primer pairs largely gave the expected results 
when comparing between embryos with wild type β-catenin. However, the data agrees with 
the findings from the β-cateninGOF allele (section 4.1.8) that the Pax3Cre allele appears to have 
slightly lower expression levels than Pax3+. 
Pax3 primer pair 1, which detects Pax3+ and Pax3Cre, but not Pax3Sp2H, detects some very 
interesting results when comparing Pax3 genotypes with or without β-catenin LOF. Pax3Cre/+ β-
cateninLOF/LOF embryos have significantly reduced Pax3 expression in comparison to Pax3Cre/+ β-
catenin+/+ embryos. Additionally, Pax3Sp2H/Cre β-cateninLOF/LOF embryos have reduced expression 
of Pax3 in comparison to Pax3Sp2H/Cre β-catenin+/+ embryos, although this difference does not 
reach significance. These data suggest that β-catenin signalling increases expression of Pax3. 
Interestingly, Pax3Sp2H/Cre β-cateninLOF/+ embryos have very similar levels of Pax3 expression to 
Pax3Sp2H/Cre β-catenin+/+ embryos, which suggests that one copy of wild type β-catenin is able to 
compensate for the β-catenin LOF caused by a single copy of the recombined β-cateninLOF 
allele. 
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Pax3 primer pair 2 detects Pax3+ and Pax3Sp2H, but not Pax3Cre. As expected using this primer 
pair Pax3Sp2H/Cre β-catenin+/+ embryos have a significantly reduced Pax3 expression of around 
half that of Pax3+/+ β-catenin+/+ embryos. However, it would be expected for Pax3Cre/+ β-
catenin+/+ embryos to have a similar reduction, but the relative expression level of these 
embryos is 0.82. This could be an indication of Pax3 compensation through autoregulation, if 
the Pax3+ allele were upregulated to compensate for loss of Pax3 expression due to the Pax3Cre 
allele. On the other hand, the data from the β-catenin GOF cross shows that Pax3Cre/+ β-
catenin+/+ embryos have around half the Pax3 expression of Pax3+/+ β-catenin+/+ embryos 
shown by RT-qPCR with Pax3 primer pair 2 (see section 4.1.8). Indeed, when normalised to 
Pax3+/+ β-catenin+/+ embryos from the relevant genetic cross, comparing Pax3Cre/+ β-catenin+/+ 
embryos from the β-catenin GOF and LOF crosses shows a significant difference in Pax3 
expression (Figure 5.17). This suggests that the higher-than-expected expression shown by 
Pax3Cre/+ β-catenin+/+ embryos in the β-catenin LOF cross could be due to slight differences in 
genetic background, or could be due to random variation. However, it is unlikely to be due to 
autoregulation. 
RT-qPCR data from Pax3 primer pair 2 shows similar results to Pax3 primer pair 1 regarding the 
effects of β-catenin LOF; Pax3Cre/+ β-cateninLOF/LOF embryos have significantly reduced Pax3 
expressed compared to Pax3Cre/+ β-catenin+/+ embryos, and Pax3Sp2H/Cre β-cateninLOF/LOF embryos 
have lower expression than Pax3Sp2H/Cre β-catenin+/+ embryos, although this difference doesn’t 
reach significance. Again, these data suggest that β-catenin increases Pax3 expression. 
Additionally, Pax3 primer pair 2 shows that Pax3Sp2H/Cre β-cateninLOF/+ and Pax3Sp2H/Cre β-
catenin+/+ embryos have similar expression levels of Pax3, which suggests that one copy of β-
catenin+ is able to compensate for β-catenin LOF caused by a single copy of the recombined β-
cateninLOF allele. 
In summary, both previously published findings (Zhao et al., 2014) and the research described 
in this chapter suggest that β-catenin is necessary for upregulation of Pax3 expression. This 
could have implications for the findings described above, which suggest that β-catenin LOF 
both increases the frequency of spinal NTDs and worsens NC defects in Pax3 heterozygous 
embryos. It is possible that because β-catenin LOF results in downregulation of wild type Pax3 
expression, Pax3 heterozygous embryos with β-catenin LOF more closely resemble Pax3 
homozygous mutant embryos; the further reduction in Pax3 expression results in higher 
frequencies of defects associated with Pax3 mutation. 
Conversely, β-catenin LOF appears to rescue cranial NTDs in Pax3 mutant embryos. In the 
absence of Pax3 function β-catenin LOF in the cranial region may be able to compensate. This 
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could be through direct means, if β-catenin LOF affected the same mechanism which causes 
cranial NTDs in Pax3 mutant embryos. Alternatively, the rescue could occur through less direct 
means, such as a summation of the downstream effects of the Pax3 and β-catenin mutations. 
5.2.5    Conclusions 
Evidence discussed in this chapter supports data from Chapter 4 that an interaction occurs 
between Pax3 and the canonical Wnt signalling pathway, as β-catenin LOF may rescue Pax3-
induced cranial NTDs. 
However, the nature of this interaction still remains uncertain, and will take further 
experiments to decipher. Β-catenin LOF appears to affect similar cellular processes to β-
catenin GOF in Pax3 mutant embryos, including neuronal differentiation and the development 
of the NC. This suggests that β-catenin acts in a dose-dependent manner. However, as 
suggested before, in vitro analysis of the NC could clarify which processes are affected, and 
their relative contribution to NC defect development. Additionally, quantification of 
proliferation, apoptosis and neuronal differentiation in the NT could provide information on 
the processes involved in rescue of cranial NTDs. 
β-catenin LOF has been found to decrease expression of Pax3. This supports recently published 
findings (Zhao et al., 2014), and could provide an explanation for the worsening on spinal NTDs 
in Pax3 heterozygous embryos. However, the mechanism for the β-catenin LOF-induced rescue 
of cranial NTDs in Pax3 mutant embryos is unclear. Further study into cellular processes in the 
NTs of these embryos could shed light on the matter. 
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6    General Discussion 
The studies described in this thesis have investigated different aspects of the phenotype of 
Splotch (Pax3 mutant) embryos, with particular focus on the development of NTDs. The 
research was divided into two main areas; mechanisms underlying spinal NTDs in Splotch 
embryos (Chapter 3), and interaction between Pax3 and the canonical Wnt signalling pathway 
in NTDs (Chapters 4 and 5). An interaction was also observed between Pax3 and the canonical 
Wnt signalling pathway in NC development, and so this was explored further. 
Findings from the research on mechanisms of spina bifida development in Splotch embryos 
suggest that a reduction in proliferation in the NT may be causative. Morphological alterations 
were observed in the NT of Sp2H/Sp2H embryos, which could provide a connection between the 
reduction in proliferation and failure of NT closure. 
The overall findings of the research on potential interactions between Pax3 and canonical Wnt 
signalling does not support the hypothesis that a canonical Wnt signalling defect exists in 
Splotch embryos, as no differences were seen in the expression of downstream target genes of 
canonical Wnt signalling. However, β-catenin mutation did appear to alter the expression of 
Pax3. This suggests that canonical Wnt signalling acts upstream of Pax3, and recently 
published data supports this theory (Zhao et al., 2014). 
 
6.1    Neural tube defects 
NTDs are an extremely heterogeneous group of birth defects, which in humans are usually 
caused by a combination of environmental and genetic factors. This makes the prediction, 
prevention and study of NTDs very difficult, and few genes have been linked with human NTD 
development. 
Many different mouse models are available for studying NTDs. They have a wide range of 
mutations, which result in many different phenotypes, different NTDs, and different 
penetrance. A huge variety of cellular and morphological alterations have been found in these 
mice, which result in the development of NTDs (see section 1.2 for more information). In a few 
cases the genes responsible for NTDs in these models – such as AMT, SCRIB and CELSR1 – have 
been associated with development of NTDs in humans, suggesting that NTD-causing genes in 
mice may play a role in some human NTDs (Lei et al., 2013; Lei et al., 2014; Narisawa et al., 
2012). Other genes, including MTHFR, have been linked to NTDs in humans, but mice carrying 
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mutations in these genes do not develop NTDs (van der Put et al., 1995). For still other genes – 
such as Pax3 – the link with NTD development in humans is less clear (See section 1.5); 
evidence suggests that Pax3 is not a major causative gene for NTDs in humans, but variations 
and polymorphisms in Pax3 may contribute to human NTD development in some cases 
(Agopian et al., 2013; Chatkupt et al., 1995; Lu et al., 2007). These discrepancies may be due to 
differences between protein function in humans and mice, but also may be because NTD 
mouse models usually carry a single gene mutation, whereas human NTDs are generally 
thought to be multigenic. Human NTD patients may carry variations and mutations in multiple 
risk genes, which can make them difficult to identify. Additionally, many risk genes are not fully 
sequenced in human NTD cases, and the studies are often small scale. Therefore, it is not 
possible to draw firm conclusions about the genetics underlying human NTDs. 
Due to these difficulties, mouse models of NTDs are usually used as examples of cellular and 
morphological defects which can occur in NTDs, rather than genetic models of mutations 
which can cause NTDs in humans. Splotch mice are an example of this – Pax3 mutations, such 
as those found in Splotch mice, are not thought to be  major risk factors of human NTDs 
(Chatkupt et al., 1995). However, it is studied as an NTD model given the high frequency of 
NTDs in mutant embryos. Any defective cellular or morphological mechanisms which occur in 
these mice may be applicable to understanding the mechanistic basis of human NTDs. In 
addition, Splotch NTDs are preventable by folic acid, providing a model to examine the 
mechanisms involved in folate-induced rescue of human NTDs. 
The hypothesis used in this section of the research was: premature neuronal differentiation 
and reduced proliferation in the NT of the Splotch embryo cause spina bifida. The research 
described in this thesis suggests that Splotch mutant embryos have reduced proliferation in 
the dorsal region of the spinal NT, although they show no premature differentiation. I also 
found that Splotch embryos have altered morphology of the NT – the NT is smaller due to 
fewer cell numbers, but proportionally thicker than wild type embryos. It appears likely that 
the smaller size of the NT is caused by the reduced proliferation rate. It also seems plausible 
that these features have a causative role in the development of spina bifida in these mutant 
embryos. For example, it is likely that reduced proliferation in the neural folds of Splotch 
mutant embryos causes morphological differences, which in turn could cause spina bifida. 
Experiments which manipulate the rate of proliferation in the NT would allow for study of the 
NT morphology and NTD frequency in Splotch embryos, and may allow a causative relationship 
to be proved or disproved. For instance, given more time, I would like to culture Splotch 
embryos in anti-mitotic agents, such as Mitomycin. This would further reduce proliferation in 
the NT, and could provide information about the effect of the proliferation defect on the 
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morphology of the NT. It could also produce data on the effect of proliferation specifically on 
the development of NTDs. It would be especially interesting to observe if Sp2H/+ embryos 
develop NTDs after being treated with anti-mitotics. These embryos are more susceptible than 
+/+ embryos to developing NTDs, and treatment with anti-mitotics could be very informative 
about the role of proliferation in NT development. 
Both Pax3 and canonical Wnt signalling are associated with the maintenance of cells in a 
proliferative, multipotent state (Keller-Peck and Mullen, 1997; Megason and McMahon, 2002). 
Therefore, the loss of either of these pathways might be expected to have a similar effect on 
phenotype – loss of proliferation and potentially premature differentiation. Additionally, as 
discussed previously, spina bifida in Splotch embryos may be caused by reduced proliferation. 
The hypothesis for this research was: interaction between Pax3 and the canonical Wnt 
signalling pathway reduces proliferation and induces premature neuronal differentiation in the 
NT and NC, resulting in NTDs and NC defects. 
Consequently, the observation that β-catenin LOF rescued certain NTDs whereas β-catenin 
GOF worsened NTDs in Pax3 mutant embryos was the opposite of the expected results. The 
data described in this thesis has shown that mutations in canonical Wnt signalling alone cause 
NTDs only at a low frequency. Therefore the rescue effect suggests a more specific interaction 
between Pax3 and canonical Wnt signalling. 
Research published in 2014 highlighted the potential link between Pax3 and canonical Wnt 
signalling (Zhao et al., 2014). In this paper, β-catenin LOF was used in combination with Pax3Cre, 
as in the research described in Chapter 5 of this thesis. The researchers found that β-catenin 
LOF reduced the expression of Pax3 and Cdx2 using in situ hybridisation, and that both of 
these genes contained upstream Tcf/Lef1 binding activation sites. This suggests that the 
expression of both Pax3 and Cdx2 is directly induced by canonical Wnt signalling. Furthermore, 
expression of a Pax3 transgene was able to rescue spina bifida in embryos with β-catenin LOF, 
which suggests that NTDs in these embryos are mediated by an alteration in Pax3 expression. 
This paper supports the data found in this thesis which suggests a link between Pax3 and the 
canonical Wnt signalling pathways. It also corroborates the finding in Chapter 5 that Pax3 
expression is reduced in embryos with β-catenin LOF, although I was unable to replicate the 
effects of β-catenin LOF on Cdx2 expression. Additionally, the discovery of Tcf/Lef1 binding 
sites upstream of the Pax3 gene, and the effect of the Pax3 transgene are evidence of 
interaction between Pax3 and the canonical Wnt signalling pathway. 
In Chapter 5 of this thesis, β-catenin LOF was shown to reduce Pax3 expression, and yet it 
rescues exencephaly in Pax3 mutant embryos. In addition to a role upstream of Pax3, this data 
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suggests that canonical Wnt signalling may also act on a mechanism downstream of Pax3. Pax3 
expression does not affect canonical Wnt signalling, so this is not a direct interaction. 
However, the pathways may converge and act antagonistically on a particular cellular 
mechanism. 
My data suggests that β-catenin GOF does not affect proliferation or neuronal differentiation 
in the cranial NT. However, this does not preclude the possibility that β-catenin LOF may act on 
these pathways. For example, if canonical Wnt signalling were to inhibit proliferation, β-
catenin GOF may have no effect, but β-catenin LOF might. It is less likely that canonical Wnt 
signalling would promote neuronal differentiation, as it would be expected that β-catenin GOF 
would cause an increase in neuronal cell numbers, which was not observed. Cell counts of 
proliferating and differentiating cells in the cranial NT of embryos with β-catenin LOF could 
provide more information about these theories. 
However, it is unlikely that canonical Wnt signalling acts through inhibition of proliferation, as 
this is a mechanism which affects spinal NT closure, and β-catenin LOF has no rescue effect on 
spinal NT closure. Therefore, it is more likely that canonical Wnt signalling acts on a 
mechanism which is essential for cranial NT closure, but not spinal neurulation. Alternatively, 
there may be a difference in requirement for β-catenin in proliferation between the cranial 
and spinal regions of the NT. Furthermore, spina bifida occurs at a higher frequency than 
exencephaly in Splotch mutant embryos. Thus spina bifida could be more resistant to rescue 
than exencephaly. 
Both β-catenin GOF and β-catenin LOF appear to affect the frequency of exencephaly more 
profoundly than the frequency of spina bifida in Pax3 mutant and heterozygous embryos. This 
supports the evidence that canonical Wnt signalling affects different processes in the cranial 
and spinal NTs. Research has shown that different mechanisms are employed in the closure of 
these two distinct regions (Massa et al., 2009; Ybot-Gonzalez and Copp, 1999). Therefore, it is 
probable that canonical Wnt signalling interacts with one of these differential mechanisms, 
thus affecting the regions very differently. 
It was shown that the actin cytoskeleton is essential for cranial, but not spinal, neurulation 
(Ybot-Gonzalez and Copp, 1999). Previous research has demonstrated interactions between 
canonical Wnt signalling and the actin cytoskeleton. For example, canonical Wnt signalling may 
have a role in wound healing by initiating an increase in α-actin-positive stress fibre formation 
(Carthy et al., 2011). Therefore it is possible that disrupted canonical Wnt signalling may affect 
the actin cytoskeleton formation enough to induce exencephaly in vulnerable embryos, such 
as Pax3 mutant embryos. It would be interesting to study the Pax3 and canonical Wnt mutant 
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embryos using markers for the actin cytoskeleton, to observe any changes which may occur. It 
would also potentially be informative to culture Splotch embryos in agents which affect the 
actin cytoskeleton, such as Cytochalasin or Latrunculin to prevent polymerisation of actin. This 
could produce information about the role of the actin cytoskeleton in Pax3-related NTDs. 
It is likely there are a large number of differences in morphology and signalling between cranial 
and spinal NT closure which have not yet been described. Therefore the interaction between 
Pax3 and canonical Wnt signalling may affect one of these processes. Further research into 
closure mechanisms which differ between regions of the NT may help to shed light on the 
process or processes which link the two pathways. 
In addition to previously discussed mechanisms, it is possible that β-catenin LOF and GOF may 
affect adherens junctions in the mutant embryos, which could be responsible for some aspects 
of the phenotype observed. Further study of adherens junctions in these embryos, possibly 
through the use of adherens junction markers, or in vitro cell assays, could provide more 
information about the potential effects of this defect on the mutant embryos. 
 
6.2    Pax3, Canonical Wnt signalling, and the neural crest 
I found that loss of canonical Wnt signalling rescues cranial NTDs in Pax3 mutant embryos. 
Therefore the NC were examined as another Pax3-expressing population of cells which may be 
affected by canonical Wnt signalling. This research has shown that in combination with Pax3 
mutation both β-catenin LOF and GOF appear to reduce the NC population and their derivative 
tissues. 
Research on embryos with β-catenin GOF suggests that in combination with the Pax3 mutation 
β-catenin GOF appears to limit specification and/or expansion of the premigratory population 
of NC, as shown by reduced expression of the NC marker FoxD3 in the spinal region of Pax3Cre/+ 
β-cateninGOF/+ and Pax3Sp2H/Cre β-cateninGOF/+ embryos compared to Pax3+/+ β-catenin+/+ 
embryos. These NC cells also appeared to have higher rates of apoptosis and premature NC 
differentiation. These defects results in massive reduction of NC derivatives, such as the DRG, 
trigeminal ganglia and vagus nerve. 
Data from β-catenin LOF suggests that in combination with Pax3 mutation, reduced canonical 
Wnt signalling also results in a reduction in size or in a failure of NC-derived tissues to develop, 
although the mechanisms behind this were not determined. 
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Together these data show that both LOF and GOF of canonical Wnt signalling cause reduced 
contribution of cells to NC derivative tissues. This suggests that normal development of the NC 
requires carefully balanced canonical Wnt signalling. It would be interesting to see if β-catenin 
LOF had similar effects on differentiation, apoptosis and differentiation in the NC population to 
β-catenin GOF, or if LOF causes reduced NC derivatives through alternative mechanisms. 
Several aspects of the β-catenin LOF and GOF NC phenotypes were very similar. For example, 
both caused complete loss of vagal nerve and trigeminal ganglion development. This data 
suggests that these structures are particularly sensitive to the balance of canonical Wnt 
signalling. 
On the other hand, some aspects of the β-catenin LOF and GOF NC phenotypes differ slightly. 
For instance, both β-catenin LOF and GOF appear to reduce DRG development. However, β-
catenin LOF embryos retain segmentation of the DRG, whereas segmentation is largely lost in 
the DRG of β-catenin GOF embryos. This could suggest that lower levels of canonical Wnt 
signalling are necessary in some areas for the correct segmentation of the DRG, and that the 
higher levels caused by β-catenin GOF makes this impossible. Additionally, β-catenin LOF 
embryos retain a small amount of ErbB3 expression in the DRG at 30+ somite stage, whereas 
β-catenin GOF embryos have lost all ErbB3 expression in the DRG at this stage. Again this could 
suggest that slightly lower levels of canonical Wnt signalling are necessary for DRG 
development. This could be due to the effect of β-catenin GOF on levels of apoptosis or 
differentiation in the DRG, compared to the effect of β-catenin LOF. Alternatively, this could 
suggest that canonical Wnt signalling aids development of the DRG, but is not essential, 
whereas over-activation of signalling inhibits DRG development. This inhibition could be due to 
ectopic activation of downstream targets, or activation of an inhibitory pathway. 
On the other hand, the differences seen in the degree of NC abnormality between β-catenin 
LOF and GOF embryos could be due to the degree of difference in canonical Wnt signalling 
caused by the recombined β-cateninLOF and β-cateninGOF alleles. Recombined β-cateninLOF 
causes a reduction in the NC and the NT, but this was not detectable by RT-qPCR on whole 
embryos. On the other hand, the GOF in canonical Wnt signalling caused by the recombined β-
cateninGOF allele was detectable by RT-qPCR, although present in the same regions. This 
suggests that the recombined β-cateninGOF allele causes a huge increase in canonical Wnt 
signalling of several fold difference. The more severe NC phenotype seen in β-catenin GOF 
embryos could be due to the greater difference in canonical Wnt signalling caused by the β-
cateninGOF allele in comparison to the β-cateninLOF allele. Additionally, β-catenin LOF causes a 
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simple loss of signalling, whereas β-catenin GOF may cause ectopic activation or inhibition of 
downstream targets. 
Determining the cellular causes of the NC defects in embryos with β-catenin LOF and GOF 
could offer more information about whether the defects are different due to the mechanisms 
involved, or whether they are different due to the degree of signalling abnormality. It could 
also provide information on the various cellular effects that can influence NT closure, some of 
which could be relevant to corresponding birth defects in humans. If I had more time, I would 
like to isolate and culture NC cells from the different genotypes, including embryos with β-
catenin LOF and GOF. These cultures could be used to study a number of cellular processes, 
including proliferation, differentiation, apoptosis and migration. Comparison of these 
processes between the genotypes could indicate the cellular processes which are abnormal in 
Pax3 mutant embryos, as well as those with β-catenin LOF and GOF. It could also indicate if 
there is an interaction between Pax3 and the canonical Wnt signalling pathway in the 
development of the NC. 
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